1	Journal	NNP	O	Journal	_	0	SENT_1	[p1l1300t81r1430b113],
2	of	IN	O	of	_	0	SENT_1	[p1l1443t81r1478b109],
3	Surgical	NNP	O	Surgical	nn	4	SENT_1	[p1l1488t81r1626b117],
4	Oncology	NNP	O	Oncology	prep_of	1	SENT_1	[p1l1640t81r1799b117],
5	2008	CD	DATE	2008	num	4	SENT_1	[p1l1812t81r2100b116],
6	;	:	O	;	_	0	SENT_1	[p1l1812t81r2100b116],
7	98:130	CD	NUMBER	98:130	num	8	SENT_1	[p1l1812t81r2100b116],
8	—	NN	O	—	dep	1	SENT_1	[p1l1812t81r2100b116],
9	134	CD	NUMBER	134	dep	8	SENT_1	[p1l1812t81r2100b116],

1	Dihydropyrimidine	NN	O	dihydropyrimidine	nn	2	SENT_2	[p1l229t192r706b251],
2	Dehydrogenases	NNS	O	dehydrogenase	_	0	SENT_2	[p1l730t192r1139b251],
3	and	CC	O	and	_	0	SENT_2	[p1l1159t192r1248b237],
4	Cytidine-Deaminase	NNP	O	Cytidine-Deaminase	nn	6	SENT_2	[p1l1270t192r1780b251],
5	Gene	NNP	PERSON	Gene	nn	6	SENT_2	[p1l1801t195r1933b237],
6	Polymorphisms	NNP	PERSON	Polymorphisms	conj_and	2	SENT_2	[p1l236t270r617b330],
7	as	IN	O	as	dep	2	SENT_2	[p1l637t286r686b316],
8	Outcome	NNP	O	Outcome	nn	9	SENT_2	[p1l707t273r942b316],
9	Predictors	NNP	O	Predictors	pobj	7	SENT_2	[p1l965t270r1217b316],
10	in	IN	O	in	_	0	SENT_2	[p1l1239t271r1281b315],
11	Resected	NNP	O	Resected	nn	15	SENT_2	[p1l1305t270r1524b316],
12	Gastric	NNP	O	Gastric	nn	15	SENT_2	[p1l1546t271r1727b316],
13	Cancer	NNP	O	Cancer	nn	15	SENT_2	[p1l1747t273r1925b316],
14	Patients	NNPS	O	Patients	nn	15	SENT_2	[p1l260t350r455b394],
15	Treated	NNP	O	Treated	prep_in	9	SENT_2	[p1l474t349r663b394],
16	With	IN	O	with	dep	2	SENT_2	[p1l685t349r807b394],
17	Fluoropyrimidine	NNP	O	Fluoropyrimidine	nn	19	SENT_2	[p1l831t349r1264b408],
18	Adjuvant	NNP	O	Adjuvant	nn	19	SENT_2	[p1l1284t349r1510b405],
19	Chemotherapy	NNP	O	Chemotherapy	pobj	16	SENT_2	[p1l1530t349r1901b408],

1	JUAN	NNP	PERSON	JUAN	nn	5	SENT_3	[p1l339t503r431b535],
2	J.	NNP	PERSON	J.	nn	5	SENT_3	[p1l446t503r466b535],
3	G	NNP	PERSON	G	nn	5	SENT_3	[p1l481t503r594b546],
4	~	NNP	PERSON	~	nn	5	SENT_3	[p1l481t503r594b546],
5	RAU	NNP	PERSON	RAU	_	0	SENT_3	[p1l481t503r594b546],
6	,	,	O	,	_	0	SENT_3	[p1l481t503r594b546],
7	MD	NNP	O	MD	appos	5	SENT_3	[p1l608t511r659b536],
8	,	,	O	,	_	0	SENT_3	[p1l608t511r659b536],
9	N10	NN	O	n10	appos	5	SENT_3	[p1l674t496r742b546],
10	,	,	O	,	_	0	SENT_3	[p1l674t496r742b546],
11	]	CD	NUMBER	]	num	13	SENT_3	[p1l674t496r742b546],
12	MIGUEL	NNP	PERSON	MIGUEL	nn	13	SENT_3	[p1l760t503r899b530],
13	CABALLERO	NNP	PERSON	CABALLERO	appos	9	SENT_3	[p1l912t503r1128b536],
14	,	,	O	,	_	0	SENT_3	[p1l912t503r1128b536],
15	MD	NNP	O	MD	nn	21	SENT_3	[p1l1142t511r1193b536],
16	,	,	O	,	_	0	SENT_3	[p1l1142t511r1193b536],
17	pro	JJ	O	pro	amod	21	SENT_3	[p1l1208t495r1296b536],
18	,	,	O	,	_	0	SENT_3	[p1l1208t495r1296b536],
19	”	JJ	O	”	amod	21	SENT_3	[p1l1208t495r1296b536],
20	MARIANO	NNP	PERSON	MARIANO	nn	21	SENT_3	[p1l1310t503r1487b530],
21	MoNzo	NNP	PERSON	MoNzo	appos	9	SENT_3	[p1l1500t493r1655b536],
22	,	,	O	,	_	0	SENT_3	[p1l1500t493r1655b536],
23	MD	NNP	O	MD	appos	9	SENT_3	[p1l1669t511r1720b536],
24	,	,	O	,	_	0	SENT_3	[p1l1669t511r1720b536],
25	mo	NN	DURATION	mo	appos	9	SENT_3	[p1l1735t496r1807b536],
26	,	,	O	,	_	0	SENT_3	[p1l1735t496r1807b536],
27	“	IN	O	“	dep	5	SENT_3	[p1l1735t496r1807b536],

1	CARMEN	NNP	PERSON	CARMEN	nn	2	SENT_4	[p1l266t548r416b575],
2	MUNOZ	NNP	PERSON	MUNOZ	_	0	SENT_4	[p1l431t548r736b582],
3	.	.	O	.	_	0	SENT_4	[p1l431t548r736b582],

1	—	NN	O	—	_	0	SENT_5	[p1l431t548r736b582],
2	.	.	O	.	_	0	SENT_5	[p1l431t548r736b582],

1	GARClA	NNP	O	GARClA	nn	5	SENT_6	[p1l431t548r736b582],
2	,	,	O	,	_	0	SENT_6	[p1l431t548r736b582],
3	PhD	NNP	O	PhD	appos	5	SENT_6	[p1l750t541r822b582],
4	,2	CD	NUMBER	,2	num	5	SENT_6	[p1l750t541r822b582],
5	JOSE	NNP	O	JOSE	_	0	SENT_6	[p1l836t548r915b581],
6	DOMINGO-DOMENECH	NN	O	domingo-domenech	dep	5	SENT_6	[p1l930t541r1435b582],
7	,	,	O	,	_	0	SENT_6	[p1l930t541r1435b582],
8	MD	NN	O	md	nn	11	SENT_6	[p1l930t541r1435b582],
9	,1	CD	NUMBER	,1	num	11	SENT_6	[p1l930t541r1435b582],
10	ALFONS	NNP	PERSON	ALFONS	nn	11	SENT_6	[p1l1452t548r1592b575],
11	NAVARRO	NNP	PERSON	NAVARRO	appos	6	SENT_6	[p1l1607t548r1794b582],
12	,	,	O	,	_	0	SENT_6	[p1l1607t548r1794b582],
13	PhD	NNP	O	PhD	appos	6	SENT_6	[p1l1808t541r1880b582],
14	,2	CD	NUMBER	,2	num	13	SENT_6	[p1l1808t541r1880b582],

1	CARLOS	NNP	PERSON	CARLOS	nn	2	SENT_7	[p1l443t594r582b622],
2	CONILL	NNP	PERSON	CONILL	_	0	SENT_7	[p1l595t594r738b628],
3	,	,	O	,	_	0	SENT_7	[p1l595t594r738b628],
4	MD	NNP	O	MD	nn	7	SENT_7	[p1l752t587r819b628],
5	,3	CD	NUMBER	,3	num	7	SENT_7	[p1l752t587r819b628],
6	MARC	NNP	PERSON	MARC	nn	7	SENT_7	[p1l833t594r936b622],
7	CAMPAYO	NNP	PERSON	CAMPAYO	appos	2	SENT_7	[p1l950t594r1140b628],
8	,	,	O	,	_	0	SENT_7	[p1l950t594r1140b628],
9	MD	NNP	O	MD	appos	2	SENT_7	[p1l1154t587r1217b628],
10	,	,	O	,	_	0	SENT_7	[p1l1154t587r1217b628],
11	‘	CD	NUMBER	‘	appos	9	SENT_7	[p1l1154t587r1217b628],
12	AND	CC	O	and	cc	11	SENT_7	[p1l1234t603r1291b621],
13	lose	VB	O	lose	rcmod	11	SENT_7	[p1l1304t594r1383b627],
14	A.	NN	O	a.	nn	17	SENT_7	[p1l1396t595r1429b622],
15	BOMBl	NNP	O	BOMBl	nn	17	SENT_7	[p1l1445t585r1573b628],
16	,	,	O	,	_	0	SENT_7	[p1l1445t585r1573b628],
17	MD	NNP	O	MD	dobj	13	SENT_7	[p1l1587t603r1639b628],
18	,	,	O	,	_	0	SENT_7	[p1l1587t603r1639b628],
19	PhD4	NN	O	phd4	appos	17	SENT_7	[p1l1653t587r1715b621],

1	’	NN	O	’	nn	3	SENT_8	[p1l341t634r493b673],
2	Oncology	NNP	O	Oncology	nn	3	SENT_8	[p1l341t634r493b673],
3	Department	NNP	O	Department	_	0	SENT_8	[p1l504t641r677b673],
4	,	,	O	,	_	0	SENT_8	[p1l504t641r677b673],
5	Institut	NNP	ORGANIZATION	Institut	nn	9	SENT_8	[p1l692t641r788b665],
6	Clinic	NNP	ORGANIZATION	Clinic	nn	9	SENT_8	[p1l798t639r882b665],
7	de	IN	ORGANIZATION	de	amod	9	SENT_8	[p1l892t639r926b665],
8	Malalties	NNP	ORGANIZATION	Malalties	nn	9	SENT_8	[p1l936t639r1065b665],
9	Hemato-Oncologiques	NNP	ORGANIZATION	Hemato-Oncologiques	dep	3	SENT_8	[p1l1076t639r1400b673],
10	(	CD	NUMBER	(	num	12	SENT_8	[p1l1412t639r1542b667],
11	ICMHO	NN	O	icmho	nn	12	SENT_8	[p1l1412t639r1542b667],
12	}	NN	O	}	dep	9	SENT_8	[p1l1412t639r1542b667],
13	of	IN	O	of	_	0	SENT_8	[p1l1554t639r1585b665],
14	Hospital	NNP	O	Hospital	nn	15	SENT_8	[p1l1592t639r1711b673],
15	Clinic	NNP	O	Clinic	prep_of	12	SENT_8	[p1l1722t639r1811b670],
16	,	,	O	,	_	0	SENT_8	[p1l1722t639r1811b670],

1	IDIBAPS	NN	O	idibap	_	0	SENT_9	[p1l212t678r333b702],
2	(	CD	NUMBER	(	num	1	SENT_9	[p1l345t676r467b710],
3	Augusto	NNP	PERSON	Augusto	nn	6	SENT_9	[p1l345t676r467b710],
4	Pi	NNP	O	Pi	nn	6	SENT_9	[p1l478t678r505b701],
5	i	FW	O	i	nn	6	SENT_9	[p1l517t678r524b701],
6	Sunyer	NNP	ORGANIZATION	Sunyer	dep	1	SENT_9	[p1l534t678r633b710],
7	Memorial	NNP	ORGANIZATION	Memorial	nn	8	SENT_9	[p1l641t676r780b701],
8	Institute	NNP	ORGANIZATION	Institute	dep	6	SENT_9	[p1l791t678r902b701],
9	for	IN	ORGANIZATION	for	_	0	SENT_9	[p1l913t676r952b701],
10	Biomedical	NNP	ORGANIZATION	Biomedical	nn	11	SENT_9	[p1l962t676r1123b701],
11	Research	NNP	ORGANIZATION	Research	prep_for	8	SENT_9	[p1l1134t676r1277b706],
12	)	RB	O	)	advmod	11	SENT_9	[p1l1134t676r1277b706],
13	,	,	O	,	_	0	SENT_9	[p1l1134t676r1277b706],
14	and	CC	O	and	_	0	SENT_9	[p1l1290t676r1344b701],
15	University	NNP	ORGANIZATION	University	prep_for	8	SENT_9	[p1l1356t678r1499b710],
16	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l1509t676r1540b701],
17	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	15	SENT_9	[p1l1547t676r1696b706],
18	,	,	O	,	_	0	SENT_9	[p1l1547t676r1696b706],
19	Barcelona	NNP	ORGANIZATION	Barcelona	nn	21	SENT_9	[p1l1710t676r1858b706],
20	,	,	O	,	_	0	SENT_9	[p1l1710t676r1858b706],
21	Spain	NNP	LOCATION	Spain	dep	1	SENT_9	[p1l1871t678r1949b710],

1	2	CD	NUMBER	2	num	2	SENT_10	[p1l59t708r72b724],
2	Laboratory	NN	O	laboratory	_	0	SENT_10	[p1l75t713r227b747],
3	of	IN	O	of	_	0	SENT_10	[p1l235t713r266b739],
4	Molecular	JJ	O	molecular	amod	5	SENT_10	[p1l270t713r417b739],
5	Biology	NN	O	biology	prep_of	2	SENT_10	[p1l426t713r534b747],
6	of	IN	O	of	_	0	SENT_10	[p1l542t713r573b739],
7	the	DT	O	the	det	8	SENT_10	[p1l579t713r622b739],
8	University	NNP	ORGANIZATION	University	prep_of	5	SENT_10	[p1l634t715r778b747],
9	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l786t713r817b739],
10	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	2	SENT_10	[p1l823t713r971b744],
11	,	,	O	,	_	0	SENT_10	[p1l823t713r971b744],
12	and	CC	O	and	dep	13	SENT_10	[p1l983t713r1037b739],
13	IDIBAPS	NNP	O	IDIBAPS	dep	10	SENT_10	[p1l1046t715r1167b739],
14	(	CD	NUMBER	(	num	13	SENT_10	[p1l1177t713r1300b747],
15	Augusto	NNP	PERSON	Augusto	nn	18	SENT_10	[p1l1177t713r1300b747],
16	Pi	NNP	PERSON	Pi	nn	18	SENT_10	[p1l1309t715r1336b738],
17	i	FW	O	i	nn	18	SENT_10	[p1l1346t715r1354b738],
18	Sunyer	NNP	ORGANIZATION	Sunyer	dep	13	SENT_10	[p1l1363t715r1462b747],
19	Memorial	NNP	ORGANIZATION	Memorial	nn	20	SENT_10	[p1l1469t713r1607b739],
20	Institute	NNP	ORGANIZATION	Institute	dep	18	SENT_10	[p1l1617t715r1727b739],
21	for	IN	ORGANIZATION	for	_	0	SENT_10	[p1l1738t713r1776b739],
22	Biomedical	NNP	ORGANIZATION	Biomedical	nn	23	SENT_10	[p1l1785t713r1946b739],
23	Research	NNP	ORGANIZATION	Research	prep_for	20	SENT_10	[p1l1956t713r2099b744],
24	)	RB	O	)	dep	13	SENT_10	[p1l1956t713r2099b744],
25	,	,	O	,	_	0	SENT_10	[p1l1956t713r2099b744],

1	Barcelona	NNP	ORGANIZATION	Barcelona	_	0	SENT_11	[p1l961t751r1109b781],
2	,	,	O	,	_	0	SENT_11	[p1l961t751r1109b781],
3	Spain	NNP	LOCATION	Spain	appos	1	SENT_11	[p1l1123t752r1200b784],

1	3Radiation	NN	O	3radiation	_	0	SENT_12	[p1l160t783r309b814],
2	Oncology	NNP	ORGANIZATION	Oncology	nn	3	SENT_12	[p1l322t788r463b822],
3	Department	NNP	ORGANIZATION	Department	dep	1	SENT_12	[p1l473t790r642b822],
4	of	IN	ORGANIZATION	of	_	0	SENT_12	[p1l651t788r683b814],
5	Hospital	NNP	ORGANIZATION	Hospital	nn	6	SENT_12	[p1l690t788r808b822],
6	Clinic	NNP	ORGANIZATION	Clinic	prep_of	3	SENT_12	[p1l819t788r909b819],
7	,	,	O	,	_	0	SENT_12	[p1l819t788r909b819],
8	IDIBAPS	NNP	O	IDIBAPS	appos	6	SENT_12	[p1l924t790r1045b814],
9	{	CD	NUMBER	{	num	8	SENT_12	[p1l1056t788r1178b822],
10	Augusto	NNP	O	Augusto	nn	18	SENT_12	[p1l1056t788r1178b822],
11	Pi	NNP	O	Pi	nn	18	SENT_12	[p1l1190t790r1216b813],
12	i	FW	O	i	nn	18	SENT_12	[p1l1228t790r1235b813],
13	Sunyer	NNP	ORGANIZATION	Sunyer	nn	18	SENT_12	[p1l1246t790r1344b822],
14	Memorial	NNP	ORGANIZATION	Memorial	nn	18	SENT_12	[p1l1353t788r1491b814],
15	Institute	NNP	ORGANIZATION	Institute	nn	18	SENT_12	[p1l1502t790r1613b814],
16	for	IN	ORGANIZATION	for	amod	18	SENT_12	[p1l1624t788r1663b814],
17	Biomedical	NNP	ORGANIZATION	Biomedical	nn	18	SENT_12	[p1l1673t788r1834b814],
18	Research	NNP	ORGANIZATION	Research	tmod	8	SENT_12	[p1l1845t788r1988b819],
19	)	RB	O	)	advmod	18	SENT_12	[p1l1845t788r1988b819],
20	,	,	O	,	_	0	SENT_12	[p1l1845t788r1988b819],

1	and	CC	O	and	dep	2	SENT_13	[p1l751t825r805b851],
2	University	NNP	ORGANIZATION	University	_	0	SENT_13	[p1l816t827r960b859],
3	of	IN	ORGANIZATION	of	_	0	SENT_13	[p1l969t825r1001b851],
4	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	2	SENT_13	[p1l1008t825r1156b856],
5	,	,	O	,	_	0	SENT_13	[p1l1008t825r1156b856],
6	Barcelona	NNP	ORGANIZATION	Barcelona	nn	8	SENT_13	[p1l1171t825r1319b856],
7	,	,	O	,	_	0	SENT_13	[p1l1171t825r1319b856],
8	Spain	NNP	LOCATION	Spain	appos	2	SENT_13	[p1l1332t827r1410b859],

1	4Pathology	NNP	O	4Pathology	nn	2	SENT_14	[p1l116t858r272b897],
2	Department	NNP	ORGANIZATION	Department	dep	20	SENT_14	[p1l283t865r452b897],
3	of	IN	ORGANIZATION	of	_	0	SENT_14	[p1l461t863r492b889],
4	Hospital	NNP	ORGANIZATION	Hospital	nn	5	SENT_14	[p1l499t863r618b897],
5	Clinic	NNP	ORGANIZATION	Clinic	prep_of	2	SENT_14	[p1l629t863r719b894],
6	,	,	O	,	_	0	SENT_14	[p1l629t863r719b894],
7	Centre	NNP	O	Centre	nn	10	SENT_14	[p1l733t864r825b889],
8	de	IN	O	de	amod	10	SENT_14	[p1l836t863r870b889],
9	Diagnostic	NNP	O	Diagnostic	nn	10	SENT_14	[p1l882t864r1034b897],
10	Biomedic	NNP	O	Biomedic	appos	5	SENT_14	[p1l1045t863r1180b889],
11	(	CD	NUMBER	(	num	13	SENT_14	[p1l1191t863r1282b894],
12	CDB	NNP	O	CDB	nn	13	SENT_14	[p1l1191t863r1282b894],
13	)	NN	O	)	dep	10	SENT_14	[p1l1191t863r1282b894],
14	,	,	O	,	_	0	SENT_14	[p1l1191t863r1282b894],
15	IDIBAP5	NN	O	idibap5	dep	20	SENT_14	[p1l1297t864r1418b889],
16	(	CD	NUMBER	(	num	15	SENT_14	[p1l1429t863r1552b897],
17	Augusto	NNP	PERSON	Augusto	nn	20	SENT_14	[p1l1429t863r1552b897],
18	Pi	NNP	PERSON	Pi	nn	20	SENT_14	[p1l1563t864r1590b888],
19	i	FW	O	i	nn	20	SENT_14	[p1l1601t864r1609b888],
20	Sunyer	NNP	O	Sunyer	_	0	SENT_14	[p1l1619t864r1718b897],
21	Memorial	NNP	O	Memorial	nn	22	SENT_14	[p1l1726t863r1864b889],
22	Institute	NNP	O	Institute	dep	20	SENT_14	[p1l1876t864r1986b889],
23	for	IN	O	for	dep	20	SENT_14	[p1l1998t863r2036b889],

1	Biomedical	NNP	O	Biomedical	nn	2	SENT_15	[p1l587t900r748b926],
2	Research	NNP	O	Research	_	0	SENT_15	[p1l759t900r902b931],
3	)	RB	O	)	advmod	2	SENT_15	[p1l759t900r902b931],
4	,	,	O	,	_	0	SENT_15	[p1l759t900r902b931],
5	and	CC	O	and	_	0	SENT_15	[p1l915t900r969b926],
6	University	NNP	ORGANIZATION	University	conj_and	2	SENT_15	[p1l981t902r1125b934],
7	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l1134t900r1165b926],
8	Barcelona	NNP	ORGANIZATION	Barcelona	nn	10	SENT_15	[p1l1173t900r1321b931],
9	,	,	O	,	_	0	SENT_15	[p1l1173t900r1321b931],
10	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	6	SENT_15	[p1l1336t900r1483b931],
11	,	,	O	,	_	0	SENT_15	[p1l1336t900r1483b931],
12	Spain	NNP	LOCATION	Spain	dep	2	SENT_15	[p1l1497t902r1574b934],

1	Background	NN	O	background	nsubj	15	SENT_16	[p1l59t1009r243b1041],
2	and	CC	O	and	_	0	SENT_16	[p1l252t1009r308b1034],
3	Objectives	NNS	O	objective	nsubj	15	SENT_16	[p1l317t1009r484b1041],
4	:	:	O	:	_	0	SENT_16	[p1l317t1009r484b1041],
5	Single	JJ	O	single	amod	7	SENT_16	[p1l496t1009r584b1041],
6	nucleotide	NN	O	nucleotide	nn	7	SENT_16	[p1l594t1009r740b1034],
7	polymorphisms	NNS	O	polymorphism	dep	1	SENT_16	[p1l749t1009r967b1041],
8	of	IN	O	of	_	0	SENT_16	[p1l977t1009r1008b1034],
9	dihydropyrimidine	NN	O	dihydropyrimidine	nn	10	SENT_16	[p1l1015t1009r1278b1041],
10	dehydrogenases	NNS	O	dehydrogenase	prep_of	7	SENT_16	[p1l1288t1009r1511b1041],
11	gene	NN	O	gene	nn	14	SENT_16	[p1l1521t1017r1587b1041],
12	(	CD	NUMBER	(	num	14	SENT_16	[p1l1597t1010r1710b1040],
13	DPYD	NN	O	dpyd	nn	14	SENT_16	[p1l1597t1010r1710b1040],
14	)	NN	O	)	dep	1	SENT_16	[p1l1597t1010r1710b1040],
15	induces	VBZ	O	induce	_	0	SENT_16	[p1l1719t1009r1826b1034],
16	dihydropyrimidine	NN	O	dihydropyrimidine	nn	22	SENT_16	[p1l1836t1009r2099b1041],
17	dehydrogenase	NN	O	dehydrogenase	nn	22	SENT_16	[p1l59t1050r269b1083],
18	enzyme	NN	O	enzyme	nn	22	SENT_16	[p1l291t1058r400b1083],
19	(	CD	NUMBER	(	num	22	SENT_16	[p1l422t1051r513b1081],
20	DPD	NN	O	dpd	nn	22	SENT_16	[p1l422t1051r513b1081],
21	)	NN	O	)	nn	22	SENT_16	[p1l422t1051r513b1081],
22	deﬁciency	NN	O	deﬁciency	dobj	15	SENT_16	[p1l535t1050r678b1083],
23	resulting	VBG	O	result	partmod	22	SENT_16	[p1l699t1050r822b1083],
24	in	IN	O	in	_	0	SENT_16	[p1l844t1050r871b1075],
25	increased	VBN	O	increase	amod	26	SENT_16	[p1l892t1050r1025b1075],
26	activity	NN	O	activity	prep_in	23	SENT_16	[p1l1046t1050r1150b1083],
27	of	IN	O	of	_	0	SENT_16	[p1l1172t1050r1202b1075],
28	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	nn	29	SENT_16	[p1l1221t1050r1414b1076],
29	derivatives	NNS	O	derivative	prep_of	26	SENT_16	[p1l1436t1050r1595b1076],
30	.	.	O	.	_	0	SENT_16	[p1l1436t1050r1595b1076],

1	Cytidine	NN	O	cytidine	nn	4	SENT_17	[p1l1618t1050r1899b1083],
2	—	CD	NUMBER	—	num	4	SENT_17	[p1l1618t1050r1899b1083],
3	deaminase	NN	O	deaminase	nn	4	SENT_17	[p1l1618t1050r1899b1083],
4	gene	NN	O	gene	nsubjpass	11	SENT_17	[p1l1921t1058r1986b1083],
5	(	CD	NUMBER	(	num	8	SENT_17	[p1l2009t1051r2099b1081],
6	CDA	NNP	ORGANIZATION	CDA	nn	8	SENT_17	[p1l2009t1051r2099b1081],
7	)	CD	NUMBER	)	num	8	SENT_17	[p1l2009t1051r2099b1081],
8	polymorphisms	NNS	O	polymorphism	dep	4	SENT_17	[p1l58t1092r277b1124],
9	have	VBP	O	have	aux	11	SENT_17	[p1l289t1092r354b1117],
10	been	VBN	O	be	auxpass	11	SENT_17	[p1l365t1092r432b1117],
11	involved	VBN	O	involve	_	0	SENT_17	[p1l443t1092r565b1117],
12	in	IN	O	in	_	0	SENT_17	[p1l576t1092r602b1116],
13	prognosis	NN	O	prognosis	prep_in	11	SENT_17	[p1l613t1092r749b1124],
14	in	IN	O	in	_	0	SENT_17	[p1l761t1092r788b1116],
15	experimental	JJ	O	experimental	amod	16	SENT_17	[p1l800t1092r983b1124],
16	tumours	NNS	O	tumour	prep_in	13	SENT_17	[p1l995t1096r1117b1117],
17	.	.	O	.	_	0	SENT_17	[p1l995t1096r1117b1117],

1	Methods	NNS	O	method	_	0	SENT_18	[p1l58t1133r198b1158],
2	:	:	O	:	_	0	SENT_18	[p1l58t1133r198b1158],
3	Analysis	NN	O	analysis	dep	1	SENT_18	[p1l211t1133r333b1165],
4	of	IN	O	of	_	0	SENT_18	[p1l345t1133r375b1158],
5	50	CD	NUMBER	50	num	10	SENT_18	[p1l384t1133r418b1158],
6	consecutive	JJ	O	consecutive	amod	10	SENT_18	[p1l429t1133r594b1158],
7	resected	JJ	O	resected	amod	10	SENT_18	[p1l604t1133r720b1158],
8	gastric	JJ	O	gastric	amod	10	SENT_18	[p1l731t1133r823b1165],
9	cancer	NN	O	cancer	nn	10	SENT_18	[p1l835t1141r928b1158],
10	patients	NNS	O	patient	prep_of	3	SENT_18	[p1l937t1133r1046b1165],
11	who	WP	O	who	nsubj	12	SENT_18	[p1l1058t1133r1117b1158],
12	received	VBD	O	receive	rcmod	10	SENT_18	[p1l1128t1133r1247b1158],
13	adjuvant	JJ	O	adjuvant	amod	14	SENT_18	[p1l1258t1133r1378b1165],
14	chemotherapy	NN	O	chemotherapy	dobj	12	SENT_18	[p1l1388t1133r1588b1165],
15	with	IN	O	with	_	0	SENT_18	[p1l1599t1133r1661b1158],
16	Tegafur	NN	O	tegafur	prep_with	12	SENT_18	[p1l1671t1133r1781b1165],
17	for	IN	O	for	_	0	SENT_18	[p1l1791t1133r1832b1158],
18	polymorphisms	NNS	O	polymorphism	prep_for	12	SENT_18	[p1l1841t1133r2060b1165],
19	of	IN	O	of	_	0	SENT_18	[p1l2072t1133r2102b1158],
20	genes	NNS	O	gene	prep_of	18	SENT_18	[p1l59t1182r137b1206],
21	DPYDI	NNP	O	DPYDI	nn	23	SENT_18	[p1l156t1174r263b1198],
22	(	CD	NUMBER	(	num	23	SENT_18	[p1l285t1174r363b1204],
23	A/G	NN	O	a/g	dep	20	SENT_18	[p1l285t1174r363b1204],
24	;	:	O	;	_	0	SENT_18	[p1l285t1174r363b1204],
25	Ile543Val	NN	O	ile543val	nn	26	SENT_18	[p1l384t1174r540b1204],
26	)	NN	O	)	dep	20	SENT_18	[p1l384t1174r540b1204],
27	,	,	O	,	_	0	SENT_18	[p1l384t1174r540b1204],
28	DPYD2	NN	O	dpyd2	nn	30	SENT_18	[p1l559t1174r667b1198],
29	(	CD	NUMBER	(	num	30	SENT_18	[p1l688t1174r760b1204],
30	C/T	NN	O	c/t	appos	26	SENT_18	[p1l688t1174r760b1204],
31	;	:	O	;	_	0	SENT_18	[p1l688t1174r760b1204],
32	Arg29Cys	NNS	O	arg29cy	dep	20	SENT_18	[p1l779t1174r934b1206],
33	)	CD	NUMBER	)	num	32	SENT_18	[p1l779t1174r934b1206],
34	and	CC	O	and	_	0	SENT_18	[p1l954t1174r1004b1199],
35	CDA	NNP	O	CDA	nn	37	SENT_18	[p1l1024t1174r1090b1199],
36	(	CD	NUMBER	(	num	37	SENT_18	[p1l1111t1174r1187b1204],
37	A/C	NN	O	a/c	dep	20	SENT_18	[p1l1111t1174r1187b1204],
38	;	:	O	;	_	0	SENT_18	[p1l1111t1174r1187b1204],
39	Lys27Gin	NN	O	lys27gin	nn	40	SENT_18	[p1l1207t1174r1365b1206],
40	)	NN	O	)	dep	20	SENT_18	[p1l1207t1174r1365b1206],
41	.	.	O	.	_	0	SENT_18	[p1l1207t1174r1365b1206],

1	The	DT	O	the	det	2	SENT_19	[p1l1385t1174r1439b1199],
2	status	NN	O	status	nsubjpass	16	SENT_19	[p1l1459t1178r1537b1199],
3	of	IN	O	of	_	0	SENT_19	[p1l1556t1174r1587b1198],
4	alleles	NNS	O	allele	prep_of	2	SENT_19	[p1l1604t1174r1692b1199],
5	(	CD	NUMBER	(	num	8	SENT_19	[p1l1713t1174r1858b1206],
6	wild	JJ	O	wild	amod	8	SENT_19	[p1l1713t1174r1858b1206],
7	—	NN	O	—	nn	8	SENT_19	[p1l1713t1174r1858b1206],
8	type	NN	O	type	dep	4	SENT_19	[p1l1713t1174r1858b1206],
9	or	CC	O	or	_	0	SENT_19	[p1l1877t1182r1906b1199],
10	at	IN	O	at	quantmod	12	SENT_19	[p1l1924t1178r1949b1199],
11	least	JJS	O	least	mwe	10	SENT_19	[p1l1967t1174r2031b1199],
12	one	CD	NUMBER	one	num	14	SENT_19	[p1l2050t1182r2099b1199],
13	polymorphism	NN	O	polymorphism	nn	14	SENT_19	[p1l58t1215r274b1247],
14	)	NN	O	)	conj_or	4	SENT_19	[p1l58t1215r274b1247],
15	was	VBD	O	be	auxpass	16	SENT_19	[p1l287t1223r340b1240],
16	correlated	VBN	O	correlate	_	0	SENT_19	[p1l353t1215r494b1240],
17	with	IN	O	with	_	0	SENT_19	[p1l505t1215r567b1240],
18	outcome	NN	O	outcome	prep_with	16	SENT_19	[p1l579t1219r699b1240],
19	and	CC	O	and	_	0	SENT_19	[p1l712t1215r761b1240],
20	toxicity	NN	O	toxicity	conj_and	18	SENT_19	[p1l773t1215r885b1247],
21	.	.	O	.	_	0	SENT_19	[p1l773t1215r885b1247],

1	Results	NNS	O	result	_	0	SENT_20	[p1l59t1256r177b1281],
2	:	:	O	:	_	0	SENT_20	[p1l59t1256r177b1281],
3	Polymorphisms	NNS	O	polymorphism	nn	4	SENT_20	[p1l187t1256r407b1288],
4	frequencies	NNS	O	frequency	nsubj	7	SENT_20	[p1l416t1256r578b1288],
5	wild	JJ	O	wild	amod	7	SENT_20	[p1l587t1256r932b1288],
6	—	NN	O	—	nn	7	SENT_20	[p1l587t1256r932b1288],
7	type/non	NN	O	type/non	dep	1	SENT_20	[p1l587t1256r932b1288],
8	—	CD	NUMBER	—	num	11	SENT_20	[p1l587t1256r932b1288],
9	wild	JJ	O	wild	amod	11	SENT_20	[p1l587t1256r932b1288],
10	—	NN	O	—	nn	11	SENT_20	[p1l587t1256r932b1288],
11	type	NN	O	type	nsubj	13	SENT_20	[p1l587t1256r932b1288],
12	were	VBD	O	be	cop	13	SENT_20	[p1l940t1264r1007b1281],
13	36/14	CD	NUMBER	36/14	rcmod	7	SENT_20	[p1l1017t1256r1095b1281],
14	in	IN	O	in	_	0	SENT_20	[p1l1104t1256r1131b1280],
15	DPYDI	NNP	O	DPYDI	nn	17	SENT_20	[p1l1138t1256r1245b1280],
16	(	CD	NUMBER	(	num	17	SENT_20	[p1l1257t1256r1332b1286],
17	A/G	NN	O	a/g	prep_in	13	SENT_20	[p1l1257t1256r1332b1286],
18	;	:	O	;	_	0	SENT_20	[p1l1257t1256r1332b1286],
19	Ile543Val	NN	O	ile543val	nn	20	SENT_20	[p1l1341t1256r1497b1286],
20	)	NN	O	)	prep_in	13	SENT_20	[p1l1341t1256r1497b1286],
21	;	:	O	;	_	0	SENT_20	[p1l1341t1256r1497b1286],
22	26/24	CD	NUMBER	26/24	prep_in	13	SENT_20	[p1l1508t1256r1587b1281],
23	in	IN	O	in	_	0	SENT_20	[p1l1595t1256r1622b1280],
24	DPYD2	NN	O	dpyd2	nn	26	SENT_20	[p1l1630t1256r1738b1280],
25	(	CD	NUMBER	(	num	26	SENT_20	[p1l1749t1256r1818b1286],
26	C/T	NN	O	c/t	prep_in	22	SENT_20	[p1l1749t1256r1818b1286],
27	;	:	O	;	_	0	SENT_20	[p1l1749t1256r1818b1286],
28	Arg29Cys	NNS	O	arg29cy	prep_in	13	SENT_20	[p1l1825t1256r1987b1288],
29	)	CD	NUMBER	)	num	28	SENT_20	[p1l1825t1256r1987b1288],
30	;	:	O	;	_	0	SENT_20	[p1l1825t1256r1987b1288],
31	and	CC	O	and	_	0	SENT_20	[p1l1998t1256r2047b1281],
32	17	CD	NUMBER	17	prep_in	13	SENT_20	[p1l2059t1256r2100b1281],
33	/	:	O	/	punct	39	SENT_20	[p1l2059t1256r2100b1281],
34	23	CD	NUMBER	23	dep	39	SENT_20	[p1l59t1296r91b1321],
35	in	IN	O	in	_	0	SENT_20	[p1l102t1296r129b1320],
36	CDA	NNP	O	CDA	prep_in	34	SENT_20	[p1l139t1296r205b1321],
37	(	CD	NUMBER	(	num	39	SENT_20	[p1l216t1296r259b1326],
38	Al	NNP	O	Al	nn	39	SENT_20	[p1l216t1296r259b1326],
39	C	NN	O	c	parataxis	7	SENT_20	[p1l261t1296r290b1325],
40	;	:	O	;	_	0	SENT_20	[p1l261t1296r290b1325],
41	Lys27Gin	NN	O	lys27gin	nsubj	47	SENT_20	[p1l300t1296r447b1328],
42	)	CD	NUMBER	)	num	41	SENT_20	[p1l300t1296r447b1328],
43	or	CC	O	or	_	0	SENT_20	[p1l457t1304r486b1321],
44	between	IN	O	between	amod	45	SENT_20	[p1l494t1296r611b1321],
45	homozygous/heterozygous	JJ	O	homozygous/heterozygous	conj_or	41	SENT_20	[p1l621t1296r998b1328],
46	were	VBD	O	be	cop	47	SENT_20	[p1l1008t1304r1075b1321],
47	39/11	CD	NUMBER	39/11	parataxis	7	SENT_20	[p1l1086t1296r1161b1321],
48	in	IN	O	in	_	0	SENT_20	[p1l1174t1296r1200b1320],
49	DPYDI	NNP	O	DPYDI	prep_in	47	SENT_20	[p1l1209t1296r1316b1320],
50	;	:	O	;	_	0	SENT_20	[p1l1321t1304r1326b1325],
51	33/17	CD	NUMBER	33/17	dep	47	SENT_20	[p1l1338t1296r1416b1321],
52	in	IN	O	in	_	0	SENT_20	[p1l1426t1296r1453b1320],
53	DPYD2	NN	O	dpyd2	prep_in	51	SENT_20	[p1l1461t1296r1569b1320],
54	and	CC	O	and	_	0	SENT_20	[p1l1580t1296r1630b1321],
55	26/24	CD	NUMBER	26/24	parataxis	7	SENT_20	[p1l1639t1296r1718b1321],
56	in	IN	O	in	_	0	SENT_20	[p1l1728t1296r1754b1320],
57	CDA	NNP	ORGANIZATION	CDA	prep_in	55	SENT_20	[p1l1765t1296r1831b1321],
58	respectively	RB	O	respectively	advmod	47	SENT_20	[p1l1841t1296r2015b1328],
59	.	.	O	.	_	0	SENT_20	[p1l1841t1296r2015b1328],

1	After	IN	O	after	mark	6	SENT_21	[p1l2026t1296r2100b1321],
2	77	CD	DURATION	77	num	3	SENT_21	[p1l59t1337r92b1362],
3	months	NNS	NUMBER	month	nsubj	6	SENT_21	[p1l103t1337r206b1362],
4	of	IN	O	of	_	0	SENT_21	[p1l217t1337r248b1362],
5	median	JJ	O	median	prep_of	3	SENT_21	[p1l256t1337r359b1362],
6	follow	VBP	O	follow	advcl	17	SENT_21	[p1l370t1337r507b1369],
7	—	CD	NUMBER	—	number	9	SENT_21	[p1l370t1337r507b1369],
8	up	IN	O	up	quantmod	9	SENT_21	[p1l370t1337r507b1369],
9	(	CD	NUMBER	(	num	10	SENT_21	[p1l519t1337r573b1367],
10	SD	NN	O	sd	dobj	6	SENT_21	[p1l519t1337r573b1367],
11	=	JJ	O	=	amod	10	SENT_21	[p1l582t1348r606b1357],
12	26.3	CD	NUMBER	26.3	num	13	SENT_21	[p1l614t1337r694b1367],
13	)	NN	O	)	dep	11	SENT_21	[p1l614t1337r694b1367],
14	,	,	O	,	_	0	SENT_21	[p1l614t1337r694b1367],
15	18	CD	NUMBER	18	num	16	SENT_21	[p1l709t1337r739b1362],
16	patients	NNS	O	patient	nsubj	17	SENT_21	[p1l750t1337r859b1369],
17	died	VBD	O	die	_	0	SENT_21	[p1l871t1337r931b1362],
18	of	IN	O	of	_	0	SENT_21	[p1l941t1337r972b1362],
19	tumour	NN	O	tumour	nn	20	SENT_21	[p1l980t1341r1082b1362],
20	relapse	NN	O	relapse	prep_of	17	SENT_21	[p1l1091t1337r1198b1369],
21	.	.	O	.	_	0	SENT_21	[p1l1091t1337r1198b1369],

1	Better	RBR	O	better	amod	2	SENT_22	[p1l1211t1337r1297b1362],
2	survival	NN	O	survival	nsubjpass	4	SENT_22	[p1l1308t1337r1418b1362],
3	was	VBD	O	be	auxpass	4	SENT_22	[p1l1429t1345r1482b1362],
4	observed	VBN	O	observe	_	0	SENT_22	[p1l1494t1337r1620b1362],
5	in	IN	O	in	_	0	SENT_22	[p1l1630t1337r1657b1361],
6	DPYDI	NN	O	dpydus	nn	7	SENT_22	[p1l1666t1337r1773b1361],
7	patients	NNS	O	patient	prep_in	4	SENT_22	[p1l1786t1337r1895b1369],
8	only	RB	O	only	advmod	7	SENT_22	[p1l1907t1337r1974b1369],
9	,	,	O	,	_	0	SENT_22	[p1l1907t1337r1974b1369],
10	for	IN	O	for	_	0	SENT_22	[p1l1985t1337r2026b1362],
11	nonwild	JJ	O	nonwild	amod	13	SENT_22	[p1l2036t1345r2099b1362, p1l59t1378r193b1410],
12	—	NN	O	—	nn	13	SENT_22	[p1l2036t1345r2099b1362, p1l59t1378r193b1410],
13	type	NN	O	type	prep_for	4	SENT_22	[p1l2036t1345r2099b1362, p1l59t1378r193b1410],
14	over	IN	O	over	_	0	SENT_22	[p1l211t1386r273b1403],
15	wild	JJ	O	wild	amod	19	SENT_22	[p1l290t1378r424b1410],
16	—	NN	O	—	nn	19	SENT_22	[p1l290t1378r424b1410],
17	type	NN	O	type	nn	19	SENT_22	[p1l290t1378r424b1410],
18	(	CD	NUMBER	(	num	19	SENT_22	[p1l443t1378r475b1408],
19	P	NN	O	p	prep_over	13	SENT_22	[p1l443t1378r475b1408],
20	=	JJ	O	=	advmod	13	SENT_22	[p1l483t1389r507b1398],
21	0.0214	CD	NUMBER	0.0214	num	22	SENT_22	[p1l515t1378r631b1408],
22	)	NN	O	)	dep	20	SENT_22	[p1l515t1378r631b1408],
23	;	:	O	;	_	0	SENT_22	[p1l515t1378r631b1408],
24	and	CC	O	and	_	0	SENT_22	[p1l651t1378r701b1403],
25	in	IN	O	in	_	0	SENT_22	[p1l718t1378r745b1402],
26	patients	NNS	O	patient	prep_in	13	SENT_22	[p1l762t1378r871b1410],
27	with	IN	O	with	_	0	SENT_22	[p1l890t1378r951b1403],
28	one	CD	NUMBER	one	num	32	SENT_22	[p1l970t1386r1019b1403],
29	or	CC	O	or	_	0	SENT_22	[p1l1038t1386r1066b1403],
30	more	JJR	O	more	conj_or	28	SENT_22	[p1l1083t1386r1155b1403],
31	heterozygous	JJ	O	heterozygous	amod	32	SENT_22	[p1l1173t1378r1360b1410],
32	polymorphisms	NNS	O	polymorphism	prep_with	26	SENT_22	[p1l1378t1378r1596b1410],
33	in	IN	O	in	_	0	SENT_22	[p1l1615t1378r1642b1402],
34	any	DT	O	any	prep_in	32	SENT_22	[p1l1660t1386r1709b1410],
35	of	IN	O	of	_	0	SENT_22	[p1l1727t1378r1758b1403],
36	the	DT	O	the	det	38	SENT_22	[p1l1773t1378r1815b1403],
37	three	CD	NUMBER	three	num	38	SENT_22	[p1l1833t1378r1903b1403],
38	genes	NNS	O	gene	prep_of	34	SENT_22	[p1l1921t1386r1999b1410],
39	tested	VBN	O	test	partmod	38	SENT_22	[p1l2018t1378r2100b1403],
40	(	CD	NUMBER	(	num	41	SENT_22	[p1l60t1418r91b1448],
41	P	NN	O	p	dobj	39	SENT_22	[p1l60t1418r91b1448],
42	=	JJ	O	=	amod	41	SENT_22	[p1l99t1429r123b1438],
43	0.0017	CD	NUMBER	0.0017	num	44	SENT_22	[p1l131t1418r246b1448],
44	)	NN	O	)	dep	42	SENT_22	[p1l131t1418r246b1448],
45	.	.	O	.	_	0	SENT_22	[p1l131t1418r246b1448],

1	In	IN	O	in	_	0	SENT_23	[p1l259t1419r288b1442],
2	10	CD	NUMBER	10	num	3	SENT_23	[p1l302t1418r333b1443],
3	pts	NNS	O	pt	prep_in	11	SENT_23	[p1l344t1422r384b1450],
4	(	RB	O	(	advmod	3	SENT_23	[p1l398t1418r483b1448],
5	20	CD	PERCENT	20	number	6	SENT_23	[p1l398t1418r483b1448],
6	%	NN	PERCENT	%	amod	3	SENT_23	[p1l398t1418r483b1448],
7	)	CD	NUMBER	)	num	9	SENT_23	[p1l398t1418r483b1448],
8	total	JJ	O	total	amod	9	SENT_23	[p1l496t1418r557b1443],
9	dose	NN	O	dose	nsubjpass	11	SENT_23	[p1l570t1418r633b1443],
10	was	VBD	O	be	auxpass	11	SENT_23	[p1l644t1426r697b1443],
11	reduced	VBN	O	reduce	ccomp	20	SENT_23	[p1l709t1418r821b1443],
12	by	IN	O	by	_	0	SENT_23	[p1l831t1418r866b1450],
13	toxicity	NN	O	toxicity	agent	11	SENT_23	[p1l878t1418r991b1450],
14	,	,	O	,	_	0	SENT_23	[p1l878t1418r991b1450],
15	only	RB	O	only	quantmod	16	SENT_23	[p1l1004t1418r1065b1450],
16	3	CD	NUMBER	3	nsubj	20	SENT_23	[p1l1078t1418r1092b1443],
17	of	IN	O	of	_	0	SENT_23	[p1l1106t1418r1136b1443],
18	them	PRP	O	they	prep_of	16	SENT_23	[p1l1145t1418r1215b1443],
19	were	VBD	O	be	cop	20	SENT_23	[p1l1227t1426r1294b1443],
20	homozygous	JJ	O	homozygous	_	0	SENT_23	[p1l1306t1418r1492b1450],
21	.	.	O	.	_	0	SENT_23	[p1l1306t1418r1492b1450],

1	Conclusions	NNS	O	conclusion	_	0	SENT_24	[p1l60t1459r249b1485],
2	:	:	O	:	_	0	SENT_24	[p1l60t1459r249b1485],
3	Gene	NNP	PERSON	Gene	nn	4	SENT_24	[p1l265t1459r338b1485],
4	polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_24	[p1l352t1459r571b1492],
5	of	IN	O	of	_	0	SENT_24	[p1l586t1459r616b1484],
6	DPYD	NN	O	dpyd	prep_of	4	SENT_24	[p1l627t1460r719b1484],
7	and	CC	O	and	_	0	SENT_24	[p1l733t1459r783b1484],
8	CDA	NNP	ORGANIZATION	CDA	prep_of	4	SENT_24	[p1l798t1460r864b1485],
9	predict	VBP	O	predict	dep	1	SENT_24	[p1l878t1459r977b1492],
10	survival	NN	O	survival	dobj	9	SENT_24	[p1l992t1459r1102b1484],
11	of	IN	O	of	_	0	SENT_24	[p1l1116t1459r1147b1484],
12	gastric	JJ	O	gastric	amod	14	SENT_24	[p1l1159t1459r1251b1492],
13	cancer	NN	O	cancer	nn	14	SENT_24	[p1l1266t1467r1358b1484],
14	patients	NNS	O	patient	prep_of	10	SENT_24	[p1l1371t1459r1480b1492],
15	treated	VBN	O	treat	partmod	14	SENT_24	[p1l1494t1459r1590b1484],
16	with	IN	O	with	_	0	SENT_24	[p1l1605t1459r1666b1484],
17	5-ﬂuorouracil-based	JJ	O	5-ﬂuorouracil-based	amod	19	SENT_24	[p1l1680t1459r1966b1485],
18	adjuvant	JJ	O	adjuvant	amod	19	SENT_24	[p1l1980t1459r2100b1492],
19	chemotherapy	NN	O	chemotherapy	prep_with	15	SENT_24	[p1l59t1501r263b1533],
20	.	.	O	.	_	0	SENT_24	[p1l59t1501r263b1533],

1	J.	NNP	O	J.	nn	2	SENT_25	[p1l58t1542r79b1568],
2	Surg	NNP	O	Surg	_	0	SENT_25	[p1l95t1542r169b1575],
3	.	.	O	.	_	0	SENT_25	[p1l95t1542r169b1575],

1	Oncol	NN	O	oncol	_	0	SENT_26	[p1l186t1541r281b1568],
2	.	.	O	.	_	0	SENT_26	[p1l186t1541r281b1568],

1	2008	CD	DATE	2008	_	0	SENT_27	[p1l296t1541r575b1571],
2	;	:	O	;	_	0	SENT_27	[p1l296t1541r575b1571],
3	98:130	CD	NUMBER	98:130	number	4	SENT_27	[p1l296t1541r575b1571],
4	-134	CD	NUMBER	-134	dep	1	SENT_27	[p1l296t1541r575b1571],
5	.	.	O	.	_	0	SENT_27	[p1l296t1541r575b1571],

1	©	RB	O	©	advmod	2	SENT_28	[p1l619t1542r645b1567],
2	2008	CD	DATE	2008	_	0	SENT_28	[p1l660t1541r732b1567],
3	Wiley-Liss	NNP	O	Wiley-Liss	dep	2	SENT_28	[p1l745t1541r918b1575],
4	,	,	O	,	_	0	SENT_28	[p1l745t1541r918b1575],
5	Inc.	NNP	ORGANIZATION	Inc.	appos	3	SENT_28	[p1l931t1542r985b1567],
6	.	.	O	.	_	0	SENT_28	[p1l931t1542r985b1567],

1	KEY	JJ	O	key	amod	2	SENT_29	[p1l139t1649r207b1677],
2	WORDS	NNS	O	word	_	0	SENT_29	[p1l220t1649r345b1678],
3	:	:	O	:	_	0	SENT_29	[p1l220t1649r345b1678],
4	dihydropyrimidine	NN	O	dihydropyrimidine	dep	2	SENT_29	[p1l369t1649r686b1685],
5	dehydrogenases	NNS	O	dehydrogenase	dep	4	SENT_29	[p1l699t1649r975b1685],
6	;	:	O	;	_	0	SENT_29	[p1l699t1649r975b1685],
7	cytidine-deaminase	NN	O	cytidine-deaminase	dep	4	SENT_29	[p1l990t1649r1325b1685],
8	;	:	O	;	_	0	SENT_29	[p1l990t1649r1325b1685],
9	polymorphisms	NNS	O	polymorphism	dep	7	SENT_29	[p1l1340t1649r1610b1685],
10	;	:	O	;	_	0	SENT_29	[p1l1340t1649r1610b1685],
11	gastric	JJ	O	gastric	amod	12	SENT_29	[p1l1625t1649r1738b1685],
12	cancer	NN	O	cancer	dep	4	SENT_29	[p1l1751t1658r1873b1684],
13	;	:	O	;	_	0	SENT_29	[p1l1751t1658r1873b1684],
14	Tegafur	NNP	O	Tegafur	dep	12	SENT_29	[p1l1888t1649r2019b1685],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_30	[p1l707t1846r1449b1913],

1	Gastric	JJ	O	gastric	amod	2	SENT_31	[p1l103t2006r318b2059],
2	cancer	NN	O	cancer	nsubj	4	SENT_31	[p1l353t2023r550b2059],
3	is	VBZ	O	be	cop	4	SENT_31	[p1l582t2006r629b2059],
4	one	CD	NUMBER	one	_	0	SENT_31	[p1l665t2023r771b2059],
5	of	IN	O	of	_	0	SENT_31	[p1l806t2006r871b2059],
6	the	DT	O	the	det	10	SENT_31	[p1l898t2006r989b2059],
7	most	RBS	O	most	advmod	8	SENT_31	[p1l1023t2014r1169b2059],
8	common	JJ	O	common	amod	10	SENT_31	[p1l1202t2023r1466b2059],
9	fatal	JJ	O	fatal	amod	10	SENT_31	[p1l1499t2006r1632b2059],
10	types	NNS	O	type	prep_of	4	SENT_31	[p1l1666t2014r1822b2075],
11	of	IN	O	of	_	0	SENT_31	[p1l1858t2006r1923b2059],
12	cancer	NN	O	cancer	prep_of	10	SENT_31	[p1l1952t2023r2149b2059],
13	around	IN	O	around	_	0	SENT_31	[p1l10t2094r218b2147],
14	the	DT	O	the	det	15	SENT_31	[p1l240t2094r331b2147],
15	world	NN	O	world	prep_around	12	SENT_31	[p1l354t2094r544b2148],
16	.	.	O	.	_	0	SENT_31	[p1l354t2094r544b2148],

1	The	DT	O	the	det	3	SENT_32	[p1l571t2094r687b2147],
2	standard	JJ	O	standard	amod	3	SENT_32	[p1l714t2094r967b2147],
3	treatment	NN	O	treatment	nsubj	13	SENT_32	[p1l990t2102r1277b2147],
4	for	IN	O	for	_	0	SENT_32	[p1l1300t2094r1388b2147],
5	locally	RB	O	locally	advmod	6	SENT_32	[p1l1410t2094r1615b2163],
6	advanced	VBN	O	advance	amod	8	SENT_32	[p1l1641t2094r1924b2147],
7	gastric	JJ	O	gastric	amod	8	SENT_32	[p1l1948t2094r2147b2163],
8	cancer	NN	O	cancer	prep_for	3	SENT_32	[p1l9t2199r206b2236],
9	is	VBZ	O	be	cop	13	SENT_32	[p1l227t2182r275b2236],
10	partial	JJ	O	partial	amod	13	SENT_32	[p1l298t2182r491b2251],
11	or	CC	O	or	_	0	SENT_32	[p1l515t2199r577b2236],
12	total	JJ	O	total	conj_or	10	SENT_32	[p1l598t2183r732b2236],
13	gastrectomy	NN	O	gastrectomy	_	0	SENT_32	[p1l756t2190r1124b2251],
14	with	IN	O	with	_	0	SENT_32	[p1l1148t2182r1281b2236],
15	regional	JJ	O	regional	amod	16	SENT_32	[p1l1302t2182r1550b2251],
16	lymphadenectomy	NN	O	lymphadenectomy	prep_with	13	SENT_32	[p1l1573t2182r2144b2251],
17	.	.	O	.	_	0	SENT_32	[p1l1573t2182r2144b2251],

1	Most	RBS	O	most	advmod	4	SENT_33	[p1l8t2271r162b2323],
2	common	JJ	O	common	amod	4	SENT_33	[p1l199t2287r463b2323],
3	adjuvant	JJ	O	adjuvant	amod	4	SENT_33	[p1l501t2270r759b2339],
4	treatments	NNS	O	treatment	nsubj	7	SENT_33	[p1l795t2278r1109b2323],
5	are	VBP	O	be	cop	7	SENT_33	[p1l1150t2287r1238b2323],
6	postoperative	JJ	O	postoperative	amod	7	SENT_33	[p1l1275t2270r1682b2339],
7	chemotherapy	NN	O	chemotherapy	_	0	SENT_33	[p1l1719t2270r2147b2339],
8	based	VBN	O	base	_	0	SENT_33	[p1l7t2358r179b2411],
9	on	IN	O	on	prepc_based_on	7	SENT_33	[p1l211t2375r284b2411],
10	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	nn	13	SENT_33	[p1l315t2358r730b2412],
11	(	CD	NUMBER	(	num	13	SENT_33	[p1l764t2358r967b2424],
12	5-FU	NN	O	5-fu	nn	13	SENT_33	[p1l764t2358r967b2424],
13	)	NN	O	)	pobj	7	SENT_33	[p1l764t2358r967b2424],
14	plus	CC	O	plus	prep	13	SENT_33	[p1l999t2358r1123b2427],
15	radiotherapy	NN	O	radiotherapy	nn	16	SENT_33	[p1l1155t2358r1538b2427],
16	[	NN	O	[	dep	14	SENT_33	[p1l1575t2359r1651b2423],
17	1	CD	NUMBER	1	number	18	SENT_33	[p1l1575t2359r1651b2423],
18	]	CD	NUMBER	]	dep	16	SENT_33	[p1l1575t2359r1651b2423],
19	or	CC	O	or	_	0	SENT_33	[p1l1688t2375r1750b2411],
20	neoadjuvant	JJ	O	neoadjuvant	amod	23	SENT_33	[p1l1779t2358r2149b2427],
21	and	CC	O	and	_	0	SENT_33	[p1l10t2447r117b2500],
22	adjuvant	JJ	O	adjuvant	conj_and	20	SENT_33	[p1l148t2446r405b2515],
23	chemotherapy	NN	O	chemotherapy	dep	14	SENT_33	[p1l435t2446r863b2515],
24	without	IN	O	without	_	0	SENT_33	[p1l894t2446r1125b2500],
25	radiotherapy	NN	O	radiotherapy	nn	26	SENT_33	[p1l1153t2447r1536b2515],
26	[	NN	O	[	prep_without	23	SENT_33	[p1l1572t2447r1668b2511],
27	2	CD	NUMBER	2	num	28	SENT_33	[p1l1572t2447r1668b2511],
28	]	NN	O	]	dep	23	SENT_33	[p1l1572t2447r1668b2511],
29	.	.	O	.	_	0	SENT_33	[p1l1572t2447r1668b2511],

1	We	PRP	O	we	nsubj	3	SENT_34	[p1l1702t2448r1800b2500],
2	previously	RB	DATE	previously	advmod	3	SENT_34	[p1l1829t2446r2148b2515],
3	reported	VBD	O	report	_	0	SENT_34	[p1l7t2535r260b2603],
4	an	DT	O	a	det	5	SENT_34	[p1l298t2551r366b2588],
5	increase	NN	O	increase	dobj	3	SENT_34	[p1l403t2534r650b2588],
6	of	IN	O	of	_	0	SENT_34	[p1l689t2534r754b2588],
7	survival	NN	O	survival	prep_of	5	SENT_34	[p1l788t2534r1025b2588],
8	in	IN	O	in	_	0	SENT_34	[p1l1063t2534r1120b2587],
9	resected	JJ	O	resected	amod	12	SENT_34	[p1l1155t2535r1405b2588],
10	gastric	JJ	O	gastric	amod	12	SENT_34	[p1l1442t2534r1640b2603],
11	cancer	NN	O	cancer	nn	12	SENT_34	[p1l1680t2551r1877b2588],
12	patients	NNS	O	patient	prep_in	3	SENT_34	[p1l1912t2535r2146b2603],
13	treated	VBN	O	treat	partmod	12	SENT_34	[p1l8t2622r214b2675],
14	with	IN	O	with	_	0	SENT_34	[p1l243t2622r376b2676],
15	adjuvant	JJ	O	adjuvant	amod	17	SENT_34	[p1l406t2622r663b2691],
16	ﬂuropyrimidine-based	JJ	O	ﬂuropyrimidine-based	amod	17	SENT_34	[p1l693t2622r1365b2691],
17	chemotherapy	NN	O	chemotherapy	prep_with	13	SENT_34	[p1l1395t2622r1822b2691],
18	in	IN	O	in	_	0	SENT_34	[p1l1852t2622r1909b2675],
19	a	DT	O	a	det	25	SENT_34	[p1l1939t2639r1970b2675],
20	short	JJ	O	short	amod	25	SENT_34	[p1l2001t2622r2149b2675],
21	randomised	JJ	O	randomised	amod	25	SENT_34	[p1l7t2710r361b2763],
22	study	NN	O	study	nn	25	SENT_34	[p1l394t2710r553b2779],
23	[	NN	O	[	nn	25	SENT_34	[p1l590t2711r686b2775],
24	3	CD	NUMBER	3	num	25	SENT_34	[p1l590t2711r686b2775],
25	]	NN	O	]	prep_in	17	SENT_34	[p1l590t2711r686b2775],
26	.	.	O	.	_	0	SENT_34	[p1l590t2711r686b2775],

1	Despite	IN	O	despite	_	0	SENT_35	[p1l720t2710r950b2779],
2	the	DT	O	the	det	4	SENT_35	[p1l981t2710r1072b2763],
3	multidisciplinary	JJ	O	multidisciplinary	amod	4	SENT_35	[p1l1103t2710r1621b2779],
4	approach	NN	O	approach	prep_despite	11	SENT_35	[p1l1654t2710r1929b2779],
5	nearly	RB	O	nearly	quantmod	6	SENT_35	[p1l1959t2710r2147b2779],
6	50	CD	PERCENT	50	num	7	SENT_35	[p1l9t2798r142b2852],
7	%	NN	PERCENT	%	npadvmod	4	SENT_35	[p1l9t2798r142b2852],
8	of	IN	O	of	_	0	SENT_35	[p1l168t2798r234b2852],
9	these	DT	O	these	det	10	SENT_35	[p1l251t2799r405b2852],
10	patients	NNS	O	patient	prep_of	4	SENT_35	[p1l428t2799r662b2867],
11	died	VBD	O	die	_	0	SENT_35	[p1l687t2798r816b2852],
12	from	IN	O	from	_	0	SENT_35	[p1l838t2798r985b2852],
13	tumour	NN	O	tumour	nn	14	SENT_35	[p1l1007t2807r1226b2852],
14	relapse	NN	O	relapse	prep_from	11	SENT_35	[p1l1246t2799r1460b2867],
15	or	CC	O	or	_	0	SENT_35	[p1l1485t2815r1546b2852],
16	metastasis	NN	O	metastasis	conj_or	14	SENT_35	[p1l1567t2798r1877b2852],
17	within	IN	O	within	_	0	SENT_35	[p1l1901t2798r2094b2852],
18	a	DT	O	a	det	21	SENT_35	[p1l2117t2815r2149b2852],
19	5-year	JJ	DURATION	5-year	amod	21	SENT_35	[p1l9t2886r202b2955],
20	period	NN	O	period	nn	21	SENT_35	[p1l224t2886r418b2955],
21	[	NN	O	[	prep_within	11	SENT_35	[p1l448t2887r632b2951],
22	1	CD	NUMBER	1	num	25	SENT_35	[p1l448t2887r632b2951],
23	—	NN	O	—	nn	25	SENT_35	[p1l448t2887r632b2951],
24	3	CD	NUMBER	3	num	25	SENT_35	[p1l448t2887r632b2951],
25	]	NN	O	]	nsubj	11	SENT_35	[p1l448t2887r632b2951],
26	.	.	O	.	_	0	SENT_35	[p1l448t2887r632b2951],

1	A	DT	O	a	det	3	SENT_36	[p1l101t2975r154b3027],
2	challenging	JJ	O	challenging	amod	3	SENT_36	[p1l187t2974r539b3043],
3	ﬁeld	NN	O	ﬁeld	nsubj	8	SENT_36	[p1l574t2974r706b3027],
4	in	IN	O	in	_	0	SENT_36	[p1l738t2974r795b3027],
5	pharmacogenomics	NNS	O	pharmacogenomic	prep_in	3	SENT_36	[p1l826t2974r1416b3043],
6	is	VBZ	O	be	cop	8	SENT_36	[p1l1450t2974r1497b3027],
7	the	DT	O	the	det	8	SENT_36	[p1l1531t2974r1622b3027],
8	identiﬁcation	NN	O	identiﬁcation	_	0	SENT_36	[p1l1655t2974r2055b3027],
9	of	IN	O	of	_	0	SENT_36	[p1l2088t2974r2153b3027],
10	patients	NNS	O	patient	prep_of	8	SENT_36	[p1l7t3062r241b3131],
11	that	WDT	O	that	nsubj	13	SENT_36	[p1l271t3063r385b3116],
12	are	VBP	O	be	cop	13	SENT_36	[p1l413t3079r502b3116],
13	likely	JJ	O	likely	rcmod	10	SENT_36	[p1l532t3062r703b3131],
14	to	TO	O	to	aux	16	SENT_36	[p1l732t3071r788b3116],
15	be	VB	O	be	auxpass	16	SENT_36	[p1l816t3063r887b3116],
16	beneﬁt	VBN	O	beneﬁt	xcomp	13	SENT_36	[p1l915t3062r1122b3116],
17	from	IN	O	from	_	0	SENT_36	[p1l1149t3062r1295b3116],
18	adjuvant	JJ	O	adjuvant	amod	20	SENT_36	[p1l1324t3063r1582b3131],
19	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	nn	20	SENT_36	[p1l1611t3062r2146b3131],
20	—	NN	O	—	prep_from	16	SENT_36	[p1l1611t3062r2146b3131],
21	based	VBN	O	base	partmod	20	SENT_36	[p1l7t3151r179b3204],
22	chemotherapy	NN	O	chemotherapy	dobj	21	SENT_36	[p1l200t3151r639b3219],
23	.	.	O	.	_	0	SENT_36	[p1l200t3151r639b3219],

1	This	DT	O	this	det	2	SENT_37	[p1l662t3151r794b3204],
2	identiﬁcation	NN	O	identiﬁcation	nsubjpass	5	SENT_37	[p1l815t3151r1216b3204],
3	has	VBZ	O	have	aux	5	SENT_37	[p1l1235t3151r1333b3204],
4	been	VBN	O	be	auxpass	5	SENT_37	[p1l1353t3151r1496b3204],
5	studied	VBN	O	study	_	0	SENT_37	[p1l1519t3151r1734b3204],
6	previously	RB	DATE	previously	advmod	5	SENT_37	[p1l1752t3151r2070b3219],
7	in	IN	O	in	_	0	SENT_37	[p1l2090t3151r2148b3203],
8	patients	NNS	O	patient	prep_in	5	SENT_37	[p1l7t3238r241b3307],
9	treated	VBN	O	treat	partmod	8	SENT_37	[p1l268t3238r474b3291],
10	with	IN	O	with	_	0	SENT_37	[p1l498t3238r632b3292],
11	5-FU	NN	O	5-fu	prep_with	9	SENT_37	[p1l657t3238r814b3292],
12	for	IN	O	for	_	0	SENT_37	[p1l839t3238r926b3291],
13	metastatic	JJ	O	metastatic	amod	18	SENT_37	[p1l950t3238r1256b3291],
14	colorectal	JJ	O	colorectal	amod	18	SENT_37	[p1l1283t3238r1581b3291],
15	cancer	NN	O	cancer	nn	18	SENT_37	[p1l1607t3255r1805b3291],
16	[	NN	O	[	nn	18	SENT_37	[p1l1834t3239r1930b3303],
17	4	CD	NUMBER	4	num	18	SENT_37	[p1l1834t3239r1930b3303],
18	]	NN	O	]	prep_for	11	SENT_37	[p1l1834t3239r1930b3303],
19	.	.	O	.	_	0	SENT_37	[p1l1834t3239r1930b3303],

1	Dihydropyrimidine	NN	O	dihydropyrimidine	nn	2	SENT_38	[p1l101t3326r686b3395],
2	dehydrogenase	NN	O	dehydrogenase	nsubj	11	SENT_38	[p1l723t3327r1175b3395],
3	(	CD	NUMBER	(	num	5	SENT_38	[p1l1213t3327r1408b3392],
4	DPD	NN	O	dpd	nn	5	SENT_38	[p1l1213t3327r1408b3392],
5	)	NN	O	)	dep	2	SENT_38	[p1l1213t3327r1408b3392],
6	is	VBZ	O	be	cop	11	SENT_38	[p1l1445t3326r1493b3380],
7	the	DT	O	the	det	11	SENT_38	[p1l1529t3327r1620b3380],
8	initial	JJ	O	initial	amod	11	SENT_38	[p1l1656t3326r1832b3380],
9	and	CC	O	and	_	0	SENT_38	[p1l1869t3326r1976b3380],
10	ratelimiting	JJ	O	ratelimiting	amod	11	SENT_38	[p1l2010t3334r2146b3380, p1l8t3415r247b3483],
11	enzyme	NN	O	enzyme	_	0	SENT_38	[p1l266t3431r500b3483],
12	in	IN	O	in	_	0	SENT_38	[p1l519t3415r577b3467],
13	the	DT	O	the	det	14	SENT_38	[p1l595t3415r686b3468],
14	catabolism	NN	O	catabolism	prep_in	11	SENT_38	[p1l705t3415r1033b3468],
15	of	IN	O	of	_	0	SENT_38	[p1l1051t3415r1117b3468],
16	5	CD	NUMBER	5	prep_of	14	SENT_38	[p1l1131t3415r1288b3468],
17	.	.	O	.	_	0	SENT_38	[p1l1131t3415r1288b3468],

1	—	NN	O	—	_	0	SENT_39	[p1l1131t3415r1288b3468],
2	.	.	O	.	_	0	SENT_39	[p1l1131t3415r1288b3468],

1	FU	NNP	O	FU	_	0	SENT_40	[p1l1131t3415r1288b3468],
2	catalysing	VBG	O	catalyse	partmod	1	SENT_40	[p1l1307t3415r1611b3483],
3	the	DT	O	the	det	4	SENT_40	[p1l1631t3415r1721b3468],
4	conversion	NN	O	conversion	dobj	2	SENT_40	[p1l1741t3415r2069b3468],
5	of	IN	O	of	_	0	SENT_40	[p1l2088t3415r2153b3468],
6	5	CD	NUMBER	5	prep_of	4	SENT_40	[p1l9t3502r166b3556],
7	.	.	O	.	_	0	SENT_40	[p1l9t3502r166b3556],

1	—	NN	O	—	_	0	SENT_41	[p1l9t3502r166b3556],
2	.	.	O	.	_	0	SENT_41	[p1l9t3502r166b3556],

1	FU	NNP	O	FU	nsubj	3	SENT_42	[p1l9t3502r166b3556],
2	to	TO	O	to	aux	3	SENT_42	[p1l191t3511r247b3556],
3	ﬂuoro	VB	O	ﬂuoro	_	0	SENT_42	[p1l273t3503r1006b3571],
4	—	CD	NUMBER	—	number	5	SENT_42	[p1l273t3503r1006b3571],
5	5,6	CD	NUMBER	5,6	num	7	SENT_42	[p1l273t3503r1006b3571],
6	—	NN	O	—	nn	7	SENT_42	[p1l273t3503r1006b3571],
7	dihydrouracil	NN	O	dihydrouracil	dobj	3	SENT_42	[p1l273t3503r1006b3571],
8	[	CD	NUMBER	[	number	9	SENT_42	[p1l1037t3503r1133b3567],
9	5	CD	NUMBER	5	dep	7	SENT_42	[p1l1037t3503r1133b3567],
10	]	NN	O	]	dep	9	SENT_42	[p1l1037t3503r1133b3567],
11	.	.	O	.	_	0	SENT_42	[p1l1037t3503r1133b3567],

1	Thymidylate	NNP	O	Thymidylate	nn	2	SENT_43	[p1l101t3590r488b3659],
2	synthase	NN	O	synthase	nsubj	6	SENT_43	[p1l519t3591r775b3659],
3	is	VBZ	O	be	cop	6	SENT_43	[p1l804t3590r851b3644],
4	an	DT	O	a	det	6	SENT_43	[p1l881t3607r950b3644],
5	important	JJ	O	important	amod	6	SENT_43	[p1l977t3591r1272b3659],
6	enzyme	NN	O	enzyme	_	0	SENT_43	[p1l1299t3607r1533b3659],
7	in	IN	O	in	_	0	SENT_43	[p1l1561t3590r1619b3643],
8	the	DT	O	the	det	9	SENT_43	[p1l1646t3591r1737b3644],
9	inhibition	NN	O	inhibition	prep_in	6	SENT_43	[p1l1765t3590r2060b3644],
10	of	IN	O	of	_	0	SENT_43	[p1l2088t3590r2153b3644],
11	cellular	JJ	O	cellular	amod	12	SENT_43	[p1l9t3679r236b3732],
12	proliferation	NN	O	proliferation	prep_of	9	SENT_43	[p1l273t3679r653b3747],
13	by	IN	O	by	_	0	SENT_43	[p1l691t3679r765b3747],
14	5-FU	NN	O	5-fu	prep_by	12	SENT_43	[p1l807t3679r978b3732],
15	.	.	O	.	_	0	SENT_43	[p1l807t3679r978b3732],

1	Cytidine	NN	O	cytidine	nn	4	SENT_44	[p1l1022t3679r1628b3747],
2	—	CD	NUMBER	—	num	4	SENT_44	[p1l1022t3679r1628b3747],
3	deaminase	NN	O	deaminase	nn	4	SENT_44	[p1l1022t3679r1628b3747],
4	enzyme	NN	O	enzyme	_	0	SENT_44	[p1l1669t3695r1902b3747],
5	(	CD	NUMBER	(	dep	4	SENT_44	[p1l1945t3679r2146b3744],
6	CDA	NNP	O	CDA	dep	4	SENT_44	[p1l1945t3679r2146b3744],
7	)	CD	NUMBER	)	num	6	SENT_44	[p1l1945t3679r2146b3744],

1	©	RB	O	©	advmod	32	SENT_45	[p2l13t45r72b103],
2	2008	CD	DATE	2008	num	5	SENT_45	[p2l108t44r274b103],
3	Wiley-Liss	NNP	O	Wiley-Liss	nn	5	SENT_45	[p2l306t44r709b119],
4	,	,	O	,	_	0	SENT_45	[p2l306t44r709b119],
5	Inc.	NNP	ORGANIZATION	Inc.	nsubj	32	SENT_45	[p2l741t45r875b103],
6	could	MD	O	could	aux	7	SENT_45	[p2l9t138r176b191],
7	inﬂuence	VB	O	inﬂuence	rcmod	5	SENT_45	[p2l212t138r489b191],
8	the	DT	O	the	det	9	SENT_45	[p2l526t138r617b191],
9	activity	NN	O	activity	dobj	7	SENT_45	[p2l656t138r880b207],
10	of	IN	O	of	_	0	SENT_45	[p2l918t138r984b191],
11	thymidylate	NN	O	thymidylate	nn	12	SENT_45	[p2l1015t138r1378b207],
12	synthase	NN	O	synthase	prep_of	9	SENT_45	[p2l1418t138r1674b207],
13	increasing	VBG	O	increase	dep	7	SENT_45	[p2l1712t138r2022b207],
14	the	DT	O	the	det	15	SENT_45	[p2l2060t138r2151b191],
15	production	NN	O	production	dobj	13	SENT_45	[p2l7t225r336b294],
16	of	IN	O	of	_	0	SENT_45	[p2l386t225r452b278],
17	deoxy-uridine	JJ	O	deoxy-uridine	amod	18	SENT_45	[p2l497t225r921b294],
18	monophosphate	NN	O	monophosphate	prep_of	15	SENT_45	[p2l972t225r1451b294],
19	from	IN	O	from	_	0	SENT_45	[p2l1501t225r1648b278],
20	deoxy-cytidine	JJ	O	deoxy-cytidine	amod	21	SENT_45	[p2l1698t225r2151b294],
21	monophosphate	NN	O	monophosphate	prep_from	13	SENT_45	[p2l8t314r487b382],
22	and	CC	O	and	_	0	SENT_45	[p2l514t314r621b367],
23	increasing	VBG	O	increase	conj_and	13	SENT_45	[p2l644t314r954b383],
24	the	DT	O	the	det	25	SENT_45	[p2l980t314r1070b367],
25	incorporation	NN	O	incorporation	dobj	23	SENT_45	[p2l1095t314r1504b382],
26	of	IN	O	of	_	0	SENT_45	[p2l1529t314r1594b367],
27	uridine	NN	O	uridine	prep_of	25	SENT_45	[p2l1612t314r1826b367],
28	into	IN	O	into	_	0	SENT_45	[p2l1851t314r1967b367],
29	DNA	NN	O	dna	nn	31	SENT_45	[p2l1992t314r2152b367],
30	cytosine	NN	O	cytosine	nn	31	SENT_45	[p2l9t401r259b470],
31	groups	NNS	O	group	prep_into	23	SENT_45	[p2l284t418r486b470],
32	[	VBP	O	[	_	0	SENT_45	[p2l518t401r671b465],
33	6,7	CD	NUMBER	6,7	number	34	SENT_45	[p2l518t401r671b465],
34	]	CD	NUMBER	]	dobj	32	SENT_45	[p2l518t401r671b465],
35	.	.	O	.	_	0	SENT_45	[p2l518t401r671b465],

1	The	DT	O	the	det	3	SENT_46	[p2l102t490r218b543],
2	gene	NN	O	gene	nn	3	SENT_46	[p2l247t507r388b559],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	13	SENT_46	[p2l417t490r887b559],
4	of	IN	O	of	_	0	SENT_46	[p2l919t490r984b543],
5	DPD	NN	O	dpd	nn	7	SENT_46	[p2l1007t491r1156b542],
6	(	CD	NUMBER	(	num	7	SENT_46	[p2l1188t491r1423b555],
7	DPYD	NN	O	dpyd	prep_of	3	SENT_46	[p2l1188t491r1423b555],
8	,	,	O	,	_	0	SENT_46	[p2l1188t491r1423b555],
9	names	NNS	O	name	appos	7	SENT_46	[p2l1455t507r1646b543],
10	of	IN	O	of	_	0	SENT_46	[p2l1678t490r1743b543],
11	enzymes	NNS	O	enzyme	prep_of	9	SENT_46	[p2l1767t507r2030b559],
12	are	VBP	O	be	auxpass	13	SENT_46	[p2l2062t507r2151b543],
13	abbreviated	VBN	O	abbreviate	conj_and	13	SENT_46	[p2l10t578r361b631],
14	in	IN	O	in	_	0	SENT_46	[p2l388t578r445b630],
15	capital	NN	O	capital	nn	16	SENT_46	[p2l472t578r673b647],
16	letters	NNS	O	letter	prep_in	13	SENT_46	[p2l700t578r884b631],
17	and	CC	O	and	_	0	SENT_46	[p2l914t578r1020b631],
18	the	DT	O	the	det	21	SENT_46	[p2l1047t578r1138b631],
19	corresponding	JJ	O	corresponding	amod	21	SENT_46	[p2l1165t578r1597b646],
20	gene	NN	O	gene	nn	21	SENT_46	[p2l1626t594r1767b646],
21	polymorphisms	NNS	O	polymorphism	prep_in	13	SENT_46	[p2l1793t578r2149b646, p2l8t666r144b719],
22	in	IN	O	in	_	0	SENT_46	[p2l185t666r243b718],
23	cursive	JJ	O	cursive	amod	26	SENT_46	[p2l282t666r498b719],
24	capital	NN	O	capital	nn	26	SENT_46	[p2l538t666r738b735],
25	letters	NNS	O	letter	nn	26	SENT_46	[p2l779t666r986b731],
26	)	NN	O	)	prep_in	21	SENT_46	[p2l779t666r986b731],
27	and	CC	O	and	_	0	SENT_46	[p2l1030t666r1137b719],
28	CDA	NNP	ORGANIZATION	CDA	conj_and	16	SENT_46	[p2l1177t666r1332b719],
29	(	CD	NUMBER	(	num	31	SENT_46	[p2l1374t667r1567b732],
30	CDA	NNP	ORGANIZATION	CDA	nn	31	SENT_46	[p2l1374t667r1567b732],
31	)	NN	O	)	nsubj	33	SENT_46	[p2l1374t667r1567b732],
32	can	MD	O	can	aux	33	SENT_46	[p2l1610t683r1713b719],
33	modiﬁed	VB	O	modiﬁed	rcmod	28	SENT_46	[p2l1752t666r2022b719],
34	the	DT	O	the	det	35	SENT_46	[p2l2060t666r2151b719],
35	activity	NN	O	activity	dobj	33	SENT_46	[p2l10t754r233b823],
36	of	IN	O	of	_	0	SENT_46	[p2l271t754r336b807],
37	theses	DT	O	theses	det	38	SENT_46	[p2l367t754r550b807],
38	enzymes	NNS	O	enzyme	prep_of	35	SENT_46	[p2l588t771r850b823],
39	and	CC	O	and	_	0	SENT_46	[p2l889t754r996b807],
40	as	IN	O	as	_	0	SENT_46	[p2l1033t771r1091b807],
41	a	DT	O	a	det	42	SENT_46	[p2l1130t771r1161b807],
42	consequence	NN	O	consequence	prep_as	13	SENT_46	[p2l1197t771r1583b823],
43	the	DT	O	the	det	44	SENT_46	[p2l1620t754r1711b807],
44	outcome	NN	O	outcome	dep	42	SENT_46	[p2l1748t762r2007b807],
45	and	CC	O	and	_	0	SENT_46	[p2l2045t754r2152b807],
46	toxicity	NN	O	toxicity	prep_as	13	SENT_46	[p2l8t841r239b910],
47	of	IN	O	of	_	0	SENT_46	[p2l263t841r329b894],
48	patients	NNS	O	patient	prep_of	46	SENT_46	[p2l346t841r581b910],
49	treated	VBN	O	treat	partmod	48	SENT_46	[p2l605t841r811b894],
50	with	IN	O	with	_	0	SENT_46	[p2l835t841r968b894],
51	chemotherapy	NN	O	chemotherapy	prep_with	49	SENT_46	[p2l991t841r1431b910],
52	.	.	O	.	_	0	SENT_46	[p2l991t841r1431b910],

1	We	PRP	O	we	nsubj	2	SENT_47	[p2l1457t842r1556b894],
2	analysed	VBD	O	analyse	_	0	SENT_47	[p2l1581t841r1844b910],
3	the	DT	O	the	det	4	SENT_47	[p2l1867t841r1957b894],
4	effect	NN	O	effect	nsubj	10	SENT_47	[p2l1982t841r2152b894],
5	of	IN	O	of	_	0	SENT_47	[p2l9t930r74b983],
6	genetic	JJ	O	genetic	amod	9	SENT_47	[p2l89t930r305b998],
7	single	JJ	O	single	amod	9	SENT_47	[p2l328t930r504b998],
8	nucleotide	NN	O	nucleotide	nn	9	SENT_47	[p2l524t930r839b983],
9	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_47	[p2l858t930r1328b998],
10	(	VBP	O	(	ccomp	2	SENT_47	[p2l1351t930r1562b995],
11	SNPS	NN	O	snp	nn	12	SENT_47	[p2l1351t930r1562b995],
12	)	NN	O	)	dobj	10	SENT_47	[p2l1351t930r1562b995],
13	of	IN	O	of	_	0	SENT_47	[p2l1584t930r1649b983],
14	DPYD	NN	O	dpyd	prep_of	12	SENT_47	[p2l1661t932r1859b982],
15	and	CC	O	and	_	0	SENT_47	[p2l1879t930r1986b983],
16	CDA	NNP	ORGANIZATION	CDA	conj_and	12	SENT_47	[p2l2008t931r2149b983],
17	in	IN	O	in	_	0	SENT_47	[p2l8t1018r66b1070],
18	patients	NNS	O	patient	prep_in	16	SENT_47	[p2l89t1018r324b1087],
19	with	IN	O	with	_	0	SENT_47	[p2l351t1018r484b1071],
20	resected	JJ	O	resected	amod	22	SENT_47	[p2l507t1018r757b1071],
21	gastric	JJ	O	gastric	amod	22	SENT_47	[p2l782t1018r981b1087],
22	cancer	NN	O	cancer	prep_with	18	SENT_47	[p2l1008t1035r1206b1071],
23	and	CC	O	and	_	0	SENT_47	[p2l1231t1018r1338b1071],
24	treated	VBN	O	treat	conj_and	10	SENT_47	[p2l1362t1018r1569b1071],
25	with	IN	O	with	_	0	SENT_47	[p2l1593t1018r1726b1071],
26	adjuvant	JJ	O	adjuvant	amod	28	SENT_47	[p2l1752t1018r2011b1087],
27	oral	JJ	O	oral	amod	28	SENT_47	[p2l2036t1018r2151b1071],
28	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	prep_with	24	SENT_47	[p2l9t1105r538b1174],
29	,	,	O	,	_	0	SENT_47	[p2l9t1105r538b1174],
30	Tegafur	NNP	O	Tegafur	appos	28	SENT_47	[p2l559t1105r804b1174],
31	.	.	O	.	_	0	SENT_47	[p2l559t1105r804b1174],

1	This	DT	O	this	det	2	SENT_48	[p2l826t1105r958b1158],
2	study	NN	O	study	nsubj	5	SENT_48	[p2l980t1105r1140b1174],
3	is	VBZ	O	be	cop	5	SENT_48	[p2l1159t1105r1206b1158],
4	the	DT	O	the	det	5	SENT_48	[p2l1225t1105r1316b1158],
5	ﬁrst	NN	O	ﬁrst	_	0	SENT_48	[p2l1336t1105r1451b1158],
6	that	WDT	O	that	nsubj	7	SENT_48	[p2l1468t1105r1581b1158],
7	compare	VBP	O	compare	rcmod	5	SENT_48	[p2l1599t1122r1859b1174],
8	CDA	NNP	ORGANIZATION	CDA	nn	11	SENT_48	[p2l1882t1106r2023b1159],
9	and	CC	O	and	_	0	SENT_48	[p2l2045t1105r2152b1158],
10	DPYD	NNP	O	DPYD	nn	11	SENT_48	[p2l7t1195r204b1246],
11	polymorphisms	NNS	O	polymorphism	dobj	7	SENT_48	[p2l239t1193r711b1262],
12	with	IN	O	with	_	0	SENT_48	[p2l750t1193r883b1246],
13	the	DT	O	the	det	14	SENT_48	[p2l919t1193r1010b1246],
14	outcome	NN	O	outcome	prep_with	7	SENT_48	[p2l1048t1202r1307b1246],
15	of	IN	O	of	_	0	SENT_48	[p2l1346t1193r1412b1246],
16	gastric	JJ	O	gastric	amod	18	SENT_48	[p2l1445t1193r1643b1262],
17	cancer	NN	O	cancer	nn	18	SENT_48	[p2l1682t1210r1880b1246],
18	patients	NNS	O	patient	prep_of	14	SENT_48	[p2l1915t1193r2150b1262],
19	treated	VBN	O	treat	partmod	18	SENT_48	[p2l8t1282r214b1335],
20	with	IN	O	with	_	0	SENT_48	[p2l239t1282r373b1335],
21	adjuvant	JJ	O	adjuvant	amod	22	SENT_48	[p2l399t1282r657b1351],
22	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	prep_with	19	SENT_48	[p2l682t1282r1194b1351],
23	based	VBN	O	base	partmod	22	SENT_48	[p2l1219t1282r1392b1335],
24	chemotherapy	NN	O	chemotherapy	dobj	23	SENT_48	[p2l1417t1282r1857b1351],
25	.	.	O	.	_	0	SENT_48	[p2l1417t1282r1857b1351],

1	*	NN	O	*	nn	2	SENT_49	[p2l12t1448r506b1513],
2	Correspondence	NN	O	correspondence	_	0	SENT_49	[p2l12t1448r506b1513],
3	to	TO	O	to	_	0	SENT_49	[p2l547t1455r616b1498],
4	:	:	O	:	_	0	SENT_49	[p2l547t1455r616b1498],
5	Miguel	NNP	PERSON	Miguel	nn	14	SENT_49	[p2l662t1448r867b1513],
6	Caballero	NNP	PERSON	Caballero	nn	14	SENT_49	[p2l909t1448r1199b1507],
7	,	,	O	,	_	0	SENT_49	[p2l909t1448r1199b1507],
8	MD	NNP	O	MD	appos	14	SENT_49	[p2l1243t1449r1371b1507],
9	,	,	O	,	_	0	SENT_49	[p2l1243t1449r1371b1507],
10	PhD	NNP	O	PhD	appos	14	SENT_49	[p2l1414t1448r1555b1507],
11	,	,	O	,	_	0	SENT_49	[p2l1414t1448r1555b1507],
12	Medical	NNP	ORGANIZATION	Medical	appos	14	SENT_49	[p2l1598t1448r1831b1498],
13	Oncology	NNP	ORGANIZATION	Oncology	nn	14	SENT_49	[p2l1873t1448r2152b1513],
14	Department	NNP	ORGANIZATION	Department	prep_to	2	SENT_49	[p2l8t1529r359b1593],
15	,	,	O	,	_	0	SENT_49	[p2l8t1529r359b1593],
16	Hospital	NNP	ORGANIZATION	Hospital	nn	18	SENT_49	[p2l410t1527r650b1593],
17	Clinic	NNP	ORGANIZATION	Clinic	nn	18	SENT_49	[p2l698t1528r869b1578],
18	Barcelona	NNP	ORGANIZATION	Barcelona	appos	14	SENT_49	[p2l918t1528r1222b1587],
19	,	,	O	,	_	0	SENT_49	[p2l918t1528r1222b1587],
20	Villarroel	NNP	LOCATION	Villarroel	nn	21	SENT_49	[p2l1271t1528r1545b1578],
21	Street	NNP	LOCATION	Street	appos	14	SENT_49	[p2l1594t1528r1758b1578],
22	170	CD	NUMBER	170	num	21	SENT_49	[p2l1812t1528r1925b1587],
23	,	,	O	,	_	0	SENT_49	[p2l1812t1528r1925b1587],
24	08036	CD	NUMBER	08036	num	21	SENT_49	[p2l1976t1527r2151b1578],
25	Barcelona	NNP	ORGANIZATION	Barcelona	nn	27	SENT_49	[p2l8t1607r312b1667],
26	,	,	O	,	_	0	SENT_49	[p2l8t1607r312b1667],
27	Spain	NNP	LOCATION	Spain	dep	21	SENT_49	[p2l340t1607r513b1672],
28	.	.	O	.	_	0	SENT_49	[p2l340t1607r513b1672],

1	Fax	NN	O	fax	_	0	SENT_50	[p2l539t1608r660b1657],
2	:	:	O	:	_	0	SENT_50	[p2l539t1608r660b1657],
3	34-932275454	CD	NUMBER	34-932275454	dep	1	SENT_50	[p2l690t1607r1116b1658],
4	.	.	O	.	_	0	SENT_50	[p2l690t1607r1116b1658],

1	E-mail	NN	O	e-mail	_	0	SENT_51	[p2l1142t1607r1351b1657],
2	:	:	O	:	_	0	SENT_51	[p2l1142t1607r1351b1657],
3	mcaba@clinic.ub.es	NNS	O	mcaba@clinic.ub.es	dep	1	SENT_51	[p2l1380t1607r1953b1658],
4	Received	VBN	O	receive	partmod	3	SENT_51	[p2l8t1697r272b1747],
5	8	CD	DATE	8	dobj	4	SENT_51	[p2l297t1697r325b1747],
6	January	NNP	DATE	January	tmod	4	SENT_51	[p2l350t1698r571b1762],
7	2008	CD	DATE	2008	num	6	SENT_51	[p2l596t1697r752b1756],
8	;	:	O	;	_	0	SENT_51	[p2l596t1697r752b1756],
9	Accepted	JJ	O	accepted	amod	10	SENT_51	[p2l779t1697r1048b1762],
10	5	CD	DATE	5	dep	3	SENT_51	[p2l1072t1696r1101b1747],
11	May	NNP	DATE	May	tmod	10	SENT_51	[p2l1128t1698r1256b1762],
12	2008	CD	DATE	2008	num	11	SENT_51	[p2l1281t1697r1418b1747],
13	DOI	NNP	O	DOI	dep	3	SENT_51	[p2l8t1785r133b1835],
14	10.1002	CD	NUMBER	10.1002	num	13	SENT_51	[p2l163t1785r684b1850],
15	/	:	O	/	punct	16	SENT_51	[p2l163t1785r684b1850],
16	jso	NN	O	jso	dep	13	SENT_51	[p2l163t1785r684b1850],
17	.21096	CD	NUMBER	.21096	num	16	SENT_51	[p2l163t1785r684b1850],
18	Published	VBN	O	publish	partmod	13	SENT_51	[p2l8t1874r289b1924],
19	online	NN	O	online	prep	18	SENT_51	[p2l312t1874r488b1924],
20	6	CD	DATE	6	dep	19	SENT_51	[p2l513t1874r544b1925],
21	June	NNP	DATE	June	tmod	18	SENT_51	[p2l568t1875r697b1925],
22	2008	CD	DATE	2008	num	21	SENT_51	[p2l722t1875r859b1925],
23	in	IN	O	in	_	0	SENT_51	[p2l885t1874r939b1924],
24	Wiley	NNP	ORGANIZATION	Wiley	nn	25	SENT_51	[p2l961t1874r1132b1939],
25	InterScience	NNP	ORGANIZATION	InterScience	prep_in	18	SENT_51	[p2l1156t1874r1512b1925],
26	(	CD	NUMBER	(	num	27	SENT_51	[p2l10t1954r891b2019],
27	www.interscience.wiley.com	NNP	O	www.interscience.wiley.com	dep	25	SENT_51	[p2l10t1954r891b2019],
28	)	CD	NUMBER	)	num	27	SENT_51	[p2l10t1954r891b2019],
29	.	.	O	.	_	0	SENT_51	[p2l10t1954r891b2019],

1	METHODS	NNS	O	method	_	0	SENT_52	[p2l840t2180r1314b2248],

1	Patients	NNS	O	patient	_	0	SENT_53	[p2l925t2343r1230b2406],

1	Main	NNP	O	Main	nn	3	SENT_54	[p2l102t2500r261b2553],
2	inclusion	NN	O	inclusion	nn	3	SENT_54	[p2l287t2500r564b2553],
3	criteria	NNS	O	criterion	nsubj	4	SENT_54	[p2l592t2500r806b2553],
4	consisted	VBD	O	consist	_	0	SENT_54	[p2l833t2500r1113b2553],
5	of	IN	O	of	_	0	SENT_54	[p2l1140t2500r1206b2553],
6	consecutive	JJ	O	consecutive	amod	7	SENT_54	[p2l1228t2500r1583b2553],
7	patients	NNS	O	patient	prep_of	4	SENT_54	[p2l1609t2500r1843b2568],
8	that	IN	O	that	complm	23	SENT_54	[p2l1871t2500r1984b2553],
9	after	IN	O	after	dep	23	SENT_54	[p2l2012t2500r2149b2553],
10	totally	RB	O	totally	advmod	12	SENT_54	[p2l8t2588r201b2657],
11	surgical	JJ	O	surgical	amod	12	SENT_54	[p2l234t2588r468b2657],
12	resection	NN	O	resection	nsubjpass	23	SENT_54	[p2l498t2588r772b2641],
13	of	IN	O	of	_	0	SENT_54	[p2l803t2588r868b2641],
14	gastric	JJ	O	gastric	amod	15	SENT_54	[p2l893t2588r1092b2657],
15	adenocarcinoma	NN	O	adenocarcinoma	prep_of	12	SENT_54	[p2l1125t2588r1637b2651],
16	,	,	O	,	_	0	SENT_54	[p2l1125t2588r1637b2651],
17	stages	NNS	O	stage	nn	18	SENT_54	[p2l1672t2596r1852b2657],
18	Ib	NN	O	ib	appos	12	SENT_54	[p2l1883t2588r1943b2641],
19	to	TO	O	to	_	0	SENT_54	[p2l1974t2596r2030b2641],
20	IV	CD	NUMBER	iv	prep_to	18	SENT_54	[p2l2061t2589r2146b2651],
21	,	,	O	,	_	0	SENT_54	[p2l2061t2589r2146b2651],
22	were	VBD	O	be	auxpass	23	SENT_54	[p2l9t2692r153b2729],
23	treated	VBN	O	treat	ccomp	4	SENT_54	[p2l176t2676r382b2729],
24	with	IN	O	with	_	0	SENT_54	[p2l405t2675r538b2729],
25	adjuvant	JJ	O	adjuvant	amod	26	SENT_54	[p2l561t2675r819b2744],
26	chemotherapy	NN	O	chemotherapy	prep_with	23	SENT_54	[p2l842t2676r1270b2744],
27	in	IN	O	in	_	0	SENT_54	[p2l1293t2676r1351b2728],
28	a	DT	O	a	det	30	SENT_54	[p2l1374t2692r1406b2729],
29	single	JJ	O	single	amod	30	SENT_54	[p2l1429t2675r1606b2744],
30	institution	NN	O	institution	prep_in	26	SENT_54	[p2l1629t2675r1951b2729],
31	.	.	O	.	_	0	SENT_54	[p2l1629t2675r1951b2729],

1	Other	JJ	O	other	amod	3	SENT_55	[p2l1979t2676r2150b2729],
2	inclusion	NN	O	inclusion	nn	3	SENT_55	[p2l8t2764r285b2817],
3	criteria	NNS	O	criterion	nsubj	4	SENT_55	[p2l307t2764r521b2817],
4	were	VBD	O	be	_	0	SENT_55	[p2l541t2780r702b2817],
5	:	:	O	:	_	0	SENT_55	[p2l541t2780r702b2817],
6	good	JJ	O	good	amod	8	SENT_55	[p2l729t2764r879b2832],
7	general	JJ	O	general	amod	8	SENT_55	[p2l900t2764r1121b2833],
8	condition	NN	O	condition	dep	29	SENT_55	[p2l1143t2764r1444b2827],
9	,	,	O	,	_	0	SENT_55	[p2l1143t2764r1444b2827],
10	no	DT	O	no	det	13	SENT_55	[p2l1468t2780r1541b2817],
11	concomitant	JJ	O	concomitant	amod	13	SENT_55	[p2l1563t2764r1938b2817],
12	severe	JJ	O	severe	amod	13	SENT_55	[p2l1961t2780r2149b2817],
13	disease	NN	O	disease	appos	8	SENT_55	[p2l9t2853r242b2916],
14	,	,	O	,	_	0	SENT_55	[p2l9t2853r242b2916],
15	appropriate	JJ	O	appropriate	amod	16	SENT_55	[p2l284t2853r627b2922],
16	hepatic	JJ	O	hepatic	amod	8	SENT_55	[p2l666t2853r901b2922],
17	,	,	O	,	_	0	SENT_55	[p2l666t2853r901b2922],
18	renal	JJ	O	renal	dep	29	SENT_55	[p2l941t2853r1092b2906],
19	and	CC	O	and	_	0	SENT_55	[p2l1132t2853r1239b2906],
20	bone	NN	O	bone	nn	22	SENT_55	[p2l1275t2853r1422b2906],
21	marrow	NN	O	marrow	nn	22	SENT_55	[p2l1461t2870r1693b2906],
22	function	NN	O	function	conj_and	8	SENT_55	[p2l1732t2853r1999b2916],
23	,	,	O	,	_	0	SENT_55	[p2l1732t2853r1999b2916],
24	and	CC	O	and	_	0	SENT_55	[p2l2042t2853r2149b2906],
25	more	JJR	DURATION	more	mwe	26	SENT_55	[p2l8t2957r162b2993],
26	than	IN	DURATION	than	quantmod	27	SENT_55	[p2l187t2940r317b2993],
27	18	CD	DURATION	18	num	28	SENT_55	[p2l349t2941r412b2993],
28	years	NNS	NUMBER	year	dep	29	SENT_55	[p2l440t2957r596b3009],
29	old	JJ	DURATION	old	parataxis	4	SENT_55	[p2l624t2940r733b2993],
30	.	.	O	.	_	0	SENT_55	[p2l624t2940r733b2993],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_56	[p2l102t3029r405b3082],
2	criteria	NNS	O	criterion	nsubj	3	SENT_56	[p2l436t3029r650b3082],
3	were	VBD	O	be	_	0	SENT_56	[p2l681t3045r841b3082],
4	:	:	O	:	_	0	SENT_56	[p2l681t3045r841b3082],
5	active	JJ	O	active	amod	6	SENT_56	[p2l880t3029r1057b3082],
6	infection	NN	O	infection	dobj	3	SENT_56	[p2l1087t3029r1373b3092],
7	,	,	O	,	_	0	SENT_56	[p2l1087t3029r1373b3092],
8	pregnancy	NN	O	pregnancy	dobj	3	SENT_56	[p2l1406t3045r1732b3097],
9	,	,	O	,	_	0	SENT_56	[p2l1406t3045r1732b3097],
10	uncontrolled	JJ	O	uncontrolled	amod	12	SENT_56	[p2l1765t3029r2149b3082],
11	arterial	JJ	O	arterial	amod	12	SENT_56	[p2l10t3117r222b3170],
12	hypertension	NN	O	hypertension	conj_or	6	SENT_56	[p2l251t3117r659b3186],
13	,	,	O	,	_	0	SENT_56	[p2l251t3117r659b3186],
14	heart	NN	O	heart	nn	15	SENT_56	[p2l691t3117r843b3170],
15	illness	NN	O	illness	dobj	3	SENT_56	[p2l871t3117r1080b3180],
16	,	,	O	,	_	0	SENT_56	[p2l871t3117r1080b3180],
17	symptomatic	JJ	O	symptomatic	amod	18	SENT_56	[p2l1115t3117r1502b3186],
18	neuropathy	NN	O	neuropathy	dobj	3	SENT_56	[p2l1534t3117r1873b3186],
19	or	CC	O	or	_	0	SENT_56	[p2l1904t3134r1966b3170],
20	other	JJ	O	other	amod	23	SENT_56	[p2l1995t3117r2150b3170],
21	additional	JJ	O	additional	amod	23	SENT_56	[p2l10t3205r310b3258],
22	malignant	JJ	O	malignant	amod	23	SENT_56	[p2l336t3205r640b3274],
23	tumours	NNS	O	tumour	dobj	3	SENT_56	[p2l664t3213r909b3258],
24	in	IN	O	in	_	0	SENT_56	[p2l936t3205r993b3257],
25	other	JJ	O	other	amod	26	SENT_56	[p2l1019t3205r1174b3258],
26	sites	NNS	O	site	prep_in	23	SENT_56	[p2l1199t3205r1345b3258],
27	.	.	O	.	_	0	SENT_56	[p2l1199t3205r1345b3258],

1	Before	IN	O	before	_	0	SENT_57	[p2l102t3292r306b3345],
2	adjuvant	JJ	O	adjuvant	amod	3	SENT_57	[p2l337t3292r595b3361],
3	chemotherapy	NN	O	chemotherapy	prep_before	7	SENT_57	[p2l624t3292r1064b3361],
4	,	,	O	,	_	0	SENT_57	[p2l624t3292r1064b3361],
5	all	DT	O	all	det	6	SENT_57	[p2l1097t3292r1169b3345],
6	patients	NNS	O	patient	nsubj	7	SENT_57	[p2l1198t3292r1432b3361],
7	underwent	VBD	O	undergo	_	0	SENT_57	[p2l1462t3292r1782b3345],
8	a	DT	O	a	det	11	SENT_57	[p2l1811t3309r1842b3345],
9	complete	JJ	O	complete	amod	11	SENT_57	[p2l1871t3292r2148b3361],
10	clinical	JJ	O	clinical	amod	11	SENT_57	[p2l9t3381r231b3434],
11	history	NN	O	history	nsubjpass	26	SENT_57	[p2l252t3381r461b3450],
12	and	CC	O	and	_	0	SENT_57	[p2l485t3381r592b3434],
13	physical	JJ	O	physical	amod	14	SENT_57	[p2l613t3381r864b3450],
14	examination	NN	O	examination	nsubjpass	26	SENT_57	[p2l888t3381r1277b3444],
15	,	,	O	,	_	0	SENT_57	[p2l888t3381r1277b3444],
16	including	VBG	O	include	nsubjpass	26	SENT_57	[p2l1302t3381r1587b3450],
17	routine	JJ	O	routine	amod	18	SENT_57	[p2l1609t3381r1823b3434],
18	haematology	NN	O	haematology	pobj	16	SENT_57	[p2l1845t3381r2146b3434, p2l9t3486r119b3538],
19	and	CC	O	and	_	0	SENT_57	[p2l141t3469r247b3522],
20	biochemistry	NN	O	biochemistry	nn	21	SENT_57	[p2l265t3469r661b3538],
21	analyses	NNS	O	analysis	conj_and	18	SENT_57	[p2l683t3469r935b3538],
22	and	CC	O	and	_	0	SENT_57	[p2l957t3469r1064b3522],
23	pathological	JJ	O	pathological	amod	24	SENT_57	[p2l1082t3469r1457b3538],
24	analysis	NN	O	analysis	conj_and	18	SENT_57	[p2l1479t3469r1718b3538],
25	was	VBD	O	be	auxpass	26	SENT_57	[p2l1740t3486r1854b3522],
26	reviewed	VBN	O	review	ccomp	7	SENT_57	[p2l1873t3469r2149b3522],
27	for	IN	O	for	_	0	SENT_57	[p2l8t3556r96b3609],
28	deﬁnitive	JJ	O	deﬁnitive	amod	29	SENT_57	[p2l120t3556r402b3609],
29	staging	NN	O	staging	prep_for	26	SENT_57	[p2l429t3556r659b3625],
30	.	.	O	.	_	0	SENT_57	[p2l429t3556r659b3625],

1	All	DT	O	all	det	2	SENT_58	[p2l102t3645r197b3697],
2	patients	NNS	O	patient	nsubjpass	4	SENT_58	[p2l254t3645r489b3713],
3	were	VBD	O	be	auxpass	4	SENT_58	[p2l550t3661r694b3698],
4	treated	VBN	O	treat	_	0	SENT_58	[p2l754t3645r960b3698],
5	with	IN	O	with	_	0	SENT_58	[p2l1019t3645r1151b3698],
6	adjuvant	JJ	O	adjuvant	amod	7	SENT_58	[p2l1211t3645r1469b3713],
7	chemotherapy	NN	O	chemotherapy	prep_with	4	SENT_58	[p2l1527t3645r1955b3713],
8	with	IN	O	with	_	0	SENT_58	[p2l2015t3645r2148b3698],
9	Mitomycin	NN	O	mitomycin	nn	10	SENT_58	[p2l8t3733r345b3802],
10	C	NN	O	c	prep_with	7	SENT_58	[p2l372t3733r436b3796],
11	,	,	O	,	_	0	SENT_58	[p2l372t3733r436b3796],
12	10	CD	NUMBER	10	num	15	SENT_58	[p2l474t3733r540b3786],
13	mg/m2	NN	O	mg/m2	nn	15	SENT_58	[p2l568t3717r772b3802],
14	i.v.	NN	O	i.v.	nn	15	SENT_58	[p2l800t3733r887b3786],
15	day	NN	DURATION	day	conj_and	7	SENT_58	[p2l919t3733r1025b3802],
16	l	NN	O	l	tmod	15	SENT_58	[p2l1061t3734r1083b3785],
17	and	CC	O	and	_	0	SENT_58	[p2l1119t3733r1225b3786],
18	Tegafur	NN	LOCATION	tegafur	conj_and	7	SENT_58	[p2l1253t3733r1500b3802],
19	,	,	O	,	_	0	SENT_58	[p2l1253t3733r1500b3802],
20	500	CD	NUMBER	500	num	23	SENT_58	[p2l1531t3733r1641b3786],
21	mg/m2	NN	O	mg/m2	nn	23	SENT_58	[p2l1670t3717r1874b3802],
22	p.o.	NN	O	p.o.	nn	23	SENT_58	[p2l1900t3750r2009b3802],
23	day	NN	DURATION	day	appos	18	SENT_58	[p2l2041t3733r2148b3802],
24	for	IN	O	for	_	0	SENT_58	[p3l8t16r96b69],
25	42	CD	NUMBER	42	num	27	SENT_58	[p3l122t16r195b69],
26	consecutive	JJ	O	consecutive	amod	27	SENT_58	[p3l224t16r579b69],
27	days	NNS	DURATION	day	prep_for	23	SENT_58	[p3l607t16r742b85],
28	within	IN	O	within	_	0	SENT_58	[p3l771t16r963b69],
29	6	CD	DURATION	6	num	30	SENT_58	[p3l992t16r1025b69],
30	weeks	NNS	NUMBER	week	prep_within	27	SENT_58	[p3l1054t16r1240b69],
31	after	IN	O	after	_	0	SENT_58	[p3l1271t16r1408b69],
32	surgery	NN	O	surgery	prep_after	4	SENT_58	[p3l1438t33r1670b85],
33	.	.	O	.	_	0	SENT_58	[p3l1438t33r1670b85],

1	This	DT	O	this	det	2	SENT_59	[p3l1701t16r1833b69],
2	treatment	NN	O	treatment	nsubjpass	4	SENT_59	[p3l1862t24r2149b69],
3	was	VBD	O	be	auxpass	4	SENT_59	[p3l9t121r122b158],
4	repeated	VBN	O	repeat	_	0	SENT_59	[p3l148t104r405b173],
5	for	IN	O	for	_	0	SENT_59	[p3l430t104r518b157],
6	four	CD	NUMBER	four	num	7	SENT_59	[p3l541t104r667b157],
7	courses	NNS	O	course	prep_for	4	SENT_59	[p3l691t121r931b157],
8	.	.	O	.	_	0	SENT_59	[p3l691t121r931b157],

1	When	WRB	O	when	advmod	5	SENT_60	[p3l101t193r282b246],
2	total	JJ	O	total	amod	3	SENT_60	[p3l332t193r465b246],
3	gastrectomy	NN	O	gastrectomy	nsubjpass	5	SENT_60	[p3l517t201r885b262],
4	was	VBD	O	be	auxpass	5	SENT_60	[p3l937t210r1050b246],
5	performed	VBN	O	perform	advcl	8	SENT_60	[p3l1101t193r1418b262],
6	the	DT	O	the	det	7	SENT_60	[p3l1467t193r1558b246],
7	patients	NNS	O	patient	nsubj	8	SENT_60	[p3l1608t193r1842b262],
8	received	VBD	O	receive	_	0	SENT_60	[p3l1893t193r2149b246],
9	parenteral	JJ	O	parenteral	amod	11	SENT_60	[p3l7t280r310b349],
10	vitamin	NN	O	vitamin	nn	11	SENT_60	[p3l351t280r581b333],
11	B12	NN	O	b12	dobj	8	SENT_60	[p3l621t281r744b333],
12	1000	CD	NUMBER	1000	num	13	SENT_60	[p3l792t281r934b333],
13	gammas	NNS	O	gamma	npadvmod	14	SENT_60	[p3l974t297r1223b349],
14	monthly	JJ	SET	monthly	advmod	11	SENT_60	[p3l1264t280r1515b349],
15	as	IN	O	as	_	0	SENT_60	[p3l1557t297r1615b333],
16	a	DT	O	a	det	17	SENT_60	[p3l1657t297r1688b333],
17	prevention	NN	O	prevention	prep_as	14	SENT_60	[p3l1726t280r2048b349],
18	of	IN	O	of	_	0	SENT_60	[p3l2088t280r2153b333],
19	vitamin	NN	O	vitamin	nn	21	SENT_60	[p3l8t368r239b421],
20	B12	NN	O	b12	nn	21	SENT_60	[p3l264t369r388b421],
21	deﬁciency	NN	O	deﬁciency	prep_of	11	SENT_60	[p3l414t368r733b437],
22	.	.	O	.	_	0	SENT_60	[p3l414t368r733b437],

1	All	DT	O	all	det	2	SENT_61	[p3l102t456r196b509],
2	patients	NNS	O	patient	nsubjpass	4	SENT_61	[p3l220t456r454b525],
3	were	VBD	O	be	auxpass	4	SENT_61	[p3l480t473r624b509],
4	checked	VBN	O	check	_	0	SENT_61	[p3l650t456r897b509],
5	for	IN	O	for	_	0	SENT_61	[p3l921t456r1008b509],
6	clinical	JJ	O	clinical	amod	7	SENT_61	[p3l1031t456r1253b509],
7	exploration	NN	O	exploration	prep_for	4	SENT_61	[p3l1279t456r1622b525],
8	and	CC	O	and	_	0	SENT_61	[p3l1647t456r1754b509],
9	biochemical	JJ	O	biochemical	amod	11	SENT_61	[p3l1776t456r2147b509],
10	blood	NN	O	blood	nn	11	SENT_61	[p3l7t544r180b597],
11	exam	NN	O	exam	conj_and	7	SENT_61	[p3l211t561r375b597],
12	including	VBG	O	include	_	0	SENT_61	[p3l405t544r690b613],
13	tumour	NN	O	tumour	nn	14	SENT_61	[p3l722t552r941b597],
14	markers	NNS	O	marker	prep_including	7	SENT_61	[p3l971t544r1213b597],
15	CEA	NNP	ORGANIZATION	CEA	nn	17	SENT_61	[p3l1247t544r1411b607],
16	,	,	O	,	_	0	SENT_61	[p3l1247t544r1411b607],
17	CA	NNP	O	CA	dep	14	SENT_61	[p3l1447t545r1550b597],
18	19.9	CD	NUMBER	19.9	num	17	SENT_61	[p3l1588t544r1710b598],
19	and	CC	O	and	_	0	SENT_61	[p3l1745t544r1852b597],
20	CA	NNP	O	CA	conj_and	14	SENT_61	[p3l1884t544r1986b597],
21	72.4	CD	NUMBER	72.4	num	20	SENT_61	[p3l2018t544r2148b597],
22	every	DT	SET	every	quantmod	23	SENT_61	[p3l9t649r173b701],
23	3	CD	SET	3	num	24	SENT_61	[p3l196t633r225b685],
24	months	NNS	NUMBER	month	tmod	20	SENT_61	[p3l251t632r471b685],
25	for	IN	O	for	_	0	SENT_61	[p3l493t632r580b685],
26	1	CD	DURATION	1	num	27	SENT_61	[p3l607t633r629b685],
27	year	NN	NUMBER	year	prep_for	4	SENT_61	[p3l657t649r799b701],
28	,	,	O	,	_	0	SENT_61	[p3l657t649r799b701],
29	every	DT	SET	every	det	31	SENT_61	[p3l824t649r988b701],
30	6	CD	SET	6	num	31	SENT_61	[p3l1010t632r1044b685],
31	months	NNS	NUMBER	month	prep_for	4	SENT_61	[p3l1065t632r1285b685],
32	for	IN	O	for	_	0	SENT_61	[p3l1308t632r1396b685],
33	the	DT	DURATION	the	det	36	SENT_61	[p3l1415t632r1506b685],
34	next	JJ	DURATION	next	amod	36	SENT_61	[p3l1527t640r1657b685],
35	4	CD	DURATION	4	num	36	SENT_61	[p3l1676t632r1711b685],
36	years	NNS	NUMBER	year	prep_for	31	SENT_61	[p3l1732t649r1890b701],
37	and	CC	O	and	_	0	SENT_61	[p3l1913t632r2020b685],
38	one	CD	NUMBER	one	prep_for	4	SENT_61	[p3l2041t649r2148b685],
39	a	DT	DURATION	a	det	40	SENT_61	[p3l10t737r41b773],
40	year	NN	DURATION	year	dep	38	SENT_61	[p3l63t737r193b789],
41	thereafter	RB	O	thereafter	advmod	4	SENT_61	[p3l215t720r516b773],
42	.	.	O	.	_	0	SENT_61	[p3l215t720r516b773],

1	An	DT	O	a	det	5	SENT_62	[p3l543t721r634b773],
2	endoscope	NN	O	endoscope	nn	5	SENT_62	[p3l657t720r975b789],
3	and	CC	O	and	_	0	SENT_62	[p3l1000t720r1107b773],
4	chest	NN	O	chest	nn	5	SENT_62	[p3l1130t720r1284b773],
5	radiography	NN	O	radiography	nsubjpass	7	SENT_62	[p3l1306t720r1671b789],
6	was	VBD	O	be	auxpass	7	SENT_62	[p3l1695t737r1809b774],
7	performed	VBN	O	perform	_	0	SENT_62	[p3l1833t720r2149b789],
8	the	DT	O	the	det	9	SENT_62	[p3l8t808r99b861],
9	third	JJ	ORDINAL	third	dobj	7	SENT_62	[p3l124t808r266b861],
10	and	CC	O	and	_	0	SENT_62	[p3l292t808r399b861],
11	the	DT	O	the	det	13	SENT_62	[p3l424t808r515b861],
12	ﬁfth	NN	O	ﬁfth	nn	13	SENT_62	[p3l540t808r664b861],
13	year	NN	DURATION	year	dobj	7	SENT_62	[p3l687t825r818b877],
14	after	IN	O	after	_	0	SENT_62	[p3l843t808r981b861],
15	surgery	NN	O	surgery	prep_after	7	SENT_62	[p3l1007t825r1240b877],
16	.	.	O	.	_	0	SENT_62	[p3l1007t825r1240b877],

1	The	DT	O	the	det	3	SENT_63	[p3l102t896r218b949],
2	retrospective	JJ	O	retrospective	amod	3	SENT_63	[p3l252t896r642b965],
3	search	NN	O	search	nsubjpass	5	SENT_63	[p3l679t896r868b949],
4	was	VBD	O	be	auxpass	5	SENT_63	[p3l904t913r1017b949],
5	performed	VBN	O	perform	_	0	SENT_63	[p3l1052t896r1368b965],
6	according	VBG	O	accord	_	0	SENT_63	[p3l1404t896r1700b965],
7	the	DT	O	the	det	8	SENT_63	[p3l1735t896r1826b949],
8	rules	NNS	O	rule	prep_according	5	SENT_63	[p3l1860t896r2005b949],
9	and	CC	O	and	_	0	SENT_63	[p3l2042t896r2149b949],
10	permission	NN	O	permission	prep_according	5	SENT_63	[p3l7t984r339b1053],
11	of	IN	O	of	_	0	SENT_63	[p3l366t984r431b1037],
12	the	DT	O	the	det	14	SENT_63	[p3l451t984r541b1037],
13	Ethic	NNP	O	Ethic	nn	14	SENT_63	[p3l566t984r724b1037],
14	Committee	NNP	O	Committee	prep_of	8	SENT_63	[p3l752t984r1087b1038],
15	of	IN	O	of	_	0	SENT_63	[p3l1113t984r1179b1037],
16	the	DT	O	the	det	17	SENT_63	[p3l1198t984r1289b1037],
17	Institution	NNP	O	Institution	prep_of	14	SENT_63	[p3l1314t984r1640b1037],
18	.	.	O	.	_	0	SENT_63	[p3l1314t984r1640b1037],

1	Sample	VB	O	sample	_	0	SENT_64	[p3l732t1184r1010b1265],
2	Collection	NNP	O	Collection	dobj	1	SENT_64	[p3l1043t1184r1426b1248],

1	Retrospective	JJ	O	retrospective	amod	2	SENT_65	[p3l102t1341r517b1410],
2	samples	NNS	O	sample	nsubjpass	8	SENT_65	[p3l543t1342r782b1410],
3	of	IN	O	of	_	0	SENT_65	[p3l809t1341r874b1395],
4	the	DT	O	the	det	6	SENT_65	[p3l893t1341r983b1395],
5	surgical	JJ	O	surgical	amod	6	SENT_65	[p3l1011t1341r1247b1410],
6	specimen	NN	O	specimen	prep_of	2	SENT_65	[p3l1273t1341r1556b1410],
7	were	VBD	O	be	auxpass	8	SENT_65	[p3l1581t1358r1725b1395],
8	evaluated	VBN	O	evaluate	_	0	SENT_65	[p3l1751t1341r2038b1395],
9	for	IN	O	for	_	0	SENT_65	[p3l2062t1341r2150b1395],
10	two	CD	NUMBER	two	num	12	SENT_65	[p3l8t1437r119b1483],
11	different	JJ	O	different	amod	12	SENT_65	[p3l155t1429r413b1483],
12	pathologist	NN	O	pathologist	prep_for	8	SENT_65	[p3l445t1429r783b1498],
13	of	IN	O	of	_	0	SENT_65	[p3l818t1429r883b1483],
14	the	DT	O	the	det	15	SENT_65	[p3l912t1430r1002b1483],
15	institution	NN	O	institution	prep_of	12	SENT_65	[p3l1037t1429r1344b1483],
16	to	TO	O	to	aux	17	SENT_65	[p3l1378t1438r1434b1483],
17	obtain	VB	O	obtain	xcomp	8	SENT_65	[p3l1469t1429r1657b1483],
18	patient	NN	O	patient	nn	20	SENT_65	[p3l1690t1429r1897b1498],
19	tumour	NN	O	tumour	nn	20	SENT_65	[p3l1931t1437r2150b1483],
20	tissue	NN	O	tissue	dobj	17	SENT_65	[p3l8t1517r194b1570],
21	.	.	O	.	_	0	SENT_65	[p3l8t1517r194b1570],

1	These	DT	O	these	det	3	SENT_66	[p3l238t1517r417b1570],
2	tumour	NN	O	tumour	nn	3	SENT_66	[p3l457t1525r676b1570],
3	samples	NNS	O	sample	nsubjpass	5	SENT_66	[p3l717t1517r956b1586],
4	were	VBD	O	be	auxpass	5	SENT_66	[p3l998t1534r1143b1571],
5	analysed	VBN	O	analyse	_	0	SENT_66	[p3l1184t1517r1448b1586],
6	for	IN	O	for	_	0	SENT_66	[p3l1487t1517r1575b1570],
7	single	JJ	O	single	amod	9	SENT_66	[p3l1616t1517r1792b1586],
8	nucleotide	NN	O	nucleotide	nn	9	SENT_66	[p3l1833t1517r2148b1570],
9	polymorphisms	NNS	O	polymorphism	prep_for	5	SENT_66	[p3l7t1605r477b1674],
10	of	IN	O	of	_	0	SENT_66	[p3l501t1605r566b1659],
11	two	CD	NUMBER	two	num	12	SENT_66	[p3l582t1614r692b1659],
12	genes	NNS	O	gene	prep_of	9	SENT_66	[p3l715t1622r884b1674],
13	of	IN	O	of	_	0	SENT_66	[p3l907t1605r973b1659],
14	DPYD	NN	O	dpyd	prep_of	12	SENT_66	[p3l986t1606r1490b1658],
15	.	.	O	.	_	0	SENT_66	[p3l986t1606r1490b1658],

1	—	NN	O	—	_	0	SENT_67	[p3l986t1606r1490b1658],
2	.	.	O	.	_	0	SENT_67	[p3l986t1606r1490b1658],

1	DPYDI	NNP	O	DPYDI	nn	3	SENT_68	[p3l986t1606r1490b1658],
2	(	CD	NUMBER	(	num	3	SENT_68	[p3l1519t1606r1773b1671],
3	A543G	NN	O	a543g	_	0	SENT_68	[p3l1519t1606r1773b1671],
4	;	:	O	;	_	0	SENT_68	[p3l1519t1606r1773b1671],
5	Ile/Val	NN	O	ile/val	nn	6	SENT_68	[p3l1795t1605r2017b1671],
6	)	NN	O	)	dep	3	SENT_68	[p3l1795t1605r2017b1671],
7	and	CC	O	and	_	0	SENT_68	[p3l2042t1606r2149b1659],
8	DPYD2	NN	O	dpyd2	nn	10	SENT_68	[p3l7t1694r239b1746],
9	(	CD	NUMBER	(	num	10	SENT_68	[p3l276t1694r425b1759],
10	C/T	NN	O	c/t	dep	3	SENT_68	[p3l276t1694r425b1759],
11	;	:	O	;	_	0	SENT_68	[p3l276t1694r425b1759],
12	Arg29Cys	NNS	O	arg29cy	dep	3	SENT_68	[p3l456t1693r971b1761],
13	)	CD	NUMBER	)	dep	12	SENT_68	[p3l456t1693r971b1761],
14	.	.	O	.	_	0	SENT_68	[p3l456t1693r971b1761],

1	—	NN	O	—	_	0	SENT_69	[p3l456t1693r971b1761],
2	.	.	O	.	_	0	SENT_69	[p3l456t1693r971b1761],

1	and	CC	O	and	dep	2	SENT_70	[p3l456t1693r971b1761],
2	polymorphism	NN	O	polymorphism	_	0	SENT_70	[p3l1002t1693r1445b1762],
3	of	IN	O	of	_	0	SENT_70	[p3l1478t1693r1544b1747],
4	CDA	NNP	O	CDA	nn	6	SENT_70	[p3l1574t1695r1715b1747],
5	(	CD	NUMBER	(	num	6	SENT_70	[p3l1753t1694r1910b1759],
6	A/C	NN	O	a/c	prep_of	2	SENT_70	[p3l1753t1694r1910b1759],
7	;	:	O	;	_	0	SENT_70	[p3l1753t1694r1910b1759],
8	Lys27Gin	NN	O	lys27gin	dep	2	SENT_70	[p3l1943t1694r2146b1761, p3l11t1782r160b1847],
9	)	NN	O	)	dep	8	SENT_70	[p3l1943t1694r2146b1761, p3l11t1782r160b1847],
10	.	.	O	.	_	0	SENT_70	[p3l1943t1694r2146b1761, p3l11t1782r160b1847],

1	The	DT	O	the	det	2	SENT_71	[p3l194t1782r310b1835],
2	status	NN	O	status	nsubjpass	16	SENT_71	[p3l343t1789r510b1835],
3	of	IN	O	of	_	0	SENT_71	[p3l543t1782r608b1835],
4	alleles	NNS	O	allele	prep_of	2	SENT_71	[p3l635t1782r824b1835],
5	(	CD	NUMBER	(	num	8	SENT_71	[p3l859t1782r1171b1850],
6	wild	JJ	O	wild	amod	8	SENT_71	[p3l859t1782r1171b1850],
7	—	NN	O	—	nn	8	SENT_71	[p3l859t1782r1171b1850],
8	type	NN	O	type	dep	4	SENT_71	[p3l859t1782r1171b1850],
9	or	CC	O	or	_	0	SENT_71	[p3l1202t1798r1264b1835],
10	at	IN	O	at	quantmod	12	SENT_71	[p3l1294t1790r1347b1835],
11	least	JJS	O	least	mwe	10	SENT_71	[p3l1376t1782r1514b1835],
12	one	CD	NUMBER	one	num	14	SENT_71	[p3l1545t1798r1651b1835],
13	polymorphism	NN	O	polymorphism	nn	14	SENT_71	[p3l1681t1782r2146b1850],
14	)	NN	O	)	conj_or	4	SENT_71	[p3l1681t1782r2146b1850],
15	was	VBD	O	be	auxpass	16	SENT_71	[p3l9t1886r122b1922],
16	correlated	VBN	O	correlate	_	0	SENT_71	[p3l150t1869r452b1922],
17	with	IN	O	with	_	0	SENT_71	[p3l477t1869r609b1923],
18	outcome	NN	O	outcome	prep_with	16	SENT_71	[p3l635t1877r911b1932],
19	,	,	O	,	_	0	SENT_71	[p3l635t1877r911b1932],
20	overall	JJ	O	overall	amod	21	SENT_71	[p3l940t1869r1146b1922],
21	survival	NN	O	survival	conj_and	18	SENT_71	[p3l1174t1869r1411b1923],
22	and	CC	O	and	_	0	SENT_71	[p3l1438t1869r1545b1922],
23	toxicity	NN	O	toxicity	conj_and	18	SENT_71	[p3l1569t1869r1810b1938],
24	.	.	O	.	_	0	SENT_71	[p3l1569t1869r1810b1938],

1	DNA	NN	O	dna	_	0	SENT_72	[p3l102t1966r252b2017],
2	isolation	NN	O	isolation	dep	1	SENT_72	[p3l272t1966r548b2017],
3	.	.	O	.	_	0	SENT_72	[p3l272t1966r548b2017],

1	DNA	NN	O	dna	nsubjpass	3	SENT_73	[p3l583t1964r743b2017],
2	was	VBD	O	be	auxpass	3	SENT_73	[p3l757t1981r870b2017],
3	obtained	VBN	O	obtain	_	0	SENT_73	[p3l893t1964r1153b2017],
4	from	IN	O	from	_	0	SENT_73	[p3l1174t1964r1320b2017],
5	parafﬁn	NN	O	parafﬁn	nn	9	SENT_73	[p3l1339t1964r1911b2033],
6	—	CD	NUMBER	—	num	9	SENT_73	[p3l1339t1964r1911b2033],
7	embedded	JJ	O	embedded	amod	9	SENT_73	[p3l1339t1964r1911b2033],
8	tumour	NN	O	tumour	nn	9	SENT_73	[p3l1931t1972r2150b2017],
9	tissue	NN	O	tissue	prep_from	3	SENT_73	[p3l8t2052r194b2105],
10	.	.	O	.	_	0	SENT_73	[p3l8t2052r194b2105],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_74	[p3l221t2052r472b2121],
2	were	VBD	O	be	auxpass	3	SENT_74	[p3l494t2069r639b2105],
3	dewaxed	VBN	O	dewax	_	0	SENT_74	[p3l661t2052r927b2105],
4	with	IN	O	with	_	0	SENT_74	[p3l946t2052r1079b2105],
5	two	CD	NUMBER	two	num	6	SENT_74	[p3l1099t2060r1210b2105],
6	washes	NNS	O	wash	prep_with	3	SENT_74	[p3l1229t2052r1444b2105],
7	of	IN	O	of	_	0	SENT_74	[p3l1467t2052r1533b2105],
8	xylene	NN	O	xylene	prep_of	6	SENT_74	[p3l1548t2052r1765b2121],
9	,	,	O	,	_	0	SENT_74	[p3l1548t2052r1765b2121],
10	followed	VBN	O	follow	partmod	6	SENT_74	[p3l1788t2052r2055b2105],
11	by	IN	O	by	_	0	SENT_74	[p3l2073t2052r2148b2121],
12	the	DT	O	the	det	13	SENT_74	[p3l8t2139r99b2192],
13	addition	NN	O	addition	agent	10	SENT_74	[p3l123t2139r370b2192],
14	of	IN	O	of	_	0	SENT_74	[p3l393t2139r458b2192],
15	1	CD	NUMBER	1	num	16	SENT_74	[p3l482t2140r504b2192],
16	ml	NN	O	ml	prep_of	13	SENT_74	[p3l533t2139r611b2192],
17	of	IN	O	of	_	0	SENT_74	[p3l635t2139r700b2192],
18	100	CD	PERCENT	100	number	19	SENT_74	[p3l725t2139r890b2192],
19	%	NN	PERCENT	%	amod	20	SENT_74	[p3l725t2139r890b2192],
20	ethanol	NN	O	ethanol	prep_of	16	SENT_74	[p3l915t2139r1136b2192],
21	to	TO	O	to	aux	22	SENT_74	[p3l1159t2147r1216b2192],
22	remove	VB	O	remove	xcomp	10	SENT_74	[p3l1239t2156r1464b2192],
23	residual	JJ	O	residual	amod	24	SENT_74	[p3l1485t2139r1724b2192],
24	xylene	NN	O	xylene	dobj	22	SENT_74	[p3l1748t2139r1964b2208],
25	.	.	O	.	_	0	SENT_74	[p3l1748t2139r1964b2208],

1	After	IN	O	after	_	0	SENT_75	[p3l1990t2139r2150b2192],
2	dewaxing	VBG	O	dewax	prepc_after	6	SENT_75	[p3l9t2227r317b2296],
3	,	,	O	,	_	0	SENT_75	[p3l9t2227r317b2296],
4	DNA	NN	O	dna	nsubjpass	6	SENT_75	[p3l341t2228r500b2280],
5	was	VBD	O	be	auxpass	6	SENT_75	[p3l516t2244r630b2281],
6	obtained	VBN	O	obtain	_	0	SENT_75	[p3l654t2227r914b2280],
7	using	VBG	O	use	xcomp	6	SENT_75	[p3l935t2227r1097b2296],
8	the	DT	O	the	det	11	SENT_75	[p3l1120t2227r1210b2280],
9	commercial	JJ	O	commercial	amod	11	SENT_75	[p3l1234t2227r1590b2280],
10	DNeasy	NN	O	dneasy	nn	11	SENT_75	[p3l1613t2229r1854b2296],
11	tissue	NN	O	tissue	dobj	7	SENT_75	[p3l1877t2227r2047b2280],
12	kit	NN	O	kit	nn	14	SENT_75	[p3l2069t2227r2149b2280],
13	(	CD	NUMBER	(	num	14	SENT_75	[p3l10t2316r267b2385],
14	Qiagen	NNP	ORGANIZATION	Qiagen	dep	11	SENT_75	[p3l10t2316r267b2385],
15	,	,	O	,	_	0	SENT_75	[p3l10t2316r267b2385],
16	GmbH	NN	O	gmbh	appos	14	SENT_75	[p3l304t2316r522b2379],
17	,	,	O	,	_	0	SENT_75	[p3l304t2316r522b2379],
18	Hilden	NNP	PERSON	Hilden	appos	14	SENT_75	[p3l557t2316r778b2379],
19	,	,	O	,	_	0	SENT_75	[p3l557t2316r778b2379],
20	Germany	NNP	LOCATION	Germany	appos	14	SENT_75	[p3l814t2316r1117b2385],
21	)	CD	NUMBER	)	num	20	SENT_75	[p3l814t2316r1117b2385],
22	according	VBG	O	accord	_	0	SENT_75	[p3l1153t2316r1448b2385],
23	to	TO	O	to	prepc_according_to	14	SENT_75	[p3l1481t2324r1537b2369],
24	the	DT	O	the	det	25	SENT_75	[p3l1570t2316r1661b2369],
25	manufacturer	NN	O	manufacturer	poss	27	SENT_75	[p3l1693t2316r2147b2369],
26	’s	POS	O	’s	_	0	SENT_75	[p3l1693t2316r2147b2369],
27	instructions	NNS	O	instruction	pobj	14	SENT_75	[p3l8t2404r376b2457],
28	.	.	O	.	_	0	SENT_75	[p3l8t2404r376b2457],

1	Genotyping	NN	O	genotyping	_	0	SENT_76	[p3l104t2501r476b2566],
2	.	.	O	.	_	0	SENT_76	[p3l104t2501r476b2566],

1	SNP	NN	O	snp	nn	2	SENT_77	[p3l512t2499r647b2552],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_77	[p3l679t2498r919b2567],
3	was	VBD	O	be	auxpass	4	SENT_77	[p3l952t2515r1066b2552],
4	performed	VBN	O	perform	_	0	SENT_77	[p3l1097t2498r1414b2567],
5	using	VBG	O	use	xcomp	4	SENT_77	[p3l1444t2498r1607b2567],
6	a	DT	O	a	det	8	SENT_77	[p3l1641t2515r1672b2552],
7	real	JJ	O	real	amod	8	SENT_77	[p3l1701t2498r1975b2552],
8	—	NN	O	—	dobj	5	SENT_77	[p3l1701t2498r1975b2552],
9	time	NN	O	time	nn	10	SENT_77	[p3l1701t2498r1975b2552],
10	PCR	NN	O	pcr	dep	16	SENT_77	[p3l2007t2499r2149b2552],
11	allelic	JJ	O	allelic	amod	13	SENT_77	[p3l10t2587r192b2640],
12	discrimination	NN	O	discrimination	nn	13	SENT_77	[p3l224t2587r661b2640],
13	TaqMan	NN	O	taqman	dep	10	SENT_77	[p3l691t2588r941b2655],
14	assay	NN	O	assay	dep	16	SENT_77	[p3l972t2603r1132b2655],
15	(	CD	NUMBER	(	num	14	SENT_77	[p3l1165t2587r1314b2652],
16	AB	NNP	O	AB	dep	5	SENT_77	[p3l1165t2587r1314b2652],
17	)	CD	NUMBER	)	num	16	SENT_77	[p3l1165t2587r1314b2652],
18	with	IN	O	with	_	0	SENT_77	[p3l1347t2587r1479b2640],
19	minor	JJ	O	minor	amod	20	SENT_77	[p3l1509t2587r1690b2640],
20	modiﬁcations	NNS	O	modiﬁcations	prep_with	16	SENT_77	[p3l1718t2587r2145b2640],
21	.	.	O	.	_	0	SENT_77	[p3l1718t2587r2145b2640],

1	All	DT	O	all	det	3	SENT_78	[p3l8t2675r103b2727],
2	PCR	NN	O	pcr	nn	3	SENT_78	[p3l123t2675r265b2728],
3	reactions	NNS	O	reaction	nsubjpass	9	SENT_78	[p3l282t2675r555b2728],
4	were	VBD	O	be	auxpass	5	SENT_78	[p3l577t2692r721b2728],
5	run	VBN	O	run	_	0	SENT_78	[p3l740t2692r840b2728],
6	in	IN	O	in	_	0	SENT_78	[p3l860t2675r917b2727],
7	duplicate	VB	O	duplicate	prepc_in	5	SENT_78	[p3l938t2675r1214b2744],
8	and	CC	O	and	_	0	SENT_78	[p3l1236t2675r1342b2728],
9	contained	VBD	O	contain	conj_and	5	SENT_78	[p3l1362t2675r1656b2728],
10	50	CD	NUMBER	50	num	11	SENT_78	[p3l1676t2675r1749b2728],
11	ng	NN	O	ng	dobj	9	SENT_78	[p3l1769t2692r1841b2744],
12	of	IN	O	of	_	0	SENT_78	[p3l1863t2675r1928b2728],
13	patient	NN	O	patient	nn	14	SENT_78	[p3l1941t2675r2149b2744],
14	DNA	NN	MISC	dna	prep_of	11	SENT_78	[p3l8t2763r183b2825],
15	,	,	O	,	_	0	SENT_78	[p3l8t2763r183b2825],
16	6.25	CD	NUMBER	6.25	num	17	SENT_78	[p3l225t2762r350b2816],
17	ul	NN	O	ul	dobj	9	SENT_78	[p3l394t2763r452b2831],
18	of	IN	O	of	_	0	SENT_78	[p3l491t2762r556b2816],
19	TaqMan	NNP	O	TaqMan	nn	25	SENT_78	[p3l587t2764r838b2831],
20	Universal	NNP	O	Universal	nn	25	SENT_78	[p3l875t2762r1166b2816],
21	Master	NNP	O	Master	nn	25	SENT_78	[p3l1203t2764r1413b2816],
22	Mix	NNP	O	Mix	nn	25	SENT_78	[p3l1450t2762r1574b2815],
23	(	NNP	O	(	nn	25	SENT_78	[p3l1613t2763r1781b2828],
24	AB	NNP	O	AB	nn	25	SENT_78	[p3l1613t2763r1781b2828],
25	)	NNP	O	)	prep_of	17	SENT_78	[p3l1613t2763r1781b2828],
26	,	,	O	,	_	0	SENT_78	[p3l1613t2763r1781b2828],
27	0.25	CD	NUMBER	0.25	num	28	SENT_78	[p3l1822t2762r1948b2816],
28	ul	NN	O	ul	dobj	9	SENT_78	[p3l1992t2763r2050b2831],
29	of	IN	O	of	_	0	SENT_78	[p3l2088t2762r2153b2816],
30	primers	NNS	O	primer	prep_of	28	SENT_78	[p3l7t2851r237b2919],
31	and	CC	O	and	_	0	SENT_78	[p3l291t2851r398b2904],
32	probes	NNS	O	probe	conj_and	30	SENT_78	[p3l447t2851r664b2919],
33	,	,	O	,	_	0	SENT_78	[p3l447t2851r664b2919],
34	and	CC	O	and	_	0	SENT_78	[p3l720t2851r826b2904],
35	water	NN	O	water	conj_and	11	SENT_78	[p3l877t2859r1045b2904],
36	for	IN	O	for	_	0	SENT_78	[p3l1095t2851r1182b2904],
37	a	DT	O	a	det	39	SENT_78	[p3l1234t2867r1265b2904],
38	ﬁnal	JJ	O	ﬁnal	amod	39	SENT_78	[p3l1316t2851r1447b2904],
39	volume	NN	O	volume	prep_for	35	SENT_78	[p3l1498t2851r1724b2904],
40	of	IN	O	of	_	0	SENT_78	[p3l1776t2851r1841b2904],
41	12.5	CD	NUMBER	12.5	num	42	SENT_78	[p3l1894t2850r2014b2904],
42	ul	NN	O	ul	prep_of	39	SENT_78	[p3l2071t2851r2144b2919],
43	.	.	O	.	_	0	SENT_78	[p3l2071t2851r2144b2919],

1	Appropriate	JJ	O	appropriate	amod	3	SENT_79	[p3l8t2939r373b3008],
2	negative	JJ	O	negative	amod	3	SENT_79	[p3l416t2939r669b3008],
3	controls	NNS	O	control	nsubjpass	6	SENT_79	[p3l712t2939r953b2992],
4	were	VBD	O	be	auxpass	6	SENT_79	[p3l997t2956r1142b2992],
5	also	RB	O	also	advmod	6	SENT_79	[p3l1186t2939r1305b2992],
6	run	VBN	O	run	_	0	SENT_79	[p3l1347t2956r1462b2992],
7	.	.	O	.	_	0	SENT_79	[p3l1347t2956r1462b2992],

1	Real-time	JJ	O	real-time	amod	2	SENT_80	[p3l1508t2939r1806b2992],
2	PCR	NN	O	pcr	nsubjpass	4	SENT_80	[p3l1850t2939r1991b2992],
3	was	VBD	O	be	auxpass	4	SENT_80	[p3l2033t2956r2147b2992],
4	performed	VBN	O	perform	_	0	SENT_80	[p3l7t3026r323b3095],
5	on	IN	O	on	_	0	SENT_80	[p3l354t3043r427b3080],
6	an	DT	O	a	det	12	SENT_80	[p3l458t3043r526b3080],
7	ABI	NNP	MISC	ABI	nn	12	SENT_80	[p3l557t3027r685b3079],
8	Prism	NNP	O	Prism	nn	12	SENT_80	[p3l715t3026r891b3080],
9	7500	CD	NUMBER	7500	num	12	SENT_80	[p3l920t3026r1069b3080],
10	Sequence	NN	O	sequence	nn	12	SENT_80	[p3l1101t3027r1388b3095],
11	Detection	NN	O	detection	nn	12	SENT_80	[p3l1419t3026r1713b3080],
12	System	NN	O	system	prep_on	4	SENT_80	[p3l1745t3027r1966b3095],
13	(	CD	NUMBER	(	num	14	SENT_80	[p3l1997t3027r2146b3092],
14	AB	NNP	O	AB	dep	12	SENT_80	[p3l1997t3027r2146b3092],
15	)	CD	NUMBER	)	num	14	SENT_80	[p3l1997t3027r2146b3092],
16	using	VBG	O	use	partmod	14	SENT_80	[p3l8t3115r170b3184],
17	the	DT	O	the	det	19	SENT_80	[p3l195t3115r285b3168],
18	following	JJ	O	following	amod	19	SENT_80	[p3l310t3115r601b3184],
19	conditions	NNS	O	condition	dobj	16	SENT_80	[p3l627t3115r957b3168],
20	:	:	O	:	_	0	SENT_80	[p3l627t3115r957b3168],
21	50	CD	NUMBER	50	number	22	SENT_80	[p3l987t3113r1139b3168],
22	°	CD	NUMBER	°	num	23	SENT_80	[p3l987t3113r1139b3168],
23	C	NN	O	c	conj_and	14	SENT_80	[p3l987t3113r1139b3168],
24	for	IN	O	for	_	0	SENT_80	[p3l1165t3115r1252b3168],
25	2	CD	DURATION	2	num	26	SENT_80	[p3l1276t3115r1310b3167],
26	min	NN	DURATION	min	prep_for	23	SENT_80	[p3l1335t3115r1467b3177],
27	,	,	O	,	_	0	SENT_80	[p3l1335t3115r1467b3177],
28	95	CD	NUMBER	95	num	30	SENT_80	[p3l1496t3113r1647b3169],
29	°	NN	O	°	nn	30	SENT_80	[p3l1496t3113r1647b3169],
30	C	NN	O	c	conj_and	14	SENT_80	[p3l1496t3113r1647b3169],
31	for	IN	O	for	_	0	SENT_80	[p3l1672t3115r1760b3168],
32	10	CD	DURATION	10	num	33	SENT_80	[p3l1790t3115r1856b3168],
33	min	NN	DURATION	min	prep_for	30	SENT_80	[p3l1881t3115r2014b3178],
34	,	,	O	,	_	0	SENT_80	[p3l1881t3115r2014b3178],
35	and	CC	O	and	_	0	SENT_80	[p3l2042t3115r2149b3168],
36	40	CD	NUMBER	40	num	37	SENT_80	[p3l8t3203r81b3256],
37	cycles	NNS	O	cycle	conj_and	14	SENT_80	[p3l108t3203r294b3271],
38	of	IN	O	of	_	0	SENT_80	[p3l322t3203r388b3256],
39	ampliﬁcation	NN	O	ampliﬁcation	prep_of	37	SENT_80	[p3l410t3203r808b3271],
40	(	CD	NUMBER	(	number	41	SENT_80	[p3l837t3201r1011b3268],
41	95	CD	NUMBER	95	num	43	SENT_80	[p3l837t3201r1011b3268],
42	°	NN	O	°	nn	43	SENT_80	[p3l837t3201r1011b3268],
43	C	NN	O	c	dep	39	SENT_80	[p3l837t3201r1011b3268],
44	for	IN	O	for	_	0	SENT_80	[p3l1039t3203r1127b3256],
45	15	CD	DURATION	15	num	46	SENT_80	[p3l1158t3203r1221b3256],
46	sec	NN	DURATION	sec	prep_for	43	SENT_80	[p3l1254t3219r1345b3256],
47	and	CC	O	and	_	0	SENT_80	[p3l1373t3203r1480b3256],
48	60	CD	NUMBER	60	num	50	SENT_80	[p3l1507t3201r1658b3256],
49	°	NN	O	°	nn	50	SENT_80	[p3l1507t3201r1658b3256],
50	C	NN	O	c	conj_and	39	SENT_80	[p3l1507t3201r1658b3256],
51	for	IN	O	for	_	0	SENT_80	[p3l1685t3203r1773b3256],
52	1	CD	DURATION	1	num	54	SENT_80	[p3l1805t3203r1827b3255],
53	min	NN	DURATION	min	nn	54	SENT_80	[p3l1859t3203r2017b3268],
54	)	NN	O	)	prep_for	50	SENT_80	[p3l1859t3203r2017b3268],
55	.	.	O	.	_	0	SENT_80	[p3l1859t3203r2017b3268],

1	For	IN	O	for	_	0	SENT_81	[p3l2045t3204r2151b3256],
2	each	DT	O	each	det	3	SENT_81	[p3l9t3291r146b3344],
3	cycle	NN	O	cycle	prep_for	7	SENT_81	[p3l180t3291r354b3360],
4	,	,	O	,	_	0	SENT_81	[p3l180t3291r354b3360],
5	the	DT	O	the	det	6	SENT_81	[p3l389t3291r479b3344],
6	software	NN	O	software	nsubj	7	SENT_81	[p3l515t3291r772b3344],
7	determined	VBD	O	determine	_	0	SENT_81	[p3l806t3291r1146b3344],
8	the	DT	O	the	det	10	SENT_81	[p3l1179t3291r1269b3344],
9	ﬂuorescent	JJ	O	ﬂuorescent	amod	10	SENT_81	[p3l1304t3291r1635b3344],
10	signal	NN	O	signal	nsubj	17	SENT_81	[p3l1669t3291r1846b3360],
11	from	IN	O	from	_	0	SENT_81	[p3l1879t3291r2025b3344],
12	the	DT	O	the	det	13	SENT_81	[p3l2057t3291r2148b3344],
13	VIC	NNP	O	VIC	prep_from	10	SENT_81	[p3l8t3380r135b3433],
14	or	CC	O	or	_	0	SENT_81	[p3l163t3396r224b3433],
15	FAM	NNP	O	FAM	conj_or	13	SENT_81	[p3l247t3380r671b3433],
16	—	CD	NUMBER	—	num	15	SENT_81	[p3l247t3380r671b3433],
17	labelled	VBD	O	label	ccomp	7	SENT_81	[p3l247t3380r671b3433],
18	probe	NN	O	probe	dobj	17	SENT_81	[p3l694t3380r881b3448],
19	.	.	O	.	_	0	SENT_81	[p3l694t3380r881b3448],

1	Statistical	JJ	O	statistical	amod	2	SENT_82	[p3l717t3579r1091b3644],
2	Analysis	NN	O	analysis	_	0	SENT_82	[p3l1120t3579r1440b3660],

1	Student	NN	O	student	poss	5	SENT_83	[p3l104t3737r381b3790],
2	’s	POS	O	’s	_	0	SENT_83	[p3l104t3737r381b3790],
3	t	NN	O	t	nn	5	SENT_83	[p3l405t3745r554b3790],
4	—	CD	NUMBER	—	num	5	SENT_83	[p3l405t3745r554b3790],
5	test	NN	O	test	nsubjpass	16	SENT_83	[p3l405t3745r554b3790],
6	and	CC	O	and	_	0	SENT_83	[p3l575t3737r682b3790],
7	Chi	NNP	O	Chi	conj_and	5	SENT_83	[p3l702t3737r1032b3805],
8	—	CD	NUMBER	—	num	7	SENT_83	[p3l702t3737r1032b3805],
9	square	JJ	O	square	amod	10	SENT_83	[p3l702t3737r1032b3805],
10	test	NN	O	test	dep	7	SENT_83	[p3l1053t3744r1158b3790],
11	or	CC	O	or	_	0	SENT_83	[p3l1178t3753r1239b3790],
12	Fisher	NNP	O	Fisher	nn	14	SENT_83	[p3l1258t3737r1447b3790],
13	exact	JJ	O	exact	amod	14	SENT_83	[p3l1467t3745r1626b3790],
14	test	NN	O	test	conj_or	10	SENT_83	[p3l1644t3745r1749b3790],
15	were	VBD	O	be	auxpass	16	SENT_83	[p3l1769t3753r1913b3790],
16	used	VBN	O	use	_	0	SENT_83	[p3l1934t3737r2072b3790],
17	to	TO	O	to	aux	18	SENT_83	[p3l2091t3745r2148b3790],
18	compare	VB	O	compare	xcomp	16	SENT_83	[p4l9t35r268b87],
19	the	DT	O	the	det	20	SENT_83	[p4l304t18r394b71],
20	outcome	NN	O	outcome	dobj	18	SENT_83	[p4l431t26r690b71],
21	according	VBG	O	accord	_	0	SENT_83	[p4l727t18r1022b87],
22	to	TO	O	to	prepc_according_to	18	SENT_83	[p4l1059t26r1115b71],
23	genotype	NN	O	genotype	pobj	18	SENT_83	[p4l1152t26r1443b87],
24	.	.	O	.	_	0	SENT_83	[p4l1152t26r1443b87],

1	Spearman	NNP	PERSON	Spearman	nn	4	SENT_84	[p4l1485t18r1785b87],
2	correlation	NN	O	correlation	nn	4	SENT_84	[p4l1821t18r2148b71],
3	coefﬁcient	NN	O	coefﬁcient	nn	4	SENT_84	[p4l9t107r327b160],
4	analysis	NN	O	analysis	nsubjpass	6	SENT_84	[p4l364t107r604b176],
5	was	VBD	O	be	auxpass	6	SENT_84	[p4l643t124r757b160],
6	used	VBN	O	use	_	0	SENT_84	[p4l795t107r933b160],
7	to	TO	O	to	aux	8	SENT_84	[p4l969t115r1025b160],
8	determine	VB	O	determine	xcomp	6	SENT_84	[p4l1064t107r1365b160],
9	the	DT	O	the	det	10	SENT_84	[p4l1403t107r1494b160],
10	correlation	NN	O	correlation	dobj	8	SENT_84	[p4l1532t107r1860b160],
11	between	IN	O	between	_	0	SENT_84	[p4l1896t107r2148b160],
12	different	JJ	O	different	amod	13	SENT_84	[p4l9t195r267b248],
13	genotypes	NNS	O	genotype	prep_between	10	SENT_84	[p4l314t203r634b263],
14	.	.	O	.	_	0	SENT_84	[p4l314t203r634b263],

1	Survival	NN	O	survival	nn	2	SENT_85	[p4l686t195r937b248],
2	probabilities	NNS	O	probability	nsubjpass	4	SENT_85	[p4l982t195r1361b263],
3	were	VBD	O	be	auxpass	4	SENT_85	[p4l1409t211r1553b248],
4	estimated	VBN	O	estimate	_	0	SENT_85	[p4l1601t195r1891b248],
5	by	IN	O	by	_	0	SENT_85	[p4l1936t195r2010b263],
6	the	DT	O	the	agent	4	SENT_85	[p4l2057t195r2148b248],

1	Journal	NNP	O	Journal	_	0	SENT_86	[p4l7t363r228b412],
2	of	IN	O	of	_	0	SENT_86	[p4l251t363r315b426],
3	Surgical	NNP	O	Surgical	nn	4	SENT_86	[p4l327t363r566b426],
4	Oncology	NNP	O	Oncology	prep_of	1	SENT_86	[p4l591t363r863b426],

1	Gene	NNP	PERSON	Gene	nn	2	SENT_87	[p4l376t587r560b647],
2	Poymorphisms	NNP	PERSON	Poymorphisms	_	0	SENT_87	[p4l589t587r1126b663],
3	in	IN	O	in	_	0	SENT_87	[p4l1154t587r1223b646],
4	Gastric	NNP	O	Gastric	nn	5	SENT_87	[p4l1253t587r1517b647],
5	Cancer	NNP	O	Cancer	prep_in	2	SENT_87	[p4l1548t587r1807b647],
6	131	CD	NUMBER	131	dep	2	SENT_87	[p4l2028t587r2145b647],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_88	[p4l9t749r460b818],
2	.	.	O	.	_	0	SENT_88	[p4l9t749r460b818],

1	—	NN	O	—	_	0	SENT_89	[p4l9t749r460b818],
2	.	.	O	.	_	0	SENT_89	[p4l9t749r460b818],

1	Meier	NNP	PERSON	Meier	nn	3	SENT_90	[p4l9t749r460b818],
2	product-limit	JJ	O	product-limit	amod	3	SENT_90	[p4l479t749r881b818],
3	method	NN	O	method	nsubjpass	9	SENT_90	[p4l902t749r1129b802],
4	and	CC	O	and	_	0	SENT_90	[p4l1152t749r1258b802],
5	the	DT	O	the	det	7	SENT_90	[p4l1280t749r1370b802],
6	log-rank	JJ	O	log-rank	amod	7	SENT_90	[p4l1392t749r1650b818],
7	test	NN	O	test	conj_and	3	SENT_90	[p4l1669t757r1774b802],
8	was	VBD	O	be	auxpass	9	SENT_90	[p4l1796t766r1909b802],
9	used	VBN	O	use	_	0	SENT_90	[p4l1932t749r2070b802],
10	to	TO	O	to	aux	11	SENT_90	[p4l2091t757r2148b802],
11	evaluate	VB	O	evaluate	xcomp	9	SENT_90	[p4l9t837r257b891],
12	the	DT	O	the	det	13	SENT_90	[p4l286t838r376b891],
13	difference	NN	O	difference	dobj	11	SENT_90	[p4l407t837r710b891],
14	between	IN	O	between	_	0	SENT_90	[p4l738t837r991b891],
15	survival	NN	O	survival	nn	16	SENT_90	[p4l1022t837r1259b891],
16	curves	NNS	O	curve	prep_between	13	SENT_90	[p4l1289t854r1498b891],
17	.	.	O	.	_	0	SENT_90	[p4l1289t854r1498b891],

1	A	DT	O	a	det	4	SENT_91	[p4l1531t838r1584b890],
2	P	NN	O	p	nn	4	SENT_91	[p4l1610t838r1844b891],
3	—	NN	O	—	nn	4	SENT_91	[p4l1610t838r1844b891],
4	value	NN	O	value	nsubjpass	7	SENT_91	[p4l1610t838r1844b891],
5	0.05	CD	NUMBER	0.05	dep	4	SENT_91	[p4l1874t837r2001b891],
6	was	VBD	O	be	auxpass	7	SENT_91	[p4l2033t854r2147b891],
7	considered	VBN	O	consider	_	0	SENT_91	[p4l9t926r336b979],
8	to	TO	O	to	aux	11	SENT_91	[p4l361t934r417b979],
9	be	VB	O	be	cop	11	SENT_91	[p4l442t926r512b979],
10	the	DT	O	the	det	11	SENT_91	[p4l537t926r628b979],
11	limit	NN	O	limit	xcomp	7	SENT_91	[p4l654t926r797b979],
12	of	IN	O	of	_	0	SENT_91	[p4l822t926r887b979],
13	signiﬁcance	NN	O	signiﬁcance	prep_of	11	SENT_91	[p4l909t926r1267b995],
14	for	IN	O	for	_	0	SENT_91	[p4l1293t926r1380b979],
15	all	DT	O	all	det	16	SENT_91	[p4l1406t926r1478b979],
16	analysis	NN	O	analysis	prep_for	13	SENT_91	[p4l1504t926r1761b994],
17	.	.	O	.	_	0	SENT_91	[p4l1504t926r1761b994],

1	Cox	NN	PERSON	cox	poss	5	SENT_92	[p4l103t1014r276b1067],
2	’s	POS	O	’s	_	0	SENT_92	[p4l103t1014r276b1067],
3	proportional	JJ	O	proportional	amod	5	SENT_92	[p4l338t1014r712b1083],
4	hazard	NN	O	hazard	nn	5	SENT_92	[p4l774t1014r977b1067],
5	model	NN	O	model	nsubj	12	SENT_92	[p4l1038t1014r1225b1067],
6	with	IN	O	with	_	0	SENT_92	[p4l1289t1014r1422b1067],
7	covariates	NNS	O	covariate	prep_with	5	SENT_92	[p4l1484t1014r1786b1067],
8	for	IN	O	for	_	0	SENT_92	[p4l1850t1014r1938b1067],
9	main	JJ	O	main	amod	11	SENT_92	[p4l1998t1014r2149b1067],
10	prognostic	JJ	O	prognostic	amod	11	SENT_92	[p4l7t1101r325b1170],
11	factors	NNS	O	factor	prep_for	7	SENT_92	[p4l365t1101r568b1155],
12	(	VBP	O	(	dep	26	SENT_92	[p4l609t1102r752b1170],
13	age	NN	O	age	dobj	12	SENT_92	[p4l609t1102r752b1170],
14	,	,	O	,	_	0	SENT_92	[p4l609t1102r752b1170],
15	gender	NN	O	gender	dobj	12	SENT_92	[p4l793t1102r1011b1170],
16	,	,	O	,	_	0	SENT_92	[p4l793t1102r1011b1170],
17	staging	NN	O	staging	dobj	12	SENT_92	[p4l1053t1101r1284b1170],
18	,	,	O	,	_	0	SENT_92	[p4l1053t1101r1284b1170],
19	positive	JJ	O	positive	amod	21	SENT_92	[p4l1324t1101r1562b1170],
20	lymph	NN	O	lymph	nn	21	SENT_92	[p4l1599t1101r1792b1170],
21	nodes	NNS	O	node	dobj	12	SENT_92	[p4l1828t1102r2002b1155],
22	and	CC	O	and	_	0	SENT_92	[p4l2042t1102r2149b1155],
23	polymorphisms	NNS	O	polymorphism	nn	24	SENT_92	[p4l7t1191r502b1259],
24	)	NN	O	)	dobj	12	SENT_92	[p4l7t1191r502b1259],
25	was	VBD	O	be	auxpass	26	SENT_92	[p4l542t1207r656b1244],
26	applied	VBN	O	apply	_	0	SENT_92	[p4l695t1191r917b1259],
27	to	TO	O	to	aux	28	SENT_92	[p4l953t1199r1010b1244],
28	determine	VB	O	determine	xcomp	26	SENT_92	[p4l1048t1191r1349b1244],
29	independent	JJ	O	independent	amod	31	SENT_92	[p4l1387t1191r1759b1259],
30	risk	NN	O	risk	nn	31	SENT_92	[p4l1794t1191r1908b1244],
31	factors	NNS	O	factor	nsubj	32	SENT_92	[p4l1943t1191r2147b1244],
32	(	VBP	O	(	ccomp	28	SENT_92	[p4l10t1279r289b1344],
33	Forward	RB	O	forward	advmod	32	SENT_92	[p4l10t1279r289b1344],
34	step	VB	O	step	dep	32	SENT_92	[p4l343t1287r460b1348],
35	Wald	NNP	PERSON	Wald	nn	37	SENT_92	[p4l514t1279r673b1332],
36	method	NN	O	method	nn	37	SENT_92	[p4l726t1279r994b1344],
37	)	NN	O	)	dobj	34	SENT_92	[p4l726t1279r994b1344],
38	,	,	O	,	_	0	SENT_92	[p4l726t1279r994b1344],
39	using	VBG	O	use	xcomp	26	SENT_92	[p4l1050t1279r1211b1348],
40	an	DT	O	a	det	43	SENT_92	[p4l1267t1296r1335b1332],
41	input	NN	O	input	nn	43	SENT_92	[p4l1388t1279r1544b1348],
42	variable	JJ	O	variable	amod	43	SENT_92	[p4l1597t1279r1838b1332],
43	criterion	NN	O	criterion	dep	48	SENT_92	[p4l1893t1279r2148b1332],
44	(	CD	NUMBER	(	num	45	SENT_92	[p4l10t1367r79b1432],
45	P	NN	O	p	npadvmod	46	SENT_92	[p4l10t1367r79b1432],
46	<	JJR	O	<	amod	43	SENT_92	[p4l98t1377r145b1421],
47	0.05	CD	NUMBER	0.05	num	48	SENT_92	[p4l165t1366r318b1432],
48	)	NN	O	)	dep	39	SENT_92	[p4l165t1366r318b1432],
49	and	CC	O	and	_	0	SENT_92	[p4l347t1366r453b1419],
50	an	DT	O	a	det	53	SENT_92	[p4l479t1383r547b1419],
51	output	NN	O	output	nn	53	SENT_92	[p4l573t1374r766b1435],
52	variable	JJ	O	variable	amod	53	SENT_92	[p4l790t1366r1031b1419],
53	criterion	NN	O	criterion	dep	56	SENT_92	[p4l1057t1366r1313b1419],
54	(	CD	NUMBER	(	num	55	SENT_92	[p4l1340t1367r1408b1432],
55	P	NN	O	p	npadvmod	56	SENT_92	[p4l1340t1367r1408b1432],
56	>	JJR	O	>	dep	39	SENT_92	[p4l1427t1377r1474b1421],
57	0.10	CD	NUMBER	0.10	num	58	SENT_92	[p4l1494t1366r1664b1432],
58	)	NN	O	)	nsubjpass	26	SENT_92	[p4l1494t1366r1664b1432],
59	.	.	O	.	_	0	SENT_92	[p4l1494t1366r1664b1432],

1	RESULTS	NNS	O	result	_	0	SENT_93	[p4l872t1562r1283b1629],

1	Patients	NNS	O	patient	_	0	SENT_94	[p4l606t1725r937b1789],
2	’	CD	NUMBER	’	num	3	SENT_94	[p4l606t1725r937b1789],
3	Characteristics	NNS	O	characteristic	dep	1	SENT_94	[p4l974t1725r1550b1789],

1	Samples	NNS	O	sample	nsubjpass	7	SENT_95	[p4l104t1883r356b1951],
2	of	IN	O	of	_	0	SENT_95	[p4l388t1882r453b1936],
3	50	CD	NUMBER	50	num	5	SENT_95	[p4l479t1882r551b1936],
4	consecutive	JJ	O	consecutive	amod	5	SENT_95	[p4l581t1882r936b1936],
5	patients	NNS	O	patient	prep_of	1	SENT_95	[p4l964t1882r1198b1951],
6	were	VBD	O	be	auxpass	7	SENT_95	[p4l1230t1899r1375b1936],
7	obtained	VBN	O	obtain	_	0	SENT_95	[p4l1406t1883r1666b1936],
8	for	IN	O	for	_	0	SENT_95	[p4l1695t1882r1782b1936],
9	the	DT	O	the	det	11	SENT_95	[p4l1810t1883r1901b1936],
10	genetic	JJ	O	genetic	amod	11	SENT_95	[p4l1931t1883r2147b1951],
11	study	NN	O	study	prep_for	7	SENT_95	[p4l11t1971r181b2039],
12	.	.	O	.	_	0	SENT_95	[p4l11t1971r181b2039],

1	All	DT	O	all	det	2	SENT_96	[p4l234t1971r329b2023],
2	samples	NNS	O	sample	nsubj	3	SENT_96	[p4l381t1971r620b2039],
3	have	VBP	O	have	_	0	SENT_96	[p4l670t1971r810b2024],
4	tumour	NN	O	tumour	nn	5	SENT_96	[p4l860t1979r1079b2024],
5	tissue	NN	O	tissue	dobj	3	SENT_96	[p4l1126t1970r1312b2024],
6	.	.	O	.	_	0	SENT_96	[p4l1126t1970r1312b2024],

1	Table	NNP	O	Table	nsubj	3	SENT_97	[p4l1366t1971r1531b2024],
2	I	PRP	O	I	dep	1	SENT_97	[p4l1581t1972r1604b2023],
3	shows	VBZ	O	show	_	0	SENT_97	[p4l1656t1970r1838b2024],
4	patients	NNS	O	patient	dobj	3	SENT_97	[p4l1887t1971r2141b2039],
5	’	CD	NUMBER	’	num	6	SENT_97	[p4l1887t1971r2141b2039],
6	characteristics	NNS	O	characteristic	dep	4	SENT_97	[p4l9t2059r457b2112],
7	.	.	O	.	_	0	SENT_97	[p4l9t2059r457b2112],

1	Total	JJ	O	total	amod	2	SENT_98	[p4l102t2147r255b2200],
2	gastrectomy	NN	O	gastrectomy	nsubjpass	4	SENT_98	[p4l278t2155r646b2216],
3	was	VBD	O	be	auxpass	4	SENT_98	[p4l668t2164r782b2200],
4	performed	VBN	O	perform	_	0	SENT_98	[p4l804t2147r1120b2216],
5	in	IN	O	in	_	0	SENT_98	[p4l1140t2147r1197b2200],
6	72	CD	PERCENT	72	num	7	SENT_98	[p4l1219t2148r1352b2201],
7	%	NN	PERCENT	%	prep_in	4	SENT_98	[p4l1219t2148r1352b2201],
8	of	IN	O	of	_	0	SENT_98	[p4l1378t2147r1443b2200],
9	the	DT	O	the	det	10	SENT_98	[p4l1458t2147r1549b2200],
10	patients	NNS	O	patient	prep_of	7	SENT_98	[p4l1570t2147r1804b2216],
11	and	CC	O	and	_	0	SENT_98	[p4l1828t2147r1935b2200],
12	partial	JJ	O	partial	amod	13	SENT_98	[p4l1955t2147r2148b2216],
13	gastrectomy	NN	O	gastrectomy	conj_and	10	SENT_98	[p4l9t2243r377b2304],
14	in	IN	O	in	_	0	SENT_98	[p4l406t2235r463b2288],
15	the	DT	O	the	det	18	SENT_98	[p4l490t2236r580b2289],
16	other	JJ	O	other	amod	18	SENT_98	[p4l609t2236r764b2289],
17	28	CD	PERCENT	28	num	18	SENT_98	[p4l791t2236r942b2289],
18	%	NN	PERCENT	%	prep_in	10	SENT_98	[p4l791t2236r942b2289],
19	.	.	O	.	_	0	SENT_98	[p4l791t2236r942b2289],

1	Extended	VBN	O	extend	dep	9	SENT_99	[p4l973t2235r1259b2289],
2	(	NN	O	(	nn	3	SENT_99	[p4l1288t2236r1424b2301],
3	D2	NN	O	d2	dobj	1	SENT_99	[p4l1288t2236r1424b2301],
4	)	CD	NUMBER	)	num	7	SENT_99	[p4l1288t2236r1424b2301],
5	lymph	NN	O	lymph	nn	7	SENT_99	[p4l1454t2236r1647b2304],
6	node	NN	O	node	nn	7	SENT_99	[p4l1674t2235r1819b2289],
7	dissection	NN	O	dissection	nsubj	29	SENT_99	[p4l1847t2235r2149b2289],
8	was	VBD	O	be	auxpass	9	SENT_99	[p4l9t2340r122b2377],
9	performed	VBN	O	perform	_	0	SENT_99	[p4l152t2324r469b2392],
10	in	IN	O	in	_	0	SENT_99	[p4l498t2324r555b2376],
11	the	DT	O	the	det	13	SENT_99	[p4l585t2324r675b2377],
12	90	CD	PERCENT	90	num	13	SENT_99	[p4l706t2324r838b2378],
13	%	NN	PERCENT	%	prep_in	9	SENT_99	[p4l706t2324r838b2378],
14	of	IN	O	of	_	0	SENT_99	[p4l872t2324r938b2377],
15	the	DT	O	the	det	16	SENT_99	[p4l963t2324r1053b2377],
16	patients	NNS	O	patient	prep_of	13	SENT_99	[p4l1082t2324r1334b2392],
17	,	,	O	,	_	0	SENT_99	[p4l1082t2324r1334b2392],
18	limited	JJ	O	limited	amod	24	SENT_99	[p4l1367t2324r1581b2377],
19	(	NN	O	(	nn	24	SENT_99	[p4l1613t2324r1749b2389],
20	D1	NN	O	d1	nn	24	SENT_99	[p4l1613t2324r1749b2389],
21	)	CD	NUMBER	)	num	24	SENT_99	[p4l1613t2324r1749b2389],
22	lymph	NN	O	lymph	nn	24	SENT_99	[p4l1781t2324r1974b2392],
23	node	NN	O	node	nn	24	SENT_99	[p4l2003t2324r2148b2377],
24	dissection	NN	O	dissection	appos	16	SENT_99	[p4l9t2411r310b2464],
25	in	IN	O	in	_	0	SENT_99	[p4l335t2411r392b2464],
26	8	CD	PERCENT	8	num	27	SENT_99	[p4l421t2412r513b2465],
27	%	NN	PERCENT	%	prep_in	24	SENT_99	[p4l421t2412r513b2465],
28	and	CC	O	and	_	0	SENT_99	[p4l543t2411r650b2464],
29	Do	VBP	O	do	conj_and	9	SENT_99	[p4l674t2412r764b2465],
30	in	IN	O	in	_	0	SENT_99	[p4l790t2411r847b2464],
31	one	CD	NUMBER	one	num	32	SENT_99	[p4l872t2428r978b2464],
32	patient	NN	O	patient	prep_in	29	SENT_99	[p4l1003t2411r1210b2480],
33	(	CD	PERCENT	(	number	34	SENT_99	[p4l1237t2412r1399b2477],
34	2	CD	PERCENT	2	dep	35	SENT_99	[p4l1237t2412r1399b2477],
35	%	NN	PERCENT	%	dep	32	SENT_99	[p4l1237t2412r1399b2477],
36	)	CD	NUMBER	)	dobj	9	SENT_99	[p4l1237t2412r1399b2477],
37	.	.	O	.	_	0	SENT_99	[p4l1237t2412r1399b2477],

1	Adjuvant	JJ	O	adjuvant	amod	2	SENT_100	[p4l102t2499r382b2568],
2	chemotherapy	NN	O	chemotherapy	nsubjpass	5	SENT_100	[p4l402t2499r830b2568],
3	was	VBD	O	be	auxpass	5	SENT_100	[p4l853t2516r966b2553],
4	well	RB	O	well	advmod	5	SENT_100	[p4l989t2499r1117b2553],
5	tolerated	VBN	O	tolerate	_	0	SENT_100	[p4l1138t2499r1404b2553],
6	and	CC	O	and	_	0	SENT_100	[p4l1425t2500r1532b2553],
7	the	DT	O	the	det	8	SENT_100	[p4l1552t2500r1643b2553],
8	compliance	NN	O	compliance	nsubj	10	SENT_100	[p4l1665t2499r2012b2568],
9	was	VBD	O	be	cop	10	SENT_100	[p4l2033t2516r2147b2553],
10	high	JJ	O	high	conj_and	5	SENT_100	[p4l8t2588r156b2657],
11	.	.	O	.	_	0	SENT_100	[p4l8t2588r156b2657],

1	All	DT	O	all	det	3	SENT_101	[p4l209t2588r304b2640],
2	Prescribed	JJ	O	prescribed	amod	3	SENT_101	[p4l354t2588r673b2641],
3	chemotherapy	NN	O	chemotherapy	nsubjpass	5	SENT_101	[p4l723t2588r1151b2656],
4	was	VBD	O	be	auxpass	5	SENT_101	[p4l1202t2604r1315b2641],
5	completed	VBN	O	complete	_	0	SENT_101	[p4l1367t2588r1682b2656],
6	in	IN	O	in	_	0	SENT_101	[p4l1731t2588r1789b2640],
7	40	CD	PERCENT	40	number	8	SENT_101	[p4l1837t2588r1911b2641],
8	(	CD	PERCENT	(	prep_in	5	SENT_101	[p4l1963t2588r2146b2653],
9	80	CD	PERCENT	80	num	10	SENT_101	[p4l1963t2588r2146b2653],
10	%	NN	PERCENT	%	dep	8	SENT_101	[p4l1963t2588r2146b2653],
11	)	CD	NUMBER	)	num	12	SENT_101	[p4l1963t2588r2146b2653],
12	patients	NNS	O	patient	dep	10	SENT_101	[p4l7t2675r258b2744],
13	.	.	O	.	_	0	SENT_101	[p4l7t2675r258b2744],

1	In	IN	O	in	_	0	SENT_102	[p4l295t2677r356b2728],
2	the	DT	O	the	det	5	SENT_102	[p4l388t2675r479b2728],
3	10	CD	NUMBER	10	num	5	SENT_102	[p4l519t2676r585b2729],
4	other	JJ	O	other	amod	5	SENT_102	[p4l619t2675r774b2728],
5	patients	NNS	O	patient	prep_in	12	SENT_102	[p4l804t2675r1038b2744],
6	(	IN	O	(	_	0	SENT_102	[p4l1074t2676r1258b2741],
7	20	CD	PERCENT	20	num	8	SENT_102	[p4l1074t2676r1258b2741],
8	%	NN	PERCENT	%	prep_(	12	SENT_102	[p4l1074t2676r1258b2741],
9	)	CD	NUMBER	)	num	10	SENT_102	[p4l1074t2676r1258b2741],
10	dosage	NN	O	dosage	nsubjpass	12	SENT_102	[p4l1293t2675r1501b2744],
11	was	VBD	O	be	auxpass	12	SENT_102	[p4l1532t2692r1646b2729],
12	reduced	VBN	O	reduce	_	0	SENT_102	[p4l1679t2675r1919b2728],
13	by	IN	O	by	_	0	SENT_102	[p4l1950t2675r2024b2744],
14	the	DT	O	the	det	15	SENT_102	[p4l2057t2675r2148b2728],
15	physician	NN	O	physician	agent	12	SENT_102	[p4l7t2763r298b2832],
16	because	IN	O	because	_	0	SENT_102	[p4l322t2764r561b2817],
17	of	IN	O	of	prepc_because_of	12	SENT_102	[p4l587t2763r653b2817],
18	toxicity	NN	O	toxicity	pobj	12	SENT_102	[p4l672t2763r914b2832],
19	.	.	O	.	_	0	SENT_102	[p4l672t2763r914b2832],

1	At	IN	O	at	_	0	SENT_103	[p4l102t2852r177b2905],
2	the	DT	O	the	det	3	SENT_103	[p4l205t2852r296b2905],
3	time	NN	O	time	prep_at	20	SENT_103	[p4l326t2852r459b2905],
4	of	IN	O	of	_	0	SENT_103	[p4l491t2852r556b2905],
5	the	DT	O	the	det	6	SENT_103	[p4l581t2852r671b2905],
6	analysis	NN	O	analysis	prep_of	3	SENT_103	[p4l703t2852r960b2921],
7	,	,	O	,	_	0	SENT_103	[p4l703t2852r960b2921],
8	19	CD	PERCENT	19	number	9	SENT_103	[p4l1000t2852r1065b2906],
9	(	CD	PERCENT	(	appos	6	SENT_103	[p4l1098t2852r1281b2917],
10	38	CD	PERCENT	38	num	11	SENT_103	[p4l1098t2852r1281b2917],
11	%	NN	PERCENT	%	dep	9	SENT_103	[p4l1098t2852r1281b2917],
12	)	CD	NUMBER	)	num	13	SENT_103	[p4l1098t2852r1281b2917],
13	patients	NNS	O	patient	nsubj	14	SENT_103	[p4l1312t2852r1547b2920],
14	had	VBD	O	have	parataxis	20	SENT_103	[p4l1578t2852r1686b2905],
15	relapse	NN	O	relapse	dobj	14	SENT_103	[p4l1714t2852r1928b2920],
16	(	CD	NUMBER	(	number	17	SENT_103	[p4l1961t2852r2055b2917],
17	18	CD	NUMBER	18	nsubj	20	SENT_103	[p4l1961t2852r2055b2917],
18	of	IN	O	of	_	0	SENT_103	[p4l2088t2852r2153b2905],
19	them	PRP	O	they	prep_of	17	SENT_103	[p4l8t2940r160b2993],
20	died	VBD	O	die	_	0	SENT_103	[p4l185t2940r354b3005],
21	)	NN	O	)	dobj	20	SENT_103	[p4l185t2940r354b3005],
22	.	.	O	.	_	0	SENT_103	[p4l185t2940r354b3005],

1	The	DT	O	the	det	3	SENT_104	[p4l383t2940r500b2993],
2	main	JJ	O	main	amod	3	SENT_104	[p4l526t2940r676b2993],
3	side	NN	O	side	nsubj	7	SENT_104	[p4l704t2940r821b2993],
4	of	IN	O	of	_	0	SENT_104	[p4l849t2940r914b2993],
5	relapse	NN	O	relapse	prep_of	3	SENT_104	[p4l933t2940r1147b3009],
6	was	VBD	O	be	cop	7	SENT_104	[p4l1172t2957r1286b2993],
7	peritoneum	NN	O	peritoneum	_	0	SENT_104	[p4l1312t2940r1659b3009],
8	in	IN	O	in	_	0	SENT_104	[p4l1684t2940r1741b2992],
9	seven	CD	PERCENT	seven	number	10	SENT_104	[p4l1769t2957r1936b2993],
10	(	CD	PERCENT	(	prep_in	7	SENT_104	[p4l1963t2940r2146b3006],
11	37	CD	PERCENT	37	num	12	SENT_104	[p4l1963t2940r2146b3006],
12	%	NN	PERCENT	%	dep	10	SENT_104	[p4l1963t2940r2146b3006],
13	)	CD	NUMBER	)	num	14	SENT_104	[p4l1963t2940r2146b3006],
14	patients	NNS	O	patient	dep	12	SENT_104	[p4l7t3028r258b3096],
15	.	.	O	.	_	0	SENT_104	[p4l7t3028r258b3096],

1	Distant	JJ	O	distant	amod	2	SENT_105	[p4l289t3027r507b3081],
2	metastases	NNS	O	metastase	nsubjpass	4	SENT_105	[p4l532t3035r853b3081],
3	were	VBD	O	be	auxpass	4	SENT_105	[p4l882t3044r1026b3081],
4	observed	VBN	O	observe	_	0	SENT_105	[p4l1054t3028r1325b3081],
5	in	IN	O	in	_	0	SENT_105	[p4l1351t3027r1408b3080],
6	12	CD	PERCENT	12	number	7	SENT_105	[p4l1441t3028r1507b3080],
7	(	CD	PERCENT	(	num	9	SENT_105	[p4l1536t3027r1719b3093],
8	63	CD	PERCENT	63	num	9	SENT_105	[p4l1536t3027r1719b3093],
9	%	NN	PERCENT	%	prep_in	4	SENT_105	[p4l1536t3027r1719b3093],
10	)	CD	NUMBER	)	num	11	SENT_105	[p4l1536t3027r1719b3093],
11	patients	NNS	O	patient	dep	9	SENT_105	[p4l1746t3027r1998b3096],
12	:	:	O	:	_	0	SENT_105	[p4l1746t3027r1998b3096],
13	5	CD	NUMBER	5	dep	9	SENT_105	[p4l2031t3027r2062b3081],
14	in	IN	O	in	_	0	SENT_105	[p4l2091t3027r2149b3080],
15	the	DT	O	the	det	16	SENT_105	[p4l8t3117r99b3170],
16	liver	NN	O	liver	prep_in	13	SENT_105	[p4l125t3117r274b3180],
17	,	,	O	,	_	0	SENT_105	[p4l125t3117r274b3180],
18	5	CD	NUMBER	5	appos	9	SENT_105	[p4l302t3117r334b3170],
19	in	IN	O	in	_	0	SENT_105	[p4l362t3117r420b3169],
20	bones	NNS	O	bone	prep_in	18	SENT_105	[p4l443t3117r617b3170],
21	and	CC	O	and	_	0	SENT_105	[p4l646t3117r752b3170],
22	2	CD	NUMBER	2	conj_and	20	SENT_105	[p4l778t3117r812b3169],
23	in	IN	O	in	_	0	SENT_105	[p4l837t3117r894b3169],
24	retroperitoneal	NN	O	retroperitoneal	nn	25	SENT_105	[p4l918t3117r1365b3185],
25	space	NN	O	space	prep_in	4	SENT_105	[p4l1393t3133r1573b3185],
26	.	.	O	.	_	0	SENT_105	[p4l1393t3133r1573b3185],

1	Single	JJ	O	single	amod	3	SENT_106	[p4l212t3316r441b3397],
2	Nucleotide	NN	O	nucleotide	nn	3	SENT_106	[p4l471t3316r876b3381],
3	Polymorphisms	NNS	O	polymorphism	_	0	SENT_106	[p4l906t3316r1497b3397],
4	Expression	NN	O	expression	dep	3	SENT_106	[p4l1528t3316r1947b3397],

1	The	DT	O	the	det	2	SENT_107	[p5l102t45r218b98],
2	status	NN	O	status	nsubj	15	SENT_107	[p5l264t53r431b98],
3	of	IN	O	of	_	0	SENT_107	[p5l476t45r541b98],
4	SNPs	NNS	O	snp	nn	5	SENT_107	[p5l581t45r743b98],
5	frequencies	NNS	O	frequency	prep_of	2	SENT_107	[p5l787t45r1134b113],
6	according	VBG	O	accord	_	0	SENT_107	[p5l1180t45r1476b113],
7	to	TO	O	to	prepc_according_to	5	SENT_107	[p5l1520t53r1576b98],
8	the	DT	O	the	det	9	SENT_107	[p5l1620t45r1710b98],
9	classiﬁcation	NN	O	classiﬁcation	pobj	5	SENT_107	[p5l1754t45r2149b98],
10	between	IN	O	between	_	0	SENT_107	[p5l7t133r260b186],
11	wild-type/non-wild-type	JJ	O	wild-type/non-wild-type	prep_between	9	SENT_107	[p5l280t133r1038b202],
12	,	,	O	,	_	0	SENT_107	[p5l280t133r1038b202],
13	were	VBD	O	be	cop	15	SENT_107	[p5l1061t150r1206b186],
14	36/14	CD	PERCENT	36/14	number	15	SENT_107	[p5l1228t133r1397b186],
15	(	CD	PERCENT	(	_	0	SENT_107	[p5l1420t133r1603b199],
16	72	CD	PERCENT	72	num	17	SENT_107	[p5l1420t133r1603b199],
17	%	NN	PERCENT	%	dep	15	SENT_107	[p5l1420t133r1603b199],
18	)	CD	NUMBER	)	nsubj	45	SENT_107	[p5l1420t133r1603b199],
19	in	IN	O	in	_	0	SENT_107	[p5l1625t133r1683b185],
20	DPYD	NN	O	dpyd	nn	21	SENT_107	[p5l1701t133r1930b185],
21	]	NN	O	]	prep_in	18	SENT_107	[p5l1701t133r1930b185],
22	;	:	O	;	_	0	SENT_107	[p5l1943t150r1954b196],
23	26/24	CD	NUMBER	26/24	conj_and	18	SENT_107	[p5l1979t133r2148b186],
24	in	IN	O	in	_	0	SENT_107	[p5l8t220r65b273],
25	DPYD2	NN	O	dpyd2	prep_in	23	SENT_107	[p5l89t221r321b273],
26	(	CD	PERCENT	(	num	25	SENT_107	[p5l351t220r554b286],
27	52	CD	PERCENT	52	number	28	SENT_107	[p5l351t220r554b286],
28	%	NN	PERCENT	%	amod	25	SENT_107	[p5l351t220r554b286],
29	)	CD	NUMBER	)	dep	23	SENT_107	[p5l351t220r554b286],
30	;	:	O	;	_	0	SENT_107	[p5l351t220r554b286],
31	and	CC	O	and	_	0	SENT_107	[p5l584t220r691b273],
32	17/23	CD	PERCENT	17/23	number	33	SENT_107	[p5l723t220r883b274],
33	(	CD	PERCENT	(	conj_and	18	SENT_107	[p5l914t220r1097b286],
34	34	CD	PERCENT	34	number	35	SENT_107	[p5l914t220r1097b286],
35	%	NN	PERCENT	%	amod	33	SENT_107	[p5l914t220r1097b286],
36	)	CD	NUMBER	)	npadvmod	33	SENT_107	[p5l914t220r1097b286],
37	in	IN	O	in	_	0	SENT_107	[p5l1124t220r1181b273],
38	CDA	NNP	O	CDA	prep_in	33	SENT_107	[p5l1210t221r1351b274],
39	or	CC	O	or	_	0	SENT_107	[p5l1380t237r1441b273],
40	between	IN	O	between	_	0	SENT_107	[p5l1464t220r1716b273],
41	homozygousl	NN	O	homozygousl	prep_between	33	SENT_107	[p5l1741t220r2150b289],
42	heterozygous	JJ	O	heterozygous	amod	41	SENT_107	[p5l8t309r410b377],
43	were	VBD	O	be	cop	45	SENT_107	[p5l442t325r587b362],
44	39/11	CD	NUMBER	39/11	num	45	SENT_107	[p5l620t309r782b363],
45	(	NN	O	(	rcmod	15	SENT_107	[p5l821t309r1004b374],
46	78	CD	PERCENT	78	number	47	SENT_107	[p5l821t309r1004b374],
47	%	NN	PERCENT	%	amod	45	SENT_107	[p5l821t309r1004b374],
48	)	CD	NUMBER	)	dep	15	SENT_107	[p5l821t309r1004b374],
49	in	IN	O	in	_	0	SENT_107	[p5l1037t309r1094b361],
50	DPYDI	NNP	O	DPYDI	prep_in	48	SENT_107	[p5l1122t309r1375b372],
51	;	:	O	;	_	0	SENT_107	[p5l1122t309r1375b372],
52	33/17	CD	PERCENT	33/17	number	53	SENT_107	[p5l1411t309r1578b362],
53	(	CD	PERCENT	(	dep	50	SENT_107	[p5l1612t309r1795b374],
54	66	CD	PERCENT	66	num	55	SENT_107	[p5l1612t309r1795b374],
55	%	NN	PERCENT	%	dep	64	SENT_107	[p5l1612t309r1795b374],
56	)	CD	NUMBER	)	dep	55	SENT_107	[p5l1612t309r1795b374],
57	in	IN	O	in	_	0	SENT_107	[p5l1827t309r1885b361],
58	DPYD2	NN	O	dpyd2	prep_in	56	SENT_107	[p5l1913t309r2146b361],
59	and	CC	O	and	_	0	SENT_107	[p5l10t397r117b450],
60	26/24	CD	PERCENT	26/24	num	61	SENT_107	[p5l146t397r315b450],
61	(	CD	PERCENT	(	prep_in	56	SENT_107	[p5l347t397r530b462],
62	62	CD	PERCENT	62	num	63	SENT_107	[p5l347t397r530b462],
63	%	NN	PERCENT	%	dep	64	SENT_107	[p5l347t397r530b462],
64	)	CD	NUMBER	)	dep	50	SENT_107	[p5l347t397r530b462],
65	in	IN	O	in	_	0	SENT_107	[p5l561t397r619b449],
66	CDA	NNP	ORGANIZATION	CDA	prep_in	64	SENT_107	[p5l651t398r792b451],
67	respectively	RB	O	respectively	advmod	50	SENT_107	[p5l823t397r1197b466],
68	.	.	O	.	_	0	SENT_107	[p5l823t397r1197b466],

1	Heterozygous	JJ	O	heterozygous	amod	3	SENT_108	[p5l1230t398r1648b466],
2	allelic	JJ	O	allelic	amod	3	SENT_108	[p5l1680t397r1862b450],
3	frequencies	NNS	O	frequency	nsubj	6	SENT_108	[p5l1894t397r2146b466, p5l9t484r123b537],
4	were	VBD	O	be	cop	6	SENT_108	[p5l148t501r292b537],
5	22	CD	PERCENT	22	num	6	SENT_108	[p5l317t484r469b547],
6	%	NN	PERCENT	%	_	0	SENT_108	[p5l317t484r469b547],
7	,	,	O	,	_	0	SENT_108	[p5l317t484r469b547],
8	34	CD	PERCENT	34	num	9	SENT_108	[p5l497t484r628b537],
9	%	NN	PERCENT	%	conj_and	6	SENT_108	[p5l497t484r628b537],
10	and	CC	O	and	_	0	SENT_108	[p5l656t484r762b537],
11	48	CD	PERCENT	48	num	12	SENT_108	[p5l784t484r919b537],
12	%	NN	PERCENT	%	conj_and	6	SENT_108	[p5l784t484r919b537],
13	of	IN	O	of	_	0	SENT_108	[p5l945t484r1011b537],
14	the	DT	O	the	det	15	SENT_108	[p5l1028t484r1119b537],
15	patients	NNS	O	patient	prep_of	12	SENT_108	[p5l1141t484r1376b553],
16	for	IN	O	for	_	0	SENT_108	[p5l1400t484r1488b537],
17	DPYDI	NNP	O	DPYDI	prep_for	15	SENT_108	[p5l1508t485r1759b547],
18	,	,	O	,	_	0	SENT_108	[p5l1508t485r1759b547],
19	DPYD2	NN	O	dpyd2	prep_for	15	SENT_108	[p5l1783t485r2015b537],
20	and	CC	O	and	_	0	SENT_108	[p5l2042t484r2149b537],
21	CDA	NNP	ORGANIZATION	CDA	nn	22	SENT_108	[p5l12t574r153b626],
22	genes	NNS	O	gene	prep_for	15	SENT_108	[p5l184t589r353b641],
23	respectively	RB	O	respectively	advmod	6	SENT_108	[p5l381t573r756b641],
24	.	.	O	.	_	0	SENT_108	[p5l381t573r756b641],

1	When	WRB	O	when	advmod	3	SENT_109	[p5l786t573r967b626],
2	we	PRP	O	we	nsubj	3	SENT_109	[p5l995t589r1080b626],
3	analysed	VBD	O	analyse	advcl	16	SENT_109	[p5l1110t573r1373b641],
4	the	DT	O	the	det	5	SENT_109	[p5l1400t573r1491b626],
5	expression	NN	O	expression	dobj	3	SENT_109	[p5l1520t573r1841b641],
6	in	IN	O	in	_	0	SENT_109	[p5l1868t573r1925b625],
7	any	DT	O	any	prep_in	3	SENT_109	[p5l1954t589r2060b641],
8	of	IN	O	of	_	0	SENT_109	[p5l2088t573r2153b626],
9	the	DT	O	the	det	11	SENT_109	[p5l8t661r99b714],
10	three	CD	NUMBER	three	num	11	SENT_109	[p5l119t661r269b714],
11	genes	NNS	O	gene	prep_of	7	SENT_109	[p5l290t678r458b730],
12	in	IN	O	in	_	0	SENT_109	[p5l480t661r537b713],
13	combination	NN	O	combination	prep_in	3	SENT_109	[p5l557t661r951b724],
14	,	,	O	,	_	0	SENT_109	[p5l557t661r951b724],
15	we	PRP	O	we	nsubj	16	SENT_109	[p5l974t678r1060b714],
16	observed	VBD	O	observe	_	0	SENT_109	[p5l1081t661r1352b714],
17	that	IN	O	that	complm	20	SENT_109	[p5l1371t661r1485b714],
18	15	CD	NUMBER	15	nsubj	20	SENT_109	[p5l1511t661r1574b714],
19	were	VBD	O	be	cop	20	SENT_109	[p5l1597t678r1742b714],
20	homozygous	JJ	O	homozygous	ccomp	16	SENT_109	[p5l1762t661r2147b730],

1	TABLE	NN	O	table	_	0	SENT_110	[p5l9t891r227b937],
2	1	CD	NUMBER	1	dep	1	SENT_110	[p5l250t892r289b938],
3	.	.	O	.	_	0	SENT_110	[p5l250t892r289b938],

1	Patients	NNS	O	patient	_	0	SENT_111	[p5l325t891r574b938],
2	’	CD	NUMBER	’	num	3	SENT_111	[p5l325t891r574b938],
3	Characteristics	NNS	O	characteristic	dep	1	SENT_111	[p5l601t891r1033b939],

1	Characteristics	NNS	O	characteristic	nn	2	SENT_112	[p5l9t1029r405b1075],
2	n	NN	O	n	_	0	SENT_112	[p5l1104t1043r1136b1075],
3	(	CD	PERCENT	(	num	4	SENT_112	[p5l1159t1029r1253b1086],
4	%	NN	PERCENT	%	dep	2	SENT_112	[p5l1159t1029r1253b1086],
5	)	CD	NUMBER	)	number	6	SENT_112	[p5l1159t1029r1253b1086],
6	(	CD	NUMBER	(	dep	7	SENT_112	[p5l1280t1029r1347b1086],
7	N	NN	O	n	dep	4	SENT_112	[p5l1280t1029r1347b1086],
8	=	JJ	O	=	advmod	4	SENT_112	[p5l1362t1049r1407b1066],
9	50	CD	NUMBER	50	number	10	SENT_112	[p5l1423t1028r1508b1086],
10	)	CD	NUMBER	)	num	11	SENT_112	[p5l1423t1028r1508b1086],
11	P	NN	O	p	dep	4	SENT_112	[p5l2018t1030r2060b1075],

1	Gender	NN	O	gender	_	0	SENT_113	[p5l9t1258r205b1305],
2	0.157	CD	NUMBER	0.157	num	1	SENT_113	[p5l1965t1258r2111b1305],

1	Male	JJ	O	male	_	0	SENT_114	[p5l75t1338r211b1384],
2	30	CD	NUMBER	30	number	3	SENT_114	[p5l1210t1338r1273b1384],
3	(	CD	NUMBER	(	num	5	SENT_114	[p5l1297t1337r1403b1395],
4	60	CD	NUMBER	60	number	5	SENT_114	[p5l1297t1337r1403b1395],
5	)	CD	NUMBER	)	npadvmod	6	SENT_114	[p5l1297t1337r1403b1395],
6	Female	JJ	O	female	amod	1	SENT_114	[p5l75t1417r271b1464],
7	20	CD	NUMBER	20	number	8	SENT_114	[p5l1209t1418r1273b1464],
8	(	CD	NUMBER	(	dep	1	SENT_114	[p5l1297t1418r1403b1475],
9	40	CD	NUMBER	40	num	10	SENT_114	[p5l1297t1418r1403b1475],
10	)	NN	O	)	dep	8	SENT_114	[p5l1297t1418r1403b1475],

1	Race	NN	O	race	_	0	SENT_115	[p5l8t1498r141b1543],

1	Caucasian	JJ	MISC	caucasian	_	0	SENT_116	[p5l76t1576r350b1623],
2	50	CD	NUMBER	50	num	3	SENT_116	[p5l1193t1576r1256b1623],
3	(	NN	O	(	dep	1	SENT_116	[p5l1280t1576r1420b1634],
4	100	CD	NUMBER	100	number	5	SENT_116	[p5l1280t1576r1420b1634],
5	)	CD	NUMBER	)	dep	3	SENT_116	[p5l1280t1576r1420b1634],

1	Age	NNP	O	Age	_	0	SENT_117	[p5l8t1655r117b1715],
2	(	CD	NUMBER	(	num	3	SENT_117	[p5l142t1655r322b1715],
3	years	NNS	NUMBER	year	dep	1	SENT_117	[p5l142t1655r322b1715],
4	)	IN	O	)	amod	3	SENT_117	[p5l142t1655r322b1715],

1	Median	JJ	O	median	_	0	SENT_118	[p5l75t1734r278b1781],
2	:	:	O	:	_	0	SENT_118	[p5l294t1735r339b1780],
3	I	PRP	O	I	dep	1	SENT_118	[p5l294t1735r339b1780],
4	:	:	O	:	_	0	SENT_118	[p5l294t1735r339b1780],
5	SD	NN	O	sd	dep	3	SENT_118	[p5l356t1735r437b1781],
6	65.1	CD	NUMBER	65.1	num	5	SENT_118	[p5l1154t1734r1263b1781],
7	:	:	O	:	_	0	SENT_118	[p5l1285t1735r1330b1780],
8	I	CD	NUMBER	i	num	10	SENT_118	[p5l1285t1735r1330b1780],
9	:	:	O	:	_	0	SENT_118	[p5l1285t1735r1330b1780],
10	10.1	CD	NUMBER	10.1	dep	3	SENT_118	[p5l1351t1735r1454b1781],
11	Range	NNP	O	Range	dep	10	SENT_118	[p5l75t1814r244b1873],
12	42-85	CD	NUMBER	42-85	num	11	SENT_118	[p5l1218t1813r1392b1860],

1	Location	NNP	O	Location	_	0	SENT_119	[p5l8t1893r246b1939],
2	0.004	CD	NUMBER	0.004	dep	1	SENT_119	[p5l1965t1893r2113b1939],

1	Corpus	NNP	O	Corpus	_	0	SENT_120	[p5l76t1971r265b2031],
2	26	CD	NUMBER	26	num	1	SENT_120	[p5l1209t1971r1273b2017],
3	(	CD	NUMBER	(	number	4	SENT_120	[p5l1297t1971r1403b2028],
4	52	CD	NUMBER	52	dep	1	SENT_120	[p5l1297t1971r1403b2028],
5	)	CD	NUMBER	)	num	6	SENT_120	[p5l1297t1971r1403b2028],
6	Antrum	NNP	ORGANIZATION	Antrum	dep	4	SENT_120	[p5l75t2052r283b2098],
7	17	CD	NUMBER	17	num	6	SENT_120	[p5l1215t2052r1271b2098],
8	(	CD	NUMBER	(	number	9	SENT_120	[p5l1297t2052r1403b2109],
9	34	CD	NUMBER	34	num	13	SENT_120	[p5l1297t2052r1403b2109],
10	)	NN	O	)	nn	13	SENT_120	[p5l1297t2052r1403b2109],
11	Cardia	NN	ORGANIZATION	cardium	nn	13	SENT_120	[p5l76t2131r253b2178],
12	7	CD	NUMBER	7	num	13	SENT_120	[p5l1225t2132r1254b2177],
13	(	NN	O	(	dep	4	SENT_120	[p5l1281t2131r1386b2189],
14	14	CD	NUMBER	14	num	15	SENT_120	[p5l1281t2131r1386b2189],
15	)	NN	O	)	dep	1	SENT_120	[p5l1281t2131r1386b2189],

1	Nodal	JJ	O	nodal	amod	2	SENT_121	[p5l8t2211r169b2257],
2	disease	NN	O	disease	_	0	SENT_121	[p5l193t2211r383b2257],
3	(	NN	O	(	nn	4	SENT_121	[p5l409t2211r495b2268],
4	N	NN	O	n	dep	2	SENT_121	[p5l409t2211r495b2268],
5	)	CD	NUMBER	)	number	6	SENT_121	[p5l409t2211r495b2268],
6	0.002	CD	NUMBER	0.002	dep	4	SENT_121	[p5l1965t2211r2113b2258],

1	No	DT	O	no	det	3	SENT_122	[p5l75t2293r154b2338],
2	14	CD	NUMBER	14	num	3	SENT_122	[p5l1215t2292r1273b2337],
3	(	NN	O	(	_	0	SENT_122	[p5l1297t2292r1403b2349],
4	28	CD	NUMBER	28	num	5	SENT_122	[p5l1297t2292r1403b2349],
5	)	CD	NUMBER	)	dep	3	SENT_122	[p5l1297t2292r1403b2349],
6	Yes	UH	O	yes	dep	8	SENT_122	[p5l76t2372r170b2417],
7	36	CD	NUMBER	36	num	8	SENT_122	[p5l1210t2371r1273b2418],
8	(	CD	NUMBER	(	rcmod	5	SENT_122	[p5l1297t2371r1403b2428],
9	72	CD	NUMBER	72	num	10	SENT_122	[p5l1297t2371r1403b2428],
10	)	NN	O	)	dep	3	SENT_122	[p5l1297t2371r1403b2428],

1	Stage	NNP	O	Stage	_	0	SENT_123	[p5l10t2450r155b2510],
2	0.01	CD	NUMBER	0.01	num	3	SENT_123	[p5l1965t2450r2074b2496],
3	1	CD	NUMBER	1	dep	1	SENT_123	[p5l2088t2450r2108b2495],

1	IB	NN	ORGANIZATION	ib	dep	8	SENT_124	[p5l75t2531r136b2576],
2	3	CD	NUMBER	3	num	1	SENT_124	[p5l1227t2530r1253b2577],
3	(	NN	O	(	dep	1	SENT_124	[p5l1281t2530r1386b2587],
4	16	CD	NUMBER	16	num	3	SENT_124	[p5l1281t2530r1386b2587],
5	)	NN	O	)	dep	8	SENT_124	[p5l1281t2530r1386b2587],
6	II	CD	NUMBER	ii	num	5	SENT_124	[p5l75t2612r118b2656],
7	13	CD	NUMBER	13	num	8	SENT_124	[p5l1215t2611r1270b2657],
8	(	NN	O	(	dep	16	SENT_124	[p5l1297t2610r1403b2668],
9	26	CD	NUMBER	26	num	11	SENT_124	[p5l1297t2610r1403b2668],
10	)	CD	NUMBER	)	num	11	SENT_124	[p5l1297t2610r1403b2668],
11	IIIA	NN	O	iium	dep	8	SENT_124	[p5l75t2690r189b2736],
12	18	CD	NUMBER	18	number	13	SENT_124	[p5l1215t2690r1271b2737],
13	(	CD	NUMBER	(	num	15	SENT_124	[p5l1297t2690r1403b2747],
14	36	CD	NUMBER	36	number	15	SENT_124	[p5l1297t2690r1403b2747],
15	)	CD	NUMBER	)	dep	11	SENT_124	[p5l1297t2690r1403b2747],
16	IIIB	NN	ORGANIZATION	iiib	dep	18	SENT_124	[p5l75t2772r181b2817],
17	8	CD	NUMBER	8	num	16	SENT_124	[p5l1228t2771r1254b2817],
18	(	NN	O	(	dep	20	SENT_124	[p5l1281t2770r1386b2828],
19	16	CD	NUMBER	16	num	18	SENT_124	[p5l1281t2770r1386b2828],
20	)	NN	O	)	dep	23	SENT_124	[p5l1281t2770r1386b2828],
21	IV	CD	NUMBER	iv	num	20	SENT_124	[p5l75t2852r144b2897],
22	8	CD	NUMBER	8	num	23	SENT_124	[p5l1228t2851r1254b2897],
23	(	NN	O	(	dep	25	SENT_124	[p5l1281t2850r1386b2908],
24	16	CD	NUMBER	16	num	25	SENT_124	[p5l1281t2850r1386b2908],
25	)	NN	O	)	_	0	SENT_124	[p5l1281t2850r1386b2908],

1	132	CD	NUMBER	132	num	2	SENT_125	[p5l12t3108r133b3168],
2	Grau	NNP	PERSON	Grau	_	0	SENT_125	[p5l351t3108r541b3168],
3	et	FW	O	et	nn	4	SENT_125	[p5l569t3113r633b3168],
4	al.	FW	O	al.	dep	2	SENT_125	[p5l661t3109r743b3168],
5	.	.	O	.	_	0	SENT_125	[p5l661t3109r743b3168],

1	versus	CC	O	versus	_	0	SENT_126	[p5l9t3287r197b3323],
2	35	CD	NUMBER	35	dep	1	SENT_126	[p5l227t3270r295b3323],
3	heterozygous	JJ	O	heterozygous	amod	2	SENT_126	[p5l324t3270r743b3339],
4	.	.	O	.	_	0	SENT_126	[p5l324t3270r743b3339],

1	When	WRB	O	when	advmod	3	SENT_127	[p5l773t3270r954b3323],
2	we	PRP	O	we	nsubj	3	SENT_127	[p5l981t3287r1066b3323],
3	analysed	VBD	O	analyse	advcl	14	SENT_127	[p5l1095t3270r1358b3339],
4	the	DT	O	the	det	6	SENT_127	[p5l1383t3270r1474b3323],
5	combined	VBN	O	combine	amod	6	SENT_127	[p5l1502t3270r1800b3323],
6	expression	NN	O	expression	dobj	3	SENT_127	[p5l1827t3270r2149b3339],
7	of	IN	O	of	_	0	SENT_127	[p5l9t3357r74b3411],
8	both	CC	O	both	preconj	9	SENT_127	[p5l87t3358r222b3411],
9	DPYD2	NN	O	dpyd2	prep_of	6	SENT_127	[p5l238t3358r471b3410],
10	and	CC	O	and	_	0	SENT_127	[p5l495t3357r602b3411],
11	CDA	NNP	ORGANIZATION	CDA	nn	12	SENT_127	[p5l623t3358r765b3411],
12	genes	NNS	O	gene	prep_of	6	SENT_127	[p5l787t3374r956b3426],
13	we	PRP	O	we	nsubj	14	SENT_127	[p5l977t3374r1062b3411],
14	observed	VBD	O	observe	_	0	SENT_127	[p5l1083t3358r1354b3411],
15	that	IN	O	that	complm	18	SENT_127	[p5l1372t3358r1486b3411],
16	17	CD	NUMBER	17	nsubj	18	SENT_127	[p5l1511t3358r1576b3410],
17	were	VBD	O	be	cop	18	SENT_127	[p5l1597t3374r1742b3411],
18	homozygous	JJ	O	homozygous	ccomp	14	SENT_127	[p5l1761t3358r2147b3426],
19	and	CC	O	and	_	0	SENT_127	[p5l10t3446r117b3499],
20	33	CD	NUMBER	33	nsubj	22	SENT_127	[p5l141t3446r208b3499],
21	were	VBD	O	be	cop	22	SENT_127	[p5l236t3462r380b3499],
22	heterozygous	JJ	O	heterozygous	conj_and	14	SENT_127	[p5l404t3446r822b3515],
23	.	.	O	.	_	0	SENT_127	[p5l404t3446r822b3515],

1	In	IN	O	in	_	0	SENT_128	[p5l849t3447r911b3498],
2	8	CD	NUMBER	8	prep_in	14	SENT_128	[p5l937t3446r966b3499],
3	of	IN	O	of	_	0	SENT_128	[p5l993t3446r1059b3499],
4	these	DT	O	these	det	6	SENT_128	[p5l1077t3446r1231b3499],
5	33	CD	NUMBER	33	num	6	SENT_128	[p5l1256t3446r1324b3499],
6	patients	NNS	O	patient	prep_of	2	SENT_128	[p5l1350t3446r1602b3514],
7	,	,	O	,	_	0	SENT_128	[p5l1350t3446r1602b3514],
8	both	DT	O	both	preconj	12	SENT_128	[p5l1627t3446r1761b3499],
9	DPYD2	NN	O	dpyd2	nn	12	SENT_128	[p5l1782t3446r2015b3498],
10	and	CC	O	and	_	0	SENT_128	[p5l2042t3446r2149b3499],
11	CDA	NNP	ORGANIZATION	CDA	nn	12	SENT_128	[p5l12t3535r153b3588],
12	genes	NNS	O	gene	nsubjpass	14	SENT_128	[p5l183t3551r352b3603],
13	were	VBD	O	be	auxpass	14	SENT_128	[p5l381t3551r525b3587],
14	mutated	VBN	O	mutate	_	0	SENT_128	[p5l554t3534r798b3587],
15	together	RB	O	together	advmod	14	SENT_128	[p5l824t3534r1074b3603],
16	and	CC	O	and	_	0	SENT_128	[p5l1101t3534r1208b3587],
17	in	IN	O	in	_	0	SENT_128	[p5l1234t3534r1292b3586],
18	the	DT	O	the	det	21	SENT_128	[p5l1319t3534r1409b3587],
19	25	CD	NUMBER	25	num	21	SENT_128	[p5l1438t3534r1507b3587],
20	other	JJ	O	other	amod	21	SENT_128	[p5l1539t3534r1694b3587],
21	patients	NNS	O	patient	prep_in	25	SENT_128	[p5l1718t3534r1970b3603],
22	,	,	O	,	_	0	SENT_128	[p5l1718t3534r1970b3603],
23	CDA	NNP	ORGANIZATION	CDA	nsubj	25	SENT_128	[p5l2005t3535r2146b3588],
24	was	VBD	O	be	cop	25	SENT_128	[p5l9t3638r122b3675],
25	heterozygous	JJ	O	heterozygous	conj_and	14	SENT_128	[p5l148t3622r550b3690],
26	in	IN	O	in	_	0	SENT_128	[p5l578t3621r635b3674],
27	17	CD	NUMBER	17	num	28	SENT_128	[p5l667t3622r731b3675],
28	patients	NNS	O	patient	prep_in	25	SENT_128	[p5l758t3621r992b3690],
29	and	CC	O	and	_	0	SENT_128	[p5l1021t3622r1128b3675],
30	CDYP2	NN	O	cdyp2	nsubj	32	SENT_128	[p5l1156t3622r1377b3675],
31	was	VBD	O	be	cop	32	SENT_128	[p5l1406t3638r1519b3675],
32	heterozygous	JJ	O	heterozygous	conj_and	14	SENT_128	[p5l1545t3622r1947b3690],
33	in	IN	O	in	_	0	SENT_128	[p5l1974t3621r2032b3674],
34	the	DT	O	the	det	37	SENT_128	[p5l2056t3622r2147b3675],
35	9	CD	NUMBER	9	num	37	SENT_128	[p5l9t3711r42b3765],
36	other	JJ	O	other	amod	37	SENT_128	[p5l69t3711r224b3764],
37	patients	NNS	O	patient	prep_in	32	SENT_128	[p5l247t3711r498b3779],
38	.	.	O	.	_	0	SENT_128	[p5l247t3711r498b3779],

1	Survival	NN	O	survival	_	0	SENT_129	[p6l306t111r624b175],
2	and	CC	O	and	_	0	SENT_129	[p6l655t112r795b174],
3	Relapse	NNP	O	Relapse	nn	4	SENT_129	[p6l825t112r1119b191],
4	Rate	NNP	O	Rate	conj_and	1	SENT_129	[p6l1150t112r1325b174],
5	According	VBG	O	accord	_	0	SENT_129	[p6l1354t111r1750b191],
6	to	TO	O	to	prepc_according_to	1	SENT_129	[p6l1780t116r1851b174],

1	SNP	NN	O	snp	nn	2	SENT_130	[p6l759t217r924b281],
2	Genotyping	NN	O	genotyping	_	0	SENT_130	[p6l955t217r1398b298],

1	At	IN	O	at	_	0	SENT_131	[p6l101t375r176b428],
2	the	DT	O	the	det	3	SENT_131	[p6l218t374r308b428],
3	time	NN	O	time	prep_at	8	SENT_131	[p6l351t374r484b428],
4	of	IN	O	of	_	0	SENT_131	[p6l528t374r593b428],
5	the	DT	O	the	det	6	SENT_131	[p6l631t375r721b428],
6	analysis	NN	O	analysis	prep_of	3	SENT_131	[p6l766t374r1006b443],
7	median	NN	O	median	nsubj	8	SENT_131	[p6l1049t374r1272b428],
8	follow	VBP	O	follow	dep	13	SENT_131	[p6l1314t374r1609b443],
9	—	CD	NUMBER	—	dobj	8	SENT_131	[p6l1314t374r1609b443],
10	up	RP	O	up	prt	8	SENT_131	[p6l1314t374r1609b443],
11	was	VBD	O	be	cop	13	SENT_131	[p6l1653t391r1766b428],
12	77	CD	DURATION	77	num	13	SENT_131	[p6l1811t376r1881b428],
13	months	NNS	NUMBER	month	_	0	SENT_131	[p6l1926t374r2147b428],
14	(	CD	NUMBER	(	num	15	SENT_131	[p6l10t463r127b528],
15	SD	NN	O	sd	npadvmod	16	SENT_131	[p6l10t463r127b528],
16	=	JJ	O	=	amod	13	SENT_131	[p6l145t487r196b505],
17	26.3	CD	NUMBER	26.3	num	18	SENT_131	[p6l214t463r384b528],
18	)	NN	O	)	nsubj	13	SENT_131	[p6l214t463r384b528],
19	.	.	O	.	_	0	SENT_131	[p6l214t463r384b528],

1	There	EX	O	there	expl	2	SENT_132	[p6l412t463r587b516],
2	were	VBD	O	be	_	0	SENT_132	[p6l610t479r754b516],
3	no	DT	O	no	det	6	SENT_132	[p6l779t479r852b516],
4	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_132	[p6l879t463r1192b531],
5	statistical	JJ	O	statistical	amod	6	SENT_132	[p6l1216t463r1500b516],
6	differences	NNS	O	difference	nsubj	2	SENT_132	[p6l1525t463r1857b516],
7	in	IN	O	in	_	0	SENT_132	[p6l1882t463r1939b515],
8	allelic	JJ	O	allelic	amod	9	SENT_132	[p6l1964t463r2146b516],
9	expression	NN	O	expression	prep_in	6	SENT_132	[p6l9t550r330b619],
10	and	CC	O	and	_	0	SENT_132	[p6l371t550r478b603],
11	localisation	NN	O	localisation	conj_and	9	SENT_132	[p6l518t550r867b603],
12	of	IN	O	of	_	0	SENT_132	[p6l909t550r974b603],
13	the	DT	O	the	det	14	SENT_132	[p6l1009t550r1099b603],
14	relapse	NN	O	relapse	prep_of	6	SENT_132	[p6l1140t550r1369b619],
15	.	.	O	.	_	0	SENT_132	[p6l1140t550r1369b619],

1	Of	IN	O	of	_	0	SENT_133	[p6l1414t550r1496b604],
2	seven	CD	NUMBER	seven	num	3	SENT_133	[p6l1533t567r1701b603],
3	patients	NNS	O	patient	prep_of	10	SENT_133	[p6l1739t550r1973b619],
4	with	IN	O	with	_	0	SENT_133	[p6l2015t550r2148b603],
5	peritoneal	JJ	O	peritoneal	amod	6	SENT_133	[p6l7t639r310b707],
6	relapse	NN	O	relapse	prep_with	3	SENT_133	[p6l332t639r563b707],
7	,	,	O	,	_	0	SENT_133	[p6l332t639r563b707],
8	ﬁve	NN	O	ﬁve	nsubj	10	SENT_133	[p6l590t638r697b692],
9	were	VBD	O	be	cop	10	SENT_133	[p6l718t655r863b692],
10	homozygous	JJ	O	homozygous	_	0	SENT_133	[p6l886t638r1271b707],
11	and	CC	O	and	_	0	SENT_133	[p6l1296t639r1403b692],
12	two	CD	NUMBER	two	nsubj	14	SENT_133	[p6l1425t647r1535b692],
13	were	VBD	O	be	cop	14	SENT_133	[p6l1557t655r1702b692],
14	heterozygous	JJ	O	heterozygous	conj_and	10	SENT_133	[p6l1725t639r2143b707],
15	.	.	O	.	_	0	SENT_133	[p6l1725t639r2143b707],

1	Of	IN	O	of	_	0	SENT_134	[p6l9t727r91b780],
2	12	CD	NUMBER	12	num	3	SENT_134	[p6l112t727r178b779],
3	patients	NNS	O	patient	prep_of	10	SENT_134	[p6l197t727r431b795],
4	with	IN	O	with	_	0	SENT_134	[p6l452t727r586b780],
5	distant	JJ	O	distant	amod	6	SENT_134	[p6l605t727r806b780],
6	metastases	NNS	O	metastase	prep_with	3	SENT_134	[p6l824t735r1164b789],
7	,	,	O	,	_	0	SENT_134	[p6l824t735r1164b789],
8	6	CD	NUMBER	6	nsubj	10	SENT_134	[p6l1188t727r1221b780],
9	were	VBD	O	be	cop	10	SENT_134	[p6l1242t743r1386b780],
10	homozygous	JJ	O	homozygous	_	0	SENT_134	[p6l1406t727r1791b795],
11	and	CC	O	and	_	0	SENT_134	[p6l1813t727r1920b780],
12	other	JJ	O	other	conj_and	10	SENT_134	[p6l1940t727r2095b780],
13	6	CD	NUMBER	6	tmod	10	SENT_134	[p6l2113t727r2147b780],
14	were	VBD	O	be	cop	15	SENT_134	[p6l9t831r153b868],
15	heterozygous	JJ	O	heterozygous	rcmod	13	SENT_134	[p6l178t815r596b883],
16	.	.	O	.	_	0	SENT_134	[p6l178t815r596b883],

1	When	WRB	O	when	advmod	3	SENT_135	[p6l100t903r281b956],
2	we	PRP	O	we	nsubj	3	SENT_135	[p6l305t919r391b956],
3	analysed	VBD	O	analyse	advcl	20	SENT_135	[p6l416t903r679b971],
4	the	DT	O	the	det	5	SENT_135	[p6l703t903r793b956],
5	survival	NN	O	survival	dobj	3	SENT_135	[p6l819t902r1056b956],
6	according	VBG	O	accord	_	0	SENT_135	[p6l1081t902r1377b971],
7	the	DT	O	the	det	9	SENT_135	[p6l1402t903r1492b956],
8	genomic	JJ	O	genomic	amod	9	SENT_135	[p6l1516t902r1775b971],
9	frequencies	NNS	O	frequency	prep_according	5	SENT_135	[p6l1799t902r2146b971],
10	for	IN	O	for	_	0	SENT_135	[p6l8t991r96b1044],
11	all	DT	O	all	det	12	SENT_135	[p6l135t991r207b1044],
12	genes	NNS	O	gene	prep_for	9	SENT_135	[p6l248t1007r416b1059],
13	analysed	VBN	O	analyse	partmod	12	SENT_135	[p6l458t991r737b1059],
14	,	,	O	,	_	0	SENT_135	[p6l458t991r737b1059],
15	no	DT	O	no	det	18	SENT_135	[p6l779t1007r851b1044],
16	statistically	RB	O	statistically	advmod	17	SENT_135	[p6l894t991r1236b1059],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_135	[p6l1279t991r1592b1059],
18	differences	NNS	O	difference	nsubjpass	20	SENT_135	[p6l1629t991r1962b1044],
19	were	VBD	O	be	auxpass	20	SENT_135	[p6l2003t1007r2147b1044],
20	observed	VBN	O	observe	_	0	SENT_135	[p6l9t1079r294b1132],
21	.	.	O	.	_	0	SENT_135	[p6l9t1079r294b1132],

1	There	EX	O	there	expl	2	SENT_136	[p6l318t1079r493b1132],
2	is	VBZ	O	be	_	0	SENT_136	[p6l514t1079r561b1132],
3	only	RB	O	only	advmod	2	SENT_136	[p6l583t1079r715b1147],
4	a	DT	O	a	det	5	SENT_136	[p6l737t1095r768b1132],
5	tendency	NN	O	tendency	nsubj	2	SENT_136	[p6l787t1079r1060b1147],
6	to	TO	O	to	_	0	SENT_136	[p6l1079t1087r1136b1132],
7	statistical	JJ	O	statistical	amod	8	SENT_136	[p6l1159t1079r1442b1132],
8	signiﬁcance	NN	O	signiﬁcance	prep_to	5	SENT_136	[p6l1466t1079r1822b1147],
9	of	IN	O	of	_	0	SENT_136	[p6l1844t1079r1909b1132],
10	a	DT	O	a	det	12	SENT_136	[p6l1926t1095r1957b1132],
11	better	JJR	O	better	amod	12	SENT_136	[p6l1975t1079r2149b1132],
12	survival	NN	O	survival	prep_of	8	SENT_136	[p6l11t1167r247b1220],
13	in	IN	O	in	_	0	SENT_136	[p6l304t1167r362b1219],
14	those	DT	O	those	det	15	SENT_136	[p6l418t1167r576b1220],
15	patients	NNS	O	patient	prep_in	12	SENT_136	[p6l632t1167r866b1236],
16	with	IN	O	with	_	0	SENT_136	[p6l925t1167r1058b1220],
17	heterozygous	JJ	O	heterozygous	amod	18	SENT_136	[p6l1114t1167r1516b1236],
18	SNPS	NNS	O	snp	prep_with	15	SENT_136	[p6l1577t1167r1738b1220],
19	of	IN	O	of	_	0	SENT_136	[p6l1798t1167r1863b1220],
20	DPYD1	NN	O	dpyd1	nn	22	SENT_136	[p6l1913t1167r2142b1219],
21	(	CD	NUMBER	(	num	22	SENT_136	[p6l10t1256r199b1321],
22	Table	NNP	O	Table	prep_of	18	SENT_136	[p6l10t1256r199b1321],
23	11	CD	NUMBER	11	number	24	SENT_136	[p6l224t1256r313b1321],
24	)	CD	NUMBER	)	num	22	SENT_136	[p6l224t1256r313b1321],
25	.	.	O	.	_	0	SENT_136	[p6l224t1256r313b1321],

1	Difference	NN	O	difference	nsubjpass	5	SENT_137	[p6l101t1345r423b1398],
2	in	IN	O	in	_	0	SENT_137	[p6l453t1345r510b1397],
3	survival	NN	O	survival	prep_in	1	SENT_137	[p6l541t1345r779b1398],
4	was	VBD	O	be	auxpass	5	SENT_137	[p6l809t1361r922b1398],
5	observed	VBN	O	observe	_	0	SENT_137	[p6l954t1345r1225b1398],
6	in	IN	O	in	_	0	SENT_137	[p6l1253t1345r1311b1397],
7	DPYDI	NN	O	dpydus	nn	8	SENT_137	[p6l1338t1345r1567b1397],
8	patients	NNS	O	patient	prep_in	5	SENT_137	[p6l1601t1345r1836b1413],
9	for	IN	O	for	_	0	SENT_137	[p6l1867t1345r1954b1398],
10	SNPs	NNS	O	snp	prep_for	5	SENT_137	[p6l1984t1345r2147b1398],
11	over	IN	O	over	_	0	SENT_137	[p6l9t1450r141b1486],
12	wild-type	JJ	O	wild-type	amod	35	SENT_137	[p6l162t1433r450b1502],
13	as	IN	O	as	_	0	SENT_137	[p6l474t1450r532b1486],
14	17	CD	NUMBER	17	num	15	SENT_137	[p6l563t1433r627b1486],
15	deaths	NNS	O	death	prep_as	12	SENT_137	[p6l652t1433r842b1486],
16	in	IN	O	in	_	0	SENT_137	[p6l865t1433r922b1485],
17	36	CD	NUMBER	36	num	18	SENT_137	[p6l946t1433r1017b1486],
18	patients	NNS	O	patient	prep_in	15	SENT_137	[p6l1039t1433r1273b1502],
19	wild-type	JJ	O	wild-type	nsubjpass	29	SENT_137	[p6l1297t1433r1586b1502],
20	versus	CC	O	versus	prep	19	SENT_137	[p6l1607t1450r1796b1486],
21	2	CD	NUMBER	2	num	22	SENT_137	[p6l1820t1433r1854b1485],
22	deaths	NNS	O	death	dep	20	SENT_137	[p6l1878t1433r2067b1486],
23	in	IN	O	in	_	0	SENT_137	[p6l2090t1433r2148b1485],
24	14	CD	NUMBER	14	num	25	SENT_137	[p6l15t1521r81b1573],
25	patients	NNS	O	patient	prep_in	22	SENT_137	[p6l118t1520r352b1589],
26	with	IN	O	with	_	0	SENT_137	[p6l392t1520r524b1574],
27	SNPS	NNS	O	snp	prep_with	25	SENT_137	[p6l563t1521r725b1574],
28	were	VBD	O	be	auxpass	29	SENT_137	[p6l765t1537r909b1574],
29	observed	VBN	O	observe	rcmod	18	SENT_137	[p6l948t1520r1234b1583],
30	,	,	O	,	_	0	SENT_137	[p6l948t1520r1234b1583],
31	P	NN	O	p	appos	18	SENT_137	[p6l1272t1521r1610b1574],
32	=	JJ	O	=	amod	31	SENT_137	[p6l1272t1521r1610b1574],
33	0.0214	CD	NUMBER	0.0214	number	34	SENT_137	[p6l1272t1521r1610b1574],
34	(	CD	NUMBER	(	dep	32	SENT_137	[p6l1651t1520r1788b1589],
35	Fig	NN	O	fig	prep_over	10	SENT_137	[p6l1651t1520r1788b1589],
36	.	.	O	.	_	0	SENT_137	[p6l1651t1520r1788b1589],

1	1	CD	NUMBER	1	num	2	SENT_138	[p6l1836t1521r1906b1586],
2	)	NN	O	)	nsubj	12	SENT_138	[p6l1836t1521r1906b1586],
3	,	,	O	,	_	0	SENT_138	[p6l1836t1521r1906b1586],
4	and	CC	O	and	dep	2	SENT_138	[p6l1947t1521r2054b1574],
5	in	IN	O	in	dep	4	SENT_138	[p6l2091t1520r2148b1573],
6	any	DT	O	any	det	7	SENT_138	[p6l10t1625r115b1677],
7	heterozygous	NN	O	heterozygous	pobj	5	SENT_138	[p6l142t1609r545b1678],
8	of	IN	O	of	_	0	SENT_138	[p6l575t1609r641b1662],
9	the	DT	O	the	det	11	SENT_138	[p6l664t1609r754b1662],
10	3	CD	NUMBER	3	num	11	SENT_138	[p6l785t1609r815b1662],
11	genes	NNS	O	gene	prep_of	7	SENT_138	[p6l848t1625r1017b1677],
12	tested	VBN	O	test	_	0	SENT_138	[p6l1046t1609r1222b1662],
13	over	IN	O	over	_	0	SENT_138	[p6l1251t1625r1383b1662],
14	homozygous	JJ	O	homozygous	amod	15	SENT_138	[p6l1409t1609r1794b1677],
15	patients	NNS	O	patient	prep_over	12	SENT_138	[p6l1823t1609r2057b1677],
16	as	IN	O	as	mark	31	SENT_138	[p6l2088t1625r2147b1662],
17	11	CD	NUMBER	11	num	18	SENT_138	[p6l16t1697r75b1749],
18	deaths	NNS	O	death	nsubjpass	31	SENT_138	[p6l139t1697r330b1750],
19	in	IN	O	in	_	0	SENT_138	[p6l389t1697r446b1749],
20	15	CD	NUMBER	15	num	22	SENT_138	[p6l510t1697r573b1750],
21	homozygous	JJ	O	homozygous	amod	22	SENT_138	[p6l633t1697r1018b1766],
22	patients	NNS	O	patient	prep_in	18	SENT_138	[p6l1076t1697r1310b1766],
23	versus	CC	O	versus	prep	22	SENT_138	[p6l1370t1714r1559b1750],
24	8	CD	NUMBER	8	num	25	SENT_138	[p6l1620t1697r1650b1750],
25	deaths	NNS	O	death	dep	23	SENT_138	[p6l1711t1697r1901b1750],
26	in	IN	O	in	_	0	SENT_138	[p6l1959t1697r2017b1749],
27	35	CD	NUMBER	35	num	29	SENT_138	[p6l2076t1697r2145b1750],
28	heterozygous	JJ	O	heterozygous	amod	29	SENT_138	[p6l8t1784r410b1853],
29	patients	NNS	O	patient	prep_in	25	SENT_138	[p6l436t1784r670b1853],
30	were	VBD	O	be	auxpass	31	SENT_138	[p6l696t1801r841b1837],
31	observed	VBN	O	observe	dep	15	SENT_138	[p6l867t1784r1154b1847],
32	,	,	O	,	_	0	SENT_138	[p6l867t1784r1154b1847],
33	P	NN	O	p	appos	15	SENT_138	[p6l1181t1786r1227b1837],
34	=	JJ	O	=	amod	33	SENT_138	[p6l1244t1808r1295b1826],
35	0.0017	CD	NUMBER	0.0017	number	36	SENT_138	[p6l1313t1784r1517b1837],
36	(	CD	NUMBER	(	num	37	SENT_138	[p6l1546t1784r1683b1853],
37	Fig	NN	O	fig	dep	33	SENT_138	[p6l1546t1784r1683b1853],
38	.	.	O	.	_	0	SENT_138	[p6l1546t1784r1683b1853],

1	2	CD	NUMBER	2	num	2	SENT_139	[p6l1713t1785r1788b1850],
2	)	CD	NUMBER	)	_	0	SENT_139	[p6l1713t1785r1788b1850],
3	.	.	O	.	_	0	SENT_139	[p6l1713t1785r1788b1850],

1	When	WRB	O	when	advmod	6	SENT_140	[p6l101t1873r281b1926],
2	relapses	NNS	O	relapse	nsubjpass	6	SENT_140	[p6l302t1873r544b1941],
3	and	CC	O	and	_	0	SENT_140	[p6l569t1873r676b1926],
4	survival	NN	O	survival	conj_and	2	SENT_140	[p6l699t1873r936b1926],
5	are	VBP	O	be	auxpass	6	SENT_140	[p6l959t1889r1048b1926],
6	analysed	VBN	O	analyse	advcl	13	SENT_140	[p6l1072t1873r1335b1941],
7	according	VBG	O	accord	_	0	SENT_140	[p6l1358t1873r1654b1941],
8	the	DT	O	the	det	9	SENT_140	[p6l1677t1873r1767b1926],
9	genotype	NN	O	genotype	prep_according	6	SENT_140	[p6l1789t1881r2065b1941],
10	of	IN	O	of	_	0	SENT_140	[p6l2088t1873r2153b1926],
11	CDA	NNP	ORGANIZATION	CDA	prep_of	9	SENT_140	[p6l12t1962r153b2015],
12	we	PRP	O	we	nsubj	13	SENT_140	[p6l177t1978r262b2014],
13	observed	VBD	O	observe	_	0	SENT_140	[p6l291t1961r563b2014],
14	no	DT	O	no	det	16	SENT_140	[p6l589t1978r662b2014],
15	statistical	JJ	O	statistical	amod	16	SENT_140	[p6l693t1961r975b2014],
16	differences	NNS	O	difference	dobj	13	SENT_140	[p6l1004t1961r1336b2014],
17	whether	IN	O	whether	complm	22	SENT_140	[p6l1366t1961r1609b2014],
18	or	CC	O	or	_	0	SENT_140	[p6l1637t1978r1698b2014],
19	not	RB	O	not	conj_or	22	SENT_140	[p6l1724t1969r1821b2014],
20	they	PRP	O	they	nsubj	22	SENT_140	[p6l1847t1961r1975b2030],
21	were	VBD	O	be	cop	22	SENT_140	[p6l2003t1978r2147b2014],
22	SNPS	NN	O	snp	ccomp	13	SENT_140	[p6l10t2049r172b2101],
23	or	CC	O	or	_	0	SENT_140	[p6l199t2065r261b2101],
24	whether	IN	O	whether	dep	29	SENT_140	[p6l285t2048r529b2101],
25	or	CC	O	or	_	0	SENT_140	[p6l553t2065r615b2101],
26	not	RB	O	not	conj_or	29	SENT_140	[p6l638t2056r734b2101],
27	they	PRP	O	they	nsubj	29	SENT_140	[p6l758t2048r886b2117],
28	were	VBD	O	be	cop	29	SENT_140	[p6l912t2065r1056b2101],
29	homozygous	JJ	O	homozygous	conj_or	13	SENT_140	[p6l1081t2048r1483b2117],
30	.	.	O	.	_	0	SENT_140	[p6l1081t2048r1483b2117],

1	When	WRB	O	when	advmod	3	SENT_141	[p6l100t2136r281b2189],
2	we	PRP	O	we	nsubj	3	SENT_141	[p6l309t2153r394b2189],
3	analysed	VBD	O	analyse	advcl	24	SENT_141	[p6l424t2136r687b2205],
4	the	DT	O	the	det	5	SENT_141	[p6l714t2136r805b2189],
5	polymorphisms	NNS	O	polymorphism	dobj	3	SENT_141	[p6l832t2136r1302b2205],
6	of	IN	O	of	_	0	SENT_141	[p6l1332t2136r1397b2189],
7	both	DT	O	both	det	8	SENT_141	[p6l1418t2136r1552b2189],
8	genes	NNS	O	gene	prep_of	5	SENT_141	[p6l1581t2153r1749b2205],
9	in	IN	O	in	_	0	SENT_141	[p6l1778t2136r1835b2189],
10	combination	NN	O	combination	nn	12	SENT_141	[p6l1863t2136r2146b2189, p6l8t2225r125b2278],
11	(	CD	NUMBER	(	num	12	SENT_141	[p6l147t2226r315b2291],
12	CDA	NNP	ORGANIZATION	CDA	prep_in	3	SENT_141	[p6l147t2226r315b2291],
13	and	CC	O	and	_	0	SENT_141	[p6l340t2225r447b2278],
14	DPYDI	NNP	O	DPYDI	conj_and	12	SENT_141	[p6l464t2225r723b2290],
15	)	CD	NUMBER	)	num	14	SENT_141	[p6l464t2225r723b2290],
16	for	IN	O	for	_	0	SENT_141	[p6l746t2225r834b2278],
17	any	DT	O	any	det	18	SENT_141	[p6l854t2242r960b2294],
18	homozygous	JJ	O	homozygous	prep_for	3	SENT_141	[p6l980t2225r1365b2294],
19	versus	CC	O	versus	prep	18	SENT_141	[p6l1387t2242r1577b2278],
20	any	DT	O	any	det	21	SENT_141	[p6l1599t2242r1705b2294],
21	heterozygous	JJ	O	heterozygous	dep	19	SENT_141	[p6l1725t2225r2145b2294],
22	,	,	O	,	_	0	SENT_141	[p6l1725t2225r2145b2294],
23	we	PRP	O	we	nsubj	24	SENT_141	[p6l9t2330r94b2366],
24	observed	VBD	O	observe	_	0	SENT_141	[p6l114t2313r386b2366],
25	that	IN	O	that	complm	41	SENT_141	[p6l404t2313r517b2366],
26	12	CD	NUMBER	12	npadvmod	41	SENT_141	[p6l543t2313r608b2365],
27	out	IN	O	out	_	0	SENT_141	[p6l629t2321r724b2366],
28	of	IN	O	of	_	0	SENT_141	[p6l743t2313r809b2366],
29	26	CD	NUMBER	26	num	32	SENT_141	[p6l824t2313r895b2366],
30	homozygous	JJ	O	homozygous	amod	32	SENT_141	[p6l915t2313r1300b2382],
31	genotype	NN	O	genotype	nn	32	SENT_141	[p6l1322t2321r1597b2382],
32	patients	NNS	O	patient	prep_out_of	41	SENT_141	[p6l1616t2313r1850b2382],
33	and	CC	O	and	_	0	SENT_141	[p6l1873t2313r1979b2366],
34	7	CD	NUMBER	7	prep_out_of	41	SENT_141	[p6l1999t2314r2032b2366],
35	out	IN	O	out	_	0	SENT_141	[p6l2054t2321r2149b2366],
36	of	IN	O	of	_	0	SENT_141	[p6l9t2400r74b2453],
37	24	CD	NUMBER	24	num	40	SENT_141	[p6l100t2400r173b2453],
38	heterozygous	JJ	O	heterozygous	amod	40	SENT_141	[p6l203t2400r605b2469],
39	genotype	NN	O	genotype	nn	40	SENT_141	[p6l638t2408r914b2469],
40	patients	NNS	O	patient	prep_out_of	41	SENT_141	[p6l944t2400r1178b2469],
41	relapsed	VBD	O	relapse	dep	24	SENT_141	[p6l1210t2400r1462b2469],
42	(	CD	NUMBER	(	num	43	SENT_141	[p6l1495t2400r1848b2469],
43	Chi-square	NN	O	chi-square	nsubj	44	SENT_141	[p6l1495t2400r1848b2469],
44	=	JJ	O	=	xcomp	41	SENT_141	[p6l1867t2424r1918b2442],
45	0.345	CD	NUMBER	0.345	num	46	SENT_141	[p6l1936t2400r2144b2466],
46	)	NN	O	)	nsubj	41	SENT_141	[p6l1936t2400r2144b2466],
47	.	.	O	.	_	0	SENT_141	[p6l1936t2400r2144b2466],

1	Furthermore	RB	O	furthermore	advmod	4	SENT_142	[p6l8t2489r402b2551],
2	,	,	O	,	_	0	SENT_142	[p6l8t2489r402b2551],
3	there	EX	O	there	expl	4	SENT_142	[p6l470t2489r620b2542],
4	were	VBD	O	be	_	0	SENT_142	[p6l684t2506r829b2542],
5	no	DT	O	no	det	7	SENT_142	[p6l895t2506r968b2542],
6	statistical	JJ	O	statistical	amod	7	SENT_142	[p6l1037t2489r1320b2542],
7	differences	NNS	O	difference	nsubj	4	SENT_142	[p6l1386t2489r1719b2542],
8	in	IN	O	in	_	0	SENT_142	[p6l1786t2489r1843b2541],
9	survival	NN	O	survival	nn	11	SENT_142	[p6l1911t2489r2147b2542],
10	(	CD	NUMBER	(	num	11	SENT_142	[p6l10t2579r78b2643],
11	P	NN	O	p	prep_in	7	SENT_142	[p6l10t2579r78b2643],
12	:	:	O	:	_	0	SENT_142	[p6l95t2602r147b2620],
13	0.4231	CD	NUMBER	0.4231	num	14	SENT_142	[p6l164t2578r410b2644],
14	)	NN	O	)	dep	7	SENT_142	[p6l164t2578r410b2644],
15	.	.	O	.	_	0	SENT_142	[p6l164t2578r410b2644],

1	When	WRB	O	when	advmod	3	SENT_143	[p6l100t2665r281b2718],
2	we	PRP	O	we	nsubj	3	SENT_143	[p6l301t2682r387b2718],
3	analysed	VBD	O	analyse	advcl	20	SENT_143	[p6l408t2665r671b2734],
4	the	DT	O	the	det	6	SENT_143	[p6l690t2665r781b2718],
5	relapse	NN	O	relapse	nn	6	SENT_143	[p6l800t2665r1014b2734],
6	rate	NN	O	rate	dobj	3	SENT_143	[p6l1033t2673r1146b2718],
7	and	CC	O	and	_	0	SENT_143	[p6l1168t2665r1275b2718],
8	survival	NN	O	survival	dobj	3	SENT_143	[p6l1296t2665r1533b2718],
9	for	IN	O	for	_	0	SENT_143	[p6l1553t2665r1640b2718],
10	the	DT	O	the	det	11	SENT_143	[p6l1658t2665r1749b2718],
11	combination	NN	O	combination	prep_for	6	SENT_143	[p6l1770t2665r2148b2718],
12	of	IN	O	of	_	0	SENT_143	[p6l9t2753r74b2806],
13	both	DT	O	both	det	15	SENT_143	[p6l103t2753r237b2806],
14	genes	NNS	O	gene	nn	15	SENT_143	[p6l273t2770r441b2822],
15	DPYD2	NN	O	dpyd2	prep_of	11	SENT_143	[p6l476t2754r708b2806],
16	and	CC	O	and	_	0	SENT_143	[p6l747t2753r854b2806],
17	CDA	NNP	ORGANIZATION	CDA	prep_of	11	SENT_143	[p6l892t2754r1033b2807],
18	we	PRP	O	we	nsubj	20	SENT_143	[p6l1065t2770r1150b2806],
19	can	MD	O	can	aux	20	SENT_143	[p6l1186t2770r1289b2806],
20	observe	VB	O	observe	_	0	SENT_143	[p6l1325t2753r1558b2806],
21	that	IN	O	that	complm	42	SENT_143	[p6l1592t2753r1706b2806],
22	11	CD	NUMBER	11	nsubj	42	SENT_143	[p6l1747t2754r1807b2806],
23	out	IN	O	out	_	0	SENT_143	[p6l1850t2761r1945b2806],
24	of	IN	O	of	_	0	SENT_143	[p6l1979t2753r2045b2806],
25	17	CD	NUMBER	17	num	27	SENT_143	[p6l2082t2754r2146b2806],
26	homozygous	JJ	O	homozygous	amod	27	SENT_143	[p6l8t2842r393b2911],
27	patients	NNS	O	patient	prep_out_of	22	SENT_143	[p6l417t2842r651b2911],
28	and	CC	O	and	_	0	SENT_143	[p6l678t2842r784b2895],
29	8	CD	NUMBER	8	prep_out_of	22	SENT_143	[p6l811t2842r841b2895],
30	out	IN	O	out	advmod	42	SENT_143	[p6l868t2850r963b2895],
31	33	CD	NUMBER	33	pobj	30	SENT_143	[p6l988t2842r1056b2895],
32	in	IN	O	in	_	0	SENT_143	[p6l1083t2842r1141b2894],
33	heterozygous	JJ	O	heterozygous	amod	34	SENT_143	[p6l1164t2842r1566b2911],
34	patients	NNS	O	patient	prep_in	30	SENT_143	[p6l1590t2842r1825b2911],
35	(	RB	O	(	advmod	30	SENT_143	[p6l1852t2842r1933b2907],
36	in	IN	O	in	_	0	SENT_143	[p6l1852t2842r1933b2907],
37	any	DT	O	any	prep_in	30	SENT_143	[p6l1957t2859r2063b2911],
38	of	IN	O	of	_	0	SENT_143	[p6l2088t2842r2153b2895],
39	both	DT	O	both	det	40	SENT_143	[p6l7t2929r142b2982],
40	genes	NNS	O	gene	prep_of	37	SENT_143	[p6l194t2930r388b2998],
41	)	IN	O	)	amod	40	SENT_143	[p6l194t2930r388b2998],
42	relapsed	VBN	O	relapse	ccomp	20	SENT_143	[p6l441t2929r709b2998],
43	,	,	O	,	_	0	SENT_143	[p6l441t2929r709b2998],
44	and	CC	O	and	_	0	SENT_143	[p6l766t2929r873b2982],
45	survival	NN	O	survival	nn	46	SENT_143	[p6l927t2929r1164b2982],
46	differences	NNS	O	difference	nsubj	49	SENT_143	[p6l1218t2929r1550b2982],
47	were	VBD	O	be	cop	49	SENT_143	[p6l1604t2946r1749b2982],
48	statistically	RB	O	statistically	advmod	49	SENT_143	[p6l1805t2929r2147b2998],
49	signiﬁcant	JJ	O	signiﬁcant	conj_and	20	SENT_143	[p6l11t3017r322b3086],
50	in	IN	O	in	_	0	SENT_143	[p6l347t3017r404b3070],
51	favour	NN	O	favour	prep_in	49	SENT_143	[p6l429t3017r625b3071],
52	of	IN	O	of	_	0	SENT_143	[p6l650t3017r715b3070],
53	heterozygous	JJ	O	heterozygous	amod	54	SENT_143	[p6l734t3017r1136b3086],
54	patients	NNS	O	patient	prep_of	51	SENT_143	[p6l1162t3017r1396b3086],
55	(	IN	O	(	_	0	SENT_143	[p6l1425t3018r1493b3083],
56	P	NN	O	p	prep_(	49	SENT_143	[p6l1425t3018r1493b3083],
57	:	:	O	:	_	0	SENT_143	[p6l1510t3041r1561b3059],
58	0.0170	CD	NUMBER	0.0170	dep	56	SENT_143	[p6l1579t3018r1803b3080],
59	;	:	O	;	_	0	SENT_143	[p6l1579t3018r1803b3080],
60	Fig	NN	O	fig	dep	56	SENT_143	[p6l1831t3017r1945b3086],
61	.	.	O	.	_	0	SENT_143	[p6l1831t3017r1945b3086],

1	3	CD	NUMBER	3	_	0	SENT_144	[p6l1976t3018r2050b3083],
2	)	NN	O	)	dep	1	SENT_144	[p6l1976t3018r2050b3083],
3	.	.	O	.	_	0	SENT_144	[p6l1976t3018r2050b3083],

1	Nevertheless	RB	O	nevertheless	advmod	29	SENT_145	[p6l101t3105r506b3168],
2	,	,	O	,	_	0	SENT_145	[p6l101t3105r506b3168],
3	comparing	VBG	O	compare	partmod	29	SENT_145	[p6l545t3105r867b3174],
4	any	DT	O	any	det	7	SENT_145	[p6l905t3122r1010b3174],
5	wild-type	JJ	O	wild-type	amod	7	SENT_145	[p6l1046t3105r1335b3174],
6	(	NN	O	(	nn	7	SENT_145	[p6l1373t3106r1501b3171],
7	n	NN	O	n	dobj	3	SENT_145	[p6l1373t3106r1501b3171],
8	:	:	O	:	_	0	SENT_145	[p6l1373t3106r1501b3171],
9	8	CD	NUMBER	8	number	10	SENT_145	[p6l1521t3106r1577b3171],
10	)	CD	NUMBER	)	nsubj	14	SENT_145	[p6l1521t3106r1577b3171],
11	versus	CC	O	versus	prep	10	SENT_145	[p6l1614t3122r1804b3158],
12	any	DT	O	any	det	13	SENT_145	[p6l1842t3122r1948b3174],
13	SNPs	NNS	O	snp	dep	11	SENT_145	[p6l1985t3106r2147b3159],
14	(	VBP	O	(	dep	7	SENT_145	[p6l10t3193r270b3259],
15	n	NN	O	n	dobj	14	SENT_145	[p6l10t3193r270b3259],
16	=	JJ	O	=	advmod	14	SENT_145	[p6l10t3193r270b3259],
17	42	CD	NUMBER	42	num	18	SENT_145	[p6l10t3193r270b3259],
18	)	NN	O	)	dep	16	SENT_145	[p6l10t3193r270b3259],
19	,	,	O	,	_	0	SENT_145	[p6l10t3193r270b3259],
20	6	CD	NUMBER	6	number	22	SENT_145	[p6l311t3193r345b3246],
21	out	IN	O	out	quantmod	22	SENT_145	[p6l385t3201r480b3246],
22	8	CD	NUMBER	8	num	23	SENT_145	[p6l520t3193r550b3246],
23	patients	NNS	O	patient	nsubj	29	SENT_145	[p6l590t3193r823b3262],
24	versus	CC	O	versus	prep	23	SENT_145	[p6l863t3210r1053b3246],
25	13	CD	NUMBER	13	dep	24	SENT_145	[p6l1098t3194r1161b3246],
26	out	IN	O	out	advmod	29	SENT_145	[p6l1204t3201r1299b3246],
27	42	CD	NUMBER	42	num	28	SENT_145	[p6l1335t3193r1408b3246],
28	patients	NNS	O	patient	pobj	26	SENT_145	[p6l1446t3193r1680b3262],
29	relapsed	VBD	O	relapse	_	0	SENT_145	[p6l1719t3193r1987b3262],
30	,	,	O	,	_	0	SENT_145	[p6l1719t3193r1987b3262],
31	also	RB	O	also	advmod	29	SENT_145	[p6l2029t3193r2147b3246],
32	without	IN	O	without	_	0	SENT_145	[p6l9t3282r239b3336],
33	statistical	JJ	O	statistical	amod	34	SENT_145	[p6l266t3282r549b3335],
34	differences	NNS	O	difference	prep_without	29	SENT_145	[p6l575t3282r907b3335],
35	in	IN	O	in	_	0	SENT_145	[p6l934t3282r991b3335],
36	survival	NN	O	survival	nn	38	SENT_145	[p6l1018t3282r1255b3336],
37	(	CD	NUMBER	(	num	38	SENT_145	[p6l1283t3283r1351b3348],
38	P	NN	O	p	prep_in	29	SENT_145	[p6l1283t3283r1351b3348],
39	=	JJ	O	=	amod	38	SENT_145	[p6l1368t3306r1419b3325],
40	0.1054	CD	NUMBER	0.1054	num	41	SENT_145	[p6l1437t3282r1683b3348],
41	)	NN	O	)	dep	39	SENT_145	[p6l1437t3282r1683b3348],
42	.	.	O	.	_	0	SENT_145	[p6l1437t3282r1683b3348],

1	Otherwise	RB	O	otherwise	advmod	15	SENT_146	[p7l103t18r428b81],
2	,	,	O	,	_	0	SENT_146	[p7l103t18r428b81],
3	of	IN	O	of	_	0	SENT_146	[p7l464t18r530b71],
4	33	CD	NUMBER	33	num	6	SENT_146	[p7l559t19r627b72],
5	heterozygous	JJ	O	heterozygous	amod	6	SENT_146	[p7l663t18r1065b87],
6	patients	NNS	O	patient	prep_of	15	SENT_146	[p7l1098t18r1350b87],
7	,	,	O	,	_	0	SENT_146	[p7l1098t18r1350b87],
8	both	DT	O	both	det	9	SENT_146	[p7l1385t18r1519b71],
9	genes	NNS	O	gene	nsubj	15	SENT_146	[p7l1553t35r1739b87],
10	,	,	O	,	_	0	SENT_146	[p7l1553t35r1739b87],
11	DPYD2	NN	O	dpyd2	conj_and	9	SENT_146	[p7l1772t19r2005b71],
12	and	CC	O	and	_	0	SENT_146	[p7l2042t18r2149b71],
13	CDA	NNP	ORGANIZATION	CDA	conj_and	9	SENT_146	[p7l12t107r153b160],
14	were	VBD	O	be	cop	15	SENT_146	[p7l174t123r318b160],
15	heterozygous	JJ	O	heterozygous	_	0	SENT_146	[p7l343t107r746b175],
16	together	RB	O	together	advmod	15	SENT_146	[p7l771t106r1021b175],
17	in	IN	O	in	_	0	SENT_146	[p7l1044t106r1102b159],
18	8	CD	NUMBER	8	num	19	SENT_146	[p7l1129t107r1159b160],
19	patients	NNS	O	patient	prep_in	15	SENT_146	[p7l1185t106r1420b175],
20	and	CC	O	and	_	0	SENT_146	[p7l1448t107r1554b160],
21	only	RB	O	only	advmod	23	SENT_146	[p7l1579t106r1710b175],
22	one	CD	NUMBER	one	num	23	SENT_146	[p7l1737t123r1843b160],
23	gene	NN	O	gene	nsubj	25	SENT_146	[p7l1868t123r2009b175],
24	was	VBD	O	be	cop	25	SENT_146	[p7l2033t123r2147b160],
25	heterozygous	JJ	O	heterozygous	conj_and	15	SENT_146	[p7l8t194r410b263],
26	in	IN	O	in	_	0	SENT_146	[p7l452t194r509b247],
27	the	DT	O	the	det	30	SENT_146	[p7l549t194r640b247],
28	25	CD	NUMBER	25	num	30	SENT_146	[p7l682t194r751b248],
29	other	JJ	O	other	amod	30	SENT_146	[p7l796t194r951b247],
30	patients	NNS	O	patient	prep_in	25	SENT_146	[p7l988t194r1239b263],
31	.	.	O	.	_	0	SENT_146	[p7l988t194r1239b263],

1	When	WRB	O	when	advmod	2	SENT_147	[p7l1283t194r1463b247],
2	analysed	VBN	O	analyse	advcl	18	SENT_147	[p7l1506t194r1768b263],
3	the	DT	O	the	det	5	SENT_147	[p7l1808t194r1899b247],
4	overall	JJ	O	overall	amod	5	SENT_147	[p7l1941t194r2147b247],
5	survival	NN	O	survival	dobj	2	SENT_147	[p7l11t282r264b345],
6	,	,	O	,	_	0	SENT_147	[p7l11t282r264b345],
7	5	CD	NUMBER	5	npadvmod	2	SENT_147	[p7l289t282r320b336],
8	out	IN	O	out	_	0	SENT_147	[p7l345t291r440b335],
9	of	IN	O	of	_	0	SENT_147	[p7l462t282r527b335],
10	8	CD	NUMBER	8	num	11	SENT_147	[p7l545t283r576b336],
11	patients	NNS	O	patient	prep_out_of	2	SENT_147	[p7l598t282r833b351],
12	versus	CC	O	versus	_	0	SENT_147	[p7l855t299r1046b335],
13	3	CD	NUMBER	3	npadvmod	14	SENT_147	[p7l1069t283r1099b336],
14	out	IN	O	out	advmod	2	SENT_147	[p7l1125t290r1220b335],
15	of	IN	O	of	advcl	18	SENT_147	[p7l1241t282r1306b335],
16	25	CD	NUMBER	25	num	17	SENT_147	[p7l1323t282r1393b336],
17	patients	NNS	O	patient	pobj	15	SENT_147	[p7l1416t282r1651b351],
18	died	VBD	O	die	dep	26	SENT_147	[p7l1674t282r1803b335],
19	for	IN	O	for	_	0	SENT_147	[p7l1823t282r1911b335],
20	tumour	NN	O	tumour	nn	21	SENT_147	[p7l1930t290r2149b335],
21	relapse	NN	O	relapse	prep_for	18	SENT_147	[p7l7t370r221b439],
22	and	CC	O	and	_	0	SENT_147	[p7l241t371r348b424],
23	survival	NN	O	survival	prep_for	18	SENT_147	[p7l367t370r604b424],
24	was	VBD	O	be	cop	26	SENT_147	[p7l622t387r736b424],
25	statistically	RB	O	statistically	advmod	26	SENT_147	[p7l758t370r1100b439],
26	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_147	[p7l1121t370r1434b439],
27	in	IN	O	in	_	0	SENT_147	[p7l1450t371r1508b423],
28	favour	NN	O	favour	prep_in	26	SENT_147	[p7l1525t370r1721b424],
29	those	DT	O	those	det	30	SENT_147	[p7l1737t371r1895b424],
30	patients	NNS	O	patient	nsubj	26	SENT_147	[p7l1912t371r2146b439],
31	who	WP	O	who	nsubj	32	SENT_147	[p7l9t458r135b511],
32	have	VBP	O	have	rcmod	30	SENT_147	[p7l161t458r301b511],
33	only	RB	O	only	quantmod	34	SENT_147	[p7l327t458r459b527],
34	one	CD	NUMBER	one	num	38	SENT_147	[p7l485t475r591b511],
35	SNPs	NN	O	snp	nn	38	SENT_147	[p7l619t459r780b511],
36	gene	NN	O	gene	nn	38	SENT_147	[p7l808t475r948b527],
37	(	CD	NUMBER	(	num	38	SENT_147	[p7l976t459r1044b524],
38	P	NN	O	p	dobj	32	SENT_147	[p7l976t459r1044b524],
39	=	JJ	O	=	amod	38	SENT_147	[p7l1061t482r1112b500],
40	0.0012	CD	NUMBER	0.0012	tmod	39	SENT_147	[p7l1130t458r1353b521],
41	;	:	O	;	_	0	SENT_147	[p7l1130t458r1353b521],
42	Fig	NN	O	fig	dep	30	SENT_147	[p7l1382t458r1496b527],
43	.	.	O	.	_	0	SENT_147	[p7l1382t458r1496b527],

1	4	CD	NUMBER	4	_	0	SENT_148	[p7l1524t458r1601b524],
2	)	NN	O	)	dep	1	SENT_148	[p7l1524t458r1601b524],
3	.	.	O	.	_	0	SENT_148	[p7l1524t458r1601b524],

1	p	NN	O	p	_	0	SENT_149	[p7l1501t1205r1747b1262],
2	=	JJ	O	=	amod	1	SENT_149	[p7l1501t1205r1747b1262],
3	0.0214	CD	NUMBER	0.0214	tmod	2	SENT_149	[p7l1501t1205r1747b1262],

1	.5	NN	NUMBER	.5	_	0	SENT_150	[p7l51t1390r87b1432],
2	‘	CD	NUMBER	‘	num	1	SENT_150	[p7l755t1403r881b1451],
3	Ian	NNP	PERSON	Ian	dep	1	SENT_150	[p7l755t1403r881b1451],
4	.	.	O	.	_	0	SENT_150	[p7l755t1403r881b1451],

1	I	PRP	O	I	_	0	SENT_151	[p7l852t1467r883b1503],
2	Wild-type	JJ	O	wild-type	amod	3	SENT_151	[p7l1050t1463r1299b1522],
3	n	NN	O	n	dep	1	SENT_151	[p7l1563t1465r1693b1512],
4	=	JJ	O	=	amod	6	SENT_151	[p7l1563t1465r1693b1512],
5	36	CD	NUMBER	36	tmod	4	SENT_151	[p7l1563t1465r1693b1512],
6	LII	NN	O	lii	dep	3	SENT_151	[p7l852t1519r1769b1576],
7	---------	CD	NUMBER	---------	num	8	SENT_151	[p7l852t1519r1769b1576],
8	}	NN	O	}	dep	1	SENT_151	[p7l852t1519r1769b1576],

1	o	NN	O	o	_	0	SENT_152	[p7l172t2060r203b2108],
2	5	CD	NUMBER	5	number	3	SENT_152	[p7l820t2057r849b2104],
3	1	CD	NUMBER	1	dep	1	SENT_152	[p7l1479t2057r1497b2102],
4	o	NN	O	o	nn	5	SENT_152	[p7l1509t2055r1538b2104],
5	Years	NNS	DURATION	year	dep	3	SENT_152	[p7l1981t2055r2135b2102],

1	Fig	NN	O	fig	_	0	SENT_153	[p7l8t2196r122b2264],
2	.	.	O	.	_	0	SENT_153	[p7l8t2196r122b2264],

1	1	LS	NUMBER	1	_	0	SENT_154	[p7l161t2196r204b2249],
2	.	.	O	.	_	0	SENT_154	[p7l161t2196r204b2249],

1	Difference	NN	O	difference	nsubjpass	5	SENT_155	[p7l287t2196r608b2249],
2	in	IN	O	in	_	0	SENT_155	[p7l665t2196r722b2248],
3	survival	NN	O	survival	prep_in	1	SENT_155	[p7l781t2196r1018b2249],
4	was	VBD	O	be	auxpass	5	SENT_155	[p7l1074t2212r1188b2249],
5	observed	VBN	O	observe	_	0	SENT_155	[p7l1247t2196r1519b2249],
6	in	IN	O	in	_	0	SENT_155	[p7l1573t2196r1631b2248],
7	DPYD1	NN	O	dpyd1	nn	9	SENT_155	[p7l1684t2196r1914b2248],
8	(	CD	NUMBER	(	num	9	SENT_155	[p7l1979t2196r2148b2261],
9	A/G	NN	O	a/g	prep_in	5	SENT_155	[p7l1979t2196r2148b2261],
10	;	:	O	;	_	0	SENT_155	[p7l1979t2196r2148b2261],
11	Ile543Val	NN	O	ile543val	dep	9	SENT_155	[p7l8t2275r326b2341],
12	)	CD	NUMBER	)	num	13	SENT_155	[p7l8t2275r326b2341],
13	patients	NNS	O	patient	nsubj	18	SENT_155	[p7l400t2275r634b2344],
14	for	IN	O	for	_	0	SENT_155	[p7l708t2275r796b2328],
15	non-wild-type	JJ	O	non-wild-type	amod	17	SENT_155	[p7l867t2275r1295b2344],
16	(	NN	O	(	nn	17	SENT_155	[p7l1371t2276r1583b2341],
17	SNPs	NNS	O	snp	prep_for	13	SENT_155	[p7l1371t2276r1583b2341],
18	)	VBP	O	)	rcmod	11	SENT_155	[p7l1371t2276r1583b2341],
19	over	IN	O	over	_	0	SENT_155	[p7l1658t2292r1790b2328],
20	wild-type	JJ	O	wild-type	amod	22	SENT_155	[p7l1862t2275r2150b2344],
21	(	NN	O	(	nn	22	SENT_155	[p7l10t2356r79b2421],
22	P	NN	O	p	prep_over	18	SENT_155	[p7l10t2356r79b2421],
23	=	JJ	O	=	amod	22	SENT_155	[p7l95t2379r147b2397],
24	0.0214	CD	NUMBER	0.0214	num	25	SENT_155	[p7l165t2355r412b2421],
25	)	NN	O	)	dep	23	SENT_155	[p7l165t2355r412b2421],
26	.	.	O	.	_	0	SENT_155	[p7l165t2355r412b2421],

1	According	VBG	O	accord	_	0	SENT_156	[p7l102t2583r420b2652],
2	to	TO	O	to	prepc_according_to	10	SENT_156	[p7l440t2591r496b2636],
3	prognosis	NN	O	prognosis	pobj	10	SENT_156	[p7l514t2583r807b2652],
4	in	IN	O	in	_	0	SENT_156	[p7l827t2583r885b2636],
5	the	DT	O	the	det	7	SENT_156	[p7l903t2583r994b2636],
6	univariate	JJ	O	univariate	amod	7	SENT_156	[p7l1012t2583r1312b2636],
7	analysis	NN	O	analysis	prep_in	3	SENT_156	[p7l1333t2583r1573b2652],
8	we	PRP	O	we	nsubj	10	SENT_156	[p7l1594t2600r1679b2636],
9	can	MD	O	can	aux	10	SENT_156	[p7l1699t2600r1802b2636],
10	classiﬁed	VB	O	classiﬁed	_	0	SENT_156	[p7l1821t2583r2102b2636],
11	a	DT	O	a	det	13	SENT_156	[p7l2121t2600r2153b2636],
12	different	JJ	O	different	amod	13	SENT_156	[p7l9t2671r268b2724],
13	genotypes	NNS	O	genotype	dobj	10	SENT_156	[p7l292t2680r596b2740],
14	in	IN	O	in	_	0	SENT_156	[p7l622t2671r679b2724],
15	those	DT	O	those	prep_in	10	SENT_156	[p7l702t2671r860b2724],
16	with	IN	O	with	_	0	SENT_156	[p7l883t2671r1016b2724],
17	favourable	JJ	O	favourable	prep_with	15	SENT_156	[p7l1040t2671r1362b2725],
18	and	CC	O	and	_	0	SENT_156	[p7l1388t2671r1495b2724],
19	those	DT	O	those	prep_in	10	SENT_156	[p7l1518t2671r1676b2724],
20	with	IN	O	with	_	0	SENT_156	[p7l1699t2671r1832b2725],
21	unfavourable	JJ	O	unfavourable	amod	22	SENT_156	[p7l1855t2671r2150b2725, p7l10t2760r133b2813],
22	outcome	NN	O	outcome	prep_with	19	SENT_156	[p7l159t2768r418b2813],
23	(	CD	NUMBER	(	num	26	SENT_156	[p7l446t2760r635b2826],
24	Table	NNP	O	Table	nn	26	SENT_156	[p7l446t2760r635b2826],
25	III	NNP	O	III	nn	26	SENT_156	[p7l661t2761r775b2826],
26	)	NN	O	)	dep	19	SENT_156	[p7l661t2761r775b2826],
27	.	.	O	.	_	0	SENT_156	[p7l661t2761r775b2826],

1	Cox	NN	PERSON	cox	poss	5	SENT_157	[p7l103t2849r275b2902],
2	’s	POS	O	’s	_	0	SENT_157	[p7l103t2849r275b2902],
3	proportional	JJ	O	proportional	amod	5	SENT_157	[p7l338t2848r713b2917],
4	hazard	NN	O	hazard	nn	5	SENT_157	[p7l775t2849r977b2902],
5	model	NN	O	model	nsubj	12	SENT_157	[p7l1039t2848r1227b2902],
6	with	IN	O	with	_	0	SENT_157	[p7l1290t2848r1424b2902],
7	covariates	NNS	O	covariate	prep_with	5	SENT_157	[p7l1486t2848r1788b2902],
8	for	IN	O	for	_	0	SENT_157	[p7l1852t2848r1940b2902],
9	main	JJ	O	main	amod	11	SENT_157	[p7l2001t2849r2151b2902],
10	prognostic	JJ	O	prognostic	amod	11	SENT_157	[p7l7t2936r326b3005],
11	factors	NNS	O	factor	prep_for	7	SENT_157	[p7l365t2936r568b2989],
12	(	VBP	O	(	_	0	SENT_157	[p7l610t2937r753b3005],
13	age	NN	O	age	nn	20	SENT_157	[p7l610t2937r753b3005],
14	,	,	O	,	_	0	SENT_157	[p7l610t2937r753b3005],
15	gender	NN	O	gender	dep	20	SENT_157	[p7l794t2936r1012b3005],
16	,	,	O	,	_	0	SENT_157	[p7l794t2936r1012b3005],
17	staging	NN	O	staging	dep	20	SENT_157	[p7l1055t2936r1286b3005],
18	,	,	O	,	_	0	SENT_157	[p7l1055t2936r1286b3005],
19	positive	JJ	O	positive	amod	20	SENT_157	[p7l1326t2936r1564b3005],
20	lymph	NN	O	lymph	dobj	12	SENT_157	[p7l1601t2936r1794b3005],
21	nodes	NNS	O	node	nsubj	25	SENT_157	[p7l1831t2936r2005b2989],
22	and	CC	O	and	_	0	SENT_157	[p7l2045t2936r2152b2989],
23	polymorphisms	NNS	O	polymorphism	conj_and	21	SENT_157	[p7l7t3024r502b3093],
24	)	RB	O	)	advmod	25	SENT_157	[p7l7t3024r502b3093],
25	showed	VBD	O	show	rcmod	20	SENT_157	[p7l542t3024r768b3078],
26	that	IN	O	that	complm	34	SENT_157	[p7l803t3024r917b3077],
27	stage	NN	O	stage	nsubj	34	SENT_157	[p7l954t3032r1105b3093],
28	and	CC	O	and	_	0	SENT_157	[p7l1143t3024r1250b3077],
29	presence	NN	O	presence	conj_and	27	SENT_157	[p7l1283t3041r1548b3093],
30	of	IN	O	of	_	0	SENT_157	[p7l1584t3024r1650b3077],
31	polymorphisms	NNS	O	polymorphism	prep_of	27	SENT_157	[p7l1679t3024r2150b3093],
32	were	VBD	O	be	cop	34	SENT_157	[p7l9t3129r153b3166],
33	independent	JJ	O	independent	amod	34	SENT_157	[p7l182t3112r554b3181],
34	factors	NNS	O	factor	ccomp	25	SENT_157	[p7l582t3112r786b3166],
35	to	TO	O	to	aux	36	SENT_157	[p7l816t3121r872b3166],
36	predict	VB	O	predict	infmod	34	SENT_157	[p7l900t3112r1112b3181],
37	survival	NN	O	survival	dobj	36	SENT_157	[p7l1143t3112r1395b3166],
38	.	.	O	.	_	0	SENT_157	[p7l1143t3112r1395b3166],

1	Lower	JJR	O	lower	amod	2	SENT_158	[p7l1427t3114r1624b3166],
2	stages	NNS	O	stage	nsubj	3	SENT_158	[p7l1654t3120r1833b3181],
3	(	VBP	O	(	dep	8	SENT_158	[p7l1866t3113r1912b3178],
4	I	PRP	O	I	dobj	3	SENT_158	[p7l1866t3113r1912b3178],
5	and	CC	O	and	_	0	SENT_158	[p7l1943t3112r2050b3166],
6	II	CD	NUMBER	ii	num	7	SENT_158	[p7l2077t3113r2149b3178],
7	)	NN	O	)	dobj	3	SENT_158	[p7l2077t3113r2149b3178],
8	had	VBD	O	have	_	0	SENT_158	[p7l8t3200r117b3253],
9	better	JJR	O	better	amod	10	SENT_158	[p7l136t3200r310b3253],
10	survival	NN	O	survival	dobj	8	SENT_158	[p7l332t3200r568b3253],
11	versus	CC	O	versus	prep	10	SENT_158	[p7l590t3217r780b3253],
12	higher	JJR	O	higher	amod	13	SENT_158	[p7l801t3200r996b3269],
13	stages	NNS	O	stage	dep	11	SENT_158	[p7l1017t3208r1197b3269],
14	(	CD	NUMBER	(	number	19	SENT_158	[p7l1222t3201r1319b3266],
15	III	CD	NUMBER	iii	number	19	SENT_158	[p7l1222t3201r1319b3266],
16	and	CC	O	and	_	0	SENT_158	[p7l1340t3200r1447b3253],
17	IV	CD	NUMBER	iv	conj_and	19	SENT_158	[p7l1467t3201r1568b3266],
18	)	CD	NUMBER	)	number	19	SENT_158	[p7l1467t3201r1568b3266],
19	(	CD	NUMBER	(	num	20	SENT_158	[p7l1593t3201r1720b3266],
20	OR	NN	O	or	dep	13	SENT_158	[p7l1593t3201r1720b3266],
21	=	JJ	O	=	amod	20	SENT_158	[p7l1737t3224r1789b3242],
22	5.035	CD	NUMBER	5.035	tmod	21	SENT_158	[p7l1807t3200r1991b3263],
23	,	,	O	,	_	0	SENT_158	[p7l1807t3200r1991b3263],
24	95	CD	PERCENT	95	number	25	SENT_158	[p7l2015t3200r2148b3254],
25	%	NN	PERCENT	%	amod	26	SENT_158	[p7l2015t3200r2148b3254],
26	CI	NN	O	ci	appos	13	SENT_158	[p7l9t3289r98b3342],
27	:	:	O	:	_	0	SENT_158	[p7l9t3289r98b3342],
28	1.404	CD	NUMBER	1.404	number	29	SENT_158	[p7l130t3288r567b3351],
29	—	CD	NUMBER	—	dep	26	SENT_158	[p7l130t3288r567b3351],
30	l8	NN	O	l8	nsubj	8	SENT_158	[p7l130t3288r567b3351],
31	.059	CD	NUMBER	.059	num	30	SENT_158	[p7l130t3288r567b3351],
32	,	,	O	,	_	0	SENT_158	[p7l130t3288r567b3351],
33	P	NN	O	p	appos	30	SENT_158	[p7l588t3290r634b3341],
34	=	JJ	O	=	amod	36	SENT_158	[p7l652t3312r703b3330],
35	0.013	CD	NUMBER	0.013	tmod	34	SENT_158	[p7l720t3289r929b3354],
36	)	NN	O	)	dep	33	SENT_158	[p7l720t3289r929b3354],
37	.	.	O	.	_	0	SENT_158	[p7l720t3289r929b3354],

1	Patients	NNS	O	patient	nsubj	12	SENT_159	[p7l951t3288r1189b3341],
2	with	IN	O	with	_	0	SENT_159	[p7l1210t3288r1343b3342],
3	heterozygous	JJ	O	heterozygous	amod	4	SENT_159	[p7l1361t3288r1764b3357],
4	allele	NN	O	allele	prep_with	1	SENT_159	[p7l1787t3288r1948b3341],
5	in	IN	O	in	_	0	SENT_159	[p7l1968t3288r2025b3341],
6	any	DT	O	any	prep_in	4	SENT_159	[p7l2046t3305r2152b3357],
7	of	IN	O	of	_	0	SENT_159	[p7l9t3376r74b3430],
8	the	DT	O	the	det	9	SENT_159	[p7l98t3377r189b3430],
9	three	CD	NUMBER	three	prep_of	6	SENT_159	[p7l218t3377r368b3430],
10	tested	VBN	O	test	partmod	1	SENT_159	[p7l397t3376r574b3430],
11	genes	NNS	O	gene	dobj	10	SENT_159	[p7l602t3393r771b3445],
12	had	VBD	O	have	_	0	SENT_159	[p7l801t3376r910b3430],
13	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_159	[p7l941t3376r1254b3445],
14	worse	JJR	O	worse	dep	13	SENT_159	[p7l1282t3393r1460b3430],
15	survival	NN	O	survival	dobj	12	SENT_159	[p7l1492t3377r1729b3430],
16	than	IN	O	than	_	0	SENT_159	[p7l1758t3376r1887b3430],
17	patients	NNS	O	patient	prep_than	12	SENT_159	[p7l1915t3377r2150b3445],
18	with	IN	O	with	_	0	SENT_159	[p7l9t3465r142b3518],
19	all	DT	O	all	det	22	SENT_159	[p7l160t3465r233b3518],
20	homozygous	JJ	O	homozygous	amod	22	SENT_159	[p7l251t3465r636b3534],
21	(	NN	O	(	nn	22	SENT_159	[p7l657t3465r785b3530],
22	OR	NN	O	or	prep_with	12	SENT_159	[p7l657t3465r785b3530],
23	:	:	O	:	_	0	SENT_159	[p7l801t3489r853b3507],
24	5.630	CD	NUMBER	5.630	dep	22	SENT_159	[p7l871t3464r1055b3528],
25	,	,	O	,	_	0	SENT_159	[p7l871t3464r1055b3528],
26	95	CD	PERCENT	95	number	27	SENT_159	[p7l1076t3464r1209b3519],
27	%	NN	PERCENT	%	amod	28	SENT_159	[p7l1076t3464r1209b3519],
28	CI	NN	O	ci	appos	24	SENT_159	[p7l1231t3465r1320b3518],
29	:	:	O	:	_	0	SENT_159	[p7l1231t3465r1320b3518],
30	2	CD	NUMBER	2	dep	22	SENT_159	[p7l1343t3465r1393b3518],
31	.	.	O	.	_	0	SENT_159	[p7l1343t3465r1393b3518],

1	122	CD	NUMBER	122	num	3	SENT_160	[p7l1407t3465r1557b3517],
2	-	:	O	-	_	0	SENT_160	[p7l1407t3465r1557b3517],
3	14.938	CD	NUMBER	14.938	_	0	SENT_160	[p7l1571t3465r1787b3528],
4	,	,	O	,	_	0	SENT_160	[p7l1571t3465r1787b3528],
5	P	NN	O	p	appos	3	SENT_160	[p7l1806t3467r1853b3517],
6	:	:	O	:	_	0	SENT_160	[p7l1870t3489r1921b3507],
7	0.001	CD	NUMBER	0.001	num	8	SENT_160	[p7l1939t3465r2148b3530],
8	)	NN	O	)	dep	3	SENT_160	[p7l1939t3465r2148b3530],
9	.	.	O	.	_	0	SENT_160	[p7l1939t3465r2148b3530],

1	Toxicity	NN	O	toxicity	_	0	SENT_161	[p7l509t3672r811b3753],
2	and	CC	O	and	_	0	SENT_161	[p7l842t3674r982b3736],
3	SNP	NN	O	snp	nn	4	SENT_161	[p7l1013t3672r1178b3737],
4	Genotyping	NN	O	genotyping	conj_and	1	SENT_161	[p7l1209t3672r1652b3753],

1	Adjuvant	JJ	O	adjuvant	amod	2	SENT_162	[p8l102t45r383b113],
2	treatment	NN	O	treatment	nsubjpass	10	SENT_162	[p8l400t52r688b98],
3	with	IN	O	with	_	0	SENT_162	[p8l707t45r840b98],
4	MMC	NN	O	mmc	prep_with	2	SENT_162	[p8l858t45r1040b98],
5	and	CC	O	and	_	0	SENT_162	[p8l1062t45r1169b98],
6	Tegafur	NNP	PERSON	Tegafur	prep_with	2	SENT_162	[p8l1187t45r1423b113],
7	has	VBZ	O	have	aux	10	SENT_162	[p8l1439t45r1538b98],
8	been	VBN	O	be	auxpass	10	SENT_162	[p8l1557t45r1700b98],
9	well	RB	O	well	advmod	10	SENT_162	[p8l1719t45r1848b98],
10	tolerated	VBN	O	tolerate	_	0	SENT_162	[p8l1867t45r2147b98],
11	.	.	O	.	_	0	SENT_162	[p8l1867t45r2147b98],

1	Mild	JJ	O	mild	amod	2	SENT_163	[p8l8t133r155b186],
2	asthenia	NN	O	asthenia	nsubj	9	SENT_163	[p8l178t133r426b186],
3	has	VBZ	O	have	aux	9	SENT_163	[p8l447t133r546b186],
4	been	VBN	O	be	cop	9	SENT_163	[p8l569t133r712b186],
5	the	DT	O	the	det	9	SENT_163	[p8l735t133r826b186],
6	most	RBS	O	most	advmod	7	SENT_163	[p8l849t141r996b186],
7	common	JJ	O	common	amod	9	SENT_163	[p8l1019t150r1283b186],
8	toxic	JJ	O	toxic	amod	9	SENT_163	[p8l1306t133r1454b186],
9	effect	NN	O	effect	_	0	SENT_163	[p8l1480t133r1665b186],
10	.	.	O	.	_	0	SENT_163	[p8l1480t133r1665b186],

1	No	DT	O	no	det	4	SENT_164	[p8l1691t134r1781b186],
2	statistically	RB	O	statistically	advmod	3	SENT_164	[p8l1808t133r2151b202],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_164	[p8l11t220r324b289],
4	differences	NNS	O	difference	nsubjpass	11	SENT_164	[p8l345t220r677b273],
5	according	VBG	O	accord	_	0	SENT_164	[p8l702t220r998b289],
6	to	TO	O	to	prepc_according_to	4	SENT_164	[p8l1020t228r1076b273],
7	SNP	NN	ORGANIZATION	snp	nn	8	SENT_164	[p8l1101t220r1236b273],
8	genotype	NN	O	genotype	pobj	4	SENT_164	[p8l1257t228r1533b289],
9	have	VBP	O	have	aux	11	SENT_164	[p8l1554t220r1695b273],
10	been	VBN	O	be	auxpass	11	SENT_164	[p8l1716t220r1858b273],
11	observed	VBN	O	observe	_	0	SENT_164	[p8l1880t220r2153b273],
12	because	IN	O	because	_	0	SENT_164	[p8l7t309r246b362],
13	of	IN	O	of	_	0	SENT_164	[p8l273t309r339b362],
14	the	DT	O	the	det	16	SENT_164	[p8l359t309r450b362],
15	low	JJ	O	low	amod	16	SENT_164	[p8l475t309r584b362],
16	grade	NN	O	grade	prep_because_of	11	SENT_164	[p8l611t309r776b378],
17	of	IN	O	of	_	0	SENT_164	[p8l803t309r869b362],
18	toxicity	NN	O	toxicity	prep_of	16	SENT_164	[p8l888t309r1119b377],
19	in	IN	O	in	_	0	SENT_164	[p8l1145t309r1202b361],
20	general	JJ	O	general	prep_in	11	SENT_164	[p8l1227t309r1465b377],
21	.	.	O	.	_	0	SENT_164	[p8l1227t309r1465b377],

1	In	IN	O	in	_	0	SENT_165	[p8l102t398r163b449],
2	10	CD	NUMBER	10	num	3	SENT_165	[p8l189t397r255b450],
3	patients	NNS	O	patient	prep_in	11	SENT_165	[p8l272t397r507b466],
4	(	IN	O	(	_	0	SENT_165	[p8l528t397r711b462],
5	20	CD	PERCENT	20	num	6	SENT_165	[p8l528t397r711b462],
6	%	NN	PERCENT	%	prep_(	11	SENT_165	[p8l528t397r711b462],
7	)	CD	NUMBER	)	num	9	SENT_165	[p8l528t397r711b462],
8	total	JJ	O	total	amod	9	SENT_165	[p8l731t397r864b450],
9	dose	NN	O	dose	nsubjpass	11	SENT_165	[p8l884t397r1020b450],
10	was	VBD	O	be	auxpass	11	SENT_165	[p8l1036t414r1151b450],
11	reduced	VBN	O	reduce	_	0	SENT_165	[p8l1169t397r1410b450],
12	by	IN	O	by	_	0	SENT_165	[p8l1426t397r1500b466],
13	toxicity	NN	O	toxicity	agent	11	SENT_165	[p8l1519t397r1749b466],
14	(	CD	NUMBER	(	number	15	SENT_165	[p8l1770t397r1826b463],
15	5	CD	NUMBER	5	num	16	SENT_165	[p8l1770t397r1826b463],
16	diarrhoea	NN	O	diarrhoea	dep	13	SENT_165	[p8l1847t397r2149b460],
17	,	,	O	,	_	0	SENT_165	[p8l1847t397r2149b460],
18	2	CD	NUMBER	2	num	19	SENT_165	[p8l9t484r44b537],
19	neutropenia	NN	O	neutropenia	appos	13	SENT_165	[p8l67t484r442b553],
20	,	,	O	,	_	0	SENT_165	[p8l67t484r442b553],
21	2	CD	NUMBER	2	num	22	SENT_165	[p8l469t484r503b537],
22	hepatotoxicity	NN	O	hepatotoxicity	appos	13	SENT_165	[p8l527t484r973b553],
23	,	,	O	,	_	0	SENT_165	[p8l527t484r973b553],
24	1	CD	NUMBER	1	num	26	SENT_165	[p8l1007t485r1029b537],
25	vomiting	VBG	O	vomit	amod	26	SENT_165	[p8l1059t484r1372b553],
26	)	NN	O	)	appos	22	SENT_165	[p8l1059t484r1372b553],
27	.	.	O	.	_	0	SENT_165	[p8l1059t484r1372b553],

1	Only	RB	O	only	quantmod	2	SENT_166	[p8l1401t484r1549b553],
2	three	CD	NUMBER	three	_	0	SENT_166	[p8l1573t484r1723b537],
3	of	IN	O	of	_	0	SENT_166	[p8l1748t484r1813b537],
4	them	PRP	O	they	nsubj	6	SENT_166	[p8l1831t484r1983b537],
5	were	VBD	O	be	cop	6	SENT_166	[p8l2005t501r2151b537],
6	heterozygous	JJ	O	heterozygous	prep_of	2	SENT_166	[p8l8t572r410b641],
7	and	CC	O	and	_	0	SENT_166	[p8l439t572r545b625],
8	seven	CD	NUMBER	seven	prep_of	2	SENT_166	[p8l572t589r740b625],
9	other	JJ	O	other	amod	10	SENT_166	[p8l764t572r919b625],
10	homozygous	JJ	O	homozygous	amod	8	SENT_166	[p8l943t572r1344b641],
11	.	.	O	.	_	0	SENT_166	[p8l943t572r1344b641],

1	DISCUSSION	NN	O	discussion	_	0	SENT_167	[p8l795t777r1364b844],

1	Our	PRP$	O	we	poss	2	SENT_168	[p8l103t938r219b991],
2	results	NNS	O	result	nsubj	3	SENT_168	[p8l239t937r435b990],
3	showed	VBD	O	show	_	0	SENT_168	[p8l461t937r688b991],
4	that	IN	O	that	complm	12	SENT_168	[p8l709t937r822b990],
5	allelic	JJ	O	allelic	amod	6	SENT_168	[p8l846t937r1028b990],
6	frequencies	NNS	O	frequency	nsubj	12	SENT_168	[p8l1051t937r1399b1006],
7	for	IN	O	for	_	0	SENT_168	[p8l1423t937r1511b990],
8	DPYDI	NN	O	dpydus	prep_for	6	SENT_168	[p8l1530t938r1760b990],
9	and	CC	O	and	_	0	SENT_168	[p8l1789t937r1896b990],
10	DPYD2	NN	O	dpyd2	conj_and	8	SENT_168	[p8l1916t938r2149b990],
11	are	VBP	O	be	cop	12	SENT_168	[p8l10t1042r99b1079],
12	similar	JJ	O	similar	ccomp	3	SENT_168	[p8l128t1025r337b1079],
13	to	TO	O	to	_	0	SENT_168	[p8l362t1033r419b1079],
14	that	DT	O	that	prep_to	12	SENT_168	[p8l446t1026r560b1079],
15	reported	VBN	O	report	partmod	14	SENT_168	[p8l584t1026r837b1094],
16	in	IN	O	in	_	0	SENT_168	[p8l864t1025r921b1078],
17	other	JJ	O	other	amod	18	SENT_168	[p8l948t1026r1103b1079],
18	studies	NNS	O	study	prep_in	15	SENT_168	[p8l1131t1025r1336b1079],
19	according	VBG	O	accord	_	0	SENT_168	[p8l1366t1025r1662b1094],
20	to	TO	O	to	prepc_according_to	15	SENT_168	[p8l1689t1034r1746b1079],
21	the	DT	O	the	det	23	SENT_168	[p8l1773t1025r1863b1079],
22	National	NNP	ORGANIZATION	National	nn	23	SENT_168	[p8l1890t1025r2151b1079],
23	Centre	NNP	ORGANIZATION	Centre	pobj	15	SENT_168	[p8l9t1113r209b1166],
24	for	IN	ORGANIZATION	for	_	0	SENT_168	[p8l252t1113r340b1166],
25	Biotechnology	NNP	ORGANIZATION	Biotechnology	nn	26	SENT_168	[p8l381t1113r827b1182],
26	Information	NNP	ORGANIZATION	Information	prep_for	23	SENT_168	[p8l870t1113r1247b1166],
27	.	.	O	.	_	0	SENT_168	[p8l870t1113r1247b1166],

1	On	IN	O	on	_	0	SENT_169	[p8l1296t1114r1384b1166],
2	the	DT	O	the	det	4	SENT_169	[p8l1427t1113r1518b1166],
3	other	JJ	O	other	amod	4	SENT_169	[p8l1562t1113r1717b1166],
4	hand	NN	O	hand	pobj	1	SENT_169	[p8l1758t1113r1921b1176],
5	,	,	O	,	_	0	SENT_169	[p8l1758t1113r1921b1176],
6	allelic	JJ	O	allelic	appos	4	SENT_169	[p8l1968t1113r2150b1166],

1	TABLE	NN	O	table	_	0	SENT_170	[p8l470t1257r572b1279],
2	II	CD	NUMBER	ii	dep	1	SENT_170	[p8l583t1257r613b1279],
3	.	.	O	.	_	0	SENT_170	[p8l583t1257r613b1279],

1	Genotypic	JJ	O	genotypic	amod	2	SENT_171	[p8l630t1257r766b1285],
2	Frequencies	NNS	O	frequency	_	0	SENT_171	[p8l776t1257r936b1285],
3	and	CC	O	and	_	0	SENT_171	[p8l947t1257r996b1279],
4	Log-Rank	JJ	O	log-rank	amod	5	SENT_171	[p8l1006t1257r1140b1285],
5	P	NN	O	p	conj_and	2	SENT_171	[p8l1148t1258r1169b1279],
6	for	IN	O	for	_	0	SENT_171	[p8l1178t1257r1217b1279],
7	all	DT	O	all	det	8	SENT_171	[p8l1227t1257r1259b1279],
8	Genes	NNS	O	gene	prep_for	2	SENT_171	[p8l1270t1257r1350b1279],

1	P	NN	O	p	_	0	SENT_172	[p8l1493t1322r1596b1347],
2	.	.	O	.	_	0	SENT_172	[p8l1493t1322r1596b1347],

1	—	NN	O	—	_	0	SENT_173	[p8l1493t1322r1596b1347],
2	.	.	O	.	_	0	SENT_173	[p8l1493t1322r1596b1347],

1	Value	NN	O	value	_	0	SENT_174	[p8l1493t1322r1596b1347],
2	;	:	O	;	_	0	SENT_174	[p8l1493t1322r1596b1347],
3	time	NN	O	time	dep	1	SENT_174	[p8l1608t1322r1663b1343],

1	SNP	NN	O	snp	nn	3	SENT_175	[p8l471t1358r526b1380],
2	(	CD	NUMBER	(	num	3	SENT_175	[p8l537t1358r651b1384],
3	number	NN	O	number	_	0	SENT_175	[p8l537t1358r651b1384],
4	)	CD	NUMBER	)	num	7	SENT_175	[p8l537t1358r651b1384],
5	Genotype	NN	ORGANIZATION	genotype	nn	7	SENT_175	[p8l789t1358r909b1386],
6	AA	NN	ORGANIZATION	aa	nn	7	SENT_175	[p8l1078t1358r1122b1379],
7	n	NN	O	n	dep	3	SENT_175	[p8l1300t1365r1315b1379],
8	(	CD	PERCENT	(	num	9	SENT_175	[p8l1326t1358r1370b1384],
9	%	NN	PERCENT	%	dep	7	SENT_175	[p8l1326t1358r1370b1384],
10	)	CD	NUMBER	)	dep	3	SENT_175	[p8l1326t1358r1370b1384],
11	to	TO	O	to	_	0	SENT_175	[p8l1489t1361r1512b1379],
12	progression	NN	O	progression	nn	13	SENT_175	[p8l1522t1358r1667b1386],
13	P	NN	O	p	prep_to	10	SENT_175	[p8l1749t1358r1853b1383],
14	.	.	O	.	_	0	SENT_175	[p8l1749t1358r1853b1383],

1	—	NN	O	—	_	0	SENT_176	[p8l1749t1358r1853b1383],
2	.	.	O	.	_	0	SENT_176	[p8l1749t1358r1853b1383],

1	Value	NN	O	value	_	0	SENT_177	[p8l1749t1358r1853b1383],
2	;	:	O	;	_	0	SENT_177	[p8l1749t1358r1853b1383],
3	survival	NN	O	survival	dep	1	SENT_177	[p8l1865t1358r1962b1380],
4	DPYDI	NNP	O	DPYDI	dep	3	SENT_177	[p8l470t1422r564b1444],
5	(	CD	NUMBER	(	num	4	SENT_177	[p8l577t1422r626b1449],
6	50	CD	NUMBER	50	number	7	SENT_177	[p8l577t1422r626b1449],
7	)	CD	NUMBER	)	num	9	SENT_177	[p8l577t1422r626b1449],
8	CC	NN	O	cc	nn	9	SENT_177	[p8l830t1422r871b1444],
9	Ile543Ile	NN	O	ile543ile	dep	4	SENT_177	[p8l1043t1422r1155b1444],
10	36	CD	NUMBER	36	number	11	SENT_177	[p8l1291t1422r1320b1444],
11	(	CD	NUMBER	(	dep	4	SENT_177	[p8l1332t1422r1381b1449],
12	72	CD	NUMBER	72	num	14	SENT_177	[p8l1332t1422r1381b1449],
13	)	NN	O	)	nn	14	SENT_177	[p8l1332t1422r1381b1449],
14	P	NN	O	p	dep	11	SENT_177	[p8l1509t1423r1528b1444],
15	:	:	O	:	_	0	SENT_177	[p8l1534t1432r1556b1439],
16	0.4965	CD	NUMBER	0.4965	num	17	SENT_177	[p8l1563t1422r1646b1444],
17	P	NN	O	p	dep	11	SENT_177	[p8l1787t1423r1805b1444],
18	:	:	O	:	_	0	SENT_177	[p8l1812t1432r1833b1439],
19	0.0663	CD	NUMBER	0.0663	dep	17	SENT_177	[p8l1840t1422r1924b1444],

1	CT	NN	O	ct	nn	3	SENT_178	[p8l832t1459r871b1480],
2	Ile543Val	NN	O	ile543val	nn	3	SENT_178	[p8l1039t1459r1160b1480],
3	ll	NN	O	ll	dep	8	SENT_178	[p8l1293t1459r1318b1480],
4	(	CD	NUMBER	(	number	5	SENT_178	[p8l1332t1459r1381b1485],
5	22	CD	NUMBER	22	dep	3	SENT_178	[p8l1332t1459r1381b1485],
6	)	CD	NUMBER	)	dep	5	SENT_178	[p8l1332t1459r1381b1485],
7	IT	PRP	O	it	dep	8	SENT_178	[p8l834t1496r869b1517],
8	Val543Val	NN	O	val543val	dep	12	SENT_178	[p8l1038t1495r1163b1517],
9	3	CD	NUMBER	3	num	10	SENT_178	[p8l1306t1495r1319b1517],
10	(	NN	O	(	dep	8	SENT_178	[p8l1332t1495r1365b1522],
11	6	CD	NUMBER	6	num	12	SENT_178	[p8l1332t1495r1365b1522],
12	)	NN	O	)	_	0	SENT_178	[p8l1332t1495r1365b1522],

1	DPYD2	NN	O	dpyd2	_	0	SENT_179	[p8l470t1532r565b1554],
2	(	CD	NUMBER	(	num	1	SENT_179	[p8l577t1532r626b1559],
3	50	CD	NUMBER	50	number	4	SENT_179	[p8l577t1532r626b1559],
4	)	CD	NUMBER	)	num	6	SENT_179	[p8l577t1532r626b1559],
5	CC	NN	O	cc	nn	6	SENT_179	[p8l830t1532r871b1554],
6	Arg29Arg	NN	O	arg29arg	dep	10	SENT_179	[p8l1037t1532r1161b1560],
7	26	CD	NUMBER	26	dep	6	SENT_179	[p8l1291t1532r1320b1554],
8	(	CD	NUMBER	(	dep	10	SENT_179	[p8l1332t1532r1381b1559],
9	52	CD	NUMBER	52	num	10	SENT_179	[p8l1332t1532r1381b1559],
10	)	NN	O	)	dep	1	SENT_179	[p8l1332t1532r1381b1559],
11	P	NN	O	p	dep	10	SENT_179	[p8l1509t1533r1528b1554],
12	:	:	O	:	_	0	SENT_179	[p8l1534t1542r1556b1549],
13	0.9452	CD	NUMBER	0.9452	num	14	SENT_179	[p8l1563t1532r1647b1554],
14	P	NN	O	p	dep	1	SENT_179	[p8l1787t1533r1805b1554],
15	:	:	O	:	_	0	SENT_179	[p8l1812t1542r1833b1549],
16	0.4937	CD	NUMBER	0.4937	dep	14	SENT_179	[p8l1840t1532r1924b1554],

1	CT	NN	O	ct	nn	2	SENT_180	[p8l832t1569r871b1590],
2	Arg29Cys	NNS	O	arg29cy	_	0	SENT_180	[p8l1036t1569r1161b1596],
3	17	CD	NUMBER	17	num	4	SENT_180	[p8l1293t1569r1319b1590],
4	(	CD	NUMBER	(	dep	2	SENT_180	[p8l1332t1569r1381b1595],
5	34	CD	NUMBER	34	number	6	SENT_180	[p8l1332t1569r1381b1595],
6	)	CD	NUMBER	)	num	8	SENT_180	[p8l1332t1569r1381b1595],
7	TT	NN	ORGANIZATION	tt	nn	8	SENT_180	[p8l834t1606r869b1626],
8	Cys29Cys	NNS	O	cys29cy	dep	4	SENT_180	[p8l1039t1605r1161b1632],
9	7	CD	NUMBER	7	number	10	SENT_180	[p8l1306t1605r1319b1626],
10	(	CD	NUMBER	(	num	8	SENT_180	[p8l1332t1605r1381b1631],
11	14	CD	NUMBER	14	num	12	SENT_180	[p8l1332t1605r1381b1631],
12	)	NN	O	)	dep	2	SENT_180	[p8l1332t1605r1381b1631],

1	CDA	NNP	ORGANIZATION	CDA	_	0	SENT_181	[p8l472t1642r530b1663],
2	(	CD	NUMBER	(	num	1	SENT_181	[p8l542t1641r591b1668],
3	50	CD	NUMBER	50	number	4	SENT_181	[p8l542t1641r591b1668],
4	)	CD	NUMBER	)	num	6	SENT_181	[p8l542t1641r591b1668],
5	AA	NN	O	aa	nn	6	SENT_181	[p8l828t1642r867b1663],
6	Lys27Lys	NNS	O	lys27ly	dep	1	SENT_181	[p8l1041t1641r1157b1669],
7	17	CD	NUMBER	17	dep	1	SENT_181	[p8l1293t1641r1319b1663],
8	(	CD	NUMBER	(	number	9	SENT_181	[p8l1332t1641r1381b1668],
9	34	CD	NUMBER	34	num	14	SENT_181	[p8l1332t1641r1381b1668],
10	)	NN	O	)	nn	14	SENT_181	[p8l1332t1641r1381b1668],
11	P	NN	O	p	nn	14	SENT_181	[p8l1509t1642r1528b1663],
12	=	JJ	O	=	amod	14	SENT_181	[p8l1534t1651r1556b1659],
13	0.9106	CD	NUMBER	0.9106	num	14	SENT_181	[p8l1563t1641r1647b1663],
14	P	NN	O	p	dep	7	SENT_181	[p8l1786t1642r1805b1663],
15	=	JJ	O	=	amod	14	SENT_181	[p8l1812t1651r1833b1659],
16	0.7190	CD	NUMBER	0.7190	tmod	15	SENT_181	[p8l1840t1641r1925b1663],

1	AC	NN	ORGANIZATION	ac	nn	2	SENT_182	[p8l828t1678r870b1700],
2	Lys27Gln	NN	O	lys27gln	_	0	SENT_182	[p8l1040t1678r1159b1706],
3	24	CD	NUMBER	24	num	4	SENT_182	[p8l1291t1678r1320b1700],
4	(	CD	NUMBER	(	dep	2	SENT_182	[p8l1332t1678r1381b1705],
5	48	CD	NUMBER	48	number	6	SENT_182	[p8l1332t1678r1381b1705],
6	)	CD	NUMBER	)	num	10	SENT_182	[p8l1332t1678r1381b1705],
7	CC	NN	ORGANIZATION	cc	nn	10	SENT_182	[p8l830t1715r871b1736],
8	Gln27Gln	NN	O	gln27gln	nn	10	SENT_182	[p8l1039t1715r1161b1736],
9	9	CD	NUMBER	9	num	10	SENT_182	[p8l1306t1715r1320b1737],
10	(	NN	O	(	dep	4	SENT_182	[p8l1332t1715r1381b1741],
11	18	CD	NUMBER	18	num	12	SENT_182	[p8l1332t1715r1381b1741],
12	)	NN	O	)	dep	2	SENT_182	[p8l1332t1715r1381b1741],

1	Journal	NNP	O	Journal	_	0	SENT_183	[p8l196t1821r299b1845],
2	of	IN	O	of	_	0	SENT_183	[p8l309t1821r339b1851],
3	Surgical	NNP	O	Surgical	nn	4	SENT_183	[p8l345t1821r456b1851],
4	Oncology	NNP	O	Oncology	prep_of	1	SENT_183	[p8l467t1821r594b1851],

1	Heterozygous	JJ	O	heterozygous	_	0	SENT_184	[p8l873t2356r1230b2415],

1	Homozygous	JJ	O	homozygous	_	0	SENT_185	[p8l892t2950r1233b3009],

1	o	NN	O	o	_	0	SENT_186	[p8l161t3449r192b3495],
2	5	CD	NUMBER	5	number	3	SENT_186	[p8l821t3444r850b3491],
3	1	CD	NUMBER	1	dep	1	SENT_186	[p8l1475t3442r1495b3486],
4	o	NN	O	o	nn	5	SENT_186	[p8l1507t3442r1536b3489],
5	Years	NNS	DURATION	year	dep	3	SENT_186	[p8l1993t3440r2144b3486],

1	Fig	NN	O	fig	_	0	SENT_187	[p8l8t3583r122b3652],
2	.	.	O	.	_	0	SENT_187	[p8l8t3583r122b3652],

1	2	LS	NUMBER	2	_	0	SENT_188	[p8l154t3584r204b3636],
2	.	.	O	.	_	0	SENT_188	[p8l154t3584r204b3636],

1	Survival	NN	O	survival	nsubj	12	SENT_189	[p8l288t3583r538b3637],
2	of	IN	O	of	_	0	SENT_189	[p8l570t3583r635b3636],
3	heterozygous	JJ	O	heterozygous	amod	4	SENT_189	[p8l660t3583r1063b3652],
4	patients	NNS	O	patient	prep_of	1	SENT_189	[p8l1093t3583r1327b3652],
5	in	IN	O	in	_	0	SENT_189	[p8l1360t3583r1417b3636],
6	any	DT	O	any	prep_in	4	SENT_189	[p8l1449t3600r1554b3652],
7	of	IN	O	of	_	0	SENT_189	[p8l1585t3583r1650b3636],
8	the	DT	O	the	det	10	SENT_189	[p8l1676t3583r1766b3636],
9	three	CD	NUMBER	three	num	10	SENT_189	[p8l1797t3583r1947b3636],
10	genes	NNS	O	gene	prep_of	6	SENT_189	[p8l1978t3600r2147b3652],
11	was	VBD	O	be	cop	12	SENT_189	[p8l9t3680r122b3716],
12	higher	JJR	O	higher	_	0	SENT_189	[p8l148t3663r343b3732],
13	than	IN	O	than	_	0	SENT_189	[p8l366t3663r495b3716],
14	homozygous	JJ	O	homozygous	amod	15	SENT_189	[p8l519t3663r904b3732],
15	patients	NNS	O	patient	prep_than	12	SENT_189	[p8l930t3663r1164b3732],
16	(	IN	O	(	_	0	SENT_189	[p8l1193t3664r1261b3729],
17	P	NN	O	p	prep_(	12	SENT_189	[p8l1193t3664r1261b3729],
18	:	:	O	:	_	0	SENT_189	[p8l1279t3687r1330b3705],
19	0.0017	CD	NUMBER	0.0017	num	20	SENT_189	[p8l1347t3663r1593b3728],
20	)	NN	O	)	dep	12	SENT_189	[p8l1347t3663r1593b3728],
21	.	.	O	.	_	0	SENT_189	[p8l1347t3663r1593b3728],

1	frequencies	NNS	O	frequency	nsubj	4	SENT_190	[p9l8t117r355b186],
2	of	IN	O	of	_	0	SENT_190	[p9l383t117r449b170],
3	CDA	NNP	ORGANIZATION	CDA	prep_of	1	SENT_190	[p9l473t118r614b171],
4	showed	VBD	O	show	_	0	SENT_190	[p9l645t117r871b170],
5	that	IN	O	that	complm	9	SENT_190	[p9l896t117r1009b170],
6	non-wild-type	JJ	O	non-wild-type	nsubj	9	SENT_190	[p9l1034t117r1462b186],
7	is	VBZ	O	be	cop	9	SENT_190	[p9l1488t117r1535b170],
8	more	RBR	O	more	advmod	9	SENT_190	[p9l1562t134r1716b170],
9	frequent	JJ	O	frequent	ccomp	4	SENT_190	[p9l1742t117r1994b186],
10	than	IN	O	than	_	0	SENT_190	[p9l2019t117r2148b170],
11	wild	JJ	O	wild	amod	13	SENT_190	[p9l9t205r297b274],
12	—	NN	O	—	nn	13	SENT_190	[p9l9t205r297b274],
13	type	NN	O	type	prep_than	9	SENT_190	[p9l9t205r297b274],
14	in	IN	O	in	_	0	SENT_190	[p9l323t205r380b258],
15	our	PRP$	O	we	poss	17	SENT_190	[p9l406t222r506b258],
16	geographic	JJ	O	geographic	amod	17	SENT_190	[p9l528t205r862b274],
17	area	NN	O	area	prep_in	13	SENT_190	[p9l891t222r1029b258],
18	.	.	O	.	_	0	SENT_190	[p9l891t222r1029b258],

1	We	PRP	O	we	nsubj	2	SENT_191	[p9l101t295r200b347],
2	investigated	VBD	O	investigate	_	0	SENT_191	[p9l226t293r589b362],
3	for	IN	O	for	mark	18	SENT_191	[p9l615t293r703b346],
4	an	DT	O	a	det	5	SENT_191	[p9l728t310r797b346],
5	association	NN	O	association	nsubj	18	SENT_191	[p9l824t293r1158b346],
6	of	IN	O	of	_	0	SENT_191	[p9l1185t293r1250b346],
7	3	CD	NUMBER	3	num	8	SENT_191	[p9l1273t294r1303b347],
8	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_191	[p9l1332t293r1802b362],
9	of	IN	O	of	_	0	SENT_191	[p9l1830t293r1895b346],
10	2	CD	NUMBER	2	num	11	SENT_191	[p9l1917t294r1951b346],
11	genes	NNS	O	gene	prep_of	8	SENT_191	[p9l1978t310r2147b362],
12	with	IN	O	with	_	0	SENT_191	[p9l9t381r142b435],
13	clinical	JJ	O	clinical	amod	14	SENT_191	[p9l178t381r399b435],
14	outcome	NN	O	outcome	prep_with	11	SENT_191	[p9l437t390r695b435],
15	in	IN	O	in	_	0	SENT_191	[p9l732t381r789b434],
16	50	CD	NUMBER	50	num	17	SENT_191	[p9l826t381r898b435],
17	patients	NNS	O	patient	prep_in	14	SENT_191	[p9l933t381r1167b450],
18	operated	VBD	O	operate	advcl	2	SENT_191	[p9l1206t382r1466b450],
19	for	IN	O	for	_	0	SENT_191	[p9l1501t381r1589b435],
20	locally	RB	O	locally	advmod	21	SENT_191	[p9l1623t381r1828b450],
21	advanced	VBN	O	advance	amod	23	SENT_191	[p9l1866t382r2149b435],
22	gastric	JJ	O	gastric	amod	23	SENT_191	[p9l9t469r207b538],
23	cancer	NN	O	cancer	prep_for	18	SENT_191	[p9l231t486r428b522],
24	and	CC	O	and	_	0	SENT_191	[p9l450t469r556b522],
25	treated	VBN	O	treat	advcl	2	SENT_191	[p9l577t469r783b522],
26	with	IN	O	with	_	0	SENT_191	[p9l804t469r937b522],
27	adjuvant	JJ	O	adjuvant	amod	28	SENT_191	[p9l959t469r1218b538],
28	Tegafur	NNP	O	Tegafur	prep_with	25	SENT_191	[p9l1237t469r1482b538],
29	.	.	O	.	_	0	SENT_191	[p9l1237t469r1482b538],

1	Polymorphisms	NNS	O	polymorphism	nsubj	5	SENT_192	[p9l1507t469r1980b538],
2	from	IN	O	from	_	0	SENT_192	[p9l2003t469r2149b522],
3	two	CD	NUMBER	two	num	4	SENT_192	[p9l8t565r119b611],
4	genes	NNS	O	gene	prep_from	1	SENT_192	[p9l147t574r315b626],
5	(	VBP	O	(	ccomp	12	SENT_192	[p9l345t558r592b623],
6	CDYP2	NN	O	cdyp2	dobj	5	SENT_192	[p9l345t558r592b623],
7	and	CC	O	and	_	0	SENT_192	[p9l622t557r729b610],
8	CDA	NNP	ORGANIZATION	CDA	dobj	5	SENT_192	[p9l758t558r924b623],
9	)	CD	NUMBER	)	num	8	SENT_192	[p9l758t558r924b623],
10	separately	RB	O	separately	advmod	5	SENT_192	[p9l955t557r1271b626],
11	,	,	O	,	_	0	SENT_192	[p9l955t557r1271b626],
12	showed	VBD	O	show	_	0	SENT_192	[p9l1302t557r1528b611],
13	no	DT	O	no	det	14	SENT_192	[p9l1554t574r1626b610],
14	association	NN	O	association	dobj	12	SENT_192	[p9l1655t557r1989b610],
15	with	IN	O	with	_	0	SENT_192	[p9l2015t557r2148b611],
16	outcome	NN	O	outcome	prep_with	12	SENT_192	[p9l9t653r284b708],
17	,	,	O	,	_	0	SENT_192	[p9l9t653r284b708],
18	whereas	IN	O	whereas	mark	27	SENT_192	[p9l311t646r556b699],
19	polymorphisms	NNS	O	polymorphism	nsubj	27	SENT_192	[p9l579t645r1049b714],
20	of	IN	O	of	_	0	SENT_192	[p9l1075t645r1140b699],
21	the	DT	O	the	det	26	SENT_192	[p9l1158t646r1249b699],
22	other	JJ	O	other	amod	26	SENT_192	[p9l1273t646r1427b699],
23	gene	NN	O	gene	nn	26	SENT_192	[p9l1450t662r1590b714],
24	(	NN	O	(	nn	26	SENT_192	[p9l1615t646r1895b711],
25	DPYDI	NN	O	dpydus	nn	26	SENT_192	[p9l1615t646r1895b711],
26	)	NN	O	)	prep_of	19	SENT_192	[p9l1615t646r1895b711],
27	showed	VBD	O	show	advcl	12	SENT_192	[p9l1923t646r2149b699],
28	in	IN	O	in	_	0	SENT_192	[p9l8t733r65b786],
29	the	DT	O	the	det	31	SENT_192	[p9l108t733r198b786],
30	univariate	JJ	O	univariate	amod	31	SENT_192	[p9l240t733r540b786],
31	analysis	NN	O	analysis	prep_in	27	SENT_192	[p9l585t733r824b802],
32	an	DT	O	a	det	33	SENT_192	[p9l870t750r938b786],
33	association	NN	O	association	dep	12	SENT_192	[p9l982t733r1316b786],
34	with	IN	O	with	_	0	SENT_192	[p9l1359t733r1492b786],
35	relapse	NN	O	relapse	nn	38	SENT_192	[p9l1533t733r1747b802],
36	and	CC	O	and	_	0	SENT_192	[p9l1792t733r1898b786],
37	overall	JJ	O	overall	nn	38	SENT_192	[p9l1941t733r2148b786],
38	survival	NN	O	survival	prep_with	33	SENT_192	[p9l11t821r263b875],
39	.	.	O	.	_	0	SENT_192	[p9l11t821r263b875],

1	When	WRB	O	when	advmod	7	SENT_193	[p9l292t821r473b874],
2	any	DT	O	any	nsubj	7	SENT_193	[p9l501t838r606b890],
3	of	IN	O	of	_	0	SENT_193	[p9l634t821r699b874],
4	the	DT	O	the	det	5	SENT_193	[p9l720t821r811b874],
5	SNPS	NNS	O	snp	prep_of	2	SENT_193	[p9l840t822r1002b875],
6	were	VBD	O	be	cop	7	SENT_193	[p9l1030t838r1175b875],
7	heterozygous	JJ	O	heterozygous	advcl	15	SENT_193	[p9l1201t821r1621b890],
8	,	,	O	,	_	0	SENT_193	[p9l1201t821r1621b890],
9	the	DT	O	the	det	10	SENT_193	[p9l1650t821r1741b874],
10	prognosis	NN	O	prognosis	nsubj	15	SENT_193	[p9l1767t821r2059b890],
11	of	IN	O	of	_	0	SENT_193	[p9l2088t821r2153b874],
12	the	DT	O	the	det	13	SENT_193	[p9l8t910r99b963],
13	patients	NNS	O	patient	prep_of	10	SENT_193	[p9l160t909r395b978],
14	were	VBD	O	be	cop	15	SENT_193	[p9l460t926r604b963],
15	better	JJR	O	better	_	0	SENT_193	[p9l666t909r840b963],
16	than	IN	O	than	_	0	SENT_193	[p9l901t910r1031b963],
17	those	DT	O	those	prep_than	15	SENT_193	[p9l1093t910r1250b963],
18	with	IN	O	with	_	0	SENT_193	[p9l1312t909r1445b963],
19	wild	JJ	O	wild	amod	21	SENT_193	[p9l1508t909r1796b978],
20	—	NN	O	—	nn	21	SENT_193	[p9l1508t909r1796b978],
21	type	NN	O	type	prep_with	17	SENT_193	[p9l1508t909r1796b978],
22	or	CC	O	or	_	0	SENT_193	[p9l1860t926r1922b963],
23	SNPS	NN	O	snp	conj_or	21	SENT_193	[p9l1985t910r2147b963],
24	homozygous	JJ	O	homozygous	amod	23	SENT_193	[p9l8t998r409b1066],
25	.	.	O	.	_	0	SENT_193	[p9l8t998r409b1066],

1	Nevertheless	RB	O	nevertheless	advmod	8	SENT_194	[p9l448t997r853b1060],
2	,	,	O	,	_	0	SENT_194	[p9l448t997r853b1060],
3	these	DT	O	these	det	4	SENT_194	[p9l891t997r1045b1051],
4	results	NNS	O	result	nsubjpass	8	SENT_194	[p9l1080t998r1276b1051],
5	could	MD	O	could	aux	8	SENT_194	[p9l1313t998r1480b1051],
6	not	RB	O	not	neg	8	SENT_194	[p9l1515t1006r1611b1051],
7	be	VB	O	be	auxpass	8	SENT_194	[p9l1644t998r1714b1051],
8	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_194	[p9l1751t997r2057b1051],
9	in	IN	O	in	_	0	SENT_194	[p9l2091t997r2149b1050],
10	the	DT	O	the	det	12	SENT_194	[p9l8t1085r99b1138],
11	multivariate	JJ	O	multivariate	amod	12	SENT_194	[p9l124t1085r487b1138],
12	analysis	NN	O	analysis	prep_in	8	SENT_194	[p9l514t1085r754b1154],
13	because	IN	O	because	_	0	SENT_194	[p9l780t1085r1019b1138],
14	of	IN	O	of	_	0	SENT_194	[p9l1045t1085r1110b1138],
15	the	DT	O	the	det	17	SENT_194	[p9l1131t1085r1221b1138],
16	short	JJ	O	short	amod	17	SENT_194	[p9l1249t1085r1397b1138],
17	number	NN	O	number	prep_because_of	8	SENT_194	[p9l1421t1085r1653b1138],
18	of	IN	O	of	_	0	SENT_194	[p9l1677t1085r1742b1138],
19	patients	NNS	O	patient	prep_of	17	SENT_194	[p9l1761t1085r2012b1154],
20	.	.	O	.	_	0	SENT_194	[p9l1761t1085r2012b1154],

1	The	DT	O	the	det	2	SENT_195	[p9l102t1174r218b1227],
2	better	JJR	O	better	dep	3	SENT_195	[p9l235t1174r409b1227],
3	outcome	NN	O	outcome	_	0	SENT_195	[p9l427t1182r685b1227],
4	of	IN	O	of	_	0	SENT_195	[p9l705t1173r770b1227],
5	heterozygous	JJ	O	heterozygous	amod	6	SENT_195	[p9l782t1174r1184b1242],
6	patients	NNS	O	patient	prep_of	3	SENT_195	[p9l1202t1174r1437b1242],
7	over	IN	O	over	_	0	SENT_195	[p9l1458t1190r1590b1227],
8	non	JJ	O	non	amod	9	SENT_195	[p9l1606t1174r2147b1242],
9	—	NN	O	—	prep_over	6	SENT_195	[p9l1606t1174r2147b1242],
10	heterozygous	JJ	O	heterozygous	amod	11	SENT_195	[p9l1606t1174r2147b1242],
11	patients	NNS	O	patient	nsubjpass	14	SENT_195	[p9l7t1261r242b1330],
12	may	MD	O	may	aux	14	SENT_195	[p9l266t1278r394b1330],
13	be	VB	O	be	auxpass	14	SENT_195	[p9l417t1262r487b1315],
14	explained	VBN	O	explain	rcmod	3	SENT_195	[p9l511t1261r805b1330],
15	by	IN	O	by	_	0	SENT_195	[p9l825t1261r900b1330],
16	two	CD	NUMBER	two	num	17	SENT_195	[p9l923t1269r1034b1315],
17	mechanisms	NNS	O	mechanism	agent	14	SENT_195	[p9l1057t1261r1447b1315],
18	:	:	O	:	_	0	SENT_195	[p9l1057t1261r1447b1315],
19	ﬁrst	NN	O	ﬁrst	dep	3	SENT_195	[p9l1476t1261r1607b1324],
20	,	,	O	,	_	0	SENT_195	[p9l1476t1261r1607b1324],
21	by	IN	O	by	dep	24	SENT_195	[p9l1631t1262r1705b1330],
22	a	DT	O	a	det	23	SENT_195	[p9l1730t1278r1761b1315],
23	reduction	NN	O	reduction	pobj	21	SENT_195	[p9l1782t1261r2068b1315],
24	in	IN	O	in	rcmod	19	SENT_195	[p9l2091t1261r2149b1314],

1	Heterozygous	JJ	O	heterozygous	amod	2	SENT_196	[p9l918t1893r1297b1956],
2	n	NN	O	n	_	0	SENT_196	[p9l1561t1897r1697b1945],
3	=	JJ	O	=	amod	2	SENT_196	[p9l1561t1897r1697b1945],
4	33	CD	NUMBER	33	tmod	3	SENT_196	[p9l1561t1897r1697b1945],

1	%	NN	O	%	nn	2	SENT_197	[p9l749t2009r1766b2044],
2	§	NN	O	§	_	0	SENT_197	[p9l749t2009r1766b2044],
3	'	''	O	'	_	0	SENT_197	[p9l749t2009r1766b2044],
4	#	#	O	#	dep	6	SENT_197	[p9l749t2009r1766b2044],
5	'	''	PERCENT	'	_	0	SENT_197	[p9l749t2009r1766b2044],
6	%	NN	PERCENT	%	rcmod	2	SENT_197	[p9l749t2009r1766b2044],
7	'	''	O	'	_	0	SENT_197	[p9l749t2009r1766b2044],
8	+	CC	O	+	dep	6	SENT_197	[p9l749t2009r1766b2044],
9	?	.	O	?	_	0	SENT_197	[p9l749t2009r1766b2044],

1	Zﬁ-éjjjjd	NN	O	zﬁ-éjjjjd	_	0	SENT_198	[p9l749t2009r1766b2044],

1	Homozyogous	JJ	O	homozyogous	amod	2	SENT_199	[p9l955t2675r1351b2738],
2	n	NN	O	n	_	0	SENT_199	[p9l1439t2688r1504b2725],
3	=	JJ	O	=	amod	2	SENT_199	[p9l1439t2688r1504b2725],
4	17	CD	NUMBER	17	tmod	3	SENT_199	[p9l1529t2679r1592b2725],

1	o	NN	O	o	_	0	SENT_200	[p9l147t3066r179b3114],
2	5	CD	NUMBER	5	number	3	SENT_200	[p9l826t3066r859b3114],
3	10	CD	DURATION	10	dep	1	SENT_200	[p9l1465t3066r1528b3114],
4	Years	NNS	DURATION	year	dep	3	SENT_200	[p9l1961t3066r2121b3116],

1	Fig	NN	O	fig	_	0	SENT_201	[p9l8t3204r122b3272],
2	.	.	O	.	_	0	SENT_201	[p9l8t3204r122b3272],

1	3	LS	NUMBER	3	_	0	SENT_202	[p9l155t3204r204b3257],
2	.	.	O	.	_	0	SENT_202	[p9l155t3204r204b3257],

1	When	WRB	O	when	advmod	3	SENT_203	[p9l285t3204r466b3257],
2	we	PRP	O	we	nsubj	3	SENT_203	[p9l494t3220r579b3257],
3	analysed	VBD	O	analyse	advcl	27	SENT_203	[p9l610t3204r873b3272],
4	the	DT	O	the	det	5	SENT_203	[p9l900t3204r991b3257],
5	survival	NN	O	survival	dobj	3	SENT_203	[p9l1022t3204r1258b3257],
6	for	IN	O	for	_	0	SENT_203	[p9l1287t3204r1375b3257],
7	the	DT	O	the	det	8	SENT_203	[p9l1401t3204r1491b3257],
8	combination	NN	O	combination	prep_for	3	SENT_203	[p9l1521t3204r1899b3257],
9	of	IN	O	of	_	0	SENT_203	[p9l1927t3204r1992b3257],
10	both	DT	O	both	det	12	SENT_203	[p9l2014t3204r2149b3257],
11	genes	NNS	O	gene	nn	12	SENT_203	[p9l9t3300r178b3352],
12	DPYD2	NN	O	dpyd2	prep_of	8	SENT_203	[p9l211t3284r444b3336],
13	(	CD	NUMBER	(	num	14	SENT_203	[p9l482t3284r636b3349],
14	C/T	NN	O	c/t	dep	12	SENT_203	[p9l482t3284r636b3349],
15	;	:	O	;	_	0	SENT_203	[p9l482t3284r636b3349],
16	Arg29Cys	NNS	O	arg29cy	dep	14	SENT_203	[p9l673t3284r1004b3352],
17	)	CD	NUMBER	)	num	16	SENT_203	[p9l673t3284r1004b3352],
18	and	CC	O	and	_	0	SENT_203	[p9l1042t3284r1149b3337],
19	CDA	NNP	O	CDA	nn	21	SENT_203	[p9l1186t3284r1327b3337],
20	(	CD	NUMBER	(	num	21	SENT_203	[p9l1365t3284r1531b3349],
21	A/C	NN	O	a/c	dep	14	SENT_203	[p9l1365t3284r1531b3349],
22	;	:	O	;	_	0	SENT_203	[p9l1365t3284r1531b3349],
23	Lys27Gin	NN	O	lys27gin	dep	14	SENT_203	[p9l1568t3284r1889b3352],
24	)	CD	NUMBER	)	num	23	SENT_203	[p9l1568t3284r1889b3352],
25	we	PRP	O	we	nsubj	27	SENT_203	[p9l1925t3300r2010b3337],
26	can	MD	O	can	aux	27	SENT_203	[p9l2045t3300r2148b3337],
27	observe	VB	O	observe	_	0	SENT_203	[p9l9t3363r242b3416],
28	that	IN	O	that	complm	49	SENT_203	[p9l283t3363r396b3416],
29	11	CD	NUMBER	11	nsubj	49	SENT_203	[p9l445t3364r504b3416],
30	out	IN	O	out	_	0	SENT_203	[p9l554t3371r649b3416],
31	of	IN	O	of	_	0	SENT_203	[p9l691t3363r756b3416],
32	17	CD	NUMBER	17	num	34	SENT_203	[p9l799t3364r864b3416],
33	homozygous	JJ	O	homozygous	amod	34	SENT_203	[p9l907t3363r1292b3432],
34	patients	NNS	O	patient	prep_out_of	29	SENT_203	[p9l1335t3363r1569b3432],
35	and	CC	O	and	_	0	SENT_203	[p9l1614t3363r1721b3416],
36	8	CD	NUMBER	8	conj_and	34	SENT_203	[p9l1765t3363r1795b3416],
37	out	IN	O	out	advmod	49	SENT_203	[p9l1840t3371r1935b3416],
38	33	CD	NUMBER	33	pobj	37	SENT_203	[p9l1978t3364r2046b3416],
39	in	IN	O	in	_	0	SENT_203	[p9l2091t3363r2149b3416],
40	heterozygous	JJ	O	heterozygous	amod	41	SENT_203	[p9l8t3443r410b3512],
41	patients	NNS	O	patient	prep_in	37	SENT_203	[p9l444t3443r679b3512],
42	(	RB	O	(	advmod	37	SENT_203	[p9l716t3443r797b3509],
43	in	IN	O	in	_	0	SENT_203	[p9l716t3443r797b3509],
44	any	DT	O	any	prep_in	37	SENT_203	[p9l832t3460r937b3512],
45	of	IN	O	of	_	0	SENT_203	[p9l972t3443r1037b3496],
46	both	DT	O	both	det	47	SENT_203	[p9l1065t3443r1199b3496],
47	genes	NNS	O	gene	prep_of	44	SENT_203	[p9l1234t3444r1426b3512],
48	)	IN	O	)	amod	47	SENT_203	[p9l1234t3444r1426b3512],
49	relapsed	VBN	O	relapse	ccomp	27	SENT_203	[p9l1462t3443r1730b3512],
50	,	,	O	,	_	0	SENT_203	[p9l1462t3443r1730b3512],
51	and	CC	O	and	_	0	SENT_203	[p9l1769t3443r1876b3496],
52	survival	NN	O	survival	nn	53	SENT_203	[p9l1911t3443r2148b3497],
53	differences	NNS	O	difference	nsubj	56	SENT_203	[p9l9t3524r341b3577],
54	were	VBD	O	be	cop	56	SENT_203	[p9l384t3541r529b3577],
55	statistically	RB	O	statistically	advmod	56	SENT_203	[p9l572t3524r914b3593],
56	signiﬁcant	JJ	O	signiﬁcant	conj_and	27	SENT_203	[p9l958t3524r1270b3593],
57	in	IN	O	in	_	0	SENT_203	[p9l1310t3524r1368b3576],
58	favour	NN	O	favour	prep_in	56	SENT_203	[p9l1408t3524r1604b3577],
59	of	IN	O	of	_	0	SENT_203	[p9l1644t3524r1709b3577],
60	heterozygous	JJ	O	heterozygous	amod	61	SENT_203	[p9l1744t3524r2147b3593],
61	patients	NNS	O	patient	prep_of	58	SENT_203	[p9l7t3604r242b3672],
62	(	IN	O	(	_	0	SENT_203	[p9l270t3604r338b3669],
63	P	NN	O	p	prep_(	56	SENT_203	[p9l270t3604r338b3669],
64	=	JJ	O	=	amod	63	SENT_203	[p9l355t3628r406b3646],
65	0.0170	CD	NUMBER	0.0170	num	66	SENT_203	[p9l424t3604r671b3669],
66	)	NN	O	)	dep	64	SENT_203	[p9l424t3604r671b3669],
67	.	.	O	.	_	0	SENT_203	[p9l424t3604r671b3669],

1	Journal	NNP	O	Journal	_	0	SENT_204	[p10l7t55r228b104],
2	of	IN	O	of	_	0	SENT_204	[p10l251t55r315b118],
3	Surgical	NNP	O	Surgical	nn	4	SENT_204	[p10l327t55r566b118],
4	Oncology	NNP	O	Oncology	prep_of	1	SENT_204	[p10l591t55r863b118],

1	Gene	NNP	PERSON	Gene	nn	2	SENT_205	[p10l375t279r559b339],
2	Poymorphisms	NNP	PERSON	Poymorphisms	_	0	SENT_205	[p10l588t279r1125b355],
3	in	IN	O	in	_	0	SENT_205	[p10l1153t279r1222b338],
4	Gastric	NNP	O	Gastric	nn	5	SENT_205	[p10l1252t279r1516b339],
5	Cancer	NNP	O	Cancer	prep_in	2	SENT_205	[p10l1547t279r1806b339],
6	133	CD	NUMBER	133	dep	2	SENT_205	[p10l2027t279r2146b339],

1	DPYD	NN	ORGANIZATION	dpyd	dep	7	SENT_206	[p10l887t1579r1064b1631],
2	and	CC	O	and	_	0	SENT_206	[p10l1087t1579r1193b1631],
3	CDA	NNP	ORGANIZATION	CDA	conj_and	1	SENT_206	[p10l1214t1577r1352b1631],
4	both	CC	O	both	dep	3	SENT_206	[p10l1373t1577r1494b1629],
5	Heterozygous	JJ	O	heterozygous	amod	6	SENT_206	[p10l1520t1577r1916b1640],
6	n	NN	O	n	conj	3	SENT_206	[p10l887t1659r995b1711],
7	=	JJ	O	=	_	0	SENT_206	[p10l887t1659r995b1711],
8	8	CD	NUMBER	8	tmod	7	SENT_206	[p10l887t1659r995b1711],

1	o	NN	O	o	_	0	SENT_207	[p10l163t2140r195b2192],
2	5	CD	NUMBER	5	number	3	SENT_207	[p10l823t2136r858b2186],
3	1	CD	NUMBER	1	dep	1	SENT_207	[p10l1461t2132r1481b2181],
4	o	NN	O	o	nn	5	SENT_207	[p10l1494t2132r1526b2181],
5	Years	NNS	DURATION	year	dep	3	SENT_207	[p10l1962t2127r2133b2177],

1	Fig	NN	O	fig	_	0	SENT_208	[p10l7t2279r121b2348],
2	.	.	O	.	_	0	SENT_208	[p10l7t2279r121b2348],

1	4	LS	NUMBER	4	_	0	SENT_209	[p10l152t2279r204b2332],
2	.	.	O	.	_	0	SENT_209	[p10l152t2279r204b2332],

1	When	WRB	O	when	advmod	3	SENT_210	[p10l284t2279r465b2332],
2	we	PRP	O	we	nsubj	3	SENT_210	[p10l499t2296r585b2332],
3	analysed	VBD	O	analyse	advcl	29	SENT_210	[p10l621t2279r884b2348],
4	the	DT	O	the	det	24	SENT_210	[p10l917t2279r1007b2332],
5	33	CD	NUMBER	33	num	6	SENT_210	[p10l1044t2279r1112b2332],
6	patients	NNS	O	patient	npadvmod	7	SENT_210	[p10l1148t2279r1382b2348],
7	heterozygous	JJ	O	heterozygous	amod	24	SENT_210	[p10l1417t2279r1819b2348],
8	in	IN	O	in	_	0	SENT_210	[p10l1855t2279r1912b2332],
9	any	DT	O	any	prep_in	7	SENT_210	[p10l1947t2296r2053b2348],
10	of	IN	O	of	_	0	SENT_210	[p10l2087t2279r2152b2332],
11	DPYD2	NN	O	dpyd2	nn	13	SENT_210	[p10l6t2360r238b2412],
12	(	CD	NUMBER	(	num	13	SENT_210	[p10l262t2360r415b2425],
13	C/T	NN	O	c/t	prep_of	9	SENT_210	[p10l262t2360r415b2425],
14	;	:	O	;	_	0	SENT_210	[p10l262t2360r415b2425],
15	Arg29Cys	NNS	O	arg29cy	dep	13	SENT_210	[p10l437t2360r769b2428],
16	)	CD	NUMBER	)	num	15	SENT_210	[p10l437t2360r769b2428],
17	or	CC	O	or	_	0	SENT_210	[p10l790t2376r852b2412],
18	CDA	NNP	O	CDA	nn	20	SENT_210	[p10l872t2360r1014b2413],
19	(	CD	NUMBER	(	num	20	SENT_210	[p10l1037t2360r1202b2425],
20	A/C	NN	O	a/c	dep	13	SENT_210	[p10l1037t2360r1202b2425],
21	;	:	O	;	_	0	SENT_210	[p10l1037t2360r1202b2425],
22	Lys27Gin	NN	O	lys27gin	nn	24	SENT_210	[p10l1224t2359r1545b2428],
23	)	NN	O	)	nn	24	SENT_210	[p10l1224t2359r1545b2428],
24	genes	NNS	O	gene	dobj	3	SENT_210	[p10l1566t2376r1752b2428],
25	,	,	O	,	_	0	SENT_210	[p10l1566t2376r1752b2428],
26	survival	NN	O	survival	nsubj	29	SENT_210	[p10l1776t2359r2012b2413],
27	was	VBD	O	be	cop	29	SENT_210	[p10l2032t2376r2146b2413],
28	statistically	RB	O	statistically	advmod	29	SENT_210	[p10l10t2440r352b2509],
29	signiﬁcant	JJ	O	signiﬁcant	dep	46	SENT_210	[p10l393t2440r706b2509],
30	better	RBR	O	better	advmod	29	SENT_210	[p10l741t2440r915b2493],
31	in	IN	O	in	_	0	SENT_210	[p10l951t2440r1009b2492],
32	the	DT	O	the	det	33	SENT_210	[p10l1046t2440r1137b2493],
33	patients	NNS	O	patient	prep_in	29	SENT_210	[p10l1174t2440r1408b2509],
34	with	IN	O	with	_	0	SENT_210	[p10l1448t2440r1580b2493],
35	only	RB	O	only	advmod	38	SENT_210	[p10l1619t2440r1750b2509],
36	one	CD	NUMBER	one	num	38	SENT_210	[p10l1789t2457r1896b2493],
37	heterozygous	JJ	O	heterozygous	amod	38	SENT_210	[p10l1933t2440r2145b2493, p10l8t2536r218b2588],
38	polymorphism	NN	O	polymorphism	prep_with	33	SENT_210	[p10l256t2519r700b2588],
39	compared	VBN	O	compare	_	0	SENT_210	[p10l737t2520r1035b2588],
40	to	TO	O	to	prepc_compared_to	38	SENT_210	[p10l1072t2528r1129b2573],
41	those	DT	O	those	det	42	SENT_210	[p10l1167t2520r1325b2573],
42	patients	NNS	O	patient	pobj	38	SENT_210	[p10l1362t2519r1596b2588],
43	with	IN	O	with	_	0	SENT_210	[p10l1636t2519r1769b2573],
44	both	DT	O	both	det	45	SENT_210	[p10l1805t2520r1939b2573],
45	genes	NNS	O	gene	prep_with	42	SENT_210	[p10l1977t2536r2146b2588],
46	(	VBP	O	(	_	0	SENT_210	[p10l9t2600r263b2665],
47	DPYD2	NN	O	dpyd2	nsubj	54	SENT_210	[p10l9t2600r263b2665],
48	and	CC	O	and	_	0	SENT_210	[p10l293t2599r399b2652],
49	CDA	NNP	ORGANIZATION	CDA	dep	51	SENT_210	[p10l427t2600r594b2665],
50	)	CD	NUMBER	)	num	49	SENT_210	[p10l427t2600r594b2665],
51	heterozygous	JJ	O	heterozygous	amod	53	SENT_210	[p10l621t2599r1023b2668],
52	(	NN	O	(	nn	53	SENT_210	[p10l1052t2600r1120b2665],
53	P	NN	O	p	nsubj	54	SENT_210	[p10l1052t2600r1120b2665],
54	=	JJ	O	=	xcomp	46	SENT_210	[p10l1137t2623r1188b2641],
55	0.0012	CD	NUMBER	0.0012	num	56	SENT_210	[p10l1206t2599r1452b2665],
56	)	NN	O	)	nsubj	46	SENT_210	[p10l1206t2599r1452b2665],
57	.	.	O	.	_	0	SENT_210	[p10l1206t2599r1452b2665],

1	the	DT	O	the	det	2	SENT_211	[p10l7t2830r98b2883],
2	activity	NN	O	activity	_	0	SENT_211	[p10l144t2829r367b2898],
3	of	IN	O	of	_	0	SENT_211	[p10l412t2829r477b2883],
4	DPD	NN	O	dpd	nn	5	SENT_211	[p10l515t2831r663b2882],
5	enzyme	NN	O	enzyme	prep_of	2	SENT_211	[p10l709t2846r942b2898],
6	or	CC	O	or	_	0	SENT_211	[p10l988t2846r1050b2883],
7	second	JJ	ORDINAL	second	prep_of	2	SENT_211	[p10l1094t2830r1301b2883],
8	by	IN	O	by	_	0	SENT_211	[p10l1343t2830r1417b2898],
9	a	DT	O	a	det	11	SENT_211	[p10l1463t2846r1494b2883],
10	directly	RB	O	directly	advmod	11	SENT_211	[p10l1537t2829r1767b2898],
11	association	NN	O	association	prep_by	2	SENT_211	[p10l1813t2829r2147b2883],
12	between	IN	O	between	_	0	SENT_211	[p10l6t2917r259b2970],
13	this	DT	O	this	det	14	SENT_211	[p10l284t2917r390b2970],
14	polymorphism	NN	O	polymorphism	prep_between	11	SENT_211	[p10l416t2917r859b2986],
15	and	CC	O	and	_	0	SENT_211	[p10l884t2917r991b2970],
16	poor	JJ	O	poor	amod	17	SENT_211	[p10l1014t2934r1154b2986],
17	prognosis	NN	O	prognosis	conj_and	14	SENT_211	[p10l1177t2917r1485b2986],
18	.	.	O	.	_	0	SENT_211	[p10l1177t2917r1485b2986],

1	It	PRP	O	it	nsubjpass	4	SENT_212	[p10l101t3008r146b3059],
2	has	VBZ	O	have	aux	4	SENT_212	[p10l175t3006r273b3059],
3	been	VBN	O	be	auxpass	4	SENT_212	[p10l304t3006r446b3059],
4	established	VBN	O	establish	_	0	SENT_212	[p10l477t3006r812b3059],
5	that	IN	O	that	complm	13	SENT_212	[p10l842t3006r955b3059],
6	80-90	CD	PERCENT	80-90	num	7	SENT_212	[p10l987t3007r1245b3060],
7	%	NN	PERCENT	%	nsubjpass	13	SENT_212	[p10l987t3007r1245b3060],
8	of	IN	O	of	_	0	SENT_212	[p10l1279t3006r1344b3059],
9	the	DT	O	the	det	11	SENT_212	[p10l1369t3006r1460b3059],
10	administered	VBN	O	administer	amod	11	SENT_212	[p10l1492t3006r1882b3059],
11	5-FU	NN	O	5-fu	prep_of	7	SENT_212	[p10l1912t3006r2069b3060],
12	is	VBZ	O	be	auxpass	13	SENT_212	[p10l2099t3006r2146b3059],
13	degraded	VBN	O	degrade	ccomp	4	SENT_212	[p11l8t24r284b93],
14	by	IN	O	by	_	0	SENT_212	[p11l317t25r391b93],
15	DPD	NN	ORGANIZATION	dpd	agent	13	SENT_212	[p11l425t26r573b77],
16	in	IN	O	in	_	0	SENT_212	[p11l609t24r666b77],
17	humans	NNS	O	human	prep_in	15	SENT_212	[p11l699t25r950b87],
18	,	,	O	,	_	0	SENT_212	[p11l699t25r950b87],
19	the	DT	O	the	det	20	SENT_212	[p11l987t25r1077b78],
20	ﬁrst	NN	O	ﬁrst	prep_in	15	SENT_212	[p11l1113t24r1229b78],
21	and	CC	O	and	_	0	SENT_212	[p11l1263t25r1370b78],
22	rate	NN	O	rate	prep_in	15	SENT_212	[p11l1402t24r1782b93],
23	—	CD	NUMBER	—	num	22	SENT_212	[p11l1402t24r1782b93],
24	limiting	VBG	O	limit	xcomp	13	SENT_212	[p11l1402t24r1782b93],
25	enzyme	NN	O	enzyme	dobj	24	SENT_212	[p11l1818t41r2051b93],
26	of	IN	O	of	_	0	SENT_212	[p11l2087t24r2152b78],
27	5	CD	NUMBER	5	prep_of	25	SENT_212	[p11l8t112r165b166],
28	.	.	O	.	_	0	SENT_212	[p11l8t112r165b166],

1	—	NN	O	—	_	0	SENT_213	[p11l8t112r165b166],
2	.	.	O	.	_	0	SENT_213	[p11l8t112r165b166],

1	FU	NN	O	fu	nn	2	SENT_214	[p11l8t112r165b166],
2	catabolism	NN	O	catabolism	_	0	SENT_214	[p11l185t112r529b175],
3	,	,	O	,	_	0	SENT_214	[p11l185t112r529b175],
4	only	RB	O	only	advmod	7	SENT_214	[p11l551t112r683b181],
5	a	DT	O	a	det	7	SENT_214	[p11l705t129r736b166],
6	small	JJ	O	small	amod	7	SENT_214	[p11l757t113r917b166],
7	part	NN	O	part	appos	2	SENT_214	[p11l936t121r1054b181],
8	of	IN	O	of	_	0	SENT_214	[p11l1073t112r1139b166],
9	the	DT	O	the	det	10	SENT_214	[p11l1153t113r1244b166],
10	5	CD	NUMBER	5	prep_of	7	SENT_214	[p11l1265t112r1421b166],
11	.	.	O	.	_	0	SENT_214	[p11l1265t112r1421b166],

1	—	NN	O	—	_	0	SENT_215	[p11l1265t112r1421b166],
2	.	.	O	.	_	0	SENT_215	[p11l1265t112r1421b166],

1	FU	NNP	O	FU	nsubjpass	3	SENT_216	[p11l1265t112r1421b166],
2	is	VBZ	O	be	auxpass	3	SENT_216	[p11l1440t112r1488b166],
3	activated	VBN	O	activate	_	0	SENT_216	[p11l1510t112r1779b166],
4	by	IN	O	by	_	0	SENT_216	[p11l1797t112r1871b181],
5	anabolic	JJ	O	anabolic	amod	6	SENT_216	[p11l1893t113r2146b166],
6	way	NN	O	way	agent	3	SENT_216	[p11l8t217r131b269],
7	[	CD	NUMBER	[	number	8	SENT_216	[p11l161t201r257b265],
8	8	CD	NUMBER	8	num	9	SENT_216	[p11l161t201r257b265],
9	]	NN	O	]	dep	3	SENT_216	[p11l161t201r257b265],
10	.	.	O	.	_	0	SENT_216	[p11l161t201r257b265],

1	As	IN	O	as	_	0	SENT_217	[p11l286t201r366b253],
2	a	DT	O	a	det	3	SENT_217	[p11l393t217r424b253],
3	result	NN	O	result	prep_as	8	SENT_217	[p11l447t200r631b263],
4	,	,	O	,	_	0	SENT_217	[p11l447t200r631b263],
5	5-FU	NN	O	5-fu	nn	6	SENT_217	[p11l659t200r816b254],
6	degradation	NN	O	degradation	nsubj	8	SENT_217	[p11l841t200r1197b269],
7	generally	RB	O	generally	advmod	8	SENT_217	[p11l1222t200r1502b269],
8	occurs	VBZ	O	occur	_	0	SENT_217	[p11l1528t217r1722b253],
9	in	IN	O	in	_	0	SENT_217	[p11l1748t200r1805b253],
10	all	DT	O	all	det	11	SENT_217	[p11l1831t200r1904b253],
11	tissues	NNS	O	tissue	prep_in	8	SENT_217	[p11l1928t200r2144b263],
12	,	,	O	,	_	0	SENT_217	[p11l1928t200r2144b263],
13	including	VBG	O	include	_	0	SENT_217	[p11l7t288r292b357],
14	tumour	NN	O	tumour	nn	15	SENT_217	[p11l312t296r531b342],
15	tissues	NNS	O	tissue	prep_including	11	SENT_217	[p11l550t288r766b351],
16	,	,	O	,	_	0	SENT_217	[p11l550t288r766b351],
17	but	CC	O	but	_	0	SENT_217	[p11l788t289r885b342],
18	it	PRP	O	it	nsubj	19	SENT_217	[p11l903t288r944b342],
19	reaches	VBZ	O	reach	conj_but	8	SENT_217	[p11l962t289r1188b342],
20	its	PRP$	O	its	poss	22	SENT_217	[p11l1209t288r1277b342],
21	highest	JJS	O	highest	amod	22	SENT_217	[p11l1298t288r1517b357],
22	level	NN	O	level	dobj	19	SENT_217	[p11l1536t289r1680b342],
23	in	IN	O	in	_	0	SENT_217	[p11l1699t288r1757b341],
24	the	DT	O	the	det	25	SENT_217	[p11l1776t289r1867b342],
25	liver	NN	O	liver	prep_in	22	SENT_217	[p11l1887t289r2024b342],
26	[	CD	NUMBER	[	number	27	SENT_217	[p11l2047t289r2143b353],
27	9	CD	NUMBER	9	num	28	SENT_217	[p11l2047t289r2143b353],
28	]	NN	O	]	dep	25	SENT_217	[p11l2047t289r2143b353],
29	.	.	O	.	_	0	SENT_217	[p11l2047t289r2143b353],

1	In	IN	O	in	_	0	SENT_218	[p11l7t378r68b429],
2	contrast	NN	O	contrast	prep_in	8	SENT_218	[p11l127t384r382b439],
3	,	,	O	,	_	0	SENT_218	[p11l127t384r382b439],
4	many	JJ	O	many	amod	6	SENT_218	[p11l444t393r610b445],
5	experimental	JJ	O	experimental	amod	6	SENT_218	[p11l670t376r1063b445],
6	studies	NNS	O	study	nsubj	8	SENT_218	[p11l1125t377r1331b430],
7	have	VBP	O	have	aux	8	SENT_218	[p11l1390t377r1530b430],
8	demonstrated	VBN	O	demonstrate	_	0	SENT_218	[p11l1590t377r1997b430],
9	the	DT	O	the	det	12	SENT_218	[p11l2056t377r2147b430],
10	intratumoural	JJ	O	intratumoural	amod	12	SENT_218	[p11l7t465r420b518],
11	DPD	NN	O	dpd	nn	12	SENT_218	[p11l462t466r610b517],
12	activity	NN	O	activity	dobj	8	SENT_218	[p11l655t465r878b533],
13	to	TO	O	to	aux	14	SENT_218	[p11l921t473r977b518],
14	affect	VB	O	affect	xcomp	8	SENT_218	[p11l1022t465r1191b518],
15	the	DT	O	the	det	16	SENT_218	[p11l1232t465r1322b518],
16	resistance	NN	O	resistance	dobj	14	SENT_218	[p11l1364t465r1663b518],
17	to	TO	O	to	_	0	SENT_218	[p11l1705t473r1761b518],
18	5	CD	NUMBER	5	prep_to	14	SENT_218	[p11l1806t464r1963b518],
19	.	.	O	.	_	0	SENT_218	[p11l1806t464r1963b518],

1	—	NN	O	—	_	0	SENT_219	[p11l1806t464r1963b518],
2	.	.	O	.	_	0	SENT_219	[p11l1806t464r1963b518],

1	FU	NNP	O	FU	_	0	SENT_220	[p11l1806t464r1963b518],
2	[	CD	NUMBER	[	num	1	SENT_220	[p11l2010t465r2143b529],
3	10	CD	NUMBER	10	num	4	SENT_220	[p11l2010t465r2143b529],
4	]	NN	O	]	dep	1	SENT_220	[p11l2010t465r2143b529],
5	.	.	O	.	_	0	SENT_220	[p11l2010t465r2143b529],

1	Previous	JJ	O	previous	amod	3	SENT_221	[p11l7t552r268b606],
2	clinical	JJ	O	clinical	amod	3	SENT_221	[p11l307t552r529b606],
3	studies	NNS	O	study	nsubj	5	SENT_221	[p11l569t552r774b606],
4	also	RB	O	also	advmod	5	SENT_221	[p11l814t553r932b606],
5	found	VBD	O	find	_	0	SENT_221	[p11l970t552r1146b606],
6	an	DT	O	a	dobj	5	SENT_221	[p11l1183t569r1252b606],
7	over	IN	O	over	_	0	SENT_221	[p11l1290t552r1769b621],
8	—	NN	O	—	nn	9	SENT_221	[p11l1290t552r1769b621],
9	expression	NN	O	expression	prep_over	5	SENT_221	[p11l1290t552r1769b621],
10	of	IN	O	of	_	0	SENT_221	[p11l1807t552r1873b606],
11	DPD	NN	ORGANIZATION	dpd	prep_of	9	SENT_221	[p11l1904t554r2052b605],
12	in	IN	O	in	_	0	SENT_221	[p11l2090t552r2148b605],
13	tumour	NN	O	tumour	nn	14	SENT_221	[p11l7t648r226b694],
14	cells	NNS	O	cell	prep_in	11	SENT_221	[p11l274t641r409b694],
15	to	TO	O	to	aux	17	SENT_221	[p11l459t649r516b694],
16	be	VB	O	be	auxpass	17	SENT_221	[p11l563t641r633b694],
17	associated	VBN	O	associate	xcomp	5	SENT_221	[p11l684t640r993b694],
18	with	IN	O	with	_	0	SENT_221	[p11l1041t640r1175b694],
19	5	CD	NUMBER	5	prep_with	17	SENT_221	[p11l1224t640r1380b694],
20	.	.	O	.	_	0	SENT_221	[p11l1224t640r1380b694],

1	—	NN	O	—	_	0	SENT_222	[p11l1224t640r1380b694],
2	.	.	O	.	_	0	SENT_222	[p11l1224t640r1380b694],

1	FU	NN	LOCATION	fu	nn	2	SENT_223	[p11l1224t640r1380b694],
2	resistance	NN	O	resistance	nsubj	23	SENT_223	[p11l1427t640r1725b694],
3	and	CC	O	and	_	0	SENT_223	[p11l1776t640r1883b694],
4	a	DT	O	a	det	6	SENT_223	[p11l1932t657r1964b694],
5	poor	JJ	O	poor	amod	6	SENT_223	[p11l2009t657r2149b709],
6	prognosis	NN	O	prognosis	conj_and	2	SENT_223	[p11l6t729r298b798],
7	in	IN	O	in	_	0	SENT_223	[p11l329t729r387b781],
8	many	JJ	O	many	amod	10	SENT_223	[p11l417t745r583b797],
9	cancer	NN	O	cancer	nn	10	SENT_223	[p11l613t745r811b782],
10	patients	NNS	O	patient	prep_in	6	SENT_223	[p11l838t729r1073b797],
11	treated	VBN	O	treat	partmod	10	SENT_223	[p11l1104t729r1310b782],
12	with	IN	O	with	_	0	SENT_223	[p11l1339t729r1472b782],
13	5-FU	NN	O	5-fu	prep_with	11	SENT_223	[p11l1503t728r1660b782],
14	[	CD	NUMBER	[	number	15	SENT_223	[p11l1694t729r1830b793],
15	11	CD	NUMBER	11	num	16	SENT_223	[p11l1694t729r1830b793],
16	]	NN	O	]	dep	13	SENT_223	[p11l1694t729r1830b793],
17	,	,	O	,	_	0	SENT_223	[p11l1694t729r1830b793],
18	including	VBG	O	include	_	0	SENT_223	[p11l1862t729r2147b797],
19	non-small	JJ	O	non-small	amod	22	SENT_223	[p11l7t816r308b869],
20	cell	NN	O	cell	nn	22	SENT_223	[p11l342t816r450b869],
21	lung	NN	O	lung	nn	22	SENT_223	[p11l483t816r615b885],
22	cancers	NNS	O	cancer	prep_including	13	SENT_223	[p11l648t833r872b869],
23	[	VBP	O	[	_	0	SENT_223	[p11l911t817r1047b881],
24	12	CD	NUMBER	12	num	25	SENT_223	[p11l911t817r1047b881],
25	]	CD	NUMBER	]	dobj	23	SENT_223	[p11l911t817r1047b881],
26	,	,	O	,	_	0	SENT_223	[p11l911t817r1047b881],
27	colorectal	JJ	O	colorectal	amod	28	SENT_223	[p11l1082t816r1379b869],
28	cancers	NNS	O	cancer	nsubj	29	SENT_223	[p11l1414t833r1638b869],
29	[	VBP	O	[	conj_and	23	SENT_223	[p11l1677t817r1790b881],
30	13	CD	NUMBER	13	num	31	SENT_223	[p11l1677t817r1790b881],
31	]	CD	NUMBER	]	dobj	29	SENT_223	[p11l1677t817r1790b881],
32	and	CC	O	and	_	0	SENT_223	[p11l1829t816r1936b869],
33	breast	NN	O	breast	nn	34	SENT_223	[p11l1967t816r2148b869],
34	cancers	NNS	O	cancer	nsubj	35	SENT_223	[p11l8t922r232b958],
35	[	VBP	O	[	conj_and	23	SENT_223	[p11l264t906r398b969],
36	14	CD	NUMBER	14	num	37	SENT_223	[p11l264t906r398b969],
37	]	CD	NUMBER	]	dobj	35	SENT_223	[p11l264t906r398b969],
38	.	.	O	.	_	0	SENT_223	[p11l264t906r398b969],

1	In	IN	O	in	_	0	SENT_224	[p11l101t994r162b1045],
2	our	PRP$	O	we	poss	3	SENT_224	[p11l195t1009r294b1046],
3	study	NN	O	study	prep_in	7	SENT_224	[p11l327t993r499b1061],
4	,	,	O	,	_	0	SENT_224	[p11l327t993r499b1061],
5	CDA	NNP	ORGANIZATION	CDA	nsubjpass	11	SENT_224	[p11l537t994r678b1046],
6	was	VBD	O	be	auxpass	7	SENT_224	[p11l706t1009r820b1046],
7	associated	VBN	O	associate	_	0	SENT_224	[p11l854t993r1164b1046],
8	to	TO	O	to	_	0	SENT_224	[p11l1196t1001r1252b1046],
9	DPYD2	NN	O	dpyd2	prep_to	7	SENT_224	[p11l1283t993r1516b1045],
10	and	CC	O	and	_	0	SENT_224	[p11l1551t993r1658b1046],
11	had	VBD	O	have	conj_and	7	SENT_224	[p11l1689t993r1797b1046],
12	prognostic	JJ	O	prognostic	amod	13	SENT_224	[p11l1828t993r2146b1061],
13	signiﬁcance	NN	O	signiﬁcance	dobj	11	SENT_224	[p11l10t1081r368b1150],
14	in	IN	O	in	_	0	SENT_224	[p11l423t1081r480b1133],
15	favour	NN	O	favour	prep_in	13	SENT_224	[p11l535t1081r731b1134],
16	of	IN	O	of	_	0	SENT_224	[p11l785t1081r851b1134],
17	heterozygous	JJ	O	heterozygous	prep_of	15	SENT_224	[p11l900t1081r1302b1150],
18	versus	CC	O	versus	_	0	SENT_224	[p11l1360t1098r1549b1134],
19	non-heterozygous	JJ	O	non-heterozygous	amod	20	SENT_224	[p11l1605t1081r2145b1150],
20	patients	NNS	O	patient	dobj	11	SENT_224	[p11l6t1168r240b1237],
21	in	IN	O	in	_	0	SENT_224	[p11l273t1168r330b1221],
22	the	DT	O	the	det	24	SENT_224	[p11l361t1168r451b1222],
23	univariate	JJ	O	univariate	amod	24	SENT_224	[p11l482t1168r781b1222],
24	analysis	NN	O	analysis	prep_in	20	SENT_224	[p11l814t1168r1070b1237],
25	.	.	O	.	_	0	SENT_224	[p11l814t1168r1070b1237],

1	This	DT	O	this	det	2	SENT_225	[p11l1105t1168r1237b1222],
2	fact	NN	O	fact	nsubj	3	SENT_225	[p11l1269t1168r1382b1222],
3	suggests	VBZ	O	suggest	_	0	SENT_225	[p11l1414t1177r1665b1237],
4	that	IN	O	that	complm	7	SENT_225	[p11l1697t1169r1811b1222],
5	CDA	NNP	ORGANIZATION	CDA	nsubj	7	SENT_225	[p11l1844t1169r1985b1222],
6	may	MD	O	may	aux	7	SENT_225	[p11l2018t1185r2147b1237],
7	play	VB	O	play	ccomp	3	SENT_225	[p11l6t1257r135b1325],
8	a	DT	O	a	det	9	SENT_225	[p11l178t1273r209b1310],
9	role	NN	O	role	dobj	7	SENT_225	[p11l247t1257r363b1310],
10	in	IN	O	in	_	0	SENT_225	[p11l403t1257r461b1309],
11	the	DT	O	the	det	12	SENT_225	[p11l500t1257r591b1310],
12	outcome	NN	O	outcome	prep_in	7	SENT_225	[p11l632t1265r890b1310],
13	of	IN	O	of	_	0	SENT_225	[p11l932t1257r997b1310],
14	these	DT	O	these	det	15	SENT_225	[p11l1032t1257r1185b1310],
15	patients	NNS	O	patient	prep_of	12	SENT_225	[p11l1225t1257r1476b1325],
16	.	.	O	.	_	0	SENT_225	[p11l1225t1257r1476b1325],

1	CDA	NNP	ORGANIZATION	CDA	nn	2	SENT_226	[p11l1523t1258r1664b1310],
2	polymorphism	NN	O	polymorphism	nsubj	16	SENT_226	[p11l1705t1257r2148b1325],
3	showed	VBD	O	show	_	0	SENT_226	[p11l10t1345r236b1398],
4	reduced	VBN	O	reduce	amod	6	SENT_226	[p11l295t1345r535b1398],
5	substrate	NN	O	substrate	nn	6	SENT_226	[p11l599t1345r864b1398],
6	activity	NN	O	activity	dobj	3	SENT_226	[p11l927t1345r1150b1414],
7	for	IN	O	for	_	0	SENT_226	[p11l1213t1345r1300b1398],
8	cytidine	NN	O	cytidine	prep_for	6	SENT_226	[p11l1360t1345r1603b1414],
9	and	CC	O	and	_	0	SENT_226	[p11l1665t1345r1772b1398],
10	cytarabine	NN	O	cytarabine	nn	12	SENT_226	[p11l1833t1345r2147b1414],
11	antineoplastic	JJ	O	antineoplastic	amod	12	SENT_226	[p11l9t1433r427b1502],
12	agents	NNS	O	agent	prep_for	6	SENT_226	[p11l483t1441r672b1502],
13	but	CC	O	but	_	0	SENT_226	[p11l724t1433r821b1486],
14	also	RB	O	also	advmod	3	SENT_226	[p11l873t1433r991b1486],
15	was	VBD	O	be	aux	16	SENT_226	[p11l1043t1450r1156b1486],
16	inﬂuencing	VBG	O	inﬂuencing	conj_but	3	SENT_226	[p11l1210t1433r1549b1502],
17	the	DT	O	the	det	18	SENT_226	[p11l1602t1433r1693b1486],
18	prognosis	NN	O	prognosis	dobj	16	SENT_226	[p11l1744t1433r2037b1502],
19	in	IN	O	in	_	0	SENT_226	[p11l2090t1433r2148b1485],
20	untreated	JJ	O	untreated	amod	21	SENT_226	[p11l7t1521r289b1574],
21	acute	JJ	O	acute	amod	23	SENT_226	[p11l324t1529r481b1574],
22	myeloid	JJ	O	myeloid	amod	23	SENT_226	[p11l515t1521r764b1589],
23	leukaemia	NN	O	leukaemia	prep_in	18	SENT_226	[p11l797t1521r1109b1574],
24	and	CC	O	and	_	0	SENT_226	[p11l1143t1521r1250b1574],
25	lymphoma	NN	O	lymphoma	nn	26	SENT_226	[p11l1284t1521r1608b1589],
26	patients	NNS	O	patient	nsubj	27	SENT_226	[p11l1639t1521r1874b1589],
27	[	VBP	O	[	conj_and	3	SENT_226	[p11l1914t1521r2143b1585],
28	15,16	CD	NUMBER	15,16	number	29	SENT_226	[p11l1914t1521r2143b1585],
29	]	CD	NUMBER	]	dobj	27	SENT_226	[p11l1914t1521r2143b1585],
30	.	.	O	.	_	0	SENT_226	[p11l1914t1521r2143b1585],

1	CDA	NNP	ORGANIZATION	CDA	nn	2	SENT_227	[p11l11t1610r152b1662],
2	gene	NN	O	gene	nsubj	4	SENT_227	[p11l179t1625r319b1678],
3	possibly	RB	O	possibly	advmod	4	SENT_227	[p11l342t1609r593b1677],
4	acts	VBZ	O	act	_	0	SENT_227	[p11l619t1616r733b1662],
5	as	IN	O	as	_	0	SENT_227	[p11l759t1625r817b1662],
6	a	DT	O	a	det	7	SENT_227	[p11l844t1625r875b1662],
7	proto-oncogene	NN	O	proto-oncogene	prep_as	4	SENT_227	[p11l897t1617r1389b1677],
8	,	,	O	,	_	0	SENT_227	[p11l897t1617r1389b1677],
9	and	CC	O	and	_	0	SENT_227	[p11l1417t1609r1523b1662],
10	SNPs	NNS	O	snp	nsubj	12	SENT_227	[p11l1549t1609r1710b1662],
11	can	MD	O	can	aux	12	SENT_227	[p11l1736t1625r1839b1662],
12	affect	VB	O	affect	conj_and	4	SENT_227	[p11l1864t1609r2034b1662],
13	the	DT	O	the	det	14	SENT_227	[p11l2056t1609r2147b1662],
14	outcome	NN	O	outcome	dobj	12	SENT_227	[p11l8t1706r267b1751],
15	and	CC	O	and	_	0	SENT_227	[p11l294t1698r401b1751],
16	prognosis	NN	O	prognosis	dobj	12	SENT_227	[p11l424t1698r716b1767],
17	in	IN	O	in	_	0	SENT_227	[p11l742t1698r800b1750],
18	some	DT	O	some	det	19	SENT_227	[p11l827t1715r983b1751],
19	neoplasia	NN	O	neoplasium	prep_in	14	SENT_227	[p11l1008t1698r1308b1767],
20	.	.	O	.	_	0	SENT_227	[p11l1008t1698r1308b1767],

1	In	IN	O	in	_	0	SENT_228	[p11l101t1786r162b1838],
2	an	DT	O	a	det	4	SENT_228	[p11l183t1802r251b1838],
3	experimental	JJ	O	experimental	amod	4	SENT_228	[p11l271t1785r666b1854],
4	study	NN	O	study	prep_in	8	SENT_228	[p11l688t1785r859b1854],
5	,	,	O	,	_	0	SENT_228	[p11l688t1785r859b1854],
6	Vitamin	NN	O	vitamin	nn	7	SENT_228	[p11l882t1785r1113b1838],
7	D3	NN	O	d3	nsubj	8	SENT_228	[p11l1132t1786r1219b1838],
8	up-regulates	VBZ	O	up-regulate	_	0	SENT_228	[p11l1241t1785r1613b1854],
9	the	DT	O	the	det	10	SENT_228	[p11l1635t1785r1725b1838],
10	expression	NN	O	expression	dobj	8	SENT_228	[p11l1745t1785r2067b1854],
11	of	IN	O	of	_	0	SENT_228	[p11l2087t1785r2153b1838],
12	CDA	NNP	ORGANIZATION	CDA	nn	13	SENT_228	[p11l11t1875r152b1927],
13	gene	NN	O	gene	prep_of	10	SENT_228	[p11l195t1890r335b1942],
14	in	IN	O	in	_	0	SENT_228	[p11l375t1874r433b1926],
15	some	DT	O	some	det	20	SENT_228	[p11l475t1890r630b1927],
16	human	JJ	O	human	amod	20	SENT_228	[p11l669t1874r875b1927],
17	solid	JJ	O	solid	amod	20	SENT_228	[p11l917t1874r1061b1927],
18	tumour	NN	O	tumour	nn	20	SENT_228	[p11l1100t1882r1319b1927],
19	cell	NN	O	cell	nn	20	SENT_228	[p11l1358t1874r1465b1927],
20	lines	NNS	O	line	prep_in	13	SENT_228	[p11l1505t1874r1645b1927],
21	as	RB	O	as	_	0	SENT_228	[p11l1688t1890r1746b1927],
22	well	RB	O	well	_	0	SENT_228	[p11l1787t1874r1916b1927],
23	as	IN	O	as	_	0	SENT_228	[p11l1957t1890r2015b1927],
24	the	DT	O	the	det	26	SENT_228	[p11l2056t1874r2147b1927],
25	monocytic	JJ	O	monocytic	amod	26	SENT_228	[p11l7t1962r325b2031],
26	leukaemia	NN	O	leukaemia	conj_and	13	SENT_228	[p11l344t1962r656b2015],
27	cell	NN	O	cell	nn	28	SENT_228	[p11l674t1962r781b2015],
28	lines	NNS	O	line	nsubj	29	SENT_228	[p11l800t1962r940b2015],
29	[	VBP	O	[	rcmod	26	SENT_228	[p11l965t1962r1194b2026],
30	17,18	CD	NUMBER	17,18	number	31	SENT_228	[p11l965t1962r1194b2026],
31	]	CD	NUMBER	]	dobj	29	SENT_228	[p11l965t1962r1194b2026],
32	.	.	O	.	_	0	SENT_228	[p11l965t1962r1194b2026],

1	Three	CD	NUMBER	three	_	0	SENT_229	[p11l1216t1962r1391b2015],
2	of	IN	O	of	_	0	SENT_229	[p11l1411t1962r1476b2015],
3	ﬁve	NN	O	ﬁve	prep_of	1	SENT_229	[p11l1488t1962r1596b2015],
4	gastric	JJ	O	gastric	amod	5	SENT_229	[p11l1613t1962r1812b2031],
5	carcinoma	NN	O	carcinoma	dep	1	SENT_229	[p11l1832t1962r2148b2015],

1	TABLE	NN	O	table	_	0	SENT_230	[p11l8t2192r226b2238],
2	III	CD	NUMBER	iii	dep	1	SENT_230	[p11l249t2193r340b2239],
3	.	.	O	.	_	0	SENT_230	[p11l249t2193r340b2239],

1	Distribution	NN	O	distribution	_	0	SENT_231	[p11l376t2192r724b2239],
2	of	IN	O	of	_	0	SENT_231	[p11l746t2192r804b2239],
3	Favourable	JJ	O	favourable	amod	6	SENT_231	[p11l821t2193r1144b2239],
4	and	CC	O	and	_	0	SENT_231	[p11l1167t2193r1272b2239],
5	Unfavourable	JJ	O	unfavourable	amod	6	SENT_231	[p11l1294t2192r1684b2239],
6	Genotypes	NNS	O	genotype	prep_of	1	SENT_231	[p11l1709t2192r2006b2252],

1	Gene	NNP	O	Gene	_	0	SENT_232	[p11l8t2329r146b2375],
2	Favourable	JJ	O	favourable	amod	3	SENT_232	[p11l747t2329r1046b2375],
3	genotypes	NNS	O	genotype	dep	1	SENT_232	[p11l1068t2335r1336b2389],
4	Unfavourable	JJ	O	unfavourable	amod	5	SENT_232	[p11l1452t2329r1818b2375],
5	genotypes	NNS	O	genotype	dep	1	SENT_232	[p11l1841t2336r2109b2389],

1	DPYD1	NN	O	dpyd1	_	0	SENT_233	[p11l6t2477r208b2522],
2	AC	NN	O	ac	dep	1	SENT_233	[p11l682t2477r773b2523],
3	.	.	O	.	_	0	SENT_233	[p11l774t2477r839b2523],

1	—	NN	O	—	_	0	SENT_234	[p11l774t2477r839b2523],
2	.	.	O	.	_	0	SENT_234	[p11l774t2477r839b2523],

1	C	NN	O	c	nn	4	SENT_235	[p11l774t2477r839b2523],
2	C	NN	O	c	nn	4	SENT_235	[p11l841t2477r883b2523],
3	CC	NN	O	cc	nn	4	SENT_235	[p11l1493t2477r1580b2523],
4	CDA/DPYD1	NN	O	cda/dpyd1	_	0	SENT_235	[p11l10t2555r359b2602],
5	/	:	O	/	punct	4	SENT_235	[p11l365t2555r589b2601],
6	DPYD2	NN	O	dpyd2	nn	7	SENT_235	[p11l365t2555r589b2601],
7	AC/CT/CT	NN	O	ac/ct/ct	dep	4	SENT_235	[p11l682t2555r977b2602],
8	AC-CC/CC-TT/CC-TT	NN	O	ac-cc/cc-tt/cc-tt	nn	11	SENT_235	[p11l1486t2555r2100b2602],
9	CDA/DPYD2	NN	O	cda/dpyd2	nn	11	SENT_235	[p11l10t2634r362b2680],
10	AC/CT	NN	O	ac/ct	nn	11	SENT_235	[p11l681t2634r876b2680],
11	AA	NN	O	aa	dep	7	SENT_235	[p11l1485t2634r1893b2680],
12	.	.	O	.	_	0	SENT_235	[p11l1485t2634r1893b2680],

1	—	NN	O	—	_	0	SENT_236	[p11l1485t2634r1893b2680],
2	.	.	O	.	_	0	SENT_236	[p11l1485t2634r1893b2680],

1	CC/CC	NN	O	cc/cc	_	0	SENT_237	[p11l1485t2634r1893b2680],
2	.	.	O	.	_	0	SENT_237	[p11l1485t2634r1893b2680],

1	—	NN	O	—	_	0	SENT_238	[p11l1485t2634r1893b2680],
2	.	.	O	.	_	0	SENT_238	[p11l1485t2634r1893b2680],

1	TT	NN	O	tt	_	0	SENT_239	[p11l1485t2634r1893b2680],

1	AC-I-AA-CC	NN	O	ac-i-aa-cc	_	0	SENT_240	[p11l682t2713r1198b2764],
2	/	:	O	/	punct	3	SENT_240	[p11l682t2713r1198b2764],
3	CT	NN	O	ct	dep	1	SENT_240	[p11l682t2713r1198b2764],
4	+	CC	O	+	_	0	SENT_240	[p11l682t2713r1198b2764],
5	CC-TT	NN	O	cc-tt	nn	6	SENT_240	[p11l1216t2713r1404b2760],
6	AC/CT	NN	O	ac/ct	dep	1	SENT_240	[p11l1486t2712r1679b2760],

1	134	CD	NUMBER	134	num	2	SENT_241	[p11l12t2971r133b3031],
2	Grau	NNP	PERSON	Grau	_	0	SENT_241	[p11l351t2971r541b3031],
3	et	FW	O	et	nn	4	SENT_241	[p11l569t2976r633b3031],
4	al.	FW	O	al.	dep	2	SENT_241	[p11l661t2972r743b3031],
5	.	.	O	.	_	0	SENT_241	[p11l661t2972r743b3031],

1	cell	NN	O	cell	nn	2	SENT_242	[p12l9t58r116b111],
2	lines	NNS	O	line	nsubj	10	SENT_242	[p12l140t58r280b111],
3	and	CC	O	and	_	0	SENT_242	[p12l306t58r413b111],
4	ﬁve	NN	O	ﬁve	nsubj	10	SENT_242	[p12l437t58r545b111],
5	of	IN	O	of	_	0	SENT_242	[p12l569t58r634b111],
6	eight	CD	NUMBER	eight	num	9	SENT_242	[p12l653t58r804b127],
7	colorectal	JJ	O	colorectal	amod	9	SENT_242	[p12l827t58r1125b111],
8	cancer	NN	O	cancer	nn	9	SENT_242	[p12l1150t75r1347b111],
9	lines	NNS	O	line	prep_of	2	SENT_242	[p12l1369t58r1510b111],
10	had	VBD	O	have	_	0	SENT_242	[p12l1534t58r1643b111],
11	increased	VBN	O	increase	amod	12	SENT_242	[p12l1666t58r1951b111],
12	levels	NNS	O	level	dobj	10	SENT_242	[p12l1975t58r2147b111],
13	of	IN	O	of	_	0	SENT_242	[p12l9t145r74b199],
14	CDA	NNP	ORGANIZATION	CDA	nn	15	SENT_242	[p12l97t146r238b199],
15	mRNA	NN	O	mrna	prep_of	12	SENT_242	[p12l265t146r479b199],
16	following	VBG	DATE	follow	_	0	SENT_242	[p12l503t145r794b214],
17	24	CD	DATE	24	num	19	SENT_242	[p12l820t146r892b198],
18	hr	NN	DATE	hr	nn	19	SENT_242	[p12l916t146r979b198],
19	treatment	NN	O	treatment	prep_following	12	SENT_242	[p12l1002t153r1289b199],
20	with	IN	O	with	_	0	SENT_242	[p12l1313t145r1446b199],
21	vitamin	NN	O	vitamin	nn	22	SENT_242	[p12l1470t145r1701b199],
22	D3	NN	O	d3	prep_with	19	SENT_242	[p12l1725t146r1830b199],
23	.	.	O	.	_	0	SENT_242	[p12l1725t146r1830b199],

1	Increased	VBN	O	increase	amod	2	SENT_243	[p12l1858t146r2148b199],
2	mRNA	NN	O	mrna	nsubjpass	20	SENT_243	[p12l8t234r223b287],
3	was	VBD	O	be	auxpass	4	SENT_243	[p12l252t250r365b287],
4	detected	VBN	O	detect	_	0	SENT_243	[p12l404t234r655b287],
5	in	IN	O	in	_	0	SENT_243	[p12l691t234r748b286],
6	gastric	JJ	O	gastric	amod	8	SENT_243	[p12l785t234r983b302],
7	cancer	NN	O	cancer	nn	8	SENT_243	[p12l1021t250r1219b287],
8	MKN	NN	O	mkn	prep_in	4	SENT_243	[p12l1253t235r1427b287],
9	45	CD	NUMBER	45	num	10	SENT_243	[p12l1463t234r1533b287],
10	cells	NNS	O	cell	dep	8	SENT_243	[p12l1573t234r1708b287],
11	after	IN	O	after	_	0	SENT_243	[p12l1747t234r1884b287],
12	3	CD	DURATION	3	num	13	SENT_243	[p12l1921t234r1951b287],
13	hr	NN	DURATION	hr	prep_after	4	SENT_243	[p12l1989t234r2053b286],
14	of	IN	O	of	_	0	SENT_243	[p12l2088t234r2153b287],
15	treatment	NN	O	treatment	prep_of	13	SENT_243	[p12l8t330r295b375],
16	with	IN	O	with	_	0	SENT_243	[p12l349t322r481b375],
17	vitamin	NN	O	vitamin	nn	18	SENT_243	[p12l535t322r766b375],
18	D3	NN	O	d3	prep_with	4	SENT_243	[p12l819t322r906b375],
19	and	CC	O	and	_	0	SENT_243	[p12l965t322r1072b375],
20	increased	VBD	O	increase	conj_and	4	SENT_243	[p12l1125t322r1411b375],
21	enzyme	NN	O	enzyme	nn	22	SENT_243	[p12l1465t339r1699b391],
22	activity	NN	O	activity	nsubjpass	24	SENT_243	[p12l1754t322r1978b391],
23	was	VBD	O	be	auxpass	24	SENT_243	[p12l2033t339r2147b375],
24	measured	VBN	O	measure	ccomp	20	SENT_243	[p12l8t409r298b463],
25	after	IN	O	after	_	0	SENT_243	[p12l341t409r478b463],
26	24-48	CD	NUMBER	24-48	num	27	SENT_243	[p12l521t410r717b463],
27	hr	NN	DURATION	hr	prep_after	24	SENT_243	[p12l761t410r834b463],
28	.	.	O	.	_	0	SENT_243	[p12l761t410r834b463],

1	These	DT	O	these	det	2	SENT_244	[p12l880t409r1059b463],
2	results	NNS	O	result	nsubj	4	SENT_244	[p12l1101t410r1296b463],
3	are	VBP	O	be	aux	4	SENT_244	[p12l1341t426r1430b463],
4	suggesting	VBG	O	suggest	_	0	SENT_244	[p12l1476t409r1795b478],
5	that	IN	O	that	complm	10	SENT_244	[p12l1838t410r1952b463],
6	CDA	NNP	ORGANIZATION	CDA	nn	7	SENT_244	[p12l1993t410r2149b463],
7	enzyme	NN	O	enzyme	nsubjpass	10	SENT_244	[p12l9t514r242b566],
8	can	MD	O	can	aux	10	SENT_244	[p12l264t514r367b551],
9	be	VB	O	be	auxpass	10	SENT_244	[p12l387t498r458b551],
10	induced	VBN	O	induce	ccomp	4	SENT_244	[p12l479t498r718b551],
11	by	IN	O	by	_	0	SENT_244	[p12l738t498r812b566],
12	some	DT	O	some	det	13	SENT_244	[p12l836t514r991b551],
13	drugs	NNS	O	drug	agent	10	SENT_244	[p12l1013t498r1178b566],
14	(	RB	O	(	advmod	10	SENT_244	[p12l1202t498r1284b563],
15	as	IN	O	as	_	0	SENT_244	[p12l1202t498r1284b563],
16	vitamin	NN	O	vitamin	nn	18	SENT_244	[p12l1307t498r1538b551],
17	D3	NN	O	d3	nn	18	SENT_244	[p12l1559t498r1672b563],
18	)	NN	O	)	prep_as	10	SENT_244	[p12l1559t498r1672b563],
19	and	CC	O	and	_	0	SENT_244	[p12l1697t498r1804b551],
20	that	IN	O	that	complm	24	SENT_244	[p12l1824t498r1937b551],
21	it	PRP	O	it	nsubjpass	24	SENT_244	[p12l1957t498r1999b551],
22	may	MD	O	may	aux	24	SENT_244	[p12l2019t514r2148b566],
23	be	VB	O	be	auxpass	24	SENT_244	[p12l7t586r77b639],
24	modiﬁed	VBN	O	modiﬁed	conj_and	10	SENT_244	[p12l103t586r371b639],
25	in	IN	O	in	_	0	SENT_244	[p12l395t586r452b638],
26	gastric	JJ	O	gastric	amod	28	SENT_244	[p12l478t586r676b655],
27	cancer	NN	O	cancer	nn	28	SENT_244	[p12l704t603r901b639],
28	cells	NNS	O	cell	prep_in	24	SENT_244	[p12l925t586r1078b639],
29	.	.	O	.	_	0	SENT_244	[p12l925t586r1078b639],

1	Studies	NNS	O	study	nsubj	3	SENT_245	[p12l104t673r322b726],
2	have	VBP	O	have	aux	3	SENT_245	[p12l348t673r488b726],
3	shown	VBN	O	show	_	0	SENT_245	[p12l516t673r708b726],
4	that	IN	O	that	complm	10	SENT_245	[p12l732t673r846b726],
5	inappropriate	JJ	O	inappropriate	amod	6	SENT_245	[p12l870t673r1274b742],
6	expression	NN	O	expression	nsubj	10	SENT_245	[p12l1300t673r1622b742],
7	of	IN	O	of	_	0	SENT_245	[p12l1648t673r1713b726],
8	CDA	NNP	ORGANIZATION	CDA	nn	9	SENT_245	[p12l1733t673r1889b726],
9	enzyme	NN	O	enzyme	prep_of	6	SENT_245	[p12l1913t690r2147b742],
10	acts	VBZ	O	act	ccomp	3	SENT_245	[p12l10t770r123b815],
11	as	IN	O	as	_	0	SENT_245	[p12l158t778r217b815],
12	a	DT	O	a	det	14	SENT_245	[p12l252t778r284b815],
13	genomic	JJ	O	genomic	amod	14	SENT_245	[p12l317t762r575b830],
14	mutator	NN	O	mutator	prep_as	10	SENT_245	[p12l609t770r845b815],
15	that	WDT	O	that	nsubj	16	SENT_245	[p12l877t762r990b815],
16	contributes	VBZ	O	contribute	rcmod	14	SENT_245	[p12l1023t762r1356b815],
17	to	TO	O	to	_	0	SENT_245	[p12l1390t770r1447b815],
18	tumorigenesis	NN	O	tumorigenesis	prep_to	16	SENT_245	[p12l1480t762r1903b831],
19	also	RB	O	also	advmod	10	SENT_245	[p12l1939t762r2057b815],
20	in	IN	O	in	_	0	SENT_245	[p12l2090t762r2148b814],
21	gastric	JJ	O	gastric	amod	22	SENT_245	[p12l9t850r207b919],
22	cancer	NN	O	cancer	prep_in	10	SENT_245	[p12l234t867r432b903],
23	[	CD	NUMBER	[	number	24	SENT_245	[p12l461t850r595b914],
24	19	CD	NUMBER	19	num	25	SENT_245	[p12l461t850r595b914],
25	]	NN	O	]	dep	10	SENT_245	[p12l461t850r595b914],
26	.	.	O	.	_	0	SENT_245	[p12l461t850r595b914],

1	Our	PRP$	O	we	poss	2	SENT_246	[p12l103t938r219b991],
2	results	NNS	O	result	nsubj	4	SENT_246	[p12l241t938r437b991],
3	may	MD	O	may	aux	4	SENT_246	[p12l464t955r592b1007],
4	suggest	VB	O	suggest	_	0	SENT_246	[p12l621t946r844b1007],
5	that	IN	O	that	complm	11	SENT_246	[p12l869t938r982b991],
6	the	DT	O	the	det	8	SENT_246	[p12l1007t938r1097b991],
7	experimental	JJ	O	experimental	amod	8	SENT_246	[p12l1124t938r1518b1007],
8	observations	NNS	O	observation	nsubjpass	11	SENT_246	[p12l1544t938r1922b991],
9	can	MD	O	can	aux	11	SENT_246	[p12l1950t955r2053b991],
10	be	VB	O	be	auxpass	11	SENT_246	[p12l2077t938r2147b991],
11	observed	VBN	O	observe	ccomp	4	SENT_246	[p12l9t1025r280b1078],
12	also	RB	O	also	advmod	11	SENT_246	[p12l307t1025r424b1078],
13	in	IN	O	in	_	0	SENT_246	[p12l452t1025r509b1078],
14	humans	NNS	O	human	prep_in	11	SENT_246	[p12l534t1025r784b1078],
15	.	.	O	.	_	0	SENT_246	[p12l534t1025r784b1078],

1	Genes	NNS	O	gene	nsubj	4	SENT_247	[p12l815t1026r1000b1078],
2	do	VBP	O	do	aux	4	SENT_247	[p12l1028t1025r1101b1078],
3	not	RB	O	not	neg	4	SENT_247	[p12l1127t1033r1223b1078],
4	act	VB	O	act	_	0	SENT_247	[p12l1250t1033r1336b1078],
5	in	IN	O	in	_	0	SENT_247	[p12l1361t1025r1419b1078],
6	isolation	NN	O	isolation	prep_in	4	SENT_247	[p12l1445t1025r1705b1078],
7	and	CC	O	and	_	0	SENT_247	[p12l1732t1025r1839b1078],
8	drugs	NNS	O	drug	nsubjpass	11	SENT_247	[p12l1865t1025r2029b1094],
9	are	VBP	O	be	auxpass	11	SENT_247	[p12l2058t1042r2147b1078],
10	often	RB	O	often	advmod	11	SENT_247	[p12l9t1114r163b1167],
11	involved	VBN	O	involve	conj_and	4	SENT_247	[p12l187t1114r448b1167],
12	in	IN	O	in	_	0	SENT_247	[p12l472t1114r529b1166],
13	complex	JJ	O	complex	amod	15	SENT_247	[p12l555t1114r814b1183],
14	metabolic	JJ	O	metabolic	amod	15	SENT_247	[p12l838t1114r1135b1167],
15	pathways	NNS	O	pathway	prep_in	11	SENT_247	[p12l1161t1114r1446b1183],
16	in	IN	O	in	_	0	SENT_247	[p12l1471t1114r1529b1166],
17	the	DT	O	the	det	18	SENT_247	[p12l1553t1114r1644b1167],
18	cell	NN	O	cell	prep_in	15	SENT_247	[p12l1670t1114r1778b1167],
19	before	IN	O	before	mark	22	SENT_247	[p12l1801t1114r1994b1167],
20	they	PRP	O	they	nsubjpass	22	SENT_247	[p12l2020t1114r2148b1183],
21	are	VBP	O	be	auxpass	22	SENT_247	[p12l10t1219r99b1255],
22	converted	VBN	O	convert	advcl	11	SENT_247	[p12l121t1202r417b1255],
23	to	TO	O	to	_	0	SENT_247	[p12l437t1210r493b1255],
24	active	JJ	O	active	amod	27	SENT_247	[p12l517t1202r693b1255],
25	or	CC	O	or	_	0	SENT_247	[p12l715t1219r777b1255],
26	inactive	JJ	O	inactive	amod	27	SENT_247	[p12l797t1202r1034b1255],
27	forms	NNS	O	form	prep_to	22	SENT_247	[p12l1055t1202r1245b1255],
28	.	.	O	.	_	0	SENT_247	[p12l1055t1202r1245b1255],

1	Variations	NNS	O	variation	nsubj	7	SENT_248	[p12l1270t1202r1576b1255],
2	in	IN	O	in	_	0	SENT_248	[p12l1598t1202r1656b1254],
3	the	DT	O	the	det	5	SENT_248	[p12l1677t1202r1768b1255],
4	DPYD	NN	O	dpyd	nn	5	SENT_248	[p12l1787t1204r1985b1254],
5	gene	NN	O	gene	prep_in	1	SENT_248	[p12l2008t1219r2148b1271],
6	can	MD	O	can	aux	7	SENT_248	[p12l9t1307r112b1343],
7	determine	VB	O	determine	_	0	SENT_248	[p12l133t1290r434b1343],
8	the	DT	O	the	det	9	SENT_248	[p12l455t1290r546b1343],
9	amount	NN	O	amount	dobj	7	SENT_248	[p12l568t1298r793b1343],
10	of	IN	O	of	_	0	SENT_248	[p12l813t1290r879b1343],
11	5-FU	NN	O	5-fu	nn	26	SENT_248	[p12l895t1290r1052b1343],
12	available	JJ	O	available	amod	26	SENT_248	[p12l1073t1290r1342b1343],
13	for	IN	O	for	_	0	SENT_248	[p12l1364t1290r1451b1343],
14	conversion	NN	O	conversion	prep_for	12	SENT_248	[p12l1470t1290r1798b1343],
15	to	TO	O	to	_	0	SENT_248	[p12l1818t1298r1875b1343],
16	FdUMP	NN	O	fdump	prep_to	14	SENT_248	[p12l1895t1290r2145b1352],
17	,	,	O	,	_	0	SENT_248	[p12l1895t1290r2145b1352],
18	and	CC	O	and	_	0	SENT_248	[p12l10t1377r117b1430],
19	variations	NNS	O	variation	prep_for	12	SENT_248	[p12l138t1377r433b1430],
20	in	IN	O	in	_	0	SENT_248	[p12l458t1377r515b1430],
21	other	JJ	O	other	amod	23	SENT_248	[p12l538t1377r693b1430],
22	gene	NN	O	gene	nn	23	SENT_248	[p12l714t1394r855b1446],
23	(	NN	O	(	prep_in	19	SENT_248	[p12l881t1377r1136b1446],
24	perhaps	RB	O	perhaps	advmod	23	SENT_248	[p12l881t1377r1136b1446],
25	CDA	NNP	ORGANIZATION	CDA	nn	26	SENT_248	[p12l1164t1378r1331b1443],
26	)	NN	O	)	prep_of	9	SENT_248	[p12l1164t1378r1331b1443],
27	can	MD	O	can	aux	28	SENT_248	[p12l1356t1394r1460b1430],
28	determine	VB	O	determine	rcmod	26	SENT_248	[p12l1483t1377r1784b1430],
29	the	DT	O	the	det	30	SENT_248	[p12l1808t1377r1898b1430],
30	amount	NN	O	amount	dobj	28	SENT_248	[p12l1923t1385r2149b1430],
31	of	IN	O	of	_	0	SENT_248	[p12l9t1466r74b1519],
32	target	NN	O	target	prep_of	30	SENT_248	[p12l96t1474r267b1535],
33	available	JJ	O	available	amod	32	SENT_248	[p12l295t1466r564b1519],
34	for	IN	O	for	_	0	SENT_248	[p12l592t1466r680b1519],
35	inhibition	NN	O	inhibition	prep_for	33	SENT_248	[p12l705t1466r1000b1519],
36	by	IN	O	by	_	0	SENT_248	[p12l1025t1466r1099b1535],
37	FdUMP	NN	O	fdump	prep_by	28	SENT_248	[p12l1126t1466r1375b1519],
38	.	.	O	.	_	0	SENT_248	[p12l1126t1466r1375b1519],

1	However	RB	O	however	advmod	8	SENT_249	[p12l1406t1467r1692b1529],
2	,	,	O	,	_	0	SENT_249	[p12l1406t1467r1692b1529],
3	there	EX	O	there	expl	8	SENT_249	[p12l1721t1466r1871b1519],
4	are	VBP	O	be	auxpass	8	SENT_249	[p12l1900t1483r1989b1519],
5	over	IN	O	over	advmod	8	SENT_249	[p12l2017t1483r2149b1519],
6	29	CD	NUMBER	29	num	7	SENT_249	[p12l9t1553r80b1607],
7	genes	NNS	O	gene	pobj	5	SENT_249	[p12l105t1570r274b1622],
8	involved	VBN	O	involve	_	0	SENT_249	[p12l297t1553r559b1606],
9	in	IN	O	in	_	0	SENT_249	[p12l580t1553r637b1606],
10	the	DT	O	the	det	11	SENT_249	[p12l660t1553r750b1606],
11	5	CD	NUMBER	5	prep_in	8	SENT_249	[p12l774t1553r931b1606],
12	.	.	O	.	_	0	SENT_249	[p12l774t1553r931b1606],

1	—	NN	O	—	_	0	SENT_250	[p12l774t1553r931b1606],
2	.	.	O	.	_	0	SENT_250	[p12l774t1553r931b1606],

1	FU	NN	LOCATION	fu	nn	2	SENT_251	[p12l774t1553r931b1606],
2	pathway	NN	O	pathway	_	0	SENT_251	[p12l953t1553r1220b1622],
3	,	,	O	,	_	0	SENT_251	[p12l953t1553r1220b1622],
4	in	IN	O	in	dep	13	SENT_251	[p12l1245t1553r1303b1606],
5	which	WDT	O	which	pobj	4	SENT_251	[p12l1325t1553r1509b1606],
6	genetic	JJ	O	genetic	amod	7	SENT_251	[p12l1532t1553r1748b1622],
7	variations	NNS	O	variation	nsubj	13	SENT_251	[p12l1772t1553r2067b1606],
8	in	IN	O	in	_	0	SENT_251	[p12l2091t1553r2148b1606],
9	any	DT	O	any	prep_in	7	SENT_251	[p12l10t1658r115b1710],
10	or	CC	O	or	_	0	SENT_251	[p12l134t1658r196b1694],
11	all	DT	O	all	prep_in	7	SENT_251	[p12l213t1641r286b1694],
12	can	MD	O	can	aux	13	SENT_251	[p12l306t1658r408b1694],
13	contribute	VB	O	contribute	dep	2	SENT_251	[p12l427t1641r732b1694],
14	to	TO	O	to	_	0	SENT_251	[p12l751t1650r807b1694],
15	systemic	JJ	O	systemic	amod	16	SENT_251	[p12l828t1641r1089b1710],
16	toxicity	NN	O	toxicity	prep_to	13	SENT_251	[p12l1108t1641r1338b1710],
17	or	CC	O	or	_	0	SENT_251	[p12l1358t1658r1420b1694],
18	antitumour	JJ	O	antitumour	amod	19	SENT_251	[p12l1438t1641r1769b1694],
19	response	NN	O	response	prep_to	13	SENT_251	[p12l1785t1658r2065b1710],
20	.	.	O	.	_	0	SENT_251	[p12l1785t1658r2065b1710],

1	In	IN	O	in	_	0	SENT_252	[p12l2087t1643r2148b1694],
2	our	PRP$	O	we	poss	3	SENT_252	[p12l9t1747r109b1783],
3	patients	NNS	O	patient	prep_in	17	SENT_252	[p12l137t1730r389b1799],
4	,	,	O	,	_	0	SENT_252	[p12l137t1730r389b1799],
5	the	DT	O	the	det	7	SENT_252	[p12l423t1730r514b1783],
6	low	JJ	O	low	amod	7	SENT_252	[p12l546t1730r655b1783],
7	grade	NN	O	grade	nsubj	17	SENT_252	[p12l688t1730r854b1799],
8	on	IN	O	on	_	0	SENT_252	[p12l886t1747r959b1783],
9	toxicity	NN	O	toxicity	nn	12	SENT_252	[p12l991t1730r1221b1799],
10	and	CC	O	and	_	0	SENT_252	[p12l1254t1730r1361b1783],
11	good	JJ	O	good	nn	12	SENT_252	[p12l1393t1730r1542b1799],
12	tolerance	NN	O	tolerance	prep_on	7	SENT_252	[p12l1572t1730r1850b1783],
13	achieved	VBN	O	achieve	partmod	12	SENT_252	[p12l1883t1730r2149b1783],
14	with	IN	O	with	_	0	SENT_252	[p12l9t1817r141b1870],
15	Tegafur	NN	O	tegafur	nn	16	SENT_252	[p12l201t1817r436b1886],
16	therapy	NN	O	therapy	prep_with	13	SENT_252	[p12l495t1817r720b1886],
17	made	VBD	O	make	_	0	SENT_252	[p12l781t1817r944b1870],
18	impossible	JJ	O	impossible	acomp	17	SENT_252	[p12l1004t1817r1331b1886],
19	to	TO	O	to	aux	20	SENT_252	[p12l1392t1825r1449b1870],
20	establish	VB	O	establish	xcomp	18	SENT_252	[p12l1510t1817r1774b1870],
21	signiﬁcant	NN	O	signiﬁcant	nn	22	SENT_252	[p12l1836t1817r2149b1886],
22	relationship	NN	O	relationship	dobj	20	SENT_252	[p12l7t1905r364b1974],
23	with	IN	O	with	_	0	SENT_252	[p12l391t1905r523b1959],
24	the	DT	O	the	det	25	SENT_252	[p12l548t1905r638b1958],
25	toxicity	NN	O	toxicity	prep_with	20	SENT_252	[p12l665t1905r895b1974],
26	of	IN	O	of	_	0	SENT_252	[p12l921t1905r987b1958],
27	patients	NNS	O	patient	prep_of	25	SENT_252	[p12l1005t1905r1256b1974],
28	.	.	O	.	_	0	SENT_252	[p12l1005t1905r1256b1974],

1	Initial	JJ	O	initial	amod	2	SENT_253	[p12l101t1993r281b2046],
2	steps	NNS	O	step	nsubjpass	5	SENT_253	[p12l320t2001r465b2062],
3	are	VBP	O	be	aux	5	SENT_253	[p12l504t2010r593b2046],
4	being	VBG	O	be	auxpass	5	SENT_253	[p12l628t1993r795b2062],
5	taken	VBN	O	take	_	0	SENT_253	[p12l831t1993r994b2046],
6	to	TO	O	to	aux	7	SENT_253	[p12l1030t2002r1086b2046],
7	integrate	VB	O	integrate	xcomp	5	SENT_253	[p12l1123t1993r1386b2062],
8	drug	NN	O	drug	nn	10	SENT_253	[p12l1424t1993r1559b2062],
9	pathway	NN	O	pathway	nn	10	SENT_253	[p12l1594t1993r1850b2062],
10	analysis	NN	O	analysis	dobj	7	SENT_253	[p12l1887t1993r2145b2062],
11	,	,	O	,	_	0	SENT_253	[p12l1887t1993r2145b2062],
12	rather	RB	O	rather	_	0	SENT_253	[p12l7t2081r185b2134],
13	than	IN	O	than	_	0	SENT_253	[p12l232t2081r361b2134],
14	single-gene	JJ	O	single-gene	amod	15	SENT_253	[p12l412t2081r758b2150],
15	studies	NNS	O	study	conj_negcc	10	SENT_253	[p12l810t2081r1032b2144],
16	,	,	O	,	_	0	SENT_253	[p12l810t2081r1032b2144],
17	into	IN	O	into	_	0	SENT_253	[p12l1084t2081r1199b2134],
18	clinical	JJ	O	clinical	amod	19	SENT_253	[p12l1250t2081r1471b2134],
19	trials	NNS	O	trial	prep_into	10	SENT_253	[p12l1521t2081r1669b2134],
20	to	TO	O	to	aux	21	SENT_253	[p12l1720t2089r1776b2134],
21	assess	VB	O	assess	xcomp	7	SENT_253	[p12l1827t2098r2007b2134],
22	the	DT	O	the	det	24	SENT_253	[p12l2056t2081r2147b2134],
23	predictive	JJ	O	predictive	amod	24	SENT_253	[p12l7t2169r308b2238],
24	power	NN	O	power	dobj	21	SENT_253	[p12l345t2186r533b2238],
25	of	IN	O	of	_	0	SENT_253	[p12l570t2169r635b2222],
26	chemotherapy	NN	O	chemotherapy	nn	27	SENT_253	[p12l668t2169r1096b2238],
27	activity	NN	O	activity	prep_of	24	SENT_253	[p12l1135t2169r1359b2238],
28	and	CC	O	and	_	0	SENT_253	[p12l1398t2169r1505b2222],
29	response	NN	O	response	conj_and	27	SENT_253	[p12l1541t2186r1820b2238],
30	.	.	O	.	_	0	SENT_253	[p12l1541t2186r1820b2238],

1	This	DT	O	this	nsubj	3	SENT_254	[p12l1861t2169r1993b2222],
2	will	MD	O	will	aux	3	SENT_254	[p12l2032t2169r2148b2222],
3	allow	VB	O	allow	_	0	SENT_254	[p12l10t2257r173b2311],
4	for	IN	O	for	_	0	SENT_254	[p12l204t2257r292b2310],
5	the	DT	O	the	det	6	SENT_254	[p12l321t2257r411b2310],
6	evaluation	NN	O	evaluation	prep_for	3	SENT_254	[p12l442t2257r754b2311],
7	of	IN	O	of	_	0	SENT_254	[p12l785t2257r850b2310],
8	gene	NN	O	gene	nn	11	SENT_254	[p12l877t2274r1063b2326],
9	—	NN	O	—	nn	11	SENT_254	[p12l877t2274r1063b2326],
10	gene	NN	O	gene	nn	11	SENT_254	[p12l1071t2274r1211b2326],
11	interactions	NNS	O	interaction	prep_of	6	SENT_254	[p12l1242t2257r1594b2310],
12	in	IN	O	in	_	0	SENT_254	[p12l1626t2257r1684b2310],
13	the	DT	O	the	det	14	SENT_254	[p12l1714t2257r1804b2310],
14	context	NN	O	context	prep_in	3	SENT_254	[p12l1836t2265r2057b2310],
15	of	IN	O	of	_	0	SENT_254	[p12l2088t2257r2153b2310],
16	anticancer	JJ	O	anticancer	amod	18	SENT_254	[p12l10t2345r321b2399],
17	drug	NN	O	drug	nn	18	SENT_254	[p12l347t2346r482b2414],
18	effect	NN	O	effect	prep_of	14	SENT_254	[p12l511t2345r696b2399],
19	.	.	O	.	_	0	SENT_254	[p12l511t2345r696b2399],

1	Drug	NN	O	drug	nn	3	SENT_255	[p12l727t2347r879b2414],
2	pathway	NN	O	pathway	nn	3	SENT_255	[p12l907t2346r1163b2414],
3	proﬁling	NN	O	proﬁling	nsubj	9	SENT_255	[p12l1189t2345r1449b2414],
4	in	IN	O	in	_	0	SENT_255	[p12l1476t2345r1533b2398],
5	advance	NN	O	advance	prep_in	3	SENT_255	[p12l1562t2346r1806b2399],
6	of	IN	O	of	_	0	SENT_255	[p12l1835t2345r1900b2399],
7	therapy	NN	O	therapy	prep_of	5	SENT_255	[p12l1922t2346r2147b2414],
8	may	MD	O	may	aux	9	SENT_255	[p12l8t2450r136b2502],
9	allow	VB	O	allow	_	0	SENT_255	[p12l178t2433r342b2486],
10	us	PRP	O	we	iobj	9	SENT_255	[p12l382t2450r446b2486],
11	a	DT	O	a	det	13	SENT_255	[p12l489t2450r520b2486],
12	greater	JJR	O	greater	amod	13	SENT_255	[p12l560t2441r770b2502],
13	chance	NN	O	chance	dobj	9	SENT_255	[p12l809t2433r1018b2486],
14	to	TO	O	to	aux	15	SENT_255	[p12l1058t2441r1115b2486],
15	achieve	VB	O	achieve	infmod	13	SENT_255	[p12l1157t2433r1384b2486],
16	the	DT	O	the	det	17	SENT_255	[p12l1424t2433r1515b2486],
17	goal	NN	O	goal	dobj	15	SENT_255	[p12l1555t2433r1683b2502],
18	of	IN	O	of	_	0	SENT_255	[p12l1724t2433r1790b2486],
19	optimising	VBG	O	optimise	amod	21	SENT_255	[p12l1825t2433r2147b2502],
20	chemotherapy	NN	O	chemotherapy	nn	21	SENT_255	[p12l9t2521r436b2590],
21	strategies	NNS	O	strategy	prep_of	17	SENT_255	[p12l462t2521r743b2590],
22	that	IN	O	that	complm	25	SENT_255	[p12l766t2521r880b2574],
23	we	PRP	O	we	nsubj	25	SENT_255	[p12l902t2538r987b2575],
24	can	MD	O	can	aux	25	SENT_255	[p12l1010t2538r1113b2574],
25	call	VB	O	call	ccomp	15	SENT_255	[p12l1137t2521r1244b2574],
26	polygenic	JJ	O	polygenic	amod	28	SENT_255	[p12l1266t2521r1564b2590],
27	pharmacogenomic	JJ	O	pharmacogenomic	amod	28	SENT_255	[p12l1586t2521r2146b2590],
28	strategies	NNS	O	strategy	dobj	25	SENT_255	[p12l11t2609r307b2678],
29	.	.	O	.	_	0	SENT_255	[p12l11t2609r307b2678],

1	REFERENCES	NNS	O	reference	_	0	SENT_256	[p12l766t2761r1389b2828],

1	l.	NNP	O	l.	nn	3	SENT_257	[p12l70t2915r114b2968],
2	Macdonald	NNP	ORGANIZATION	Macdonald	nn	3	SENT_257	[p12l159t2915r500b2968],
3	JS	NNP	ORGANIZATION	JS	_	0	SENT_257	[p12l525t2915r610b2978],
4	,	,	O	,	_	0	SENT_257	[p12l525t2915r610b2978],
5	Smalley	NNP	PERSON	Smalley	nn	6	SENT_257	[p12l640t2915r885b2984],
6	SR	NN	O	sr	appos	3	SENT_257	[p12l913t2915r1018b2978],
7	,	,	O	,	_	0	SENT_257	[p12l913t2915r1018b2978],
8	Benedetti	NNP	PERSON	Benedetti	nn	9	SENT_257	[p12l1046t2915r1335b2968],
9	J	NNP	PERSON	J	appos	3	SENT_257	[p12l1361t2916r1405b2978],
10	,	,	O	,	_	0	SENT_257	[p12l1361t2916r1405b2978],
11	et	FW	O	et	nn	12	SENT_257	[p12l1433t2923r1487b2968],
12	al.	FW	O	al.	appos	3	SENT_257	[p12l1513t2915r1600b2968],
13	:	:	O	:	_	0	SENT_257	[p12l1513t2915r1600b2968],
14	Chemoradiotherapy	NN	O	chemoradiotherapy	dep	3	SENT_257	[p12l1632t2915r2146b2968, p12l161t3011r267b3063],
15	after	IN	O	after	_	0	SENT_257	[p12l301t2994r439b3048],
16	surgery	NN	O	surgery	prep_after	14	SENT_257	[p12l472t3011r694b3063],
17	compared	VBN	O	compare	_	0	SENT_257	[p12l727t2995r1025b3063],
18	with	IN	O	with	prepc_compared_with	16	SENT_257	[p12l1058t2994r1191b3048],
19	surgery	NN	O	surgery	pobj	16	SENT_257	[p12l1226t3011r1447b3063],
20	alone	RB	O	alone	advmod	19	SENT_257	[p12l1482t2995r1642b3048],
21	for	IN	O	for	_	0	SENT_257	[p12l1676t2994r1763b3048],
22	adenocarci	JJ	O	adenocarci	amod	24	SENT_257	[p12l1796t2994r2146b3048],
23	—	NN	O	—	nn	24	SENT_257	[p12l1796t2994r2146b3048],
24	noma	NN	O	noma	prep_for	19	SENT_257	[p12l160t3091r328b3127],
25	of	IN	O	of	_	0	SENT_257	[p12l349t3074r414b3127],
26	the	DT	O	the	det	30	SENT_257	[p12l430t3074r520b3127],
27	stomach	NN	O	stomach	nn	30	SENT_257	[p12l544t3074r794b3127],
28	or	CC	O	or	_	0	SENT_257	[p12l816t3091r877b3127],
29	gastroesophageal	NN	O	gastroesophageal	nn	30	SENT_257	[p12l897t3074r1417b3143],
30	junction	NN	O	junction	prep_of	24	SENT_257	[p12l1433t3074r1702b3143],
31	.	.	O	.	_	0	SENT_257	[p12l1433t3074r1702b3143],

1	N	NN	O	n	nn	3	SENT_258	[p12l1726t3075r1780b3127],
2	Engl	NNP	O	Engl	nn	3	SENT_258	[p12l1799t3074r1941b3143],
3	J	NNP	O	J	nsubj	4	SENT_258	[p12l1962t3075r1990b3127],
4	Med	VBD	O	med	_	0	SENT_258	[p12l2011t3074r2148b3127],
5	200l	CD	NUMBER	200l	dobj	4	SENT_258	[p12l161t3155r759b3217],
6	;	:	O	;	_	0	SENT_258	[p12l161t3155r759b3217],
7	345:725	CD	NUMBER	345:725	num	8	SENT_258	[p12l161t3155r759b3217],
8	—	NN	O	—	dep	5	SENT_258	[p12l161t3155r759b3217],
9	730	CD	NUMBER	730	dep	8	SENT_258	[p12l161t3155r759b3217],
10	.	.	O	.	_	0	SENT_258	[p12l161t3155r759b3217],

1	2	LS	NUMBER	2	_	0	SENT_259	[p12l64t3234r114b3287],
2	.	.	O	.	_	0	SENT_259	[p12l64t3234r114b3287],

1	Cunningham	NNP	ORGANIZATION	Cunningham	nn	2	SENT_260	[p12l161t3233r551b3302],
2	D	NNP	ORGANIZATION	D	_	0	SENT_260	[p12l582t3235r651b3296],
3	,	,	O	,	_	0	SENT_260	[p12l582t3235r651b3296],
4	Allum	NNP	PERSON	Allum	nn	5	SENT_260	[p12l686t3234r879b3287],
5	WH	NNP	PERSON	WH	appos	2	SENT_260	[p12l910t3235r1052b3296],
6	,	,	O	,	_	0	SENT_260	[p12l910t3235r1052b3296],
7	Stenning	NNP	PERSON	Stenning	nn	8	SENT_260	[p12l1089t3233r1354b3302],
8	SP	NN	O	sp	appos	2	SENT_260	[p12l1389t3234r1477b3296],
9	,	,	O	,	_	0	SENT_260	[p12l1389t3234r1477b3296],
10	et	FW	O	et	nn	11	SENT_260	[p12l1513t3242r1567b3287],
11	al.	FW	O	al.	appos	2	SENT_260	[p12l1599t3234r1686b3287],
12	:	:	O	:	_	0	SENT_260	[p12l1599t3234r1686b3287],
13	MAGIC	NNP	O	MAGIC	nn	14	SENT_260	[p12l1724t3234r1970b3287],
14	Trial	NNP	O	Trial	dep	2	SENT_260	[p12l2003t3233r2147b3287],
15	Participants	NNS	O	participant	dep	14	SENT_260	[p12l159t3313r532b3382],
16	.	.	O	.	_	0	SENT_260	[p12l159t3313r532b3382],

1	Perioperative	JJ	MISC	perioperative	amod	2	SENT_261	[p12l576t3313r978b3382],
2	chemotherapy	NN	O	chemotherapy	_	0	SENT_261	[p12l1019t3313r1447b3382],
3	versus	CC	O	versus	prep	2	SENT_261	[p12l1488t3330r1678b3366],
4	surgery	NN	O	surgery	dep	3	SENT_261	[p12l1722t3330r1944b3382],
5	alone	RB	O	alone	advmod	4	SENT_261	[p12l1986t3313r2148b3366],
6	for	IN	O	for	_	0	SENT_261	[p12l160t3393r248b3446],
7	resectable	JJ	O	resectable	amod	9	SENT_261	[p12l270t3393r573b3446],
8	gastroesophageal	NN	O	gastroesophageal	nn	9	SENT_261	[p12l599t3393r1119b3462],
9	cancer	NN	O	cancer	prep_for	2	SENT_261	[p12l1147t3410r1354b3446],
10	.	.	O	.	_	0	SENT_261	[p12l1147t3410r1354b3446],

1	N	NN	O	n	nn	3	SENT_262	[p12l1383t3395r1436b3446],
2	Engl	NNP	O	Engl	nn	3	SENT_262	[p12l1460t3393r1602b3462],
3	J	NNP	O	J	nsubj	4	SENT_262	[p12l1627t3395r1655b3447],
4	Med	VBD	O	med	_	0	SENT_262	[p12l1679t3393r1817b3446],
5	2006	CD	DATE	2006	dobj	4	SENT_262	[p12l1843t3393r2142b3456],
6	;	:	O	;	_	0	SENT_262	[p12l1843t3393r2142b3456],
7	355	CD	NUMBER	355	num	9	SENT_262	[p12l1843t3393r2142b3456],
8	:	:	O	:	_	0	SENT_262	[p12l1843t3393r2142b3456],
9	11-20	CD	NUMBER	11-20	dep	5	SENT_262	[p12l167t3474r375b3527],
10	.	.	O	.	_	0	SENT_262	[p12l167t3474r375b3527],

1	3	LS	NUMBER	3	_	0	SENT_263	[p13l65t21r114b74],
2	.	.	O	.	_	0	SENT_263	[p13l65t21r114b74],

1	Grau	NNP	PERSON	Grau	nn	2	SENT_264	[p13l161t21r309b74],
2	JJ	NN	PERSON	jj	_	0	SENT_264	[p13l337t22r410b83],
3	,	,	O	,	_	0	SENT_264	[p13l337t22r410b83],
4	Estape	NN	PERSON	estape	nn	5	SENT_264	[p13l441t22r642b89],
5	J	NN	PERSON	j	appos	2	SENT_264	[p13l670t22r714b84],
6	,	,	O	,	_	0	SENT_264	[p13l670t22r714b84],
7	Fuster	NNP	PERSON	Fuster	nn	8	SENT_264	[p13l745t22r934b74],
8	J	NNP	PERSON	J	appos	2	SENT_264	[p13l961t22r1004b84],
9	,	,	O	,	_	0	SENT_264	[p13l961t22r1004b84],
10	et	FW	O	et	nn	11	SENT_264	[p13l1036t28r1090b74],
11	al.	FW	O	al.	appos	2	SENT_264	[p13l1119t20r1205b74],
12	:	:	O	:	_	0	SENT_264	[p13l1119t20r1205b74],
13	Randomized	JJ	O	randomized	amod	14	SENT_264	[p13l1239t20r1622b74],
14	trial	NN	O	trial	dep	2	SENT_264	[p13l1650t20r1771b74],
15	of	IN	O	of	_	0	SENT_264	[p13l1800t20r1866b74],
16	adjuvant	JJ	O	adjuvant	amod	17	SENT_264	[p13l1891t20r2149b89],
17	chemotherapy	NN	O	chemotherapy	prep_of	14	SENT_264	[p13l160t100r588b169],
18	with	IN	O	with	_	0	SENT_264	[p13l627t100r760b153],
19	mitomycin	NN	O	mitomycin	prep_with	17	SENT_264	[p13l797t100r1125b169],
20	plus	CC	O	plus	_	0	SENT_264	[p13l1161t100r1285b169],
21	ftorafur	NN	O	ftorafur	conj_plus	14	SENT_264	[p13l1324t100r1556b153],
22	versus	CC	O	versus	prep	21	SENT_264	[p13l1592t117r1781b153],
23	mitomycin	NN	O	mitomycin	dep	22	SENT_264	[p13l1820t100r2148b169],
24	alone	RB	O	alone	advmod	23	SENT_264	[p13l161t181r322b234],
25	in	IN	O	in	_	0	SENT_264	[p13l353t181r411b233],
26	resected	JJ	O	resected	amod	30	SENT_264	[p13l440t181r689b234],
27	locally	RB	O	locally	advmod	26	SENT_264	[p13l720t181r925b250],
28	advanced	JJ	O	advanced	amod	30	SENT_264	[p13l958t181r1241b234],
29	gastric	JJ	O	gastric	amod	30	SENT_264	[p13l1272t181r1470b250],
30	cancer	NN	O	cancer	prep_in	23	SENT_264	[p13l1504t198r1711b234],
31	.	.	O	.	_	0	SENT_264	[p13l1504t198r1711b234],

1	J	NNP	O	J	nn	3	SENT_265	[p13l1746t182r1774b234],
2	Clin	NNP	O	Clin	nn	3	SENT_265	[p13l1805t181r1933b234],
3	Oncol	NNP	O	Oncol	_	0	SENT_265	[p13l1966t181r2147b234],
4	1998	CD	DATE	1998	num	3	SENT_265	[p13l167t260r797b323],
5	;	:	O	;	_	0	SENT_265	[p13l167t260r797b323],
6	16:1036	CD	NUMBER	16:1036	number	7	SENT_265	[p13l167t260r797b323],
7	—	CD	NUMBER	—	dep	3	SENT_265	[p13l167t260r797b323],
8	1039	CD	DATE	1039	dep	7	SENT_265	[p13l167t260r797b323],
9	.	.	O	.	_	0	SENT_265	[p13l167t260r797b323],

1	.	.	O	.	_	0	SENT_266	[p13l105t383r114b392],

1	Kohne	NNP	O	Kohne	nn	2	SENT_267	[p13l161t339r357b392],
2	CH	NN	O	ch	_	0	SENT_267	[p13l381t339r500b402],
3	,	,	O	,	_	0	SENT_267	[p13l381t339r500b402],
4	Folprecht	NN	O	folprecht	nn	5	SENT_267	[p13l525t339r816b408],
5	G	NN	O	g	appos	2	SENT_267	[p13l839t339r906b392],
6	:	:	O	:	_	0	SENT_267	[p13l839t339r906b392],
7	Current	JJ	DATE	current	amod	8	SENT_267	[p13l936t339r1166b392],
8	perspectives	NNS	O	perspective	dep	2	SENT_267	[p13l1187t339r1559b408],
9	in	IN	O	in	_	0	SENT_267	[p13l1583t339r1640b392],
10	the	DT	O	the	det	11	SENT_267	[p13l1663t339r1753b392],
11	treatment	NN	O	treatment	prep_in	8	SENT_267	[p13l1777t347r2064b392],
12	of	IN	O	of	_	0	SENT_267	[p13l2088t339r2153b392],
13	metastatic	JJ	O	metastatic	amod	15	SENT_267	[p13l160t419r465b472],
14	colorectal	JJ	O	colorectal	amod	15	SENT_267	[p13l493t419r790b472],
15	cancer	NN	O	cancer	prep_of	11	SENT_267	[p13l817t436r1024b472],
16	.	.	O	.	_	0	SENT_267	[p13l817t436r1024b472],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_268	[p13l1053t420r1181b472],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_268	[p13l1208t419r1389b472],
3	2004	CD	DATE	2004	num	2	SENT_268	[p13l1415t419r1901b481],
4	;	:	O	;	_	0	SENT_268	[p13l1415t419r1901b481],
5	l5	CD	NUMBER	l5	num	6	SENT_268	[p13l1415t419r1901b481],
6	:43	CD	NUMBER	:43	dep	2	SENT_268	[p13l1415t419r1901b481],
7	—	NN	O	—	dep	6	SENT_268	[p13l1415t419r1901b481],
8	53	CD	NUMBER	53	num	7	SENT_268	[p13l1415t419r1901b481],
9	.	.	O	.	_	0	SENT_268	[p13l1415t419r1901b481],

1	.	.	O	.	_	0	SENT_269	[p13l105t543r114b552],

1	van	NN	PERSON	van	nn	3	SENT_270	[p13l160t516r266b552],
2	Kuilenburg	NNP	PERSON	Kuilenburg	nn	3	SENT_270	[p13l297t499r636b568],
3	AB	NNP	O	AB	_	0	SENT_270	[p13l667t499r786b552],
4	:	:	O	:	_	0	SENT_270	[p13l667t499r786b552],
5	Dihydropyrimidine	NN	O	dihydropyrimidine	nn	6	SENT_270	[p13l821t499r1405b568],
6	dehydrogenase	NN	O	dehydrogenase	dep	3	SENT_270	[p13l1437t499r1889b568],
7	and	CC	O	and	_	0	SENT_270	[p13l1921t499r2027b552],
8	the	DT	O	the	det	9	SENT_270	[p13l2056t499r2147b552],
9	efﬁcacy	NN	O	efﬁcacy	dep	3	SENT_270	[p13l160t578r395b647],
10	and	CC	O	and	_	0	SENT_270	[p13l431t579r538b632],
11	toxicity	NN	O	toxicity	conj_and	9	SENT_270	[p13l572t578r802b647],
12	of	IN	O	of	_	0	SENT_270	[p13l838t578r904b632],
13	5	CD	NUMBER	5	number	14	SENT_270	[p13l934t578r1389b632],
14	—	CD	NUMBER	—	num	15	SENT_270	[p13l934t578r1389b632],
15	ﬂurorouracil	NN	O	ﬂurorouracil	prep_of	9	SENT_270	[p13l934t578r1389b632],
16	.	.	O	.	_	0	SENT_270	[p13l934t578r1389b632],

1	Eur	NNP	O	Eur	nn	3	SENT_271	[p13l1427t580r1537b632],
2	J	NNP	O	J	nn	3	SENT_271	[p13l1569t580r1597b632],
3	Cancer	NNP	O	Cancer	_	0	SENT_271	[p13l1632t579r1847b632],
4	2004	CD	DATE	2004	num	3	SENT_271	[p13l1881t579r2142b641],
5	;	:	O	;	_	0	SENT_271	[p13l1881t579r2142b641],
6	40	CD	NUMBER	40	num	8	SENT_271	[p13l1881t579r2142b641],
7	:	:	O	:	_	0	SENT_271	[p13l1881t579r2142b641],
8	939-950	CD	NUMBER	939-950	dep	3	SENT_271	[p13l161t658r451b712],
9	.	.	O	.	_	0	SENT_271	[p13l161t658r451b712],

1	Journal	NNP	O	Journal	_	0	SENT_272	[p13l7t874r228b924],
2	of	IN	O	of	_	0	SENT_272	[p13l250t874r315b938],
3	Surgical	NNP	O	Surgical	nn	4	SENT_272	[p13l326t873r565b938],
4	Oncology	NNP	O	Oncology	prep_of	1	SENT_272	[p13l591t874r863b938],
5	6	CD	NUMBER	6	num	4	SENT_272	[p13l39t950r89b1005],
6	.	.	O	.	_	0	SENT_272	[p13l39t950r89b1005],

1	Jackson	NNP	PERSON	Jackson	nn	2	SENT_273	[p13l135t951r377b1005],
2	RC	NNP	O	RC	_	0	SENT_273	[p13l428t951r544b1005],
3	:	:	O	:	_	0	SENT_273	[p13l428t951r544b1005],
4	The	DT	O	the	det	5	SENT_273	[p13l600t950r718b1004],
5	regulation	NN	O	regulation	dep	2	SENT_273	[p13l769t950r1079b1020],
6	of	IN	O	of	_	0	SENT_273	[p13l1132t950r1198b1004],
7	thymidylate	JJ	O	thymidylate	amod	8	SENT_273	[p13l1243t950r1609b1020],
8	biosynthesis	NN	O	biosynthesis	prep_of	5	SENT_273	[p13l1660t950r2037b1020],
9	in	IN	O	in	_	0	SENT_273	[p13l2091t950r2148b1004],
10	Novikoff	NNP	O	Novikoff	nn	12	SENT_273	[p13l135t1031r418b1085],
11	hepatoma	NN	O	hepatoma	nn	12	SENT_273	[p13l471t1031r770b1101],
12	cells	NNS	O	cell	prep_in	8	SENT_273	[p13l828t1031r965b1085],
13	and	CC	O	and	_	0	SENT_273	[p13l1027t1031r1135b1085],
14	the	DT	O	the	det	15	SENT_273	[p13l1192t1031r1284b1085],
15	effects	NNS	O	effect	prep_of	5	SENT_273	[p13l1344t1031r1543b1085],
16	of	IN	O	of	_	0	SENT_273	[p13l1604t1031r1671b1085],
17	amethopterin	NN	O	amethopterin	prep_of	15	SENT_273	[p13l1725t1031r2145b1101],
18	,	,	O	,	_	0	SENT_273	[p13l1725t1031r2145b1101],
19	5	CD	NUMBER	5	num	21	SENT_273	[p13l137t1113r803b1183],
20	—	NN	O	—	nn	21	SENT_273	[p13l137t1113r803b1183],
21	ﬂuorodeoxyuridine	NN	O	ﬂuorodeoxyuridine	prep_of	15	SENT_273	[p13l137t1113r803b1183],
22	,	,	O	,	_	0	SENT_273	[p13l137t1113r803b1183],
23	and	CC	O	and	_	0	SENT_273	[p13l848t1114r956b1168],
24	3	CD	NUMBER	3	num	26	SENT_273	[p13l999t1114r1468b1168],
25	—	NN	O	—	nn	26	SENT_273	[p13l999t1114r1468b1168],
26	deazauridine	NN	O	deazauridine	prep_of	15	SENT_273	[p13l999t1114r1468b1168],
27	.	.	O	.	_	0	SENT_273	[p13l999t1114r1468b1168],

1	J	NNP	O	J	nn	3	SENT_274	[p13l1513t1115r1541b1168],
2	Biol	NNP	O	Biol	nn	3	SENT_274	[p13l1581t1114r1711b1168],
3	Chem	NNP	O	Chem	_	0	SENT_274	[p13l1753t1114r1935b1168],
4	1978	CD	DATE	1978	num	3	SENT_274	[p13l1982t1114r2145b1177],
5	;	:	O	;	_	0	SENT_274	[p13l1982t1114r2145b1177],
6	253:7440	CD	NUMBER	253:7440	number	7	SENT_274	[p13l137t1193r644b1247],
7	—	CD	NUMBER	—	dep	3	SENT_274	[p13l137t1193r644b1247],
8	7446	CD	NUMBER	7446	dep	7	SENT_274	[p13l137t1193r644b1247],
9	.	.	O	.	_	0	SENT_274	[p13l137t1193r644b1247],

1	.	.	O	.	_	0	SENT_275	[p13l80t1318r89b1327],

1	Somasekaram	NNP	MISC	Somasekaram	nn	2	SENT_276	[p13l138t1274r566b1327],
2	A	NNP	MISC	A	_	0	SENT_276	[p13l597t1274r667b1337],
3	,	,	O	,	_	0	SENT_276	[p13l597t1274r667b1337],
4	Jarmuz	NNP	O	Jarmuz	nn	5	SENT_276	[p13l700t1275r919b1327],
5	A	NNP	O	A	appos	2	SENT_276	[p13l951t1274r1021b1336],
6	,	,	O	,	_	0	SENT_276	[p13l951t1274r1021b1336],
7	How	WRB	O	how	advmod	18	SENT_276	[p13l1055t1275r1200b1327],
8	A	DT	O	a	nsubj	18	SENT_276	[p13l1231t1274r1301b1337],
9	,	,	O	,	_	0	SENT_276	[p13l1231t1274r1301b1337],
10	et	FW	O	et	nn	11	SENT_276	[p13l1336t1282r1390b1327],
11	al.	FW	O	al.	appos	8	SENT_276	[p13l1422t1274r1509b1327],
12	:	:	O	:	_	0	SENT_276	[p13l1422t1274r1509b1327],
13	Intracellular	JJ	O	intracellular	amod	14	SENT_276	[p13l1546t1273r1922b1327],
14	localization	NN	O	localization	dep	11	SENT_276	[p13l1953t1273r2146b1327, p13l137t1353r323b1407],
15	of	IN	O	of	_	0	SENT_276	[p13l363t1353r429b1407],
16	human	JJ	O	human	amod	17	SENT_276	[p13l463t1353r671b1407],
17	cytidine	NN	O	cytidine	prep_of	14	SENT_276	[p13l712t1353r956b1423],
18	deaminase	NN	O	deaminase	dep	2	SENT_276	[p13l997t1353r1335b1407],
19	.	.	O	.	_	0	SENT_276	[p13l997t1353r1335b1407],

1	J	NNP	O	J	nn	4	SENT_277	[p13l1378t1354r1407b1407],
2	Biol	NNP	O	Biol	nn	4	SENT_277	[p13l1446t1353r1576b1407],
3	Chem	NNP	O	Chem	nn	4	SENT_277	[p13l1617t1353r1799b1407],
4	l999	NN	O	l999	_	0	SENT_277	[p13l1846t1353r2143b1417],
5	;	:	O	;	_	0	SENT_277	[p13l1846t1353r2143b1417],
6	274	CD	NUMBER	274	num	8	SENT_277	[p13l1846t1353r2143b1417],
7	:	:	O	:	_	0	SENT_277	[p13l1846t1353r2143b1417],
8	28405-28412	CD	NUMBER	28405-28412	dep	4	SENT_277	[p13l137t1435r584b1488],
9	.	.	O	.	_	0	SENT_277	[p13l137t1435r584b1488],

1	.	.	O	.	_	0	SENT_278	[p13l80t1560r89b1569],

1	Fischel	NNP	O	Fischel	nn	2	SENT_279	[p13l135t1514r355b1568],
2	JL	NNP	O	JL	_	0	SENT_279	[p13l392t1516r484b1578],
3	,	,	O	,	_	0	SENT_279	[p13l392t1516r484b1578],
4	Etienne	NNP	PERSON	Etienne	nn	5	SENT_279	[p13l524t1514r757b1568],
5	MC	NNP	PERSON	MC	appos	2	SENT_279	[p13l794t1515r928b1578],
6	,	,	O	,	_	0	SENT_279	[p13l794t1515r928b1578],
7	Spector	NNP	PERSON	Spector	nn	8	SENT_279	[p13l970t1515r1202b1584],
8	T	NN	O	t	appos	2	SENT_279	[p13l1238t1516r1293b1578],
9	,	,	O	,	_	0	SENT_279	[p13l1238t1516r1293b1578],
10	et	FW	O	et	nn	11	SENT_279	[p13l1334t1523r1388b1568],
11	al.	FW	O	al.	appos	2	SENT_279	[p13l1426t1515r1513b1569],
12	:	:	O	:	_	0	SENT_279	[p13l1426t1515r1513b1569],
13	Dihydropyrimidine	NN	O	dihydropyrimidine	nn	14	SENT_279	[p13l1555t1514r2147b1584],
14	dehydrogenase	NN	O	dehydrogenase	dep	2	SENT_279	[p13l136t1595r611b1665],
15	:	:	O	:	_	0	SENT_279	[p13l136t1595r611b1665],
16	A	DT	O	a	det	18	SENT_279	[p13l634t1596r688b1648],
17	tumoral	JJ	O	tumoral	amod	18	SENT_279	[p13l705t1595r943b1649],
18	target	NN	O	target	dep	2	SENT_279	[p13l961t1603r1136b1665],
19	for	IN	O	for	_	0	SENT_279	[p13l1152t1595r1240b1649],
20	ﬂuorouracil	NN	O	ﬂuorouracil	nn	21	SENT_279	[p13l1257t1595r1613b1649],
21	modulation	NN	O	modulation	prep_for	18	SENT_279	[p13l1631t1595r1995b1649],
22	.	.	O	.	_	0	SENT_279	[p13l1631t1595r1995b1649],

1	Clin	NNP	O	Clin	nn	3	SENT_280	[p13l2018t1595r2148b1649],
2	Cancer	NNP	O	Cancer	nn	3	SENT_280	[p13l137t1677r353b1730],
3	Res	NNP	O	Res	_	0	SENT_280	[p13l377t1678r488b1730],
4	1995	CD	DATE	1995	num	3	SENT_280	[p13l523t1677r1045b1740],
5	;	:	O	;	_	0	SENT_280	[p13l523t1677r1045b1740],
6	1:991	CD	NUMBER	1:991	num	7	SENT_280	[p13l523t1677r1045b1740],
7	—	NN	O	—	dep	3	SENT_280	[p13l523t1677r1045b1740],
8	996	CD	NUMBER	996	dep	7	SENT_280	[p13l523t1677r1045b1740],
9	.	.	O	.	_	0	SENT_280	[p13l523t1677r1045b1740],

1	.	.	O	.	_	0	SENT_281	[p13l80t1801r89b1810],

1	Ho	NNP	O	Ho	nn	2	SENT_282	[p13l136t1758r226b1810],
2	DH	NNP	O	DH	_	0	SENT_282	[p13l246t1758r372b1820],
3	,	,	O	,	_	0	SENT_282	[p13l246t1758r372b1820],
4	Townsend	NNP	PERSON	Townsend	nn	5	SENT_282	[p13l394t1757r706b1810],
5	L	NNP	PERSON	L	appos	2	SENT_282	[p13l724t1758r786b1820],
6	,	,	O	,	_	0	SENT_282	[p13l724t1758r786b1820],
7	Luna	NNP	PERSON	Luna	nn	8	SENT_282	[p13l808t1758r966b1810],
8	MA	NNP	PERSON	MA	appos	2	SENT_282	[p13l984t1757r1122b1820],
9	,	,	O	,	_	0	SENT_282	[p13l984t1757r1122b1820],
10	et	FW	O	et	nn	11	SENT_282	[p13l1145t1765r1199b1810],
11	al.	FW	O	al.	appos	2	SENT_282	[p13l1219t1757r1307b1810],
12	:	:	O	:	_	0	SENT_282	[p13l1219t1757r1307b1810],
13	Distribution	NN	O	distribution	dep	2	SENT_282	[p13l1332t1757r1703b1810],
14	and	CC	O	and	_	0	SENT_282	[p13l1723t1757r1831b1810],
15	inhibition	NN	O	inhibition	dep	2	SENT_282	[p13l1850t1757r2149b1810],
16	of	IN	O	of	_	0	SENT_282	[p13l137t1836r203b1891],
17	dihydrouracil	NN	O	dihydrouracil	nn	19	SENT_282	[p13l254t1836r665b1906],
18	dehydrogenase	NN	O	dehydrogenase	nn	19	SENT_282	[p13l723t1837r1180b1906],
19	activities	NNS	O	activity	prep_of	13	SENT_282	[p13l1239t1836r1511b1891],
20	in	IN	O	in	_	0	SENT_282	[p13l1569t1836r1626b1890],
21	human	JJ	O	human	amod	22	SENT_282	[p13l1682t1837r1890b1891],
22	tissues	NNS	O	tissue	prep_in	19	SENT_282	[p13l1945t1837r2147b1891],
23	using	VBG	O	use	partmod	22	SENT_282	[p13l135t1917r299b1987],
24	5	CD	NUMBER	5	num	26	SENT_282	[p13l329t1917r748b1971],
25	—	NN	O	—	nn	26	SENT_282	[p13l329t1917r748b1971],
26	ﬂuorouracil	NN	O	ﬂuorouracil	dobj	23	SENT_282	[p13l329t1917r748b1971],
27	as	IN	O	as	_	0	SENT_282	[p13l778t1934r837b1971],
28	a	DT	O	a	det	29	SENT_282	[p13l867t1934r899b1971],
29	substrate	NN	O	substrate	prep_as	23	SENT_282	[p13l928t1917r1212b1971],
30	.	.	O	.	_	0	SENT_282	[p13l928t1917r1212b1971],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_283	[p13l1244t1917r1582b1971],
2	Res	NNP	O	Res	_	0	SENT_283	[p13l1608t1918r1720b1971],
3	1986	CD	DATE	1986	dep	2	SENT_283	[p13l1756t1917r2143b1981],
4	;	:	O	;	_	0	SENT_283	[p13l1756t1917r2143b1981],
5	6:781	CD	NUMBER	6:781	num	6	SENT_283	[p13l1756t1917r2143b1981],
6	—	NN	O	—	dep	2	SENT_283	[p13l1756t1917r2143b1981],
7	784	CD	NUMBER	784	dep	6	SENT_283	[p13l136t1999r264b2052],
8	.	.	O	.	_	0	SENT_283	[p13l136t1999r264b2052],

1	Ichikawa	NNP	PERSON	Ichikawa	nn	2	SENT_284	[p13l136t2078r417b2132],
2	W	NNP	O	W	_	0	SENT_284	[p13l466t2080r548b2142],
3	,	,	O	,	_	0	SENT_284	[p13l466t2080r548b2142],
4	Uetake	NNP	O	Uetake	nn	5	SENT_284	[p13l602t2078r818b2132],
5	H	NNP	O	H	appos	2	SENT_284	[p13l871t2080r940b2142],
6	,	,	O	,	_	0	SENT_284	[p13l871t2080r940b2142],
7	Shirota	NNP	PERSON	Shirota	nn	8	SENT_284	[p13l997t2078r1216b2132],
8	Y	NN	PERSON	y	appos	2	SENT_284	[p13l1267t2080r1327b2141],
9	,	,	O	,	_	0	SENT_284	[p13l1267t2080r1327b2141],
10	et	FW	O	et	nn	11	SENT_284	[p13l1382t2087r1436b2132],
11	al.	FW	O	al.	appos	2	SENT_284	[p13l1489t2078r1576b2132],
12	:	:	O	:	_	0	SENT_284	[p13l1489t2078r1576b2132],
13	Combination	NN	O	combination	dep	2	SENT_284	[p13l1635t2078r2034b2132],
14	of	IN	O	of	_	0	SENT_284	[p13l2087t2078r2153b2132],
15	dihydropyrimidine	NN	O	dihydropyrimidine	nn	16	SENT_284	[p13l137t2158r710b2228],
16	dehydrogenase	NN	O	dehydrogenase	prep_of	13	SENT_284	[p13l771t2158r1229b2228],
17	and	CC	O	and	_	0	SENT_284	[p13l1291t2158r1400b2212],
18	thymidylate	NN	O	thymidylate	nn	21	SENT_284	[p13l1459t2158r1825b2228],
19	synthase	NN	O	synthase	nn	21	SENT_284	[p13l1888t2158r2147b2228],
20	gene	NN	O	gene	nn	21	SENT_284	[p13l137t2258r278b2310],
21	expressions	NNS	O	expression	prep_of	13	SENT_284	[p13l323t2241r676b2310],
22	in	IN	O	in	_	0	SENT_284	[p13l720t2241r779b2294],
23	primary	JJ	O	primary	amod	24	SENT_284	[p13l820t2241r1062b2310],
24	tumors	NNS	O	tumor	prep_in	13	SENT_284	[p13l1106t2249r1316b2295],
25	as	IN	O	as	_	0	SENT_284	[p13l1362t2258r1420b2295],
26	predictive	JJ	O	predictive	amod	27	SENT_284	[p13l1464t2241r1769b2310],
27	parameters	NNS	O	parameter	prep_as	24	SENT_284	[p13l1811t2249r2146b2310],
28	for	IN	O	for	_	0	SENT_284	[p13l136t2322r225b2376],
29	the	DT	O	the	det	30	SENT_284	[p13l299t2322r390b2376],
30	efﬁcacy	NN	O	efﬁcacy	prep_for	27	SENT_284	[p13l467t2322r705b2392],
31	of	IN	O	of	_	0	SENT_284	[p13l783t2322r848b2376],
32	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	nn	33	SENT_284	[p13l918t2322r1638b2392],
33	—	NN	O	—	prep_of	30	SENT_284	[p13l918t2322r1638b2392],
34	based	VBN	O	base	partmod	33	SENT_284	[p13l918t2322r1638b2392],
35	chemotherapy	NN	O	chemotherapy	dobj	34	SENT_284	[p13l1714t2322r2147b2392],
36	for	IN	O	for	_	0	SENT_284	[p13l136t2401r225b2455],
37	metastatic	JJ	O	metastatic	amod	39	SENT_284	[p13l257t2401r567b2455],
38	colorectal	JJ	O	colorectal	amod	39	SENT_284	[p13l603t2402r904b2455],
39	cancer	NN	O	cancer	prep_for	35	SENT_284	[p13l939t2418r1149b2455],
40	.	.	O	.	_	0	SENT_284	[p13l939t2418r1149b2455],

1	Clin	NNP	O	Clin	nn	3	SENT_285	[p13l1188t2401r1318b2455],
2	Cancer	NNP	O	Cancer	nn	3	SENT_285	[p13l1352t2402r1569b2455],
3	Res	NNP	O	Res	_	0	SENT_285	[p13l1602t2403r1713b2455],
4	2003	CD	DATE	2003	num	3	SENT_285	[p13l1749t2401r2143b2465],
5	;	:	O	;	_	0	SENT_285	[p13l1749t2401r2143b2465],
6	9:786	CD	NUMBER	9:786	num	7	SENT_285	[p13l1749t2401r2143b2465],
7	—	NN	O	—	dep	3	SENT_285	[p13l1749t2401r2143b2465],
8	791	CD	NUMBER	791	dep	7	SENT_285	[p13l136t2481r264b2535],
9	.	.	O	.	_	0	SENT_285	[p13l136t2481r264b2535],

1	Higashiyama	NNP	PERSON	Higashiyama	nn	2	SENT_286	[p13l136t2563r541b2633],
2	M	NNP	O	M	_	0	SENT_286	[p13l575t2564r658b2627],
3	,	,	O	,	_	0	SENT_286	[p13l575t2564r658b2627],
4	Kodama	NNP	PERSON	Kodama	nn	5	SENT_286	[p13l698t2563r955b2617],
5	K	NNP	PERSON	K	appos	2	SENT_286	[p13l991t2564r1058b2626],
6	,	,	O	,	_	0	SENT_286	[p13l991t2564r1058b2626],
7	Yokouchi	NNP	PERSON	Yokouchi	nn	8	SENT_286	[p13l1098t2563r1390b2617],
8	H	NNP	O	H	appos	2	SENT_286	[p13l1427t2564r1496b2627],
9	,	,	O	,	_	0	SENT_286	[p13l1427t2564r1496b2627],
10	et	FW	O	et	nn	11	SENT_286	[p13l1536t2571r1590b2617],
11	al.	FW	O	al.	appos	2	SENT_286	[p13l1627t2563r1714b2617],
12	:	:	O	:	_	0	SENT_286	[p13l1627t2563r1714b2617],
13	Thymidylate	NNP	O	Thymidylate	nn	14	SENT_286	[p13l1756t2563r2147b2632],
14	synthase	NN	O	synthase	dep	2	SENT_286	[p13l139t2643r398b2712],
15	and	CC	O	and	_	0	SENT_286	[p13l454t2643r562b2697],
16	dihydropyrimidine	NN	O	dihydropyrimidine	nn	18	SENT_286	[p13l617t2642r1191b2712],
17	dehydrogenase	NN	O	dehydrogenase	nn	18	SENT_286	[p13l1247t2642r1705b2712],
18	activities	NNS	O	activity	conj_and	14	SENT_286	[p13l1762t2642r2034b2697],
19	in	IN	O	in	_	0	SENT_286	[p13l2090t2643r2148b2696],
20	non	JJ	O	non	amod	26	SENT_286	[p13l135t2723r441b2777],
21	—	JJ	O	—	amod	26	SENT_286	[p13l135t2723r441b2777],
22	small	JJ	O	small	amod	26	SENT_286	[p13l135t2723r441b2777],
23	cell	NN	O	cell	nn	26	SENT_286	[p13l482t2723r591b2777],
24	lung	NN	O	lung	nn	26	SENT_286	[p13l632t2723r765b2793],
25	cancer	NN	O	cancer	nn	26	SENT_286	[p13l807t2740r1007b2777],
26	tissues	NNS	O	tissue	prep_in	14	SENT_286	[p13l1046t2723r1264b2777],
27	:	:	O	:	_	0	SENT_286	[p13l1046t2723r1264b2777],
28	Relationship	NN	O	relationship	dep	2	SENT_286	[p13l1310t2723r1696b2793],
29	with	IN	O	with	prep	28	SENT_286	[p13l1738t2723r1872b2777],
30	in	FW	O	in	nn	31	SENT_286	[p13l1915t2725r1969b2777],
31	vitro	FW	O	vitro	dep	32	SENT_286	[p13l2008t2725r2147b2777],
32	sensitivity	NN	O	sensitivity	dep	29	SENT_286	[p13l139t2804r448b2874],
33	to	TO	O	to	_	0	SENT_286	[p13l474t2812r531b2858],
34	5	CD	NUMBER	5	number	35	SENT_286	[p13l558t2804r993b2858],
35	—	CD	NUMBER	—	num	36	SENT_286	[p13l558t2804r993b2858],
36	ﬂuorouracil	NN	O	ﬂuorouracil	prep_to	29	SENT_286	[p13l558t2804r993b2858],
37	.	.	O	.	_	0	SENT_286	[p13l558t2804r993b2858],

1	Lung	NN	O	lung	nn	2	SENT_287	[p13l1022t2805r1182b2874],
2	Cancer	NN	O	cancer	_	0	SENT_287	[p13l1208t2804r1425b2858],
3	2001	CD	DATE	2001	dep	2	SENT_287	[p13l1450t2804r2017b2868],
4	;	:	O	;	_	0	SENT_287	[p13l1450t2804r2017b2868],
5	34:407	CD	NUMBER	34:407	num	6	SENT_287	[p13l1450t2804r2017b2868],
6	-416	CD	NUMBER	-416	dep	2	SENT_287	[p13l1450t2804r2017b2868],
7	.	.	O	.	_	0	SENT_287	[p13l1450t2804r2017b2868],

1	Nakagawa	NNP	PERSON	Nakagawa	nn	2	SENT_288	[p13l135t2887r459b2957],
2	T	NN	O	t	_	0	SENT_288	[p13l499t2888r555b2951],
3	,	,	O	,	_	0	SENT_288	[p13l499t2888r555b2951],
4	Tanaka	NNP	PERSON	Tanaka	nn	5	SENT_288	[p13l599t2887r820b2941],
5	F	NN	O	f	appos	2	SENT_288	[p13l860t2888r912b2951],
6	,	,	O	,	_	0	SENT_288	[p13l860t2888r912b2951],
7	Takata	NNP	ORGANIZATION	Takata	nn	8	SENT_288	[p13l956t2887r1160b2941],
8	T	NN	ORGANIZATION	t	appos	2	SENT_288	[p13l1201t2888r1256b2950],
9	,	,	O	,	_	0	SENT_288	[p13l1201t2888r1256b2950],
10	et	FW	O	et	nn	11	SENT_288	[p13l1301t2895r1356b2941],
11	al.	FW	O	al.	appos	2	SENT_288	[p13l1398t2887r1485b2941],
12	:	:	O	:	_	0	SENT_288	[p13l1398t2887r1485b2941],
13	Predictive	JJ	O	predictive	amod	14	SENT_288	[p13l1533t2887r1841b2941],
14	value	NN	O	value	dep	2	SENT_288	[p13l1881t2887r2044b2941],
15	of	IN	O	of	_	0	SENT_288	[p13l2087t2887r2153b2941],
16	dihydropyrimidine	NN	O	dihydropyrimidine	nn	18	SENT_288	[p13l136t2966r710b3036],
17	dehydrogenase	NN	O	dehydrogenase	nn	18	SENT_288	[p13l756t2967r1214b3036],
18	expression	NN	O	expression	prep_of	14	SENT_288	[p13l1259t2966r1584b3036],
19	in	IN	O	in	_	0	SENT_288	[p13l1628t2966r1686b3020],
20	tumor	NN	O	tumor	nn	21	SENT_288	[p13l1730t2975r1913b3021],
21	tissue	NN	O	tissue	prep_in	18	SENT_288	[p13l1956t2967r2145b3030],
22	,	,	O	,	_	0	SENT_288	[p13l1956t2967r2145b3030],
23	regarding	VBG	O	regard	partmod	2	SENT_288	[p13l135t3047r427b3117],
24	the	DT	O	the	det	25	SENT_288	[p13l480t3047r572b3101],
25	efﬁcacy	NN	O	efﬁcacy	dobj	23	SENT_288	[p13l627t3047r864b3117],
26	of	IN	O	of	_	0	SENT_288	[p13l919t3047r985b3101],
27	postoperatively	RB	O	postoperatively	advmod	28	SENT_288	[p13l1031t3047r1503b3117],
28	administered	VBN	O	administer	amod	29	SENT_288	[p13l1558t3047r1953b3101],
29	UFT	NNP	O	UFT	prep_of	25	SENT_288	[p13l2005t3048r2148b3101],
30	(	CD	NUMBER	(	nsubj	40	SENT_288	[p13l138t3130r672b3200],
31	Tegafur	NNP	O	Tegafur	dep	30	SENT_288	[p13l138t3130r672b3200],
32	+	CC	O	+	_	0	SENT_288	[p13l138t3130r672b3200],
33	Uracil	NNP	O	Uracil	conj_+	31	SENT_288	[p13l138t3130r672b3200],
34	)	CD	NUMBER	)	dep	30	SENT_288	[p13l138t3130r672b3200],
35	in	IN	O	in	_	0	SENT_288	[p13l711t3130r769b3183],
36	patients	NNS	O	patient	prep_in	34	SENT_288	[p13l802t3130r1040b3199],
37	with	IN	O	with	_	0	SENT_288	[p13l1077t3130r1212b3184],
38	p	NN	O	p	prep_with	36	SENT_288	[p13l1245t3138r1465b3200],
39	—	CD	NUMBER	—	num	38	SENT_288	[p13l1245t3138r1465b3200],
40	stage	NN	O	stage	rcmod	29	SENT_288	[p13l1245t3138r1465b3200],
41	I	PRP	O	I	nsubj	42	SENT_288	[p13l1502t3131r1525b3183],
42	nonsmall	VBP	O	nonsmall	ccomp	40	SENT_288	[p13l1560t3130r1977b3184],
43	—	JJ	O	—	amod	46	SENT_288	[p13l1560t3130r1977b3184],
44	cell	NN	O	cell	nn	46	SENT_288	[p13l1560t3130r1977b3184],
45	lung	NN	O	lung	nn	46	SENT_288	[p13l2013t3130r2147b3200],
46	cancer	NN	O	cancer	dobj	42	SENT_288	[p13l136t3226r346b3264],
47	.	.	O	.	_	0	SENT_288	[p13l136t3226r346b3264],

1	J	NNP	O	J	nn	3	SENT_289	[p13l375t3211r403b3264],
2	Surg	NNP	O	Surg	nn	3	SENT_289	[p13l430t3210r570b3279],
3	Oncol	NNP	O	Oncol	_	0	SENT_289	[p13l597t3210r781b3264],
4	2002	CD	DATE	2002	num	3	SENT_289	[p13l807t3210r1298b3274],
5	;	:	O	;	_	0	SENT_289	[p13l807t3210r1298b3274],
6	8l	CD	NUMBER	8l	num	7	SENT_289	[p13l807t3210r1298b3274],
7	:87	CD	NUMBER	:87	dep	3	SENT_289	[p13l807t3210r1298b3274],
8	—	NN	O	—	dep	7	SENT_289	[p13l807t3210r1298b3274],
9	92	CD	NUMBER	92	num	8	SENT_289	[p13l807t3210r1298b3274],
10	.	.	O	.	_	0	SENT_289	[p13l807t3210r1298b3274],

1	Ichikawa	NNP	PERSON	Ichikawa	nn	2	SENT_290	[p13l136t3290r417b3344],
2	W	NNP	O	W	_	0	SENT_290	[p13l466t3291r547b3353],
3	,	,	O	,	_	0	SENT_290	[p13l466t3291r547b3353],
4	Uetake	NNP	O	Uetake	nn	5	SENT_290	[p13l602t3290r818b3344],
5	H	NNP	O	H	appos	2	SENT_290	[p13l870t3291r940b3353],
6	,	,	O	,	_	0	SENT_290	[p13l870t3291r940b3353],
7	Shirota	NNP	PERSON	Shirota	nn	8	SENT_290	[p13l997t3290r1216b3344],
8	Y	NN	PERSON	y	appos	2	SENT_290	[p13l1267t3291r1327b3353],
9	,	,	O	,	_	0	SENT_290	[p13l1267t3291r1327b3353],
10	et	FW	O	et	nn	11	SENT_290	[p13l1382t3298r1436b3343],
11	al.	FW	O	al.	appos	2	SENT_290	[p13l1489t3290r1576b3343],
12	:	:	O	:	_	0	SENT_290	[p13l1489t3290r1576b3343],
13	Combination	NN	O	combination	dep	2	SENT_290	[p13l1635t3290r2034b3344],
14	of	IN	O	of	_	0	SENT_290	[p13l2087t3290r2153b3343],
15	dihydropyrimidine	NN	O	dihydropyrimidine	nn	16	SENT_290	[p13l137t3370r710b3440],
16	dehydrogenase	NN	O	dehydrogenase	prep_of	13	SENT_290	[p13l772t3370r1229b3440],
17	and	CC	O	and	_	0	SENT_290	[p13l1291t3370r1400b3424],
18	thymidylate	NN	O	thymidylate	nn	21	SENT_290	[p13l1459t3370r1825b3440],
19	synthase	NN	O	synthase	nn	21	SENT_290	[p13l1888t3370r2147b3440],
20	gene	NN	O	gene	nn	21	SENT_290	[p13l137t3469r278b3522],
21	expressions	NNS	O	expression	prep_of	13	SENT_290	[p13l323t3452r676b3522],
22	in	IN	O	in	_	0	SENT_290	[p13l720t3452r778b3505],
23	primary	JJ	O	primary	amod	24	SENT_290	[p13l820t3452r1062b3522],
24	tumors	NNS	O	tumor	prep_in	13	SENT_290	[p13l1106t3460r1316b3506],
25	as	IN	O	as	_	0	SENT_290	[p13l1362t3469r1420b3506],
26	predictive	JJ	O	predictive	amod	27	SENT_290	[p13l1464t3452r1769b3522],
27	parameters	NNS	O	parameter	prep_as	24	SENT_290	[p13l1811t3460r2146b3522],
28	for	IN	O	for	_	0	SENT_290	[p13l136t3531r225b3586],
29	the	DT	O	the	det	30	SENT_290	[p13l271t3531r363b3585],
30	efﬁcacy	NN	O	efﬁcacy	prep_for	27	SENT_290	[p13l413t3531r650b3601],
31	of	IN	O	of	_	0	SENT_290	[p13l701t3531r767b3585],
32	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	nn	33	SENT_290	[p13l810t3531r1529b3601],
33	—	NN	O	—	prep_of	30	SENT_290	[p13l810t3531r1529b3601],
34	based	VBN	O	base	partmod	33	SENT_290	[p13l810t3531r1529b3601],
35	chemotherapy	NN	O	chemotherapy	dobj	34	SENT_290	[p13l1578t3532r2011b3601],
36	for	IN	O	for	_	0	SENT_290	[p13l2061t3531r2150b3585],
37	metastatic	JJ	O	metastatic	amod	39	SENT_290	[p13l136t3612r445b3665],
38	colorectal	JJ	O	colorectal	amod	39	SENT_290	[p13l502t3612r803b3665],
39	cancer	NN	O	cancer	prep_for	35	SENT_290	[p13l858t3629r1069b3665],
40	.	.	O	.	_	0	SENT_290	[p13l858t3629r1069b3665],

1	Clin	NNP	O	Clin	nn	3	SENT_291	[p13l1128t3612r1257b3666],
2	Cancer	NNP	O	Cancer	nn	3	SENT_291	[p13l1312t3613r1529b3666],
3	Res	NNP	O	Res	_	0	SENT_291	[p13l1581t3613r1693b3665],
4	2003	CD	DATE	2003	num	3	SENT_291	[p13l1749t3612r2143b3675],
5	;	:	O	;	_	0	SENT_291	[p13l1749t3612r2143b3675],
6	9:786	CD	NUMBER	9:786	num	7	SENT_291	[p13l1749t3612r2143b3675],
7	—	NN	O	—	dep	3	SENT_291	[p13l1749t3612r2143b3675],
8	791	CD	NUMBER	791	dep	7	SENT_291	[p13l136t3693r264b3747],
9	.	.	O	.	_	0	SENT_291	[p13l136t3693r264b3747],

1	Horiguchi	NNP	PERSON	Horiguchi	nn	2	SENT_292	[p14l136t19r445b89],
2	J	NNP	PERSON	J	_	0	SENT_292	[p14l482t21r526b83],
3	,	,	O	,	_	0	SENT_292	[p14l482t21r526b83],
4	Yoshida	NNP	PERSON	Yoshida	nn	5	SENT_292	[p14l567t19r813b74],
5	T	NN	O	t	appos	2	SENT_292	[p14l849t21r905b83],
6	,	,	O	,	_	0	SENT_292	[p14l849t21r905b83],
7	Koibuchi	NNP	PERSON	Koibuchi	nn	8	SENT_292	[p14l946t19r1226b74],
8	Y	NN	PERSON	y	appos	2	SENT_292	[p14l1264t21r1323b84],
9	,	,	O	,	_	0	SENT_292	[p14l1264t21r1323b84],
10	et	FW	O	et	nn	11	SENT_292	[p14l1364t28r1418b73],
11	al.	FW	O	al.	appos	2	SENT_292	[p14l1455t19r1543b74],
12	:	:	O	:	_	0	SENT_292	[p14l1455t19r1543b74],
13	DPD	NN	O	dpd	nn	14	SENT_292	[p14l1586t21r1735b73],
14	activity	NN	O	activity	dep	2	SENT_292	[p14l1775t19r2002b89],
15	and	CC	O	and	_	0	SENT_292	[p14l2041t19r2149b74],
16	immunohistochemical	JJ	O	immunohistochemical	amod	18	SENT_292	[p14l136t100r818b155],
17	DPD	NN	O	dpd	nn	18	SENT_292	[p14l851t102r1001b154],
18	expression	NN	O	expression	dep	2	SENT_292	[p14l1034t100r1359b170],
19	in	IN	O	in	_	0	SENT_292	[p14l1391t100r1449b154],
20	human	JJ	O	human	amod	22	SENT_292	[p14l1480t101r1688b155],
21	breast	NN	O	breast	nn	22	SENT_292	[p14l1719t101r1903b155],
22	cancer	NN	O	cancer	prep_in	14	SENT_292	[p14l1934t117r2144b155],
23	.	.	O	.	_	0	SENT_292	[p14l1934t117r2144b155],

1	Oncol	NNP	MISC	Oncol	nn	2	SENT_293	[p14l137t181r321b236],
2	Rep	NNP	MISC	Rep	_	0	SENT_293	[p14l346t183r468b251],
3	2004	CD	DATE	2004	num	2	SENT_293	[p14l495t181r985b245],
4	;	:	O	;	_	0	SENT_293	[p14l495t181r985b245],
5	11:65	CD	NUMBER	11:65	number	6	SENT_293	[p14l495t181r985b245],
6	—	CD	NUMBER	—	dep	2	SENT_293	[p14l495t181r985b245],
7	72	CD	NUMBER	72	dep	6	SENT_293	[p14l495t181r985b245],
8	.	.	O	.	_	0	SENT_293	[p14l495t181r985b245],

1	Efferth	JJ	PERSON	efferth	amod	2	SENT_294	[p14l135t264r350b318],
2	T	NN	PERSON	t	_	0	SENT_294	[p14l379t265r435b328],
3	,	,	O	,	_	0	SENT_294	[p14l379t265r435b328],
4	Volm	NN	O	volm	nn	5	SENT_294	[p14l467t264r632b318],
5	M	NN	O	m	appos	2	SENT_294	[p14l660t265r742b318],
6	:	:	O	:	_	0	SENT_294	[p14l660t265r742b318],
7	Pharmacogenetics	NNS	O	pharmacogenetic	dep	2	SENT_294	[p14l777t264r1334b334],
8	for	IN	O	for	_	0	SENT_294	[p14l1365t264r1454b318],
9	individualized	JJ	O	individualized	amod	11	SENT_294	[p14l1482t264r1920b318],
10	cancer	NN	O	cancer	nn	11	SENT_294	[p14l1949t281r2149b318],
11	chemotherapy	NN	O	chemotherapy	prep_for	7	SENT_294	[p14l136t343r581b413],
12	.	.	O	.	_	0	SENT_294	[p14l136t343r581b413],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_295	[p14l610t344r936b398],
2	Ther	NNP	O	Ther	_	0	SENT_295	[p14l962t344r1107b397],
3	2005	CD	DATE	2005	num	2	SENT_295	[p14l1132t343r1299b398],
4	:	:	O	:	_	0	SENT_295	[p14l1132t343r1299b398],
5	155	CD	NUMBER	155	num	7	SENT_295	[p14l1314t343r1466b398],
6	-	:	O	-	_	0	SENT_295	[p14l1314t343r1466b398],
7	176	CD	NUMBER	176	dep	2	SENT_295	[p14l1480t343r1601b398],
8	.	.	O	.	_	0	SENT_295	[p14l1480t343r1601b398],

1	Epeldegui	NN	MISC	epeldeguus	nn	2	SENT_296	[p14l135t424r446b494],
2	M	NN	O	m	_	0	SENT_296	[p14l483t425r566b488],
3	,	,	O	,	_	0	SENT_296	[p14l483t425r566b488],
4	Widney	NNP	PERSON	Widney	nn	5	SENT_296	[p14l605t424r844b494],
5	DP	NN	O	dp	appos	2	SENT_296	[p14l882t425r986b488],
6	,	,	O	,	_	0	SENT_296	[p14l882t425r986b488],
7	Martinez	NNP	PERSON	Martinez	appos	5	SENT_296	[p14l1026t424r1500b478],
8	.	.	O	.	_	0	SENT_296	[p14l1026t424r1500b478],

1	—	NN	O	—	_	0	SENT_297	[p14l1026t424r1500b478],
2	.	.	O	.	_	0	SENT_297	[p14l1026t424r1500b478],

1	Maza	NNP	PERSON	Maza	nn	2	SENT_298	[p14l1026t424r1500b478],
2	O	NNP	O	O	_	0	SENT_298	[p14l1539t425r1607b478],
3	:	:	O	:	_	0	SENT_298	[p14l1539t425r1607b478],
4	Pathogenesis	NN	O	pathogenesis	dep	2	SENT_298	[p14l1650t424r2048b494],
5	of	IN	O	of	_	0	SENT_298	[p14l2087t424r2153b478],
6	AIDS	NNP	MISC	AIDS	nn	7	SENT_298	[p14l136t507r309b561],
7	lymphoma	NN	O	lymphoma	prep_of	4	SENT_298	[p14l330t507r673b576],
8	:	:	O	:	_	0	SENT_298	[p14l330t507r673b576],
9	Role	NN	O	role	dep	4	SENT_298	[p14l696t507r839b561],
10	of	IN	O	of	_	0	SENT_298	[p14l858t507r924b561],
11	oncogenic	JJ	O	oncogenic	amod	12	SENT_298	[p14l938t507r1250b576],
12	Viruses	NNS	O	virus	prep_of	9	SENT_298	[p14l1269t507r1483b561],
13	and	CC	O	and	_	0	SENT_298	[p14l1504t507r1612b561],
14	B	NN	O	b	nn	15	SENT_298	[p14l1629t508r1673b560],
15	cell	NN	O	cell	conj_and	4	SENT_298	[p14l1696t507r1805b561],
16	activationassociated	VBN	O	activationassociate	partmod	15	SENT_298	[p14l1824t507r2146b561, p14l137t587r451b641],
17	molecular	JJ	O	molecular	amod	18	SENT_298	[p14l491t587r799b641],
18	lesions	NNS	O	lesion	dobj	16	SENT_298	[p14l839t586r1066b641],
19	.	.	O	.	_	0	SENT_298	[p14l839t586r1066b641],

1	Curr	NNP	O	Curr	nn	3	SENT_299	[p14l1112t587r1251b641],
2	Opin	NNP	O	Opin	nn	3	SENT_299	[p14l1292t587r1442b656],
3	Oncol	NNP	O	Oncol	_	0	SENT_299	[p14l1485t587r1668b641],
4	2006	CD	DATE	2006	num	3	SENT_299	[p14l1712t586r2143b650, p14l135t669r264b722],
5	;	:	O	;	_	0	SENT_299	[p14l1712t586r2143b650, p14l135t669r264b722],
6	18:444448	CD	NUMBER	18:444448	dep	3	SENT_299	[p14l1712t586r2143b650, p14l135t669r264b722],
7	.	.	O	.	_	0	SENT_299	[p14l1712t586r2143b650, p14l135t669r264b722],

1	Marsh	NNP	PERSON	Marsh	nn	2	SENT_300	[p14l135t749r330b803],
2	S	NNP	O	S	_	0	SENT_300	[p14l365t750r420b813],
3	,	,	O	,	_	0	SENT_300	[p14l365t750r420b813],
4	McLeod	NNP	PERSON	McLeod	nn	5	SENT_300	[p14l456t749r716b803],
5	HL	NNS	O	hl	appos	2	SENT_300	[p14l749t751r866b803],
6	:	:	O	:	_	0	SENT_300	[p14l749t751r866b803],
7	Cancer	NNP	O	Cancer	dep	2	SENT_300	[p14l905t750r1122b804],
8	pharmacogenetics	NNS	O	pharmacogenetic	dep	7	SENT_300	[p14l1154t749r1724b819],
9	.	.	O	.	_	0	SENT_300	[p14l1154t749r1724b819],

1	Br	NN	O	br	nn	3	SENT_301	[p14l1762t751r1839b803],
2	J	NN	O	j	nn	3	SENT_301	[p14l1870t751r1899b804],
3	Cancer	NN	O	cancer	_	0	SENT_301	[p14l1933t750r2150b804],
4	2004	CD	DATE	2004	dep	3	SENT_301	[p14l137t831r588b894],
5	;	:	O	;	_	0	SENT_301	[p14l137t831r588b894],
6	90:8	CD	NUMBER	90:8	number	7	SENT_301	[p14l137t831r588b894],
7	—	CD	NUMBER	—	dep	3	SENT_301	[p14l137t831r588b894],
8	11	CD	NUMBER	11	dep	7	SENT_301	[p14l137t831r588b894],
9	.	.	O	.	_	0	SENT_301	[p14l137t831r588b894],

1	Watanabe	NNP	PERSON	Watanabe	nn	2	SENT_302	[p14l135t911r436b965],
2	S	NNP	O	S	_	0	SENT_302	[p14l481t911r536b974],
3	,	,	O	,	_	0	SENT_302	[p14l481t911r536b974],
4	Uchida	NNP	PERSON	Uchida	nn	5	SENT_302	[p14l581t910r802b965],
5	T	NN	O	t	appos	2	SENT_302	[p14l844t912r902b965],
6	:	:	O	:	_	0	SENT_302	[p14l844t912r902b965],
7	Expression	NN	O	expression	dep	2	SENT_302	[p14l949t910r1289b980],
8	of	IN	O	of	_	0	SENT_302	[p14l1332t910r1399b965],
9	cytidine	NN	O	cytidine	nn	10	SENT_302	[p14l1437t910r1682b980],
10	deaminase	NN	O	deaminase	prep_of	7	SENT_302	[p14l1725t910r2047b965],
11	in	IN	O	in	_	0	SENT_302	[p14l2091t910r2148b964],
12	human	JJ	O	human	amod	14	SENT_302	[p14l135t991r343b1045],
13	solid	JJ	O	solid	amod	14	SENT_302	[p14l377t991r523b1045],
14	tumors	NNS	O	tumor	prep_in	10	SENT_302	[p14l554t999r764b1045],
15	and	CC	O	and	_	0	SENT_302	[p14l799t991r907b1045],
16	its	PRP$	O	its	poss	17	SENT_302	[p14l939t991r1008b1045],
17	regulation	NN	O	regulation	conj_and	10	SENT_302	[p14l1041t991r1351b1061],
18	by	IN	O	by	_	0	SENT_302	[p14l1383t991r1458b1061],
19	1	CD	NUMBER	1	number	20	SENT_302	[p14l1497t992r1519b1044],
20	alpha	NN	O	alpha	amod	23	SENT_302	[p14l1560t991r2146b1061],
21	,25	CD	NUMBER	,25	num	23	SENT_302	[p14l1560t991r2146b1061],
22	—	NN	O	—	nn	23	SENT_302	[p14l1560t991r2146b1061],
23	dihydrox	NN	O	dihydrox	prep_by	17	SENT_302	[p14l1560t991r2146b1061],
24	—	CD	NUMBER	—	num	25	SENT_302	[p14l1560t991r2146b1061],
25	yVitaminD3	NN	O	yvitamind3	dep	23	SENT_302	[p14l136t1074r517b1143],
26	.	.	O	.	_	0	SENT_302	[p14l136t1074r517b1143],

1	Biochim	NNP	PERSON	Biochim	nn	3	SENT_303	[p14l546t1074r810b1128],
2	Biophys	NNP	PERSON	Biophys	nn	3	SENT_303	[p14l834t1074r1087b1143],
3	Acta	NNP	PERSON	Acta	_	0	SENT_303	[p14l1114t1074r1258b1128],
4	1996	CD	DATE	1996	num	3	SENT_303	[p14l1290t1074r1889b1137],
5	;	:	O	;	_	0	SENT_303	[p14l1290t1074r1889b1137],
6	l312	CD	NUMBER	l312	num	7	SENT_303	[p14l1290t1074r1889b1137],
7	:99	CD	NUMBER	:99	dep	3	SENT_303	[p14l1290t1074r1889b1137],
8	—	NN	O	—	dep	7	SENT_303	[p14l1290t1074r1889b1137],
9	104	CD	NUMBER	104	num	8	SENT_303	[p14l1290t1074r1889b1137],
10	.	.	O	.	_	0	SENT_303	[p14l1290t1074r1889b1137],

1	Matsumoto	NNP	O	Matsumoto	nn	2	SENT_304	[p14l135t1155r483b1207],
2	Y	NN	O	y	_	0	SENT_304	[p14l522t1155r582b1217],
3	,	,	O	,	_	0	SENT_304	[p14l522t1155r582b1217],
4	Marusawa	NN	PERSON	marusawa	nn	5	SENT_304	[p14l622t1155r941b1207],
5	H	NN	PERSON	h	appos	2	SENT_304	[p14l977t1155r1046b1217],
6	,	,	O	,	_	0	SENT_304	[p14l977t1155r1046b1217],
7	Kinoshita	NNP	PERSON	Kinoshita	nn	8	SENT_304	[p14l1088t1154r1385b1207],
8	K	NNP	PERSON	K	appos	2	SENT_304	[p14l1423t1155r1491b1217],
9	,	,	O	,	_	0	SENT_304	[p14l1423t1155r1491b1217],
10	et	FW	O	et	nn	11	SENT_304	[p14l1532t1162r1586b1207],
11	al.	FW	O	al.	appos	2	SENT_304	[p14l1625t1154r1713b1207],
12	:	:	O	:	_	0	SENT_304	[p14l1625t1154r1713b1207],
13	Helicobacter	NNP	PERSON	Helicobacter	nn	15	SENT_304	[p14l1756t1154r2149b1207],
14	pylori	NN	PERSON	pylorus	nn	15	SENT_304	[p14l135t1234r317b1303],
15	infection	NN	O	infection	nsubj	16	SENT_304	[p14l338t1233r609b1288],
16	triggers	VBZ	O	trigger	dep	2	SENT_304	[p14l628t1233r860b1303],
17	aberrant	JJ	O	aberrant	amod	18	SENT_304	[p14l883t1234r1133b1288],
18	expression	NN	O	expression	dobj	16	SENT_304	[p14l1153t1233r1477b1303],
19	of	IN	O	of	_	0	SENT_304	[p14l1499t1233r1564b1287],
20	activation-induced	JJ	O	activation-induced	amod	22	SENT_304	[p14l1580t1233r2149b1288],
21	cytidine	NN	O	cytidine	nn	22	SENT_304	[p14l136t1314r380b1384],
22	deaminase	NN	O	deaminase	prep_of	18	SENT_304	[p14l403t1314r725b1368],
23	in	IN	O	in	_	0	SENT_304	[p14l748t1314r806b1368],
24	gastric	JJ	O	gastric	amod	25	SENT_304	[p14l827t1314r1028b1384],
25	epithelium	NN	O	epithelium	prep_in	22	SENT_304	[p14l1052t1314r1395b1384],
26	.	.	O	.	_	0	SENT_304	[p14l1052t1314r1395b1384],

1	Nat	NNP	O	Nat	nn	2	SENT_305	[p14l1419t1316r1530b1368],
2	Med	NNP	O	Med	_	0	SENT_305	[p14l1550t1314r1690b1368],
3	2007	CD	DATE	2007	num	2	SENT_305	[p14l1712t1315r2143b1378, p14l135t1396r264b1449],
4	;	:	O	;	_	0	SENT_305	[p14l1712t1315r2143b1378, p14l135t1396r264b1449],
5	13:470476	CD	NUMBER	13:470476	dep	2	SENT_305	[p14l1712t1315r2143b1378, p14l135t1396r264b1449],
6	.	.	O	.	_	0	SENT_305	[p14l1712t1315r2143b1378, p14l135t1396r264b1449],

